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Summary
Matrix Metalloproteinases (MMPs) are a family of multi-domain proteases which orchestrate tissue
homeostasis in a highly complex proteolytic network. In this way, severe diseases, mainly related to
tissue degradation, occur when MMPs are incorrectly regulated. Within MMPs, the subfamily of col-
lagenases has the very peculiar activity of degrading triple helical and fibrillar collagen, which are im-
mune to virtually all other proteases. During tumordevelopment, theoverexpressionof collagenolytic
MMPs leads to the degradation of the extracellular matrix components with the consequent release
of tumorous cells and possible occurrence of tumor metastasis. For these reasons, MMPs have been
the target of pharmacological research for at least three decades. The Matrix Metalloproteinase-1
enzyme was the first MMP to be sequenced and is one of the most important collagenolytic MMPs.
The active form of MMP-1 is constituted by two domains: a catalytic domain, responsible for the pro-
teolytic action of the enzyme, and a hemopexin-like domain, which serves as crucial partner in the
collagenolytic mechanism. Both have approximately 20 kDa and are linked by an unstructured hinge
region of 14 amino acids.
Is currently accepted that the intrinsic flexibility between the MMP-1 domains (and of MMPs in
general) is responsible to a large extent for the collagenolytic action of the enzyme, although such
flexibility has not yet been described in detail. In addition, despite the many clues that have been
drawn on the collagenolytic mechanism, the movements of the molecular machinery that promote it
are not yet clearly understood. In this work, we aimed at describing the reciprocal reorientation of the
MMP-1domains and tounveil the complex that is formedbetweenMMP-1 and a triple helical substrate
that mimics the natural collagen.
To achieve our purpose, we functionalized the inactive (E219A) catalytic domain of MMP-1 at posi-
tions H132C and K136C, in both truncated and full length constructs, with the newly developed para-
magnetic Lanthanide(III) tag, CLaNP-5. High field NMR equipment served to acquire high resolution
paramagnetic data (pseudo contact shifts and residual dipolar couplings) on the (Ln)MMP-1 constructs.
Several Ln(III) ions were probed in order to acquire a large body of complementary data. The bioinfor-
matic tools available in the CERM laboratory and at the WeNMR Web Portal were used to derive the
corresponding Δχ-tensors. In the process, we develop a method, within the CYANA program, aimed
at refining existing X-ray models using liquid state paramagnetic NMR restraints. The method proved
to be successful and two solution refined models were obtained for the catalytic and the hemopexin
domains. The method proved also highly reliable in identifying X-ray models which do not reflect the
solution state of the protein, as is the case of the mobile Calmodulin.
The refined models of the MMP-1 domains served as input, along with the large body of paramag-
netic NMR data and SAXS data, in the Maximum Occurrence analysis, which was used to obtain a fully
descriptive 3D map of the conformational space sampled by MMP-1, with detail on both position and
orientation. This information, obtained by paramagnetic NMR, is pioneer in the field and is not consid-
ered by the X-ray crystallographic models. The conformational map showed that the conformations
that are more prone to occur in solution are effective to the collagenolytic action, and, instead, those
xxvii
that do not favor such action are much less relevant in the conformational space explored by MMP-1.
After that, we were able to isolate, also in solution, the complex between the inactive (Ln)MMP-
1 enzyme and a triple helix peptide (THP) at the instant prior to the proteolytic cleavage of the in-
dividual substrate chain. We acquired paramagnetic NMR data on the complex which allowed us to
determine the relative orientation of the domains when actively ligating and unwinding the collagen-
like substrate. MMP-1 revealed to be rigid in behavior and its conformation to slightly differ from
the X-ray models. Finally, we merged all the data acquired during this project with several previously
published and independent data on this interaction to generate a completely data driven model of
the latest step of the MMP-1-THP interaction. The model obtained nicely respects all the inputted
data and many other published data regarding, for example, the crucial collagenolytic exosites on the
hemopexin domain.
The results presented in this thesis illuminate two crucial gaps that existed in the understanding of
the collagenolytic mechanism performed by MMP-1, which are its prologue and final step. Also, they
can be extrapolated to other MMPs to help unveil the molecular mechanism of this peculiar family of
enzymes and serve as basis for developing future pharmacological approaches.
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Sumário
AsMetaloproteinases daMatrix (MMPs) são uma família de proteínas comvários domínios que orques-
tram a homeostase dos tecidos através de uma complexa rede proteolítica. Desta forma, a desregu-
lação da actividade das MMPs é responsável por doenças severas, principalmente relacionadas com a
degradação dos tecidos. Dentro das MMPs, a subfamília das colagenases possui a peculiar actividade
de degradar tanto o colagénio de hélice tripla como o colagénio fibrilar, que são imunes a virtual-
mente todas as restantes proteases. Durante o desenvolvimento tumoral, a sobreexpressão deMMPs
collagenolíticas leva à degradação dos componentes da matriz extracelular com consequente liber-
tação de células tumorais e possível formação de metastases. Por estas razões, as MMPs têm sido
alvo de estudos farmacológicos desde há mais de quatro décadas. A Metaloproteinase-1 da Matriz
foi a primeira MMP a ser sequenciada e é uma das colagenases mais importantes. A forma activa da
MMP-1 é constituída por dois domínios: o domínio catalítico, responsável pela acção proteolítica, e o
domínio hemopexínico, que tem um papel crucial no mecanismo de collagenólise. Ambos têm aproxi-
madamente 20 kDa e estão interligados por um segmento peptídico não estruturado de catorze amino
ácidos.
É actualmente aceite que a flexibilidade intrínseca entre os dois domínios da MMP-1 (e das MMPs
em geral) é responsável em grande medida pela acção colagenolítica da enzima. No entanto esta fle-
xibilidade não foi ainda descrita cuidadosamente. Também, apesar das variadas pistas que se têm
obtido sobre o mecanismo de degradação do colagénio, os movimentos da maquinaria molecular que
a promovem não são ainda entendidos na sua totalidade. Neste trabalho, tivemos como objectivo
descrever detalhadamente a reorientação recíproca dos domínios daMMP-1 e posteriormente revelar
o complexo formado entre a enzima e um substrato de hécie tripla que mimetiza o colagénio natural.
Para alcançar o nosso objectivo, funcionalizámos o domínio catalítico da MMP-1, inactivo (E219A),
na proteína truncada e na proteína completa, nas posições H132C e K136C, com a nova sonda param-
agnética [(Ln)CLaNP-5]. Diversos equipamentos deRMNde campoalto foramusados para obter dados
paramagnéticos de alta resolução (desvios de pseudocontacto e acoplamentos dipolares residuais) re-
lativos aos derivados (Ln)MMP-1. Foram usados vários Lantanídeos de modo a adquirirmos um vasto
conjunto de dados paramagnéticos complementares. As ferramentas bioinformáticas disponíveis no
laboratório e no Portal Web WeNMR foram usadas para obter os correspondentes tensores para-
magnéticos. Durante este processo, desenvolvemos um método, dentro do programa CYANA, capaz
de refinar modelos de raios-X usando dados de RMN paramagnético no estado líquido. O método foi
bem sucedido, e obtivemos os modelos refinados dos dois domínios da MMP-1. O método provou
também ser muito fidedigno em identificar modelos de cristalografica que não são coerentes com a
estrutura real no estado líquido, como é o caso da proteína móvel a Calmodulina.
Os modelos refinados serviram como “input” nos cálculos de “Maximum Occurrence”, juntamente
com outros dados independentes e previamente publicados. Deste modo, obtivemos um mapa tridi-
mensional completo e descritivo do espaço conformacional explorado pela MMP-1, com detalhe quer
na posição quer na orientação relativa dos domínios. Esta informação, obtida por RMNparamagnético,
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é pioneira neste campo e não é considerada pelos modelos de cristalografia. O mapa conformacional
mostrou que as conformaçoes presentes durante mais tempo em solução são também aquelas que
estão direccionadas para o ataque colagenolítico.
Posteriormente, isolámos, também em solução, o complexo entre a (Ln)MMP-1 inactiva e um pep-
tídeo de hélice tripla (em inglês, THP), no instante anterior à clivagem proteolítica de uma das cadeias
singulares. Os dados de RMN paramagnético sobre o complexo permitiram-nos determinar a orien-
tação dos domínios da enzima quando da ligação ao THP e consequente desenrolar da tripla hélice.
Neste estado, a MMP-1 revela-se rígida e com uma orientação ligeiramente diferente dos modelos de
raios-X. Finalmente, conjugámos todos os dados adquiridos neste projecto com outros previamente
publicados de modo a gerar um modelo inteiramente derivado de informação experimental. O mo-
delo obtido concorda com todos os dados introduzidos e ainda com outra informação independente,
nomeadamente, estudos mutacionais nos locais ligação exógenos do domínio hemopexínico.
Os resultados aqui apresentados revelam dois passos desconhecidos no processo colagenolítico:
o prólogo e o estado final do complexo envolvido. Estes dados podem ser também extrapolados para
outras MMPs de modo a desvendar os mecanismos moleculares desta peculiar família de enzimas e
servir como base para a pesquisa de novas abordagens farmacológicas.
xxx
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Introduction
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Chapter 1
Paramagnetic NMR
1.1 Overview
NuclearMagnetic Resonance (NMR) has grown since its beginnings as a tool to explore the structure of
small molecules at the atomic level, evolving over the years towards the direction of macromolecules,
proteins and oligonucleotides, and, more recently, solving very large molecular weight complexes.
With the increasing size of the studiedmolecules, the traditional (diamagnetic)NMRobservables (such
as NOEs) were no longer sufficient to obtain detailed solutions of the multidimensional molecular
structures and dynamics. The introduction of long range NMR paramagnetic restraints fostered the
study of large molecular weight systems, in their structure and dynamics, to a high level of resolution;
benefiting from an ever increasing pool of NMR sequences and sample preparation techniques, the
quality of such information improves by the year.
This chapter explains the theory behind paramagnetism in NMR, describing the nature of themag-
netic susceptibility tensor and the different structural restraints that can be obtained when a param-
agnetic center is present in the macromolecular sample; also, the practical aspects on how to acquire
and process such observables are reviewed. It is also the aim of this chapter to detail and summarize
the different strategies that have been implemented to date to functionalize macromolecules with
the necessary paramagnetic centers. Finally, the concept of Maximum Occurrence is expanded which
is necessary to clearly visualize the results obtained.
1.2 The magnetic susceptibility tensor
What is the magnetic susceptibility? When a substance is exposed to a permanent external mag-
netic field (H) it responds to its presence by generating itself a magnetic field (M), that vanishes upon
thedisappearanceof theexternalmagnetic pressure. The intensityof thismagnetic response is termed
magnetic susceptibility (χ), it can be diamagnetic or paramagnetic in nature, and is definedmathemat-
ically as a proportionality constant between the induced magnetization (M, magnetic response) and
the applied magnetic field (H), equation 1.1 (Bertini et al., 2002a; Koehler and Meiler, 2011):
 =
M
H
(1.1)
The paramagnetic susceptibility derives from unpaired electrons in the substance (transition met-
als or Lanthanide ions, for instance) which generate a magnetic dipole moment that displays positive
values (χ>0), attracting the substance to the external magnetic field. On the contrary, diamagnetic
susceptibilities are characterized by negative χ values (χ<0) and repel the substance from the applied
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Figure 1.1: The representation of the magnetic susceptibility in a tensor frame. χxx, χyy and χzz repre-
sent the induced field strength in the different directions. The position of Hi relative to the origin of
the magnetic tensor frame can be described by the vector ri and the respective direction cosine (mi,
ni, li).
magnetic field (H). Within a macromolecule, the presence of a paramagnetic center rules out the dia-
magnetic contribution deriving from the rest of the atoms because the paramagnetic χ is orders of
magnitude higher (Bertini et al., 2001a).
The magnetic susceptibility tensor The magnetic susceptibility (χ) tensor is the geometric mathe-
matical representation of the magnetic susceptibility and describes the interaction of the electronic
magnetic dipole moment with the applied magnetic field (H) (Bertini et al., 2002a). The χ-tensor is
defined by three principal components, χxx, χyy and χzz, in a coordinate frame with origin on the para-
magnetic center, which indicate the intensity of the induced field in each direction. The χ-tensor can
be represented in a generic molecular reference frame (Xframe, Yframe, Zframe) where a position in space
that senses a givenmagnetic strength, say of a proton 1Hi, can be referenced to the paramagnetic cen-
ter by a metal-proton distance vector, ri, and the respective direction cosines (mi, ni, li) represented
by the scalar products of ri with the unit vectors, rx, ry, rz along χxx, χyy and χzz, Figure 1.1 (Banci et al.,
1996; Emerson and La Mar, 1990).
In the case of paramagnetic centers, the χ tensor can express two conditions, the isotropic (χiso) and
the anisotropic (Δχ) conditions. Isotropic χ tensors have a magnetic moment equal in every direction,
χxx = χyy = χzz, while the Δχ tensor is defined by the deviation of the χ tensor from spheric symmetry.
The Δχ-tensor has an axial (Δχax) and rhombic (Δχrh) components that describe the spatial asymmetries
of the magnetic moment and are described by equations 1.2 and 1.3, respectively:
ax = zz   1
2
(xx + yy) (1.2)
rh = xx   yy (1.3)
Consequently, as seen above, the isotropic situation is met when χxx = χyy = χzz which results in Δχax
and Δχrh components equal to zero, Δχ-tensor is said to vanish (Otting, 2010). The axial and rhombic
components, and therefore the Δχ-tensor, can be imagined as an ellipsoid spanned by the three prin-
cipal axes, χxx, χyy and χzz, centered about the paramagnetic center, where the χ and Δχ-tensors share
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the same axis system – more details can be found in Section 1.4.2 and Figure 1.5, when explaining
pseudocontact shifts.
The diamagnetic anisotropy Protein and nucleic acids have peptide bonds and ring systems that
express diamagnetic anisotropy which could influence the observed paramagnetic anisotropy (Banci
et al., 1998a; Brandes and Kearns, 1986; Maret et al., 1975; Worcester, 1978). This, can be usually ne-
glected in proteins because the diamagnetic contributions cancel each other out due to their different
orientations, and, as previously said, they are ofweakermagnitude. Nevertheless, there are situations
where the diamagnetic contribution can be nonnegligible. In DNA andRNA, ring systems stack and the
diamagnetic anisotropy becomes additive (Maret et al., 1975), resulting in consequent partial align-
ment of the macromolecule inside the external field. In such cases corrections to the paramagnetic
effects have to be considered. The overall molecular susceptibility is the sum of both diamagnetic and
paramagnetic contributions:
mol = dia + para (1.4)
Remarks These basic concepts of themagnetic susceptibility tensor and its applicability to NMRwill
be further elucidated in the next section when explaining the NMR paramagnetic observables which
are the useful structural restraints that the experimentalists look for; nevertheless, a complete and
deeper mathematical explanation on the nature and origin of the magnetic susceptibility in NMR has
been extensively detailed in literature (Bertini et al., 2002a, 2002b).
1.3 Paramagnetic Centers in NMR
1.3.1 The case of Lanthanide(III) ions
The beginnings Lanthanide(III) ions, also known as rare earth metal ions, have, during the last 40-50
years, settled their importance in complementing NMR as a tool for structural biology. It was in the
late 60’s, early 70’s, when Eu(III) complexes were used to induce shifts in the proton resonances of
compounds that yield otherwise crowded spectra, thus improving the information that could be ex-
tracted (Hinckley, 1969; Sanders andWilliams, 1970). Also, the diverse applicability of Ln(III) ions soon
started to become evident when Gd(III) was used to induce structural dependent relaxation (Lewis et
al., 1962; Morallee et al., 1970). This was the period when Lanthanide(III) ions gained strong impetus
in structural biology by NMR; many works (Barry et al., 1971, 1974; Campbell et al., 1973a; Dwek et al.,
1971) and reviews (von Ammon and Fischer, 1972; Cockerill et al., 1973; Mayo, 1973; Reuben, 1973a,
1973b, 1975) were published at the time. Moreover, not only in NMR but in many other spectroscopic
techniques, such as luminescence techniques, Ln(III) ions gained relevance (Reuben, 1975).
The contemporary events Over the years, with the developments in NMR methodologies and in
the theory for exploiting paramagnetic NMR effects as restraints for structural characterization of
macromolecules, Lanthanide(III) ions have gained an ever increasing importance as agents that induce
such restraints. The characteristics and the usability of Ln(III) ions in this field of research have been
recently and extensively reviewed (Bertini et al., 2008a; Geraldes, 1993; Koehler and Meiler, 2011;
Otting, 2008; Pintacuda et al., 2007; Rodriguez-Castañeda et al., 2006; Su and Otting, 2010). So, what
makes Lanthanide(III) ions so suited and appealing for NMR in structural biology?
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Lanthanides(III) ions’ chemical characteristics TheLn(III) ionshaveelectronic configurations [Xe]4fn,
wheren spans from0 to14. Thefirst and the last Lanthanides in the series, Lanthanum(III) andLutetium(III),
have no unpaired electrons, n = 0 and 14, respectively, and are therefore diamagnetic (Peters et al.,
1996). All other Ln(III) ions have increasing n along the series in a way that all present unpaired elec-
trons and, consequently, paramagnetism. Diamagnetism and paramagnetism are discussed in Section
1.2 - What is the magnetic susceptibility?
Ln(III) 4f orbitals are shielded by 5s and 6s orbitals which render all Ln(III) ions chemically very simi-
lar. Firstly, all Lanthanides are stable in their +3 oxidation state. Secondly, the orbital shielding hinders
4f electrons to be readily available for interactions with ligands (chelating moieties), so, the Ln(III)-
ligand interactions are electrostatic in their nature. Thirdly, their ionic radius changes only slightly,
decreasing along the series from 1.18 Å for Lanthanum(III) to 0.97 Å for Lutetium(III) with all other
thirteen Lanthanide(III) ions lying in between (Shannon and Prewitt, 1969). The consistent and, nev-
ertheless, over expected decreasing of the ionic radii of Ln(III) is called the Lanthanide contraction
(Cotton, 2007).
The paramagnetism of Lanthanides Lanthanum(III) and Lutetium(III) are diamagnetic, but all the
other Ln(III) ions are paramagnetic because of their unpaired electrons (Bleaney, 1972). The param-
agnetic characteristics are considerably different along the series, they depend on the intrinsic prop-
erties of the Lanthanide itself and on the chemistry and geometry of the inner coordination sphere
that holds the Ln(III) inside a chelating complex (Mironov et al., 2001, 2002). The Ln(III) ions form sta-
ble complexes with usually 8 strong anionic ligands, like oxygen- or nitrogen-donor atoms, leaving the
ninth position free to bind a molecule of water (Moeller et al., 1965). In a cubic ligand environment
all the paramagnetic Lanthanides(III) are magnetically isotropic, but for all other coordination geome-
tries, from elongated and compresses tetragonal prism to tetragonal antiprism and dodecahedron,
only Gd(III) expresses isotropic paramagnetism while the rest of the paramagnetic Ln(III) ions are of
anisotropic nature (Mironov et al., 2001, 2002).
The anisotropic characteristics of the whole Ln(III) series (with exception of the radioactive prome-
thium and gadolinium)where tested for different ligand environments (von Ammon and Fischer, 1972;
Bertini et al., 2001b) and largely reviewed (Koehler and Meiler, 2011; Otting, 2008, 2010; Pintacuda et
al., 2007; Su andOtting, 2010). Despite their chemical similarity, Lanthanides(III) present very different
magnetic characteristics. It can be said that the first half of the series has low anisotropic susceptibil-
ity (Δχ) and the second half has high anisotropic susceptibility, while Gd(III) lies isotropic in between
(Figure 1.2).
Despite that the anisotropy of the Lanthanides(III) reacts differently along the series to changes in
the coordination geometry (Mironov et al., 2001), the general rule explained above holds true for the
multitude of complex geometries. From Figure 1.2 it is possible to see that Lanthanides even present
opposite orientations of their z-axis susceptibility tensor (χzz), which can be further used to discrim-
inate between pairs with the similar susceptibility, such as for Ho(III) and Tm(III) or Eu(III) and Nd(III);
the importance of such combinations will be elucidated when explaining the nature of paramagnetic
restraints.
Summing up the alluring characteristics Lanthanides(III) show very similar ionic radii, charge sta-
bility and a particular electron configuration that allows for a chelatingmoiety, either within a protein
(Bertini et al., 2001b; Corson et al., 1983) or a chemical compound, to coordinate all Ln(III) series with-
out significant changes in its structure and with very similar, although not equal, affinities (Nitz et al.,
2004). This means that all Lanthanides(III) can be screened in the same system and, because of their
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Figure 1.2: The magnitude of the Δχax component (10-32m3) for the different Lanthanides derived
from a fixed protein matrix (D9k). Pm(III) and Gd(III) are represented with (x) because the former is
a radioactive element and the latter has isotropic χ-tensor. Values were extracted from Bertini et al.,
2001b.
very different magnetic anisotropies, a combination of sets of paramagnetic restraints derived from
the different Lanthanides(III) can be easily acquired.
Lanthanides have no known biological function which makes their use practically not conflictive
with a given system under study. Also, and very interestingly, Ln(III) can occupy natural metal binding
sites of Ca2+, Mg2+, Mn2+ and, thus, the chemical advantages of Ln(III) ion as paramagnetic probes can
be transferred to metal binding proteins (Allegrozzi et al., 2000; Bertini et al., 2000a, 2001b, 2001c,
2002c; Darnall and Birnbaum, 1973; Lee and Sykes, 1980a; Smolka et al., 1971). Another strategy to
incorporate Ln(III) ions into a system is by its functionalization with a synthetic Ln(III)-chelating tag.
These procedures have become almost routine and virtually any system can be functionalized with
Lanthanide(III) tags, which renders Ln(III) ions extremely versatile paramagnetic probes. Extensive
details on paramagnetic tagging strategies can be found in Section 1.3. As detailed above (The param-
agnetism of Lanthanides), the anisotropic susceptibility of the Ln(III) ions is strongly dependent on the
coordination sphere of the ligand (Lisowski et al., 2004; Mironov et al., 2001, 2002), the paramagnetic
Ln(III) effect can be further tuned by modulating and optimizing the characteristics of the chelating
tag.
Practical highlights: Ln(III)-derived restraints Gd(III) has an isotropic χ-tensor and induces nuclear
relaxation by the Solomon-Bloembergen-Morgan mechanism (Section 1.4.1); it is, therefore, highly
suited for the generation of paramagnetic relaxation enhancements and does not generate neither
pseudocontact shifts nor residual dipolar couplings (Sections 1.4.2 and 1.4.3, respectively). On the
other hand, the remaining eleven paramagnetic Lanthanides(III) are highly suited to generate PCSs
and RDCs, because of their diverse anisotropies (Figure 1.2).
As a consequence, each Ln(III) generates a different set of restraints that can be put together to in-
crease the resolution of the paramagnetic driven structural calculations (Section 1.5). For short range
resolution Ln(III) ions of low susceptibility can be used, as Ce(III), Sm(III) or Eu(III), while for long range
effects stronger Ln(III), like Tm(III), Dy(III) or Tb(III), may be desirable; the measurement of PCSs as far
as 40 Å away from the paramagnetic center has been reported (Allegrozzi et al., 2000), PREs as far as
30 Å (Gaponenko et al., 2000a) and RDCs as large as 40 Hz (Bertini et al., 2001b). It is very important
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to underline that, as previously stated, the unpaired 4f electrons are buried by the 5s and 6s orbitals
and, so, do not easily delocalize to the ligand orbitals, which renders paramagnetic (hyperfine) shifts
generated by Ln(III) to be almost exclusively of pseudocontact nature (Barry et al., 1971, 1974), con-
trasting with the dominant contact shifts observed for transition metals (Bertini et al., 1993a). The
hyperfine paramagnetic shifts are addressed in Section 1.4.2.
The diamagnetic references Because paramagnetic restraints are obtained by direct subtraction
of the diamagnetic spectrum from the paramagnetic spectrum (see following sections), a diamag-
netic reference is crucial to measure paramagnetic restraints; La(III) and Lu(III) are perfect diamag-
netic probes that can be used as they can substitute any other lanthanide without significant struc-
tural changes in the structure of the complex. They have theminimum and themaximum ionic radii of
the series, La(III) will better reference the first half of the series while Lu(III) would be preferred as dia-
magnetic reference for the second half; other ions such as Y(III) are also generally used as diamagnetic
references for Ln(III) (Moeller et al., 1965; Vlasie et al., 2007).
Other spectroscopic potentialities of Lanthanides(III) Although it is not the subject of thiswork, it
is also important to emphasize the use of Lanthanide(III) ions in other fields of research andmedicine:
the isotropic susceptibility tensor of Gd(III) has been vastly explored as relaxation enhancement agent
inMagnetic Resonance Imaging (Bottrill et al., 2006; Geraldes and Laurent, 2009; Geraldes et al., 2010;
Merbach et al., 2013), while other Lanthanides(III) have been used for their luminescent and fluores-
cent properties (Bünzli, 2006, 2010; Taraska and Zagotta, 2010; Vázquez-Ibar et al., 2002).
1.3.2 The case of naturally occurring transition metals
The first magnetic centers in proteins to be explored by paramagnetic NMR techniques were, natu-
rally, those provided by nature in Metalloproteins which bear metals (Tolman et al., 1995) such as iron
(Gochin and Roder, 1995a), copper (Arnesano et al., 2003) or cobalt (Bertini et al., 1991). In fact, the
theory behind paramagnetic restraints (Section 1.4 and 1.5.2) was initially developed by studying such
proteins (Bertini et al., 1993a). The Magnetic Resonance Center in Florence (CERM) gave a tremen-
dous contribution to this field of research by solving several structures while detailing and exploring
the paramagnetic NMR theory itself (Arnesano et al., 2006).
The study of naturally occurring paramagnetic metalloproteins is not the scope of this thesis, nev-
ertheless its historical relevance is absolute. Here, two most relevant differences between transition
metals and lanthanide(III) ions, which are necessary to bear in mind when using paramagnetic NMR,
are briefly highlighted.
The naturally occurring transition metal ions in proteins express magnetic susceptibilities that are
one or two orders of magnitude lower than those of Lanthanide(III) ions in the conditions found ex-
perimentally (Barbieri et al., 2004). This difference can be further accentuated when the magnetic
susceptibility of the Lanthanides is fine tuned and improved by their chelating moiety (Section 1.6).
This is one of the reasons why the use of transition metals as paramagnetic probes in NMR has been
overtaken by Lanthanide(III) ions, specially when seeking for long range information. When studying
transitionmetal centers it is also necessary to consider that the unpaired electrons in thesemetals are
not shielded by external electron orbitals, like in the case of Lanthanide(III) ions, which creates a large
contribution to the contact shift termof the hyperfine shifts (Section 1.4.2 - Fermi contact shifts). Such
contribution can be explored to solve the geometric nature of metal cluster environments or, instead,
it has to be considered as a disadvantage, when exploring shifts of pseudocontact nature.
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1.4 The paramagnetic restraints
1.4.1 Paramagnetic Relaxation Enhancement
Figure 1.3: Graphical representation of
the decay in NMR signal intensity due to
the PRE effect.
A brief in the physical concept The magnetic moment
originatedby theunpairedelectrons in aparamagnetic cen-
ter interacts with the surrounding nuclear spins (e.g. 1H)
through magnetic dipolar interactions. The fast electron
spin relaxation of metal ions defined by the electron spin
relaxation time, τs, in the order of 10-8 to 10-13 s, creates a
random and unpredictable fluctuating magnetic field that
enhances the relaxation of the proton spins that would,
otherwise, occur in the absence of a paramagnetic center;
this phenomenon is, therefore, termed paramagnetic re-
laxation enhancement (PRE) – Figure 1.3. Recall that in
NMR, fast relaxation is translated into less resolved signals
and, in an extreme, the loss of resolution may broaden the
peak beyond detection.
PREs on the NMR spectra PREs (Γ) are experimentally
measured by the difference between the protons’ relaxation rate found in the paramagnetic state
(Rpara) and the diamagnetic state (Rdia) (Iwahara et al., 2004a), according to the equation:
  = Rpara  Rdia (1.5)
PREs by dipolar interactions The enhancement of the nuclei relaxation by a through-space (dipo-
lar) interactionwith unpaired electrons in the samplewas firstly described by the Solomonmechanism
(Solomon, 1955), which later became conventionally known as Solomon-Bloembergen and Morgan
(SBM) equations (Bloembergen, 1957; Bloembergen and Morgan, 1961; Solomon, 1955):
 1 =
2
5
0
4
2
2I g
22B(S + 1)JSB(!I) (1.6)
 2 =
1
15
0
4
2
2I g
22BS(S + 1)f4JSB(0) + 3JSB(!I)g (1.7)
where, Γ1 and Γ2 represent the longitudinal and transversal enhancements of relaxation rate, re-
spectively, g is theelectrong-factor,ωI/2π is the Larmor frequencyof theproton, μ0/4π is themagnetic
permeability of a vacuum (Clore and Iwahara, 2009), and JSB(ω) is thegeneralized spectral density func-
tion for the reduced correlation function, given by equation 1.8, where r is the distance between the
unpaired electron and the nucleus:
JSB(!) = r
 6 c
1 + (!c)2
(1.8)
 1c = 
 1
r + 
 1
s (1.9)
The correlation time, τc, is defined by equation 1.9, where τr is the rotational correlation time of
the macromolecule and τs is the effective electron spin relaxation time. Despite that the Solomon-
Bloembergen and Morgan equations take in consideration some simplified approximations, it holds
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valid for high magnetic fields (>10 T) which are actually the conditions where the experiments take
place nowadays (Westlund, 1995).
Within a magnetic field (B0), an induced electronic field (Be) is generated by the differences in
populations of the electronic spin levels. This electronic field is permanent, characteristic of each
substance and is always aligned to the external B0. A contribution to the nuclear spin relaxation arises
from the dipolar interaction with the Be which is characterized by the fluctuations of Be sensed by the
nuclear spins. Additionally to the electronic spin relaxation, these fluctuations arise from molecular
tumbling relative to B0. This is also described as the thermal averaging of electronic spin, or “Curie-
spin” relaxation (Gueron, 1975). The “Curie-spin” contribution to the longitudinal (Γ1) relaxation is
small and usually not considered (Bertini et al., 1989), whereas, the enhancement caused in transversal
relaxation (Γ2) is highly relevant, and in the case of Lanthanides(III) (Bertini et al., 2002b) is given by
equation 1.10; symbols have the same meaning as in equations 1.6 to 1.9:
 2;Curie spin =
1
5
0
4
2 !2Ig4J4BJ2(J + 1)2
(3kBT )2r6

4r +
3r
1 + (!Ir)2
  4c   3c
1 + (!Ic)

(1.10)
Another important contribution to the nuclear spin relaxation is the contact or hyperfine contri-
bution (Solomon and Bloembergen, 1956). This contribution, of scalar (through-bond) nature, is only
significant if the nucleus is directly bound to, or in the near scalar vicinity of, the paramagnetic center.
The contact contribution is negligible for Ln(III) ions except for nucleii directly bound to the particular
case of Gd(III) (Alsaadi, et al., 1980), although it may be relevant in studies of naturally paramagnetic
metalloproteins with transition metal ions.
Field dependence of PREs 1H-Γ2: SBM or Curie-spin? The value of PRE is dominated by the SBM
mechanism or by Curie-spin relaxation depending on the characteristics of the paramagnetic center
and on the size of the molecule (Bertini et al., 2002b; Clore and Iwahara, 2009; Westlund, 1995). Note
that the Curie-spin relaxation is approximately proportional to the square of the external magnetic
field (B20 ) (Bertini et al., 1993a; Everett and Johnson, 1972). Let us consider a macromolecule with a
given size and a fixed rotational correlation time, τr, which is independent of the external magnetic
field. If the used paramagnetic probe (see Section 1.6) has an electron spin relaxation time, τs, that
is much longer than the rotational correlation time of the whole system, then  1r   1s which re-
sults in r  c according to equation 1.9. Contrarily to τr, τs is dependent on the magnetic field, and
upon the condition r  c, the correlation time (τc) will be consequently independent on themagnetic
field. This will result in a field-independent 1H-Γ2 from equation 1.7 with a negligible contribution of
Γ2,Curie-spin from equation 1.10; in this condition, the SBM mechanism rules the PRE effect. When the
rotational correlation time is comparable to the electron relaxation time, 1H-Γ2 will contain a contri-
bution of the field dependent τs and Γ2,Curie-spin. Making the opposite reasoning, for  1s   1r the
enhancement in relaxation 1H-Γ2 will be mostly influenced by Γ2,Curie-spin and consequently highly de-
pendent on the external field.
Isotropic probes or anisotropic probes to measure PRE? Isotropic (χiso) probes have none or neg-
ligible anisotropy (Δχ), and are characterized by slow electronic spin relaxation times (τs within the ns
to μs range). For systems up to approximately 40 kDa, the field contribution to PRE can be considered
negligible (Clore and Iwahara, 2009). But for very large systems with τr larger than 50 ns, around 100
kDa, the Curie-spin relaxation can have a contribution to PRE of 20% at high fields for isotropic probes
like Gd(III) or Mn(III) (Clore and Iwahara, 2009). The system can be eventually forced back to a field-
independent situation using probes with longer electron spin relaxation times such as nitroxide-spin
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labels that have τs of about 10-7 s. On the other hand, for magnetically anisotropic probes, such as
for paramagnetic Ln(III) ions, except Gd(III), which relax in the picosecond to the nanosecond range,
the contribution of τs is higher and the relaxation enhancement is ruled by the Curie-spin mechanism
and has a consequent strong dependence on the external magnetic field (Bertini et al., 1989). A table
summarizing the electron relaxation times for different transition metals and Lanthanides(III) can be
found in the literature (Bertini et al., 1993a).
Moreover, apart from the different concepts in relaxation, isotropic susceptibility tensors do not
causePCSsnorRDCs like anisotropic tensorsdoand thePREeffect is kept simple toanalyze. Anisotropic
susceptibility tensors also generate cross-correlation and other relaxation mechanisms (Boisbouvier
et al., 1999; Pintacuda et al., 2004a) and extra paramagnetic effects inherent to molecular alignment
are necessary to be considered (Iwahara et al., 2004a; Woessner, 1962). For these reasons, PREs are
usually measured using magnetically isotropic probes based on Gd(III) ions (Section 1.3.1), Mn(II) or
nitroxide-spin labels (Section 1.6.3).
The distance dependence of PREs as single restraint Directly from equations 1.6, 1.7 and 1.10, it
is conclusive that PREs depend on the r-6 distance between the nucleus and the paramagnetic cen-
ter. Because in the optimal conditions of measurement the dependence of PREs with the χ-tensor is
purely isotropic, the r-6 Hi-M distance-dependence is actually the single structural restraint that can
be extracted from PREs. Nevertheless, this single restraint proved to be very powerful specially in ob-
taining information on low populated states of protein-protein complexes (Bashir et al., 2010; Clore
et al., 2007; Suh et al., 2007; Tang et al., 2006, 2008; Ubbink, 2009; Volkov et al., 2010; Yu et al., 2009).
A separate chapter is dedicated in reviewing the practical aspects of exploring this restraint (Section
1.5.1).
1.4.2 Pseudocontact Shifts
The hyperfine shift Themagnetic moment of the unpaired electrons in a paramagnetic probe inter-
acts with the nuclear spins of the macromolecular sample generating a hyperfine contribution to the
energy levels of the excited nuclei (Bertini et al., 1993a, 1996, 2001a; Kurland and McGarvey, 1970; La
Mar et al., 1978; McConnell and Robertson, 1958). In other words, it can be said that the presence of
an extra magnetic field, with origin on the unpaired electrons, sums to the external permanent field
changing the effective B0 that is sensed by the nuclei and results in a consequent contribution to the
chemical shift; this contribution does not average to zero with the molecular tumbling due to the χ-
tensor anisotropy. The hyperfine shifts can result from two different contributions (Geraldes, 1993):
the Fermi contact and the pseudocontact contributions. It can be eventually considered an extra dia-
magnetic contribution to the hyperfine shift that arises from electrostatic interactions or ion-induced
ligand conformational changes, but it is usually not considered because it is directly subtracted when
measuring paramagnetic NMR shifts against the diamagnetic reference, see equation 1.11 bellow.
Fermi contact shifts Fermi contact shifts (CS) are a consequence of the scalar interaction between
the paramagnetic electrons and the nuclear spins, and, as such, they depend on bond and dihedral
angles and reach a maximum distance of four covalent bonds. CS have origin in the delocalization of
the unpaired electron spin density through the network of covalent bonds (Banci et al., 1996; Barry et
al., 1974; Dobson et al., 1973; Geraldes, 1993). Contact shifts produce very large effects and are only
observed in the proximity sphere of the paramagnetic center. For these reasons, they have served
as structural restraints to define the coordination environment of the metal in paramagnetic metallo-
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proteins (Aono et al., 1998; Bertini et al., 1994, 1995, 2000b), but they hold no meaning as long range
structural restraints.
Contact shifts aremore pronouncedwhen the paramagnetic probes are transitionmetals that have
their unpaired electrons in the outer electronic shells (Section 1.3.2). In these cases, it is necessary to
separate the scalar contribution from the dipolar contribution in the observed paramagnetic shifts
(Dobson et al., 1973; Reilley et al., 1975; Reuben, 1973a, 1973b).
Figure 1.4: Schematic representation
of the pseudocontact shifts in the NMR
HSQC spectrum. In black the diamag-
netic peaks and in gray the paramagnetic
peaks.
Measuring Pseudocontact shifts Pseudocontact shifts
(PCSs) (Bertini et al., 2001a; Bleaney, 1972; Kurland and
McGarvey, 1970; McConnell and Robertson, 1958), contrar-
ily to PREs, are observed only in the presence of a para-
magnetic anisotropic probe. They derive from the dipolar
interactions between the electron magnetic moment and
the nuclear spins. As previously said, in The hyperfine shift
paragraph, the hyperfine interaction that occurs in param-
agnetic conditions results in changes in the chemical shift
of the nuclei resonances. By this means, pseudocontact
shifts are easily measured in a 1H-15N-HSQC experiment as
the difference in chemical shift (δ) between the paramag-
netic sample and thediamagnetic reference (Figure 1.4 and
equation 1.11):
PCS = para   dia (1.11)
where, ΔδPCS is the observed pseudocontact shift, δpara is the chemical shift in the paramagnetic
sample and δdia is the chemical shift in the diamagnetic sample. PCSs are usually measured for the
F2 dimension, because of the higher resolution that can be obtained due to the high gyromagnetic
ratio (γ) of the proton, the small spectral window in the F2 dimension and, because 15N resonances
are more sensitive to variations in the backbone torsion angles which incorporates addicional errors
in the measurement. This latter condition specially holds true for metal binding proteins where the
diamagnetic andparamagneticmetals aredirectly incorporated into the structure (Jensenet al., 2006).
The geometric dependence of PCSs The anisotropic χ-tensor describes a magnetic field that varies
in space – Section 1.2 – and, because of that, ΔδPCS, for a given resonance (e.g. 1H), possesses both dis-
tance and angular dependence on its position relative to the paramagnetic center. Thus, PCSs are high
quality, information rich, structural restraints. Amathematical equation describes the relationship be-
tween the observed PCSs and the relative respective positions between nuclei and the paramagnetic
center (Bertini et al., 2001a; Kurland and McGarvey, 1970; McConnell and Robertson, 1958):
PCS(ppm) =
1
12r3
[ax(3 cos
2   1) + 3
2
rh sin
2 cos 2'] (1.12)
where, Δχax andΔχrh are theaxial and rhombic componentsof themagnetic susceptibility anisotropy
tensor (Δχ), r is the distance between the observed nuclei and the paramagnetic center, θ and φ are
the polar coordinates of the nuclear spin with respect to the principal axes of the Δχ. An extensive
mathematical derivation of this relationship can be found in literature (Bertini et al., 2002a). From
equation 1.2 and 1.3, in Section 1.2, one can observe that in an isotropic situation, Δχax and Δχrh are
equal to zero, which cancels out the second term of equation 1.12, ΔδPCS = 0, and therefore no PCSs
are observed. Other conclusion that can be extracted from equation 1.12 is that PCSs decay with 1/r3
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in contrast with paramagnetic relaxation enhancements that decaymuch faster, 1/r6 – refer to Section
1.4.1. Since anisotropic χ-tensors raise both PCS andPRE effects, this slower decay allows for PCSmea-
surements as far as 60 Å away from the metal center in the case of Ln(III) ions (Allegrozzi et al., 2000;
Biekofsky et al., 1999; Ubbink et al., 1998) without much interference of the PRE contribution, which
is valuable for the high quality standards of PCSs. As a consequence of all the three equations, 1.2, 1.3
and 1.12, amap of the observed PCSs is usually depicted as isosurfaces of PCSmagnitude (i.e., induced
shift) centered on the paramagnetic ion and with shape according to the Δχ-tensor. A representation
of the PCS isosurfaces was drawn on the frame of Figure 1.1 (Section 1.2) for representation, the an-
gles θ and φ were also added – Figure 1.5. It is, at this point, necessary to understand the geometric
symmetry upon which PCSs depends on; please refer to Section 1.4.3 - Geometric symmetry.
Figure 1.5: Schematic representation of the differ-
ent magnetic anisotropies felt by the nuclei as a
function of their spatial position.
Lanthanides(III) with their different param-
agnetic susceptibilities can be used to tune the
strength of observed PCSs (Bertini et al., 2002b),
to obtain either far reaching or closely resolved
PCSs, as is the case for Dy(III) and Ce(III), respec-
tively – refer to Figure 1.2 in Section 1.3.1.
Δχ-tensor derived from PCSs PCSs are strong
restraints for experimental derivation of the Δχ-
tensor (Gochin and Roder, 1995a; Otting, 2010).
The geometric dependency of PCSs is defined by
eight parameters: the spatial coordinates of the
metal ion, the three Euler angles defining theori-
entation of the Δχ-tensor with respect to the co-
ordinate system of the protein (which the Ln(III)
is actually attached to), and theaxial and rhombic
components of Δχ (Banci et al., 1997a). Theoreti-
cally, only eight measured PCSs are necessary to
position the Δχ-tensor with respect to the pro-
tein, provided its 3D structure is known. Experi-
mentally, as much PCSs as possible are welcome to define with precision the Δχ-tensor and these are
to be, ideally, equally distributed around themetal ion in all three directions of the coordinate system
spanned by the tensor (Bertini et al., 2001b, 2001d); with a large number of PCSs used in the Δχ cal-
culation, wrong assignments are unlikely to affect its accuracy (Schmitz et al., 2006). Details on the
approaches to derive the Δχ-tensor from PCSs as well as an historical perspective is given in Section
1.5.2.
Mobility that affects PCSs Despite that pseudocontact shifts have a distance and angular depen-
dence to the paramagnetic center, small localized mobility of protein residues is not expressed in
ΔδPCS, see Figure 1.8 in Section 1.4.3 on the following page. This makes PCSs very robust restraints to
derive Δχ-tensors and stand as the base to give impulse to more complex studies, such as on protein-
protein complexes (Keizers et al., 2010; Ubbink et al., 1998) and on protein ligand interactions (John
et al., 2006; Pintacuda et al., 2007).
On the other hand, PCSs are very sensitive to mobility between the paramagnetic tensor and the
protein frames. Variations on the frames’ angle will have a drastic effect on the magnitude of ΔδPCS,
because it will be accompanied by strong fluctuations on the sensed magnetic field (B0 + Δχ). This
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effect is likely to occur when the paramagnetic probe (say Ln(III) ion) is held to the protein by an ar-
tificially attached tag. This undesired mobility of tags is detailed in Section 1.6 where the different
strategies for paramagnetic functionalization of macromolecules are presented.
The effect of large structural motions on PCSs, like domain mobility, is addressed in Section 1.8
when discussing the Maximum Occurrence approach.
Choosing the field to measure PCSs Ln(III)-derived pseudocontact shifts are strongly dependent
on Curie-spin relaxation, which increases with the square of the magnetic field strength (Clore and
Iwahara, 2009), but the magnitude of the PCSs do not depend on the external field because they are
measured in p.p.m. and the field contribution to the hyperfine shift is already normalized (Bertini et
al., 2002a, 2002b). This means that at the highest magnetic fields available for NMR systems (> 700
MHz) the measurement of PCSs will surely be hindered by Curie-spin relaxation, while at magnetic
fields of lower intensity (≤ 500MHz) PCSs will be rendered with higher quality because of the reduced
enhancement in relaxation.
Remarks To conclude, pseudocontact shifts have been settled as strongly reliable NMR structural
restraints in structural biology (Bertini et al., 2001d; John and Otting, 2007; Saio et al., 2010; Schmitz
et al., 2012). They are originated by the presence of a paramagnetic center with anisotropic χ attached
to the macromolecule, that can either be a naturally occurring ferromagnetic center (Bertini et al.,
2008a) or artificially implanted Lanthanide(III) ions (Otting, 2008). PCSs are measured simply by the
difference between δpara and δdia of 1H resonances in a 1H-15N-HSQC spectrum and, therefore, only
15N labeled samples are required. In case of large proteins, 13C-15N labeled samples can eventually be
used to help resolving the peak crowding through experiments like 3D-HNCA. PCSs have thus been
used extensively to solve structural unknowns in the field of proteins, nucleic acids and drug discovery
(Allegrozzi et al., 2000; Biekofsky et al., 1999; John et al., 2006; Ubbink et al., 1998).
1.4.3 Residual dipolar couplings
Theweak alignment In an isotropic situation, themolecular tumbling is equal in every direction and,
consequently, inside a magnetic field, the large internuclear dipolar couplings are averaged to exactly
zero. As described in Section 1.2, in the presence of a static external field (B0), paramagnetic centers,
like ferromagnetic transition ions or Lanthanide(III) ions implanted into a macromolecule, express an
induced magnetic field (M) that aligns to B0 in the same way the needle of a compass aligns with the
Earth’s magnetic field. The resulting alignment is residual, in the order of 10-3 comparative to per-
manent alignment, but is enough to generate a quantifiable one bond dipolar effect that would be
otherwise averaged to zero in isotropic situations. The alignment of the paramagnetic probe forces
the alignment of the whole macromolecule. This effect is termed Residual Dipolar Coupling (RDC)
(Bax, 2003; Prestegard, 1998; Tjandra et al., 1996, 1997; Tolman et al., 1995; Van Zijl et al., 1984).
Measuring RDCs experimentally RDCs are expressed in the NMR spectra as a contribution, in sim-
ilar magnitude, to the scalar J-coupling, and are experimentally observed as a positive or negative
contribution to the multiplet components of a given bond, e.g. H-HN, in the Heteronuclear Single-
Quantum Correlation (HSQC)-like spectra that are acquired without decoupling (Figure 1.6). RDCs can
beobtainedby simply subtracting theheteronuclear J-couplingobserved in thediamagnetic reference
sample to the measured coupling J + D in the paramagnetic sample, in equation 1.13 only referred as
J, note the analogy with PREs and PCSs measurement, equation 1.5 and 1.11, respectively:
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JRDCij = J
para
ij   Jdiaij (1.13)
It is necessary to consider that, the longer the time the macromolecule is aligned to B0, the larger
the RDC is, and if the alignment increases a lot from its residual nature, it could become large enough
to be impossible to measure.
Figure 1.6: Schematic representation of
the residual dipolar coupling asobserved
in the IPAP-HSQC experiment. Black
peaks represent the diamagnetic condi-
tion and gray peaks the paramagnetic
condition.
The most commonly used method for RDC measure-
ment is the IPAP method (Ottiger et al., 1998), although
many others have been proposed (Bhattacharya et al.,
2010; Guo et al., 2010; Liao et al., 2011; Prestegard et
al., 2004; Tjandra et al., 1996; Yang et al., 1999). RDCs
are mostly measured in the 1H-15N bonds of the back-
bone amide protons of a protein because those are the
easiest to acquire and require only 15N monolabeled sam-
ples. Nonetheless, RDCs can be extracted from many
other bonds which definitively serve as strong restraints
for structural resolution (Boisbouvier et al., 2004; Jaroniec
et al., 2005; Prestegard et al., 2004; Tjandra et al., 1997).
Geometric dependence of RDCs Themagnitude and the
sign of the RDC depend on the orientation of the 1H-15N
bond tensor respectively to the alignment tensor Δχ, that is
by itself aligned with B0. With this being said, it is straight-
forward to conclude that RDCs encode valuable structural
information. The direction of the bond vectorwithin the alignment frame is relatedwith themeasured
RDCs through the equation 1.14 (Bertini et al., 2002a; Clore et al., 1998a):
RDC (Hz) =
 B20
15kT
ijh
163r3ij
[ax(3 cos
2   1) + 3
2
rh sin
2 cos 2'] (1.14)
where, RDC is the residual dipolar couplingmeasured according to equation 1.13, rij is the distance
between nuclei i and j, which is not related to the paramagnetic center, θ is the angle between the
i-j internuclear vector and the z-axis of the χ-tensor, φ is the angle between the projection of the i-j
internuclear vector in the xy-plane and the x-axis of the χ-tensor, B0 is the staticmagnetic field strength
andh thePlanck’s constant. γi andγj aregyromagnetic ratios of thenuclei. Contrarily toPCSs andPREs,
RDCs are distance-independent restraints, they do not dependon the distance between the probe and
the vector bond, only on the orientation of the bond vector towards the alignment tensor Δχ (Figure
1.7). This means that the effect of a single paramagnetic center can equally generate RDCs for the
whole macromolecule.
Geometric symmetry The terms within brackets ([···]) of equations 1.12 and 1.14, that corresponds
to the dependency of PCSs andRDCs on theΔχ-tensor are equal, and therefore the following explaina-
tion applies to both. The geometric dependence of the PCSs and RDCs on the Δχ-tensor, [cos2(   1)]
and [sin2  cos(2')], imposes that a single solution, i.e. a couple of θ and φ angles, cannot satisfy an
RDC or PCS value. In fact, for each Δχ-tensor, there is an entire cone of (θ, φ) solutions centered on
the z-axis of the alignment tensor that can agree with a given RDC or PCS value (Bax, 2003). Depend-
ing on the degree of rhombicity of the Δχ-tensor, the cone of solutions is consequently distorted. So,
each alignment tensor will have its corresponding cone of solutions. In order to solve the degeneracy
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Figure 1.7: Schematic representation of the geometric dependence of residual dipolar couplings. Nu-
clei N and H were chosen as examples. Inside the magnetic field the χzz orientation is equal to the
orientation of B0. The angles represented are those of equation 1.14.
and restrain the possible solutions to a maximum of two, at least three different alignment tensors
are necessary (Bax and Grishaev, 2005; Bertini et al., 2002b, 2005; Ramirez and Bax, 1998; Ulmer et
al., 2003). The more the orientations of the Δχ-tensors differ, the better the geometric degeneracy
will be solved. Lanthanide(III) ions have usually very similar orientation of their Δχ-tensor z-axis and,
when using a single attachment point, even with three different probes it can be difficult to resolve
degeneracies.
High fields higher RDCs but... From equation 1.14 the square proportionality of RDC with B0is ev-
ident; an higher B0 originates an higher induced field and a consequent higher degree of alignment.
This could be an advantage but, it is necessary to consider that paramagnetic anisotropic probes ex-
erts significant nuclear relaxation at high fields, and Curie-spin effects must be considered, specially
in the case of Ln(III)-based probes – refer to Sections 1.3.1 and 1.4.1.
Mobility that affects RDCs The dependency of RDCs on the observed bond vector’s angle with B0
dictates that small localized internal dynamics of the protein residues strongly impacts the observed
RDCs because small motions are translated in large angle amplitude variations. These motions are
responsible for a decrease in the RDC value due to averaging along the different angle orientations.
Figure 1.8 represents in a scheme both PCS (Section 1.4.2 - Mobility that affects PCSs) and RDC depen-
dency on internal dynamics.
Also, following the same principles as for PCSs, if the paramagnetic center is implemented in the
protein through an external chelating probe, independent movements of such probe with respect to
the protein frame will have drastic consequences on the observed RDCs and on the reliability of the
RDC-derived Δχ-tensor (Rodriguez-Castañeda et al., 2006). The different strategies for paramagnetic
functionalization of macromolecules, as well as their advantages and disadvantages are described in
Section 1.6.
Δχ-tensor derived from RDCs Calculating the Δχ-tensor from RDCs follows basically the same com-
putational approach as deriving it from PCSs (see Section 1.4.2 - Δχ-tensor derived fromPCSs, and Sec-
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Figure 1.8: In an example, the mobility in the amide protons changes the H-HN vector angle with B0 in
a much larger extent that it changes the angle between the proton (H) and the metal center. Figure
adapted from Assfalg et al., 2003.
tion 1.5.2, for review see Koehler and Meiler, 2011). The acquired restraints are fitted on a structure,
or ensemble, to equation 1.14 searching for a reduction of a defined target function. But, contrarily
to PCSs, in the case of RDCs only five parameters are unknown, because RDCs are distance indepen-
dent and the three coordinates that define the position of the tag with respect to the protein are not
necessary to calculate.
The generalized order parameter The Δχ-tensors are always derived based on rigid models, or en-
sembles of models. However, the measured RDCs strongly reflect the internal dynamics, which are
virtually omnipresent and are characterized by themotions of the observed bond vectors (for example
on the H-HN bond, see Figure 1.8); they contribute to the reduction of the observed RDCs by motional
averaging. If such motions are not taken into account when calculating the Δχ-tensor (Section 1.5.2),
the result might not be accurate because the RDCs back-calculated from the PCS-derived Δχ-tensor
will be over estimated with respect to the observed values (Tolman et al., 1997). In order to correct
for this behavior, it is necessary to introduce what is called a generalized order parameter (S) (Lipari
and Szabo, 1982) that is basically a scaling factor to reduce themagnitude of the Δχ-tensor accordingly
to the predicted dynamics of the considered bond vector. An accurate estimation of the generalized
(dipolar) order parameter S, for a given protein, domain or residue, can be derived from relaxation
measurement experiments, relaxation order parameter (S2) (Clore and Schwieters, 2006; Iwahara and
Clore, 2010). Therefore, the order parameter S is generally added to the second term of equation 1.14
to correct for such localized mobility (Bouvignies et al., 2007; Tjandra and Bax, 1997). Although the
order parameter S can be calculated for each residue separately, it is usually valid to consider an av-
erage value for the whole structure, as long as the internal localized mobility is within a certain range
across the protein (Tjandra et al., 1997).
A brief on experimental considerations A single Ln(III) ion could orient extremely large macro-
molecules and RDCs could be measured all over the molecule; however the higher the MW of the
macromolecule the higher the diamagnetic contribution to themolecular alignment, which could lead
to reduction of the observed RDCs (Section 1.2).
Interestingly, the RDC dependency onmotion opens new possibilities for studying dynamics of the
secondary structures (Bertini et al., 2002d; Chou et al., 2001; Lange et al., 2008; Salmon et al., 2012) or
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even motions of whole domains (Bertini et al., 2004a) that can occur within a protein. In combination
with PCSs, RDCs became a very powerful tool to study protein dynamics in solution, causing an every
increasing impact in this field of research.
Alignment by externalmedia Here the use of a paramagnetic center has been considered to force a
weak alignment of the macromolecule inside the magnetic field. However, different strategies based
on external alignmentmedia have been also extensively explored (Bax, 2003; Prestegard and Kishore,
2001; Prestegard et al., 2000); refer to Section 1.7. Nevertheless, the residual dipolar coupling theory
that applies to the magnetically oriented macromolecules also applies, in full analogy, to the case of
alignment by external media (Tjandra and Bax, 1997).
Remarks A deeper mathematical description of residual dipolar couplings can be found in the liter-
ature (Bax and Grishaev, 2005; Bax et al., 2001; Bertini et al., 2002a; Blackledge, 2005; Kramer et al.,
2004; Prestegard et al., 2004; Tolman and Ruan, 2006), but such a description does not lie within the
scope of this work.
1.4.4 Other Observable Paramagnetic Effects
Additionally to the three paramagnetic observables studied in the previous sections, other paramag-
netic effects exist, likedipolar shieldinganisotropy cross-correlated relaxation (DSA/DDcross-correlation)
(Bertini, et al., 2002c; Pintacuda, et al., 2003), DSA/chemical shielding anisotropy (DSA/CSA) cross-
correlation (Pintacuda et al., 2004a) and residual anisotropic chemical shifts (RACS) (John et al., 2005),
which are also important and have to be consider. However they are not so generally exploited; thus,
they will not be explained here as they are not within the scope of this work; detailed revisions and
different works can be found in the literature (Koehler and Meiler, 2011; Otting, 2008).
1.5 Practical Aspects Of:
1.5.1 Paramagnetic Relaxation Enhancements
Brief revision of concepts As discussed in Section 1.4.1, the acquisition of PREs is highly favored
for isotropic probes, such as Mn(III) and Gd(III) ions as well as nitroxide spin-labels. Two samples are
thus necessary for the experimental measurement of PRE: the diamagnetic reference and the para-
magnetic sample; PRE (Γ) is the difference between the relaxation rates in the paramagnetic and the
diamagnetic samples, equation 1.5.
Measuring T2 and not T1 Despite that PRE could be measured on both T1 and T2 relaxations and on
any NMR sensitive nuclei, it has been theoretically proposed and experimentally demonstrated that
is a more reliable approach to measure PRE on proton signals and on T2 relaxation (Iwahara et al.,
2004a, 2007). This is so because 1H-Γ2 is a more sensitive phenomenon because of the large nuclear
gyromagnetic ratio of the protons, the dependency of 1H-Γ2 on the spectral density function at zero-
frequency and the lower sensitivity of 1H-Γ2 to the effects of internal motions and cross-correlations
compared to the longitudinal PRE rate, 1H-Γ1.
Single point versus two point measurement It has been a common practice in the literature to
obtain PREs from a single sampling point. PRE 1H-Γ2 values were extracted from a modified HSQC
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spectrum (Donaldson, et al., 2001) for each sample and were calculated as simple rates of the peaks
heights in diamagnetic and paramagnetic samples (Idia and Ipara, respectively) as a function of the delay
T, which is the delay of the INEP sequence, given by (Clore and Iwahara, 2009; Iwahara et al., 2007):
Idia(T ) = Idia(0) exp( R2;diaT ) (1.15)
Ipara = Ipara(0) exp f (R2;dia +  2)Tg (1.16)
According to Clore and co-workers, this measurement of PRE has no physical meaning because it
carries contributions from PRE 1H-Γ1, from the delays for transference of coherence and, also, it is
depended on the data processing protocol (Clore and Iwahara, 2009). To overcome this practical limi-
tation, the authors (Iwahara et al., 2007) proposed a two-time-point measurement for obtaining 1H-Γ2
rates. Two points measured on the diamagnetic and paramagnetic samples at two different delays,
Ta=0 and Tb=ΔT, are related to the enhancement of transverse relaxation by the following equation:
 2 = R2;para  R2;dia = 1
Tb   Ta ln
Idia(Tb)Ipara(Ta)
Idia(Ta)Ipara(Tb)
(1.17)
The related error of such approach was also addressed by the authors (Clore and Iwahara, 2009;
Iwahara et al., 2007) along with the calculation of the time for the secondmeasured point (ΔT) and its
dependence with the expected Γ2.
Mobility of the paramagnetic probe affects PRE Another important contribution to the use of
PREs as structural restraints was the understanding that the mobility inherent to the paramagnetic
functionalization tags vastly used nowadays (Section 1.6) does compromise the accuracy of PREs and
that the Solomon-Bloembergen-Morgan equation (1.7) does only hold true for paramagnetic centers
completely fixed within the macromolecule frame. To overcome this limitation, Iwahara et al., 2004a
presented a computational approach that does correct for tag mobility independently of its degree
and,moreover, they concluded that the approach should always beusedbecause it does not adderrors
to the calculations in cases when the tag shows little or no mobility.
The contribution of undesired diamagnetic species Magnetic isotropic probes used to acquire
PREs do not cause paramagnetic shifts. For this reason, and in this case, the peak corresponding to
the paramagnetic species superimposes the reference peak of the diamagnetic sample. It is there-
fore imperative to completely wash away the remaining diamagnetic species that may be present in
the paramagnetic sample after the procedure of protein-tag functionalization. Small amounts of dia-
magnetic species will have a large contribution to the measured PRE. The authors have described the
error obtained for percentages of diamagnetic contamination between 1-5% (Iwahara et al., 2007)
and how the real 1H-Γ2 value can be extracted. The diamagnetic contribution due to contamination is
definitively relevant and should be taken in consideration.
The “solvent”PRE issue It is a commonpractice to say “the higher the concentration the better” when
referring to NMR samples. However, when dealing with PRE measurements, high concentrations can
become a drawback. At concentrations higher than 0.8 ~ 1 mM, the nuclei in one molecule will not
only feel the intramolecular PRE from the directly attached tag but will also report the effect from
the neighboring molecules that crowd the solution at high concentrations. In this way, significant
errors are introduced in the measurement of PREs (Clore and Iwahara, 2009).
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Remarks The above mentioned developments, along with others by the same authors, hold the
ground for setting PREs as a very accurate and easy to measure structural restraint (Donaldson et
al., 2001; Iwahara and Clore, 2006; Iwahara et al., 2003, 2004b).
1.5.2 PCSs and RDCs on the χ-tensor Calculation
Overview The physical nature of the pseudocontact shift (PCS) and the residual dipolar coupling
(RDC) was discussed in their respective Sections, 1.4.2 and 1.4.3. Here are detailed the practical as-
pects of using these paramagnetic structural restraints in macromolecular structure elucidation. Spe-
cial focus is given to the libraries FANTASIAN and CYANA, as well as to their predecessors FANTASIA
and DYANA, because these were the libraries used throughout this work. It is however of critical im-
portance to always bear in mind the other related tools, and their chronological relevance, that the
scientific community have made available.
Brief historical perspective In the mid seventies, Lanthanides started to be used to elucidate the
structural features of macromolecules (Barry et al., 1971, 1974; Campbell et al., 1973a, 1973b, 1975;
Morallee et al., 1970; Lee and Sykes, 1980a, 1980b, 1980c, 1981, 1983), however, this field of research
had to wait two decades before seeing its most outstanding developments (Geraldes and Luchinat,
2003). Initially, paramagnetic metalloproteins posed several difficulties to NMR spectroscopists be-
cause of the disruptive influence of paramagnetism in the NMR spectra. Nonetheless, many studies
were possible in these proteins (Banci et al., 1993a, 1993b; Bertini et al., 1992a, 1992b, 1993b, 1993c;
Dugad et al., 1990).
Already in the mid nineties, it was proposed that an X-ray structure could be refined by energy
minimization protocols using pseudocontact shifts (PCSs, Section 1.4.2) derived from the paramag-
netic metal ion in the protein as additional structural restraints (Gochin and Roder, 1995b). This con-
cept was further developed when the Florence laboratory proposed the program routine FANTASIA
(Finding ANisotropy Tensors: A SImplex Approach) for the refinement of NMR structures of paramag-
netic metalloproteins (Banci et al., 1996).
The interactive approach The FANTASIA routine (Banci et al., 1996) was defined in such a way that,
given: i) a known protein structure, or ensemble (in the case of NMR structures), ii) a set of experimen-
tally obtained PCSs and iii) a position within the protein frame where to place the origin of paramag-
netic center, for example the paramagnetic center in a hemeprotein (Arnesano et al., 2006), FANTASIA
could extract from equation 1.12 the five independent parameters that define the Δχ-tensor with re-
spect to the protein frame. In this way, FANTASIA calculated the best fit of the Δχax, the Δχrh and the
three independent direction cosines of themagnetic susceptibility anisotropy tensor (Section 1.2) in a
process that aimed at minimizing the difference between the back-calculated and the observed PCSs.
Then, the five independent parameters of Δχ served as input to the PSEUDIANA routine (Banci et
al., 1996), a module of DIANA (Güntert and Wüthrich, 1991; Güntert et al., 1991), that, in combination
withNOEs, forced arrangements in the structures, moving the atom iwith respect to themetal (center
of the paramagnetic χ-tensor) or vice-versa. The algorithm searched to minimize the target function
implemented in PSEUDIANA, which, as a novelty of the time, considered also the contribution of the
PCSs. The target function increased when the back-calculated and observed PCSs diverged by a value
higher than a given tolerance, which is also defined in the input of PSEUDIANA, in similarity to FAN-
TASIA. The tolerance was defined by the average chemical shift difference between the diamagnetic
reference and those protons that are far from the metal center, 15 Å (Banci et al., 1996). The contri-
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bution of possible motions inside the protein as well as the quality of the initial ensemble was also
necessary to consider (Banci et al., 1997b).
In this case of structural refinement, because the DIANA routine benefits from an already available
structure/ensemble and due to limitations of the software itself, only the last three steps ofminimiza-
tion the NOEs and the PCSs were considered simultaneously – see later comparison. The new refined
structures obtained from thePSEUDIANA served themselves as input to FANTASIA for a newΔχ-tensor
calculation. This iterative procedure is important because convergence between the experimental re-
straints and the calculated model is not obtained from a single refinement step. In this work (Banci
et al., 1996), eighteen interactive steps (FANTASIA↔ PSEUDIANA) were performed to achieve conver-
gence (< 1%) of the axial and rhombic components of the Δχ-tensor. The joint use of NOEs and PCSs
reduced the RMSD (root mean square deviation) of the ensemble of 17 structures of the Cytochrome
c variant from 0.70 Å to 0.58 Å (Banci et al., 1996), thus proving that paramagnetic centers can help
to define the structure of proteins instead of being a nuisance to NMR spectroscopists (Banci et al.,
1994).
In a later work, a module called PCSHIFT was proposed for the library SANDER of AMBER 4.1
(Weiner and Kollman, 1981) that performed restrained energyminimizations which could use PCSs for
further refinement of the structural ensemble (Banci et al., 1997c). A limitation that was still present
in this protocol was that a single position for the metal was considered for all the ensemble (Banci et
al., 1997b).
The FANTASIA /DIANA /PSEUDIANA toolswere succeededby the combination FANTASIAN /DIANA
/ PSEUDIANA (Banci et al., 1997a, 1997c, 1998b; Güntert et al., 1997). In this second update, the basic
iterative strategy (see later, Figure 1.9) was kept for Δχ-tensor calculation and protein refinement but
some relevant modifications to the protocol were indeed introduced.
The first introduced change was on the calculation of the Δχ-tensor by FANTASIAN. Previously
(Banci et al., 1996, 1997b), FANTASIA fitted equation 1.12 to the experimental PCSs with five param-
eters (as explained above). Instead, in this approach, FANTASIAN (Banci et al., 1997a, 1997c) fits the
experimental data considering eight independent parameters: the same five, plus the three spatial
coordinates, X, Y and Z, that place the paramagnetic center with respect to the protein frame. This
constituted a significant improvement to deal with NMR ensembles where the position of the param-
agnetic center cannot be absolutely defined, or as is the case of refining single X-ray structures from
artificially attached tags (Section 1.6) where the correct position of the tag has to be determined ex-
perimentally. In this way, the calculated Δχ-tensor (with all its eight unknowns) depends solely on ex-
perimental data. However, many studies have used an averagedΔχ-tensor obtained from independent
calculations on each of the structures of the ensemble (Arnesano et al., 1998a, 1998b, 1999a), with the
target function adjusted accordingly. The other important modification was at the level of the DYANA
/ PSEUDYANA calculations (Banci et al., 1998b; Güntert et al., 1997). Here, the PCSs are introduced
at the initial calculation step, along with NOEs and other restraints, when the input protein sequence
is still random coil; this differs from the previous approach of DIANA (Banci et al., 1996) where the
PCSs were introduced only at the final refinement steps after the main 3D fold of the protein was
obtained. The greatest contrast to the previous protocols is that, in DYANA/PSEUDYANA routines,
both the origin of the paramagnetic center and the orientation of the Δχ-tensor are recalculated at
this step which renders the approachmuchmore dependent on the experimental data. Thus, it is only
necessary to input the Δχax and Δχrh, in contrast with the previous DIANA/PSEUDIANA routines where
itwas also necessary to input the independent direction cosineswere necessary to input. FANTASIAN /
DYANA / PSEUDYANA combination were extensively used to resolve and/or obtain solution structures
of, mainly, heme containing proteins (Arnesano et al., 1998a, 1999a, 1999b; Banci et al., 1998c, 2002).
More recently, a protocol for automated structure calculation, by the name of CYANA, was devel-
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Figure 1.9: Schematic representation of the strategy used to incorporate PCSs and RDCs into the
structure calculation/refinement. An initial model is necessary to roughly derive an initial anisotropy
tensor. The model and the tensor are then refined iteratively across the consecutive cycles.
oped (Güntert, 2004; Herrmann et al., 2002). Consequently, the PARAMAGNETIC CYANA package for
introducing paramagnetic restraints in the CYANA’s structural calculations was presented (Barbieri et
al., 2004). Again, the strategy for Δχ-tensor derivation from an initial 3D model (FANTASIAN) and the
consecutive iterative protocol of structure calculation was maintained respectively to the previous
packages (FANTASAN / DYANA / PSEUDYANA) . The new PARAMAGNETIC CYANA package was, how-
ever, much more flexible in incorporating other paramagnetic restraints along with PCSs, like RDCs
or cross-correlation effects. A final scheme of the iterative procedure of Δχ-tensor calculation and
protein structure calculation and refinement is depicted in Figure 1.9.
Treatment of the anisotropy components In Section 1.2 we have seen that the anisotropic suscep-
tibility tensor has three components (χxx, χyy and χzz). In many bioinformatic routines, the Δχ-tensor
parameters (Δχax and Δχrh) are derived in the form of the susceptibility components which have then
to be converted according to equation 1.2 and 1.3. However, the definition of the axes is purely arbi-
trary because the program simply outputs the three values without referencing. The most accepted
convention is that which considers |χzz| ≥ |χyy| ≥ |χxx| (Bertini et al., 2002b; Clore et al., 1998b; Schmitz
et al., 2008). However, in some cases χyy and χxx are interchanged.
The Q factor At the end of the calculation, when convergence of the Δχ-tensor is met upon applica-
tion of the iterative protocol (Figure 1.9), it is necessary to assess the quality of the structure(s) gen-
erated. The overall quality of the structure (or ensemble) is quantified by the Q factor value; this is a
measure of the discrepancy between the experimental (observed) restraint and those back-calculated
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from the final structure and derived Δχ-tensor. Equation 1.18 represents the Q factor for the PCS,
where pcsobs and 
pcs
calc are, respectively, the observed and calculated PCS values for a given residue and
n represents all the residues considered. Nonetheless, equation 1.18 can be adapted for any struc-
tural restraint (Cornilescu et al., 1998; Koehler and Meiler, 2011). Alongside with the Q factor, to
represent the quality of the results, the experimentally acquired restraints are plotted against the
back-calculated values, and the closer the plotted dots are to the diagonal (x = y) the better the fit is.
Q =
vuuut
P
n
(pcsobs   pcscalc)2P
n
(pcsobs)
2
(1.18)
Deriving the Δχ-tensor from RDCs After the development of FANTASIAN, the tool FANTAORIENT
was developed (Banci et al., 1998a) which performed the determination of the Δχ-tensor based on the
experimental acquired RDCs, instead of the PCSs. Due to their nature, PCSs and RDCs nicely comple-
ment each other; PCSs are very robust in deriving the accurate Δχ-tensor parameters of the paramag-
netic center because they are virtually not affected by localized mobility (Figure 1.8), therefore, they
can accurately position the HN protons with respect to the paramagnetic center and vice-versa. On
the other hand, the RDCs can correctly orient the H-N vectors in the anisotropy frame (Figure 1.7). It
is important to highlight the study of Bertini et al., 2001d, in which the contribution of the different
paramagnetic restraints to structural definition was assessed, where it was proved that the PCSs and
RDCs have the largest contribution.
AnisoFIT and the WeNMR GRID-Enabled Web Portal By the time the tools to exploit NMR data
were developed, they had to be handled directly on the command line, accessed by some terminal,
which required an experienced user to perform repetitive tasks. Nowadays, the use of such tools is
much more facilitated to external users of the NMR facilities. The WeNMR GRID-enabled web portal
(Wassenaar et al., 2012) gathers many of the NMR dedicated tools available and offers a very user
friendly interface that is pleasant to the eye and efficient in the labor. Among the available tools,
AnisoFIT1 is the one that gathers, in a single application, all the functionalities of FANTASIAN and FA-
TAORIENT along with many other FANTA* tools that were developed over the course of the years and
is, therefore, used preferably to the command line approach.
Other packages The above referred software packages are those that were used to prepare the re-
sults presented in this work. However, other interesting packages were developed to carry the same
functions and even others (Koehler and Meiler, 2011). When dealing with paramagnetic metal cen-
ters, the Δχ-tensor independent parameters can also be extracted from an initial model and a set of
experimental restraints by the programs DIPOCOUP (Meiler et al., 2000), REDCAT (Valafar and Preste-
gard, 2004) and NUMBAT (Schmitz et al., 2008). Otherwise, in the strict case of using alignment me-
dia to generate RDCs (Section 1.7) other tools are available to calculate the alignment tensor: PALES
(Zweckstetter and Bax, 2000), PATI (Berlin et al., 2009) and TRAMITE (Azurmendi and Bush, 2002).
For structure refinement, a PARArestraints module (Banci et al., 2004) was developed for XPLOR-NIH
(Schwieters et al., 2003) analogously to those developed previously for DYANA and CYANA packages
(Banci et al., 1998b; Barbieri et al., 2004).
Remarks It was described here how themeasured paramagnetic restraints, specially pseudocontact
shifts, are in practical terms related with the calculation of solution structures. An accumulation of
1http://py-enmr.cerm.unifi.it/access/index/anisofit
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iterative steps of Δχ-tensor calculation↔ structure refinement is necessary to achieve convergence
of both. The number of steps will mostly depend on the accuracy of the starting structure or ensem-
ble. The reader is referred here to some important reviews (Bertini and Luchinat, 1999; Bertini et al.,
2002b, 2005, 2008a). Despite the great contribution of paramagnetic restraints to the precision of the
ensembles obtained, there is still a dependence on the use of diamagnetic restraints such as NOEs and
torsion angles to drive the overall shape of the macromolecule in de novo calculations. Nonetheless,
some recentworks attemptedwith success to solve protein structures based only on paramagnetic re-
straints (Hus et al., 2000) and on the sole combination of PCSs and backbone chemical shifts (Schmitz
et al., 2012).
1.6 Paramagnetic Probes in NMR for Structural Biology
In the previous sections we elucidated the magnetic susceptibility tensor (χ-tensor), and also the na-
ture of the anisotropic magnetic susceptibility and how it is expressed in the presence of an external
magnetic field. The presence of magnetic anisotropy in a sample inside a magnetic field generates
changes in the NMR spectra that can be exploited for the structural information that they carry; the
three most commonly observed restraints are PCSs, RDCs and PREs (Section 1.4). Initially, the pres-
ence ofmagnetic anisotropy was explored in proteins that naturally carry a paramagnetic center, such
as Cytochromes (Arnesano et al., 2006). The treatment of paramagnetic restraints for structure eluci-
dation enjoyed great improvement during the late 90’s (see Section 1.5.2) and consequently an urgent
need emerged to introduce paramagnetic properties to otherwise diamagnetic proteins. For proteins
with metal binding sites, naturally occurring metals could be straightforwardly substituted by Lan-
thanide(III) ions, Section 1.3.1 (Bertini et al., 2004a). On the other hand, for proteins which it is not
possible nor desirable to do so, several strategies for introducing paramagnetic centers have been
proposed. Such strategies comprehend approaches such as: i) covalently attached small synthetic
compounds that carry a paramagnetic center, ii) functionalizing the protein with a whole metal bind-
ing peptide domain, iii) soluble paramagnetic synthetic tags, iv) small nitroxide-spin labels, v) andmore
recently tags bound to unnatural amino-acids. In this chapter all these different strategies are summa-
rized, as well as, the results obtained in the literature. Special focus is given to the magnitude of the
generated Δχ-tensors as well as comments on tags’ strengths and weaknesses. The different strate-
gies will be commented in different subchapters but it is necessary to bear in mind the chronological
relationship that entangle them all.
1.6.1 Small Synthetic Metal Binding Tags
1.6.1.1 Covalently Cys-attached Tags
Small synthetic compounds that chelate paramagnetic metal ions have been used and strongly devel-
oped in the recent years as tools to introduce paramagnetic properties in proteins. These tags have
small molecular weights and so, are unlikely to interfere with the system’s function. Also, they can
be rapidly improved because coordination chemistry is a vast field of knowledge and in constant de-
velopment. These small tags can coordinate many ions, from transition metals to Lanthanides, and,
therefore, be tuned to the desired paramagnetic effect (Section 1.3).
As the title of the section indicates (Covalently Cys-attached Tags), the macromolecules are func-
tionalized with this type of tags via disulfide bridges (S-S). On one hand, the tag is composed of a
chelating moiety linked by a chemical arm to one or two S-S bonds with a leaving group, usually a
sulfinic acid (SO2Me) group or a 2-pyridylthio group. On the other hand, the protein has to be engi-
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Figure 1.10: Schematic coupling reaction between a tag and an engineered protein. The tag R carries
the S-S bond with a leaving group, while the protein P performs the S- nucleofilic attack.
neered so that one (or two) of the surface amino-acids is mutated to a cysteine. Normally, naturally
occurring surface cysteines are a nuisance and have to be mutated to serines. The attachment pro-
tocol is somewhat straightforward, the reaction between the tag and the protein will occur sponta-
neously by the well known reaction of thiol-disulfide exchange (Gilbert, 1990, 1995; Smith et al., 1975;
Zecherle et al., 1992). Figure 1.10 schematizes this reaction for a case of a tag with two attachment
points. Strategies for tag attachment are deeply discussed within context in CLaNPs developments
and characterization.
EDTA-based chelating tags EDTA-Iron complexes covalently attached to proteinswere initially used
in the late 80’s early 90’s to study protein-DNA interactions (Ebright et al., 1992; Rana and Meares,
1991). These studies inspired the later use of EDTA-based tags to introduce paramagnetic properties
in diamagnetic proteins (Rodriguez-Castañeda et al., 2006). So, an EDTA-based tag is composed of an
EDTA chelating moiety, a linker and an S-S functionalization bond (Figure 1.11).
The use of EDTA-based tags was firstly tested in the protein Barnase (Dvoretsky et al., 2002; Gapo-
nenko et al., 2000b; Figure 1.11a-b) and later used to define the orientation of the STAT4NT homod-
imer (Gaponenko et al., 2002, 2004) and the structure of the solvent exposed loop in the ArgN protein
was refined with paramagnetic restraints (Pintacuda et al., 2004b). These initial studies represented
the proof of concept that such approach could be used to improve the quality and quantity of the
paramagnetic-derived information possible to extract from NMR analysis. Despite that, this approach
was still at its beginnings. The magnitude of the restraints collected was small, RDCs ranged 3-4 Hz
and PCSs were mainly in the order of 0.2-0.3 ppm with the exception for (Co)EDTA-Barnase which
generated PCSs of 2 ppm; nevertheless, paramagnetic relaxation enhancements were measured for
(Mn)EDTA~ as far as 46 Å from the metal center. This EDTA-based tag displayed chirality when bound
to Lanthanides, which resulted in two different anisotropy tensors present in solution and the con-
sequent splitting of the peaks (Ikegami et al., 2004; Rodriguez-Castañeda et al., 2006). Also, EDTA
contributes with just six coordination sites for binding Ln(III) ions instead of the required nine; the low
affinity of EDTA for Ln(III) hindered its use (Pintacuda et al., 2004b).
In order to solve the isomerism issues, a modification to the EDTA tag was proposed (Ikegami et
al., 2004; Leonov et al., 2005). Changing the linker of EDTA C-1 position to a linker with defined stere-
ochemistry and equal to the linker in the C-2 position (Figure 1.11c-d), it was possible to obtain two
EDTA-based tags, one (R,R) and one (R,S), that present only one stereoisomer when strongly bound to
Lanthanides(III).With these tags, RDCs ranging from5 to 8Hzwere obtained. However, having a single
methanethiosulfonyl (MTS) linker as attaching point to the protein, the tag still presented strong mo-
bility with respect to the protein frame. This motion was later considerably reduced by changing the
linker to others with less spatial mobility (Figure 1.11e-f) and PCSs as high as 0.5 ppm were observed
(Haberz et al., 2006).
Nowadays, EDTA-based tags continue to be used in DNA-protein studies (Iwahara and Clore, 2010;
Iwahara et al., 2003, 2004b), relaxation studies in solid-state NMR studies (Nadaud et al., 2009), and
in studies of oligosaccharide dynamics (Erdélyi et al., 2011; Yamamoto et al., 2011) and have also suc-
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Figure 1.11: The different EDTA-derivatives used for NMR in structural biology as described in the
text.
ceeded in inducing multiple alignment of membrane proteins (Kamen et al., 2007).
Figure 1.12: CLaNP-1: the chemical
structure of bis(MTS) derivative of DTPA.
Dots represent the atoms involved in
Ln(III) coordination.
CLaNPs developments and characterization The devel-
opment of EDTA-based tags and the many other strategies
(detailed in their respective chapters) prompted the devel-
opment of a family of small synthetic Lanthanide(III) bear-
ing tags, named CLaNPs (Cage Lanthanide NMR Probe),
that pioneered the joint contribution of five main char-
acteristics: i) selective reactivity with engineered cys-
teine (Cys) residues in the protein’s surface, ii) capacity to
strongly hold Ln(III) ions that are capable of both short and
long range restraints, iii) no significant distortion of the
protein structure, iv) negligible mobility within the protein
frame, avoiding observable averaging and v) no isomerism,
leading to a single anisotropy tensor present in solution.
CLaNPs acquired great importance in the field and, because one of them was the basis of the exper-
imental part of this doctoral thesis, a special attention to the development of this family of tags is
given here.
The first published CLaNP2 (Prudêncio et al., 2004), CLaNP-1, was based on a modification of the
DTPA (diethylene-triaminepentaacetic acid) chelating agent. DTPA was chosen because of its high
capacity to strongly coordinate Lanthanides, its high solubility and the ease to be modified. The car-
boxylate end groups of DTPAwere functionalizedwith S-(2-methylaminomethyl)methanesulfothioate
(MTS) – bi-amide-bis(MTS)-DTPA (Figure 1.12). As we will see, bis-MTS functionalization is common to
all CLaNPs developed so far.
2The term CLaNP to refer to all CLaNPs (-1, -3, -5 and -7).
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Figure 1.13: Ideal positions for (Ln)CLaNP attachment. The amino-acids to mutate are displayed as
sticks over a cartoon represented protein backbone. The α-helix and the β-sheet are highlighted in
dark gray. A) on an α-helix: two consecutive residues on the same phase and pointing outwards to
the solution. B) on a β-strand: two consecutive residues pointing outwards to the solution. Residues
represented areHis132/Lys136 for A) and Thr148/Thr150 for B) of theHumanFibroblast Collagenase (PDB
Code: 1HFC).
The sulfotioate groups of the MTS arms are able to react selectively and quantitatively with free
sulfydryl (-S-) groups present in solution; these correspond to the cystein residues engineered on the
surface of the protein. After reaction of the probe with the protein, a disulfide bridge will be formed
between each arm of the bis(MTS)-CLaNP1 and each Cys on the surface (Figure 1.10), and the reaction
will release two sulfinic acid groups as side product.
The surface Cys residues can be introduced in the protein through selective mutations, while nat-
urally occurring surface Cys that are not favorable to the study can, in principle, be mutated to serine
residues without structure disruption in order not to interfere in the tag attachment. The engineered
Cys residues should be placed such that they distance 6-10 Å from each other with their side chains
pointing towards the solvent. To increase the rigidity between the tag and the protein frame, the dou-
ble Cysmutation should be placed in a secondary structure, α-helix or β-sheet, that is, two consecutive
residues with the same phase on an α-helix or two consecutive residues pointing in the same direction
on a β-sheet (Figure 1.13). Attaching the tag to flexible regions should be avoided because relative
mobility between the tag and the protein would decrease the accuracy of the observed data (refer
to Mobility that affects PCSs on page 13). However, the authors (Prudêncio et al., 2004) did attach
CLaNP-1 to a loop of Pseudoazurin (Psaz), and by that time they didn’t make any comment on it.
In the CLaNP-1 first publication (Prudêncio et al., 2004), the authors were able to observe strong
pseudocontact shifts up to 40 Å away from the metal center of the double cysteine mutant of Psaz,
(Yb)CLaNP-dCPsaz. However, several shifted peaks were observed for each amide proton across the
whole protein. This behavior derives from the various isomeric forms that bis(MTS)-DTPA is able to
adopt for ions with high coordination number, such as Lanthanides. Upon binding to the protein the
bis(MTS)-DTPA becomes part of a cyclic compound that can have up to eight diastereomers and con-
sequently originates different orientations of the magnetic susceptibility tensor (χ) (Geraldes, et al.,
1993; Merbach, et al., 2013). These different orientations of χ affect the way the protons’ resonances
feel the paramagnetic metal ion, thus the magnetic contribution of the paramagnetic center to the
field experienced by the protons will be different for each isomer. In the case of PCSs, different val-
ues are observed for the same amide proton. In this first work on (Yb)CLaNP-dCPsaz, the authors
were able to overcome this splitting issue and calculate the tensor for the three most abundant di-
astereoisomers, however, not straightforwardly.
In conclusion, CLaNP-1 revealed itself as a very promising beginning for what would become the
CLaNP project, because it generated large and long range proton PCSs without internally incorpo-
28 CHAPTER 1. PARAMAGNETIC NMR
rating Lanthanides into the protein (Allegrozzi et al., 2000). Such approach would, in principle, allow
the measurement of paramagnetic NMR observables in proteins independently of their intrinsic mag-
netism –measurement of RDCs and PREswas also envisaged by the authors. Despite the promising re-
sults, CLaNP-1 still carried the side effect of coordination isomerismwhich originated several χ-tensors
in solution and carried the consequent detrimental effects of peak superimposition and intensity loss;
such issues would be overcome in the successive CLaNP versions.
Figure 1.14: Chemical structure of
CLaNP-3 (Vlasie et al., 2007). The
SO2CH3 are the leaving groups for the
tag-protein reaction - refer to Figure
1.10.
The successor of CLaNP-1 was CLaNP-3 (Vlasie et al.,
2007). Differently from the former, which was based on
a DTPA chelating group, CLaNP-3 was based instead on
a DOTA (DOTA=1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetraacetate)macrocyclic chelator (Figure 1.14). The probe
CLaNP-3 aimed mainly at overcoming the χ-tensor mul-
tiplicity that was observed in (Ln)CLaNP-1. DOTA-based
complexes display several isomers in solution organized
in two enantiomeric pairs of diastereoisomers, as earlier
observed and described by NMR data (Aime et al., 1997;
Desreux, 1980; Merbach, et al., 2013). After attaching the
(Ln)CLaNP-3 tag to the variant of pseudoazurin, the com-
plex displayed four distinguishable isomers and different χ-tensor species were observed in similarity
to (Ln)CLaNP-1. Four possible χ-tensors could be foreseen, however, only two were observed; this
event, according to the authors, depended on two different exchange regimes, the macrocycle iso-
meration and the arm rotation, of which only one is observed in the 1H dimension (Merbach, et al.,
2013). This χ multiplicity into two species was observed to be mild and even absent in many proton
resonances across the protein, which indicates that the two χ-tensors were significantly similar in ori-
entation. In conclusion, CLaNP-3 representeda significant improvement toCLaNP-1because it renders
spectra easier to analyze, but there were still different χ-tensors present in solution. Improvements
could still be made on the following versions of CLaNP tags.
Polásek et al., 2004, developed Lanthanide(III) complexes of a pyridine N-oxide analogue of DOTA
(H3DO3A-pyNox) that expressed a single square antiprismaticM isomer in solution; it served as the ba-
sis for the development of a latter CLaNP version, CLaNP-5 (Keizers et al., 2007). The H3DO3A-pyNox
was functionalizedwith anotherpyridineN-oxide ring for symmetry reasons and theS-(2-methylamino-
methyl)-methanesulfothioate (MTS) arms were also inserted into the complexing molecule for later
anchoring to theengineered cysteines. Twovariants ofCLaNP-5wereprepared: a) CLaNP-5.1withonly
one MTS derivation and b) CLaNP-5.2 with two MTS functional arms (Figure 1.15). Both CLaNPs were
attached to single E51C and double E51C/E52C Pseudoazurin (Psaz) mutants, respectively, and PCSs
and RDCs were measured. The observed PCSs were 2-4 times higher for (Ln)CLaNP-5.2-Paz than for
(Ln)CLaNP-5.1-Paz. It was rapidly evident that the paramagnetic observables arising from (Ln)CLaNP-
5.1-Paz mutant suffer from severe averaging due to the higher mobility between the probe and the
protein because of its single point of attachment. Much larger PCS and RDC values were observed
for the double point of anchoring tag, (Ln)CLaNP-5.2, when compared with (Ln)CLaNP-5.1 and other
inorganic tags (Rodriguez-Castañeda et al., 2006). CLaNP-5.2 proved, to be superior to CLaNP-5.1, the
former took the lead and was thereafter named only as CLaNP-5.
In a more detailed analysis and description of CLaNP-5 (Keizers et al., 2008), the PCS-derived χ-
tensors for four different Lanthanides were calculated and their reproducibility examined by anchor-
ing the probe to different positions on Psaz protein (L8C/K10C, E51C/E54C, and D100C/S104C). The
conclusiondictated that theαandβEuler angleswere similar for all Ln(III) ions,meaning that theprobe
is the major determinant of the tensor orientation and that the tensors parameters (∆χax, ∆χrh) are
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Figure 1.15: The molecular structures of: left) CLaNP-5.1 and right) ClaNP-5.2. After Keizers et al.,
2008, CLaNP-5.2 became known just as CLaNP-5.
kept independent from the probe position and the chemical environment on the protein surface. The
(Gd)CLaNP-5 position based on PRE data, instead of PCS, and the fluorescent properties of (Eu)CLaNP-
5 were also addressed by the authors (Keizers et al., 2008). The main drawback of (Ln)CLaNP-5 tag is
its intrinsic +3 charge, that, when attached to the protein, alters its overall chargewhich can eventually
influence the protein’s interaction with potential partners. For this reason, it is important to choose
positively charged residues to mutate to Cys so that the overall charge is compensated.
In conclusion, it was experimentally demonstrated that CLaNP-5 yields paramagnetic restraints
(PCSs, RDCs and PREs) of very high quality that derive from i) the rigid anchoring of the probe in the
protein frame through twopoints of attachment, ii) the presence of only one isomer in solution, mean-
ing that all data can fit one single χ tensor, iii) the nature of the probe, a DOTA-based compound that
can coordinate all the Lanthanide series ions without changing its chemistry, and by these means,
CLaNP-5 can be tuned to the desired paramagnetic strength, iv) the characteristics of the χ tensor
which depend solely on the probe chemistry and metal used, as they are independent of the protein
environment. The latter characteristic renders paramagnetic observables predictable, which makes
this probe a very versatile approach to study a large variety of systems, even in very large protein-
protein complexes where the tridimentional structures are unknown. Since its development, CLaNP-5
has been used in studies of protein internal dynamics (Dasgupta et al., 2011; Hass et al., 2010; Xu et
al., 2009), and protein-protein interactions (Keizers et al., 2010). The (Ln)CLaNP-5 was the chosen tag
to accomplish the studies proposed in this thesis.
Figure 1.16: The structure of CLaNP-7.
The pyridine-N-oxide groups in CLaNP-5
(Figure 1.15) are substituted by two p-
nitrophenol groups.
Very recently a new version of CLaNP was published
– CLaNP-7, Figure 1.16 (Liu et al., 2012). The structural
difference between CLaNP-5 and CLaNP-7 is the substitu-
tion of the pyridine-N-oxide groups in the former by two p-
nitrophenol groups (Woods et al., 2004) in the latter. This
confers a yellowcolor to the tagwhichmakes theNMRsam-
ple preparation more comfortable. The chemical substi-
tution of the pyridine-N-oxide by the p-nitrophenol rings
gives the tag an overall charge of +1/0 when binding to a
Ln(III) ion, which is an advantage compared to the+3 charge
in CLaNP-5. This variance of +1/0 charge derives from the
CLaNP-7 chemical configuration that allows the coordina-
tion of a H2O or an OH- molecule to the ninth position of the coordination sphere. The PCSs and RDCs
of (Yb/Tm)CLaNP-7weremeasured in different Psaz andCytochrome c (Cyt c)mutants and the authors
concluded that the tensor magnitudes are very close, although slightly smaller, to the Δχ-tensors ob-
tained for (Ln)CLaNP-5. Moreover, the two tags presented different tensor orientations and for this
reason they can be used to obtain different sets of restraints from the same couple of mutations. It
has also concluded that CLaNP-7 is rigidly held within the protein frame and adopts only one isomer.
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Apeculiar behaviorwas detectedwhen attaching (Yb)CLaNP-7 to the Cyt cN56C/L58C. The authors
obtained different sets of PCSs and RDCs when experimenting different pH values in the sample, and,
consequently, different Δχ-tensors could be calculated. The authors proved that the presence of a
histidine residue in the vicinity of the tag renders its magnetism pH sensitive. CLaNP-7 changes slowly
between two SA enantiomers, Δλλλλ and Λδδδδ, that yield identical PCSs but, when a neighboring
histidine binds to the H2O/OH molecule at the ninth coordination position, it breaks the symmetry
between the two enantiomers. The protonation state of the ε2 proton of the histidine favors either
one or the other enantiomer, but both species are always present. The authors proved that the pH
dependence effect can be shifted on and off by selective His/Ala mutations.
CLaNP-7 proved to be an attractive complement to CLaNP-5, as together they yield different Δχ-
tensors and therefore more structural restraints can be obtained from the same pair of mutations;
(Yb)CLaNP-7 can be further tuned by the sample pH, when in presence of a helper His residue, yielding
extra sets of restraints. The reduced charge renders the tag-protein complex closer to the natural
state.
OtherDOTA-based LanthanideChelating Tags The cyclen derivativeDOTA (1,4,7,10-tetraazacyclo-
dodecane-1,4,7,10-tetraacetate) is highly suited for Lanthanide Chelating Tags (LCTs) because of its
strong affinity towards Ln(III) ions, in the order of 10-25 to 10-27 mol.L-1 (Rocklage and Watson, 1993).
Also, we have seen that CLaNP-5 has been established as a very versatile and robust Lanthanide chelat-
ing tag. However, a major drawback is inherent to the probe, as its use requires two free solvent ex-
posed cysteines on the surfaceof theprotein. As alternatives, otherDOTA-based Lanthanide chelating
tagswithonlyoneanchoringarmandbulkier substituentsweredeveloped: theM8-SPy tag (Häussinger
et al., 2009) and the C1 tag (Graham et al., 2011) (Figure 1.17).
Figure 1.17: a) the Δ(δδδδ) [Dy(M8-SPy)], also known as DOTA-M8 and b) the C1 tag.
DOTA M8-SPy tag (Häussinger et al., 2009) consists of an eight-fold stereospecific methyl deriva-
tive of the DOTA moiety (Figure 1.17a) that can coordinate Lanthanide(III) ions, displaying a single
Δ(δδδδ)-configuration in solution. M8-SPy presents an extremely high affinity towards Ln(III), in fact
the authors claim that they were not able to dissociate the (Ln)M8-SPy complex once formed. This
makes M8-SPy a tag suited for any kind of buffer conditions and studies, even in extreme conditions
such as those required for protein denaturation. The eightmethyl groups greatly renderM8-SPy a very
bulky tag, which, coupled with polar and hydrophobic interactions between the tag and the protein,
render it rigidwithin the protein frameup to a considerable extent. PCSs as high as 5 ppmandRDCs up
to 20 Hz were observed for (Dy)M8-SPy-Ubiquitin; derived axial components of the Δχ-tensor ranged
from 30 to 40 10-32m3. The M8-SPy tag presented paramagnetic effects comparable to CLaNP-5 and
to systems were the Ln(III) ion is buried inside the protein structure after substitution of a naturally
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occurring metal. Nevertheless, the authors did identify mobility of the tag, which was observed by
reduction of the Δχ-tensor with temperature increase and a presence of a second species due to cis-
trans isomerazation of the linker’s peptidic bond. The authors claim that modifications in the linker to
improve the tag’s rigidity are on the way.
Later, in 2011, a newDOTA-based tag (named C1) was proposed (Graham et al., 2011; Dickins et al.,
2003)whichwasbasedona cyclenwith three chiral groupsof (S)-2-Bromo-N-(1-phenylethyl)acetamide
and anon chiral pedant arm for cysteine attachment (Figure 1.17b). TheC1 tagwas reported to acquire
a single enantiomeric conformation in solution when bound to Ln(III) ions and, even at high tempera-
tures a single species was always observed, in contrast to what was observed for the M8-SPy tag. The
bulkiness created by the (S)-1-phenylethanamine arms restricts the motions of the (Ln)DOTA moiety,
rendering it fixed relative to the protein frame. Δχ-tensors derived for different Lanthanides were
considerably high, with a maximum |Δχax| for Tm(III) of 37 (10-32m3) and RDCs measured over 20 Hz,
and the authors concluded that high quality restraints could be obtained. To note, a surprisingly high
Δχ-tensor for Yb(III) was observed. The alignment tensors for the different Lanthanideswere found to
have the same orientation in the C1 tag, and different alignments could be obtained using a tag with
opposite chirality, using (R)-1-phenylethanamine instead of (S)-1-phenylethanamine.
Despite the recentness of the C1 tag, it has been already used in many studies, such as studying
the folding of proteins (de la Cruz et al., 2011), measuring high-precision distances by EPR (Kaminker
et al., 2012; Yagi et al., 2011) and probing structural conformation changes of proteins upon substrate
binding (Jaudzems et al., 2012).
Dipicolinic acid derivative tags In parallel to the development of DOTA-based lanthanide chelating
tags, small dipicolinic acid (DPA) derivative tags were conceived for the same proposes. Up to date,
fivemain tags have been used, their structures are summarized in Figure 1.18 (Jia et al., 2011a, 2011b;
Li et al., 2012; Man et al., 2010; Su et al., 2008b).
Figure 1.18: DPA-derivative tags. a) 4MDPA b) 4MMDPA c)MDPA d) vynil-4MMDPA e) maleimide-
4MMDPA.
Dipicolinic tags are meant to bind to proteins through one single cysteine but they can, however,
mimic double anchoring properties because they chelate lanthanide ions with nanomolar affinity and
still leave free ligand sites that can be further exploited for coordination by a carboxyl group from a
side chain of a neighboring amino acid. For this, the cys residue is usually engineered 5-6 Å nearby a
glutamate or an aspartate. DPA-tags have very low molecular weight with linkers of only one or two
rotatable bonds, thus diastereomers are absent in the DTP-protein adducts and a single Δχ-tensor
is present in solution. Their small size also reduces the likelihood of their interference with protein
structure and interactions. DPA-tags display axial components of the Δχ-tensor that are on average
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half (for 4MMDPA) or less than half (for 3MDPA and 4MDPA) of other more potent tags, usually |Δχax|
ranges between 5 and 10 (10-32m3). Observed PCSswere usually smaller than 1 ppmand inducedRDCs
less than 5Hz.
Differently from the traditional S-S bridge formation, an alternative strategy of tag-protein attach-
ment based on a thiol-ene reaction was proposed for vinyl-4MMDPA (Figure 1.18d) and maleimide-
derivatives (Figure 1.18e) (Li et al., 2012). The nature of this reaction consists on tethering the tag
and the protein through an R’C-SR” bond, which is inert even in the presence of DTT or TCEP, thus
prolonging the life of the adduct. Themaleimide derivative displayed critical chirality and consequent
diastereomers were found in solution; and thus its use was discarded.
As overall conclusion, despite the differences in affinity and Δχ-tensors between the DPA-tags, all
of them are reliable for generating paramagnetic constraints in diamagnetic proteins and they very
well complement each other by generating Δχ-tensors of different orientations and strengths. They
needonly one cysteine to bind proteins, but they depend also on the presence of a neighbor side-chain
carboxylic group; it is therefore very difficult if not impossible to predict with precision the paramag-
netic properties of these tags. 4MDPA displayed tensors similar to 3MDPA or 4MMDPA depending on
the protein to which it is attached. It is also necessary to consider that the experiments presented
in the literature were run in the presence of an excess of free Lanthanide(III) species. This must be
underlined as a drawback depending on the system under study. (Gd)4MMDPA tag has been also used
to measure nanometer-scale distances by EPR (Potapov et al., 2010). Up to now, DPA-tags have not
been reported in studies with other macromolecules other than proteins.
IDA-SHandNTA-SHLanthanide tags Minimalmolecularweight Lanthanide chelating tags have also
been proposed: a derivative of the tridentate chelator iminodiacetic acid (IDA) and cysteine, referred
as IDA-SH (Swarbrick et al., 2011a), and a hybrid between the tetradentate chelator nitrilotriacetic acid
(NTA) and cysteine, referred as NTA-SH (Swarbrick et al., 2011b) (Figure 1.19). These two tags have low
affinity towards Lanthanides and were, therefore, devised to perform exchange experiments where
both diamagnetic and paramagnetic species are recorded simultaneously. This is accomplished by
introducing twoLn(III) species, a diamagnetic [Lu(III) or La(III)] and aparamagnetic [Tm(III), for instance]
(John et al., 2007a, 2007b, 2007c).
Figure 1.19: a) IDA-SH b) NTA-SH, derivative tags.
Even if exchange experiments are not intended, the necessary presence of free Ln(III) ions (up to
6 equivalents) can constitute a severe disadvantage if the system in study does not tolerate such con-
ditions. In similarity with the DPA-derived tags, the IDA-SH and NTA-SH tags attach to a single surface
cysteine and require the presence of a negatively charged carboxylic group from an aspartate or a
glutamate residue to assist in the coordination of the Lanthanide(III) ion. This extra coordination is es-
sential to hold the tag rigid with respect to the protein and to favor the anisotropy of the Lanthanide
so that a significant paramagnetic effect can be observed. The authors of these tags later published
an assay on the best strategies for their use (Yagi et al., 2013). It was concluded that IDA-SH has prefer-
ence for an aspartate residue in the close vicinitywhile theNTA-SH tag has preference for a glutamate.
It is necessary to consider that both aspartate and glutamate residues, if not naturally present, have
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also to be engineered along with the functionalization cysteine.
Contrarily to what occurs for DOTA-derived tags (detailed on previous sections), the expressed Δχ-
tensor of IDA-SH andNTA-SH tags highly depends on the chemical environment around the tag, as very
different resultswereobtained for theproteins tested. Also, thePCS-basedposition calculated for the
different Lanthanides tested significantly varied, in agreement with the unexpected low anisotropies
found for Tm(III), Yb(III) and Er(III) (Swarbrick et al., 2011a).
A double NTA-SH conjugate tag was engineered in Ubiquitin (Swarbrick et al., 2011b). This is a pe-
culiar strategy that can be applied to this kind of tags, creating the possibility to mimic the behavior
of a double anchoring tag; but, consequently, this strategy requires the presence of two surface cys-
teines. In this case, higher affinity towards Lanthanideswasobtained and considerably high anisotropy
tensors were derived. The Lanthanide ions can be removed from the tag by washing with EDTA and a
second functionalization of the sample with another Lanthanide can be performed.
Small tagswith lowaffinities towards Lanthanides, suchasNTA-SHand IDA-SHand theDPA-derivatives,
offer different opportunities that DOTA-derived tags don’t, like performing exchange experiments
and Lanthanide washing. Also these tags have very small molecular weight and are less prone to in-
terfere with the nature of the protein. However, their small affinity towards Lanthanides and the
dependence on a neighbor aspartate or glutamate must be considered when designing the tag strat-
egy.A review on the coordination chemistry of Lanthanide complexes with IDA, NTA and ODA can be
found elsewhere (Kremer et al., 2008).
Figure 1.20: The cya-PH-TAHA tag.
TAHA-derivative tag TheCys-Ph-TAHA (cysteinyl-phenyl-
triaminohexaacetate) (Peters et al., 2011) is a highly sym-
metric tag that yields a single Δχ-tensor in solution when
bound to Lanthanides; it offers nine coordination sites and
forms stable complexes with affinities in the femtomolar
range (Viguier et al., 2001); refer to Figure 1.20. It is stable
at different temperatures and can functionalize the pro-
tein quantitatively with no diamagnetic traces observed.
The attachment protocol is the same as represented in Fig-
ure 1.10 but with just one attachment point.
The tag was firstly tested on Ubiquitin (T12C and S57C)
with both Tm(III) and Tb(III). The obtained axial components of the PCS-derived Δχ-tensors ranged
from12 to 17 (10-32m3). Themobility of the tag resulted in different calculated positions for themetal
center but this could be corrected by using a common position for both Tm(III) and Tb(III). Similarly to
M8-SPy (Other DOTA-based Lanthanide Chelating Tags on page 30), it was also observed in one of the
mutants a second paramagnetic species (2%), that did not increase with temperature. The different
mutants tested revealed different alignment tensors. The weaker alignment obtained is due to the
mobility of the tag inherent to a single point of attachment, which in the case of Cys-Ph-TAHA (S57C-
Ubiquitin) and also depends on the neighboring protein’s surface. The tag was also attached to the 90
kDa ternary complex of LacR/DNA/IPTG. Relevant quality datawas obtained, but the results regarding
the paramagnetic effects are yet to be published.
In conclusion, the authors (Peters et al., 2011) state that: Cys-Ph-TAHA is easy to synthesize, can be
attached quantitatively to a single cysteine residue, reproduce good quality PCS and RDC data, there
is no significant contribution of other anisotropic species and has excellent thermal stability. On the
other hand, as disadvantages: i) the tag also revealed some mobility that is necessary to consider, ii)
is not stable at denaturating conditions of pH, iii) display small susceptibility tensors when compared
to CLaNP-5 (Keizers et al., 2008) and M8-SPy (Häussinger et al., 2009) and C1 (Graham et al., 2011).
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Nevertheless, its use on LacR suggests the great potential of this tag.
Figure 1.21: The 4VPyMTA tag.
4VPyMTA tag The tag 4VPyMTA was published very re-
cently (Yang et al., 2013); Figure 1.21. This small molecular
weight symmetric tag has seven coordination ligands and
binds to Ln(III) ions with very high affinity (Ka > 10-18 M-1)
(Pellegatti et al., 2008), and only one anisotropic species is
observed in solution. It tethers to the protein to a single
point of attachment (cys) through a thiol-ene reaction – a
similarity to vinyl-4MMDPA (1.6.1.1 - Dipicolinic acid deriva-
tive tags). This kind of tether is inert under reducing conditions, thus the authors claim the benefits of
this tag in studies in situ. Spectra of functionalized Ubiquitin were of very high quality, PCSs could be
extracted and the Δχ-tensor calculated. Values for different Ln(III) ions ranged from 1 to 4.3 (10-32m3).
Considerably different valueswhereobtained for Tb(III) andTm(III), in contrast toother studies (Bertini
et al., 2001b) – Figure 1.2, Section The case of Lanthanide(III) ions. With lower magnitude of param-
agnetism, more peaks are observable because fewer are broadened beyond detection. Despite the
lower Δχ-tensor, the high affinity for Ln(III) ions and the chemical stability of the 4VPyMTA tag makes
its use has to be considered in structural biology studies.
1.6.1.2 Soluble Lanthanide Chelating Tags
Overview Soluble Lanthanide(III) ions chelating probes have been adapted from their use as MRI
contrast agents (Geraldes and Laurent, 2009) to be used in parallel as co-solutes in strategies to screen
protein’s surfaces in solution. Such tags alsopresentedalternatives to theuseof soluble nitroxide-spin
labels – Section 1.6.3, (Bernini et al., 2009; Geraldes and Luchinat, 2003). Figure 1.22 depicts the most
used soluble Lanthanide(III) chelating probes.
Paramagnetic isotropic probes with low or neutral charge and only one inner-sphere free site, in-
teract, in solution, non-specifically with the protein’s surface and a general enhancement in relaxation
occurs for exposed residues (see PRE in Section 1.4.1). Consequently, a protein-protein binding inter-
action can be studied because the interaction surface of both partners becomes solvent-inaccessible
upon interaction. Probes with different characteristics of charge, solubility, polarity and coordination
spheres can be used to tune the experiment conditions according to the study’s aim.
Caged Probes Simple probes like EDTA, DOTA and DTPA ligands (Figure 1.22a-d) have been success-
fully used forprobing the surface interactionbetween the catalytic domainofMatrixMetalloproteinase-
3 and the N-terminal domain of TIMP-1 (Arumugam et al., 1998). DTPA, that has higher affinity for
Ln(III) than EDTA, was used to probe protein’s surfaces (Petros et al., 1990) and to resolve resonances
overlap in 2D spectra (Sattler and Fesik, 1997). DOTA has been used to identify hydrophobic patches in
the proteins’ surface (Dalgarno et al., 1982) andmore recently to characterize the mixed DHPP/OmpX
micelle (Hilty et al., 2004). The neutral bismethylamide derivative of DTPA, [Gd(DTPA-BMA)(H2O)] (Fig-
ure 1.22d), do not show specific interaction with the protein surface (Pintacuda and Otting, 2002) and
was used to probe the interaction surface of the ERp29 dimer (Liepinsh et al., 2001), the binding of
HoxD9 to DNA (Iwahara et al., 2006) and the aggregation of the bovine pancreatic trypsin inhibitor
(Bernini et al., 2006a). More recently, a large molecular size probe with two Gd(III) ions complexed,
Gd2L7(H2O)2 in Figure 1.22e, was proposed as a very promising probe to study nascent aggregation
phenomena with the study of hen egg white lysozyme (HEWL) (Bernini et al., 2006b).
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Figure 1.22: a) the EDTA molecule b) the DTPA-molecue c) DOTA-derivative tags d) the DTPA-BMA
derivative e) [Gd2(L7)(H2O)2] f) soluble derivatives of dipicolinic acid tags.
Alternatively, charged probesmay adhere tightly to the protein’s surface and induce localized PREs
or PCSs, if an anisotropic Lanthanide is used. This is the case of Ln(DOTP)5- (Geraldes et al., 1992) that
was usedwith Tb(III) andGb(III) to study the conformational changes of ssDNA-binding gene 5 proteins
(Dick et al., 1989). Positive or negative charged probes can be used selectively in the different charged
partners of an electron exchange complex (Almeida et al., 2011). [Gd(DO3A)(H2O)2], has two free
inner-sphere sites that can be occupied by side chain carboxyl groups, thus acting as a site-specific
probe (Aime et al., 2002).
Soluble dipicolinic acid derivative tags Dipicolinic acid derivative compounds have been used as
Lanthanide carrying tags covalently attached to proteins (Dipicolinic acid derivative tags, on page 31).
However, they can also be used as soluble tags in the formof [La(DPA)3]3- (Su et al., 2009), Figure 1.22f.
The authors shown that this negatively charged tag can bind specifically to positive patches in the pro-
tein’s surface. Such patches were identified as being two neighbor Lys and/or Arg residues whose side
chains point to the same site. An electrostatic interaction holds the tag to these patches with lowmil-
limolar affinity. The authors argue that these tags are useful because no Cys engineering is required
for attachment (Figure 1.10 and CLaNPs developments and characterization, on page 26), however,
it is necessary to engineer positively charged aminoacids (Jia et al., 2011b). On the measurement of
PCSs, the tag showed significant reorientation upon binding which culminated in observed small PCSs
and consequent Δχ-tensors of low magnitude. Nevertheless, [Gd(DPA)3]3- showed a promising use in
PREmeasurement because the magnitude of the induced PRE can be tuned by the tag concentration,
allowing for measurement of both short range and long range effects (Jia et al., 2011b) and is not
affected by reorientation. Modifications in DPA yielded multiple soluble tags with increased affinity
towards positive binding sites in the protein’s surface and which are able to bind at different posi-
tions on the protein (Wei et al., 2013). However, conformation exchange forced the Δχ-tensors to be
averaged to small values, but the PRE measurement strategy, as for [Gd(DPA)3]3-, still hold valid.
36 CHAPTER 1. PARAMAGNETIC NMR
1.6.2 Lanthanide Binding Peptide Tags
Metal binding loops that occur naturally in proteins havebeenwell characterized. Adifferent approach
to introduce paramagnetic properties in diamagnetic proteins consists in mimicking thosemetal bind-
ingpeptidicmoieties and introducing them into theprotein structure, for example, copying zinc-fingers
(Gaponenko et al., 2000b) or EF-hands (Ma and Opella, 2000) or by designing new high affinity binding
loops (Franz et al., 2003; Martin et al., 2005; Nitz et al., 2003, 2004; Wöhnert et al., 2003). The binding
peptide tags are then functionalized with transition metals (Donaldson et al., 2001; Yu et al., 2009) or,
more advantaging, with Lanthanide(III) ions.
Generally, Lanthanide Binding Tags (LBTs) are engineered at the C- or N-termini of the protein but
suchapproaches lead to considerablemotionof the tagdue to thehighmobility of thepeptideextrem-
ities; it was nevertheless possible to measure RDCs of about 8 Hz (Wöhnert et al., 2003). Moreover,
with this strategy, the binding sites are reduced to only two. To improve the efficiency of LBTs in gen-
erating high quality PCSs and RDCs, an enantiomerically pure LBT was attached to ArgN via a disulfide
linkage. The attachment protocol used here is different: the free -SH at the end of the LBT is firstly
activated with Ellman’s reagent, in order to gain a leaving group, only afterwards the LBT-protein at-
tachment follows as explained in Figure 1.10 (Su et al., 2006).
The bulkiness of the LBT rendered it rigid within the protein frame, RDCs up to 21 Hz were mea-
sured, and very high Δχ-tensor were obtained for ArgN-LBP2, Δχax(Dy) = 34.7 and Δχax(Tb) = 45.9
(10-32m3). This ligation approach can also be used to place the LBT in different parts of the protein
(Su et al., 2008a). Later, the quality of a double anchoring point LBT (C-terminus and disulfide bridge)
was also assessed, which yielded an improvement in the observed paramagnetic effect (Saio et al.,
2009), and a consequent successful proof of concept in the determination of protein-protein com-
plexes (Saio et al., 2010). An LBT carrying two Lanthanides was also developed and its alignment ca-
pabilities was assessed (Silvaggi et al., 2007), and it showed an alignment higher than EDTA-based
synthetic tags but lower than the reported -SH linked LBT. LBTs have also been successful in describ-
ing protein-ligand interactions (Zhuang et al., 2008). More recently, LBTs were incorporated inside
protein loops (Barthelmes et al., 2011). The authors measured nM affinities towards Ln(III) ions, RDCs
between 15-20 Hz and Δχax values around 22 (10-32m3), but somemobility was nevertheless detected.
LBTs can also be optimized to enhance the luminescent properties of some Lanthanide ions such
as Tb(III) or Eu(III) (Franz et al., 2003; Martin et al., 2005; Wöhnert et al., 2003) even with the use of
unnatural amino acids (Reynolds et al., 2008). These properties have been explored to study protein
interactions (Sculimbrene and Imperiali, 2006) and also to enrich cellular protein delivery studies (Goda
et al., 2007; Sandtner et al., 2007). LBTs were also envisaged as MRI contrast agents (Daughtry et al.,
2012) and double Lanthanide binding tags (dLBTs) have also been successfully used in aiding phase
solving problems in X-ray structure determination (Silvaggi et al., 2007). The general use of LBTs was
reviewed (Allen and Imperiali, 2010).
1.6.3 Nitroxide-Spin Labels
Paramagnetic centers with isotropic electron spin distribution, Δχ-tensor = 0, have huge PRE contri-
butions (Sections 1.3.1 and 1.4.1), which decreases with the r-6 distance between the nuclei and the
paramagnetic center, and do not cause the appearance of PCSs andRDCs – nitroxide-spin labels, Gd(III)
and Mn(II) ions are major examples of such centers.
As a clarification note, nitroxide-spin labels are stable R2NO• radicals, so they should instead be
termed aminoxyl-spin labels (Bernini et al., 2009), because the term nitroxide suggests the presence
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of a nitro group (-NO2) which is not the case for these compounds3; however, they came to be com-
mercially known as nitroxides.
The use of nitroxide-spin (NO, >N-O•) labels in structural biology is far older and vaster than the use
of Lanthanide carrying probes (Griffith and McConnell, 1966); they have being used as EPR probes to
study local environment (Edwards et al., 2001; Qin et al., 2001, 2003) and measure distances between
two molecular positions (Macosko et al., 1999; Schiemann et al., 2003). In NMR, nitroxide-spin labels
were for the first time used in hen egg white lysozyme (Schmidt and Kuntz, 1984) and were accom-
panied latter by many others that have been also developed (Clore and Iwahara, 2009; Keana, 1978;
Keizers and Ubbink, 2011; Su and Otting, 2010). The NO-spin labels functionalize proteins by disul-
fide bridges with free exposed thiol groups of the protein, as explain in Section 1.6.1.1, Figure 1.10 or
by previous activation as for LBTs – Lanthanide binding peptides (tags). Other attachment strategies
have also been used, like using iodide or maleimide groups that react with free thiol groups in the
protein’s surface but form more stable tethers, in similarity with the DPA-tags – 1.6.1.1 on page 31.
Figure 1.23 shows themost used >N-O• tags that are also commercially available: a) (1-Oxyl-2,2,5,5-
tetramethylpyrroline-3-methyl) methanethiosulfonate, MTSSL (CAS 81213-52-7) (Battiste and Wag-
ner, 2000; Berliner et al., 1982; Gaponenko et al., 2000a) b) 3-Iodomethyl-(1-oxy-2,2,5,5-tetramethyl-
pyrroline) (CAS 76893-33-9) (Hankovszky et al., 1980) c) (1-Oxyl-2,2,5,5-tetramethylpyrrolidin-3-yl)
Methyl Methanethiosulfonate (CAS 201403-46-5) (Mchaourab et al., 1999) d) 3-(2-Iodoacetamido)-
2,2,5,5-tetramethyl-1-pyrrolidinyloxy (3-(2-Iodoacetamido)-PROXYL) (CAS27048-01-7) (OgawaandMc-
Connell, 1967) e) 4-(2-Iodoacetamido)-2,2,6,6,-tetramethyl-1-piperidinyloxy, Iodoacetamido-TEMPO
(CAS 25713-24-0) f) 4-maleimido-2,2,6,6-tetramethyl-1-piperidinyl-oxyl, 4-Maleimido-TEMPO
(CAS 15178-63-9) (Griffith andMcConnell, 1966; Tang et al., 2007) g) 3-Maleimido-2,2,5,5-tetramethyl-
1-pyrrolidinyloxy (Maleimido-PROXYL) (CAS 5389-27-5) (Griffith and McConnell, 1966). A large list of
NO-spin labels are commercially available.
NO-spin labels have been also used as unnatural amino acids, such as the tag TOAC which corre-
sponds to TEMPO functionalized into an amino acid (Karim et al., 2007; Lindfors et al., 2008; Marchetto
et al., 1993), or even as soluble co-solvent approaches, like the compounds TEMPO, TEMPOL and TEM-
PONE (Fesik et al., 1991; Jain et al., 2001; Niccolai et al., 2001; Petros et al., 1990; Scarselli et al., 1999;
Yuan et al., 1999). Other, bolder strategies, have also been used (Dunhamet al., 1998; Hilty et al., 2004;
Kim et al., 2009).
In the case of nitroxide-spin labels, the diamagnetic reference spectrum can be acquired by reduc-
ing the tag with 2-3 fold excess of ascorbic acid or other agents (Kosen, 1989).
1.6.4 Unnatural Amino Acids
In the recent years, the use of unnatural amino acids is growing in several fields of research (Wang
et al., 2006), and they begin to be implemented as strategies to exploit paramagnetic properties
in biomolecules under NMR analysis (Loscha et al., 2012). BpyAla amino acid was incorporated into
the structure of West Nile virus NS2B-NS3 by cell-free expression (Nguyen et al., 2011). The mutant
H87BpyAla bounds the high-spin Cobalt(II) with a dissociation constant of 1.9 µM, which resulted in a
slow exchange between the free and Co(II)-protein and both diamagnetic and paramagnetic species
were observed in the 1H-15NHSQC spectrum. Nevertheless, values of Δχ characteristic of the high-spin
Co(II) were calculated from the high quality PCSs obtained.
Unnatural amino acids have been proposed as anchoring sites for small lanthanide chelating tags,
so to avoid the use of surface artificial cysteine residues. The approach has been testedwith theC1 tag
3UPAC. Compendium of Chemical Terminology, 2nd ed. (the ”Gold Book”). Compiled by A. D. McNaught and A. Wilkinson.
Blackwell Scientific Publications, Oxford (1997). XML on-line corrected version: http://goldbook.iupac.org (2006-) created by
M. Nic, J. Jirat, B. Kosata; updates compiled by A. Jenkins. ISBN 0-9678550-9-8. doi:10.1351/goldbook.
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Figure 1.23: Different commercially available nitroxide-spin labels that are tethered to the protein
through multiple strategies. Names and references where these nitroxide-spin labels have been used
can be found in the text.
(Loh et al., 2013) (recall Section 1.6.1.1 -OtherDOTA-based LanthanideChelating Tags onpage 30, Gra-
ham et al., 2011) which was chemically attached to a p-azido-L-phenylalanine (AzF) by Cu(I)-catalyzed
azide-alkyne cycloaddition click chesmitry. It was necessary to use a longer tag-protein tether to ob-
tain high yields in the tag reaction of ligation. Despite some mobility of the tag, it was possible to
measure significant Δχ-tensors, e.g., Δχax (Tm-Glu18AzF) = 9.7 x 10-32m3, and high quality paramag-
netic data.
Unnatural amino acids that carry a nitroxide radical have also been used – refer to the above Sec-
tion 1.6.3 - Nitroxide-Spin Labels. Recently, multi dentated amino acids for Ln(III) ligation were incor-
porated into an artificial loop binding peptide and used in combination to obtain femtomolar Ln(III)
affinities (Niedźwiecka et al., 2012), but its applicability in paramagnetic NMR has not yet been re-
ported.
1.6.5 Conclusions
Since the theory behind the paramagnetic effects onNMRwas discovered (Section 1.4) and the strate-
gies for its exploitation were developed (Section 1.5), several approaches to induce such paramag-
netism on all kinds of biological systems are being investigated. Today, we can say that a huge library
of approaches to induce paramagnetic effects on NMR spectra is available. Which one is the best? If I
may say it here, I would say none. The nature of the system strongly determines the best approach to
use, and each of themhas its particular advantages and itmight be advantageous to use a combination
of the methods. For this reason, a complete understanding of the possibilities available is necessary
to obtain the best benefit out of them.
1.7 Alignment Media
Residual dipolar couplings arise when the observed molecule slightly reorients inside the magnetic
field (Section 1.4.3). Several diamagnetic strategies, that differ from the paramagnetism-based ap-
proaches, have been explored as vehicles to induce residual molecular alignment. Such strategies are
generally known as alignment media and consist in different phases, like gels, membranes or phages,
that are added to the sample solution. The interaction between the molecular sample (e.g., a protein)
and this alignment phase is responsible for the residual orientation and can be as varied as the type of
interactions that occur between molecules, such as steric (clashes), electrostatic or hydrophobic. The
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chemistry of the phase (alignmentmedia) also defines its stability and behaviour in the sample buffer,
which further determines the obtained alignment.
With the first demonstration of sucessful alignment (Tjandra and Bax, 1997), many different dia-
magnetic alignment strategies have been developed in order to optimize or regulate the induced ori-
entation for the system under study. The symmetry dependence of RDCs demands that several align-
ment tensors are used in combination, so to obtain a singular solution for the orientation of the bond
vector and also information on its dynamics. For this reason, the alignment media have also to be de-
veloped in order to induce alignmentswith different orientations, analogously to the strategy of using
different Ln(III) ions.
The recently developed alignmentmedia canbe summarized as follows: cetylpyridinium-basedme-
dia (Barrientos et al., 2000; Prosser et al., 1998), filamentous phage (Clore et al., 1998c; Hansen et al.,
1998), purple membrane fragments (Koenig et al., 1999), cellulose crystallites (Fleming et al., 2000),
compressed polyacrylamide gel (Tycko et al., 2000), alkyl poly(ethylene glycol) based media (Rückert
and Otting, 2000), strained acrylamide/acrylate copolymers (Meier et al., 2002), embedded filamen-
tous Pf1 phage in polyacrylamide matrix (Trempe et al., 2002), phospholipidic membranes (Lorieau et
al., 2013), lyotropic liquid crystalline phases (Thiele et al., 2011) and others (Dama and Berger, 2012;
Meyer et al., 2012; Trigo-Mouriño et al., 2012). Complete reviews on the properties of alignment me-
dia and the details on the respective sample preparations can be found in literature (Bax et al., 2001;
Fleming and Matthews, 2004; Higman et al., 2011; Tolman and Al-Hashimi, 2003).
1.8 Interdomain Mobility of Proteins: The MaxOcc Approach
Overview In thebeginnings of structural biology, scientists thought that all proteinswere structures
of rigid building blocks necessary to accomplish their catalytic or structural function. However, the
growing knowledge showed over the years that flexibility is necessary for proteins to perform their
functions. In many cases, proteins function as multiple rigid bodies attached by flexible linkers, while
in others, completely unfolded protein structures spontaneously adapt to the needs. The approach
presentedhere, theMaximumOccurrenceapproach, focuson the former cases: multi-domainproteins
that have intrinsic large scale mobility given by a flexible linker.
As it is the scope of this thesis, the study of protein’s interdomain mobility will be approached
by paramagnetic NMR data and techniques. An introductory explanation on the data that can be ex-
tracted fromparamagnetic NMRwas given in Section 1.4. Here some conceptswill be briefly reviewed
and others explained in more detail.
Observing averaged paramagneticNMRdata (PCSs andRDCs) As itwas described, PCSs andRDCs
contain geometric structural information, PCSs mirror the position of the nuclei with respect to the
paramagnetic center (Section 1.4.2) and RDCs contain information on the orientation of a given bond
vector relative to the z-axis of Δχ (Section 1.4.3). We have also seen how localized motions affect
differently the PCSs and the RDCs (Figure 1.8 on page 17). Here, it is important to scale up that notion
to the large motions that occur in interdomain flexible proteins.
So, how can one study the interdomain mobility of proteins? Consider a system with two partners
A and B, where A and B are two domains linked by a short flexible sequence in a multidomain protein
(Figure 1.24). A basic strategy is necessary to be adopted in order to study the intrinsic motion of the
AB system. Firstly, the experimental observation has to be referenced to one of the partners (say A)
so that, afterwards, one can observe the mobility of B relative to A. In this way, it is possible to probe
the interdomain (partner) mobility of the system (Bertini et al., 2008a, 2011; Fragai et al., 2013).
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Figure 1.24: The representation of amo-
bile system AB, in a two-domain pro-
tein. The M represents the paramag-
netic metal, see explanation further in
the text.
We will focus here on the use of PCSs and RDCs ob-
tained from paramagnetic NMR. In order to obtain a com-
plete experimental description of the AB system from
paramagnetic NMR data, the experimentalist has to an-
chor the paramagnetic center to A and measure PCSs and
RDCs on both A and B; the different strategies for para-
magnetic functionalization of proteins have been analyzed
(Section 1.6). If the A and B systems can be well expressed
independently, it is more productive to priorly acquire the
data on the truncated domain (partner)A and then acquire
the whole set of data on the AB system. Recall that, due
to the symmetry dependence of PCSs and RDCs (Section
1.4.3 - Geometric symmetry), at least threemetal ions (Lan-
thanides in the most common case) must be used to over-
come the appearance of multiple solutions (also known as
“ghost” solutions). The PCS-derived Δχ-tensor is more reli-
able because PCSs are not significantly affected by the localized mobility (Figure 1.8 on page 17), we
will refer mainly to it when performing comparisons between derived tensors.
Only when the paramagnetic parameters (Δχax and Δχrh) (Section 1.2) have been derived for the
domain A, and for the different selected metals, the experimentalist can look at the domain B. At
this point two situations can be observed. The first and the simplest situation occurs when the AB
system is totally rigid. This case is identified by the quality of the RDC sets and respective Δχ-tensor
obtained for the domain B, that are necessarily of the same magnitude as those of the domain A. In
order words, the Δχ parameters obtained for domain B are the same as those obtained for domain A.
The same holds true for back-calculated data: using the Δχ-tensors obtained fromA, the experimental
values observed on B can be easily and accurately predicted. Conceptually, in a rigid system, B is just
an extension of A.
The second possible case occurs when the AB domains move with respect to each other. What
will we expect to see in this situation? As in any life observation, here specially in NMR spectroscopy,
what the observer sees results from a contribution of all the states that the observed object acquires
within the time scale resolution of the observation. PCSs and RDCs are no exception to this rule. RDCs
reflect motions that occur any faster than 10-2 seconds, these motions encompass the majority of the
proteinsmotions, and so, large proteinmovements (AB internalmotion)will be expressed as averaged
RDCs which are measured on the B domain. Somewhat similarly, PCSs can reflect time scales faster
than 0.03 seconds at 500 MHz (Fragai et al., 2013). Recall that PCSs are hyperfine contributions and
therefore their time scale subjectivity depends on the external field B0. Either way, 500 MHz is one
of the field strengths most desirable to measure PCSs in large systems (Section 1.4.2 - Choosing the
field to measure PCSs). An important concept is necessary to retain here: in the presence of motion
between A and B, the experimental data that we observe from B, relative to A, is a weighted average
fromall the states that theBdomain samples. This concept is of crucial importance to later understand
the Maximum Occurrence strategy.
In a mobile condition, the observed PCSs and RDCs of the B domain are averages from all the sam-
pled conformations, and because they both range between positive and negative values, they are
constrained to be of lower magnitude when compared to a rigid situation. Consequently, the RDC-
derived Δχ-tensor for domain Bwill be also of lower magnitude than that obtained for domain A. The
decreased magnitude of the RDC-derived Δχ-tensors from B is the first finger print of interdomain
motion. We can estimate the degree of freedom of the two domains by calculating a simple ratio be-
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tween the Δχ-tensors (RDC) [Δχ(BRDC)/Δχ(ARDC)]: the smaller the ratio the higher averaging suffered
by the RDCs and hence the higher the mobility condition. This ratio is termed the order parameter.
After this initial observation, the intrinsic mobility of the AB system can be represented by the
range of RDC values that can be back-calculated for domain B from three different conditions: i) the
PCS-derived Δχ-tensor in the condition of rigidity, ii) the real condition, that is, back-calculating the
RDCs from the RDC-derived Δχ-tensor of the B domain, and iii) a final theoretical condition where
uniform sampling of the all the possible conformations is allowed and hence a minimal range of RDC
values. A histogram is used to depict these three situations, please refer to Figure 4 of Bertini et al.,
2004.
Nevertheless, it is only possible to apply the above referred strategy if thedomainsA andBmoveas
rigid bodies themselves. If significant intradomainmotions occur, like largemobile loops or secondary
structure movements, the derived Δχ-tensors will contain also that information and therefore the in-
terdomain mobility can no longer be derived accurately. How can the experimentalist assure that no
intradomain motions are present? RDCs are distance-independent restraints, contrarily to PCSs and
PREs that decay with distance, and, therefore, if the same motion affects equally all the RDCs, they
can always be fitted to a single alignment tensor. On the other hand, if different intradomain motions
are present in combinationwith large interdomainmotions, it will not be possible to fit thewhole RDC
set to a single alignment tensor (Fragai et al., 2013).
So far, we have conceptualized how the experimentalist can identify the presence of rigid body
interdomain motion in proteins from paramagnetic NMR data, specifically from PCSs and RDCs. It has
been also explained how it can be initially assessed by an order parameter between the Δχ-tensors
derived from the different sets of data. From here, we will continue the explanation on how to use
the PCS and RDC data, and other, to fully detail the interdomain motions of proteins.
Determing the average of motion Many approaches have been developed to assess the average
conformation or dynamics of a multidomain system that can be obtained from average data (Anthis
et al., 2011; Bashir et al., 2010; Bernadó et al., 2005, 2007; Iwahara and Clore, 2006; Lange et al., 2008;
Lindorff-Larsen et al., 2005; Volkov et al., 2006; Zhang et al., 2007). The Maximum Occurrence (Max-
Occ) approach that is described here conceptually differs from the referred above approaches as it
does not determine an average, instead, it determines the weight of each possible conformation as
we will detail now.
The concept of Maximum Occurrence Before explaining the approach itself, it is necessary to un-
derstand the concept it explores. The Maximum Occurrence (MaxOcc) (Bertini et al., 2010; Dasgupta
et al., 2011; Luchinat et al., 2012; Nagulapalli et al., 2012) is an evolution of a previous developed
method termed theMaximumAllowed Probability (MAP) (Bertini et al., 2004a, 2007, 2008a). TheMax-
Occ approach aims at determining the maximum contribution that a given conformation, considering
a mobile system (AB), can give to the observed averaged data. By this means, at the end of the anal-
ysis, the MaxOcc output will be a given number (not an ensemble) of conformations (generally 1·000)
that describe the complete and possible conformational space that the system can sample. To each
conformation it will be attributed a given MaxOcc value derived from the calculations. This MaxOcc
value is actually themaximumweight at which the corresponding conformation could fit an ensemble
of conformations that describes the complete conformational space without increasing a given target
function above a certain value (to be explained further). The MaxOcc value is represented as percent-
age (%), where 0% is an absolutely absent conformation and 100% corresponds to the existence of a
single conformation (the case of a rigid system). It is also necessary to understand that the MaxOcc
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value represents a maximum, that is a ceiling, for each conformation and, therefore, many conforma-
tions can have, for instance, a MaxOcc value of 50%. In other words, the MaxOcc approach will unveil
the conformations that can exist for longer times in solution within the mobile systemAB. It does dif-
fer from the other approaches above referred that aim to describe a mobile system by obtaining few
or single average conformations.
The restraints inputted in MaxOcc In order to perform the MaxOcc calculation it is necessary to
give an input that contains information on the conformations that are sampled by the AB system. So,
according to the previous explanation, the MaxOcc calculation will have as input the PCS-derived Δχ-
tensor from domain A and the PCSs and RDCs observed for the mobile domain B. It can also have
as input SAXS data, that have been shown to be relevant in the calculation process. Paramagnetic
relaxation enhancements can also be inputted (Bertini et al., 2012a), but its use is somehow limited
to their decay with the r-6, and therefore if the domain B is too far from the paramagnetic tag, its use
might be neglected. A specific weight is attributed to each set of restraints at the input step, and this
will correspond to specific multiplication factors in the final target function (see later equation 1.19).
This weight attributed to each kind of restraint (PCS/RDC/SAXS) serves to normalize to each other the
magnitude of the restraints, because the computer program reads them simply as numbers without
consideration of the units of measurement.
Other data that is necessary to input are the coordinates (PDB) of the rigid domains A and B, and,
as explained in Section 1.5 and studied in the experimental Chapter 5 (The Catalytic Domain ofMMP-1
Studied Through Lanthanide Tags), these will better fit the calculations if previously refined to the
experimental PCS and RDC data.
Generating the conformational space MaxOcc does not calculate average conformations, it calcu-
lates the contribution of each conformation to the experimental data (above in The concept of Max-
imum Occurrence). Thus, before applying the experimental data to the calculation it is necessary to
generate the whole conformational space that the AB system can sample. MaxOcc uses the library
RanCh to perform this task (Bernadó et al., 2007; Bertini et al., 2010; Petoukhov et al., 2012). Firstly,
the linker is generated as empty Cα-atoms, then, from the inputted domain structures, the RanCh
algorithm randomly generates protein conformations that are possible considering only the allowed
areas of the quasi-Ramachandran plot of the linker’s Cα-atoms (Kleywegt, 1997). By default, 50·000
conformations are generated, they are considered to represent the whole conformational space pos-
sible to be sampled by the AB system. All these conformations are saved as PDBs. At last, for each of
the 50·000 conformations, the PCSs and RDCs for both domains are back-calculated from the inputted
PCS-derived Δχ-tensor.
TheMaxOcc calculation and output Once the full conformational space has been simulated by the
generationof the50·000 conformations, theprotocol proceeds to the calculationof theactualMaxOcc
values. Due to the large time demanded by theMaxOcc calculations, usually only 1·000 conformations
out of those 50·000 are randomly selected to be analyzed, as they are considered to still represent the
complete conformational space of the AB system (Bertini et al., 2010).
Each of these 1·000 conformations will be inserted into an ensemble of 51 conformations, where
the other 50 were randomly selected from the pool of 50·000. This ensemble represents the con-
formations explored by the system AB at a given moment. A fixed weight is given to the selected
conformation, starting from 0.001%, and the remaining weight is distributed across the other 50 con-
formations. The ensemble of structures will be minimized according to a target function. That target
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function represents the agreement between the experimental and the back-calculated restraints, for
each restraint set (PCS/RDC/SAXS), considering the 51 conformations of the ensemble and theweight
attributed to each of the conformations and also theweight given to each restraint set. Thus, theMax-
Occ target function (TF) for an ensemble is given by:
TF = aPCSqPCS + aRDCqRDC + aSAXSSAXS + aweightfweight (1.19)
where a is the weight given to each set of restraints (see The restraints inputted in MaxOcc), q is
the Q factor (PCS/RDC) calculated over the ensemble of structures according to equation 1.20, recall
similarity with equation 1.18. χSAXS is the SAXS χ factor calculated according equation 5 in Bertini et al.,
2010 (not shown). The last term of equation 1.19 is a normalization of the weights of the structures
in the ensemble given by equation 8 of Bertini et al., 2010 (not shown).
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In equation 1.20, n is the number of structures in the ensemble and k the number of restraints
(PCS/RDC),obsi is the observed PCS/RDC value for a given residue i,calcij is the calculated PCS/RDC
value for the same residue i in the structure j, wj is the weight given to the structure j within the en-
semble. Except for the chosen conformation, the other 50 conformations that constitute de ensemble
family are exchanged with the pool of 50·000 during theminimization process. Thus, at the end of the
minimization, a target function is obtained for the ensemble between the chosen conformation and
the other 50 conformations that best represents the experimental data. At the end of this calculation,
a higher weight is given to the chosen conformation and thewhole calculation is repeated. By default,
the weights are increased by steps of 0.05%. The MaxOcc calculation ends for a given structure when
the target function obtained for the ensemble overcomes a predefined threshold (see What defines
the TF threshold), see Figure 1.25. At this point, a MaxOcc value is attributed to the selected confor-
mation that corresponds to the weight given to it at which the ensemble overcame the TF threshold.
In other words, is the maximum weight at which is possible to fit a given conformation within an en-
semble and still be in agreement with the experimental data and within the experimental error. The
procedure follows for each of the 1·000 selected conformations. For some conformations the TF will
overcome the threshold at weights lower than 0.05% while for others it can go as high as any given
value < 100% (Figure 1.26). At the end, 1·000 conformations with their respective MaxOcc value will
describe the conformational distribution (that is the motion) of the AB system.
Figure 1.25: The different steps of the MaxOcc calculation. The weight of the selected structure
(black) is increased with each calculation up to when the target function (TF) found for the ensemble
overcomes the calculated threshold (right square). In gray the members of the ensemble of confor-
mations and white the conformations belonging to the large RanCh pool.
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Figure 1.26: Thegraphical representationof theTFobtained for thedifferentweights probed for each
selected conformation. Note the different weights at which each conformation (within an ensemble)
overcomes the TF. Three hypothetical conformations are represented as examples. A TF threshold of
0.266 was defined following the example in Bertini et al., 2010.
What defines the TF threshold To define the minimum target function (TF) of the conformational
ensemble, a MaxOcc calculation is performed where no structure has a fixed weight. In this case, the
ensemble is composed solely on the structures taken from the large pools and the respective weights
given by the minimization protocol. The TF threshold is defined as 20% higher than the minimum TF
value. Themargin of 20% considers the fluctuations in theminimization algorithm and the experimen-
tal error on the data (Bertini et al., 2010).
Representing the results Usually, the MaxOcc results are graphically represented by showing the
1·000 studied conformations fitted on the domain A. The B domain is depicted as a three axial tensor
centered at the center of mass of the domain and with an orientation equal to that of the correspond-
ing PDB file. Additionally, the tensors representing the B domain are colored according to their Max-
Occ value. In this way, a mushroom-like picture is obtained where it is possible to visualize the regions
in space (conformations) that can exist is solution for longer periods of time.
The resolution of the results Interestingly, the MaxOcc approach discriminates those regions in
space that are more prone to be occupied by the B domain and, additionally, it also discriminates the
preferable orientations within a certain region. Nevertheless, the MaxOcc results do not show abrupt
discontinuities upon slight rotationalmovements, as amaximumof 2%was found for rotations of 10%
(Bertini et al., 2010). Because of the joint use of PCSs, RDC and SAXS data, the MaxOcc value reveals
information on the translation and rotation of Bwith respect to A.
The studies with Calmodulin The MaxOcc approach was established using the peculiar mobile sys-
tem of Calmodulin (CaM) (Bertini et al., 2010; Dasgupta et al., 2011; Nagulapalli et al., 2012). The
N-terminal domain of CaM was functionalized with different Lanthanides and the data was acquired
accordingly. The authors (Bertini et al., 2010) found a nicely distributed profile of the maximum pos-
sible weights (MaxOcc values) for the different conformations. More importantly, the authors found
that the CaM conformations already known in literature had considerable low MaxOcc value (< 15%)
with respect to those new conformations that were found to have higher MaxOcc values (up to 35%).
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MaxOcc on the WeNMRWeb Portal Similarly to AnisoFIT (Section 1.5.2 - AnisoFIT and the WeNMR
GRID-EnabledWebPortal) theMaxOcc protocol is also available for users at theWeNMRGRID-enabled
web portal4 (Bertini et al., 2012b; Wassenaar et al., 2012). There, the users can access a friendly inter-
face to run and analyze the MaxOcc calculations.
4http://py-enmr.cerm.unifi.it/access/index/maxocc

Chapter 2
Matrix Metalloproteinases
2.1 Historical Overview
The fascination for Matrix Metalloproteinases (MMP) by experimentalist came from the discovery of
a collagenolytic activity in tissues of vertebrates, with emphasis on tadpoles, but also on rat, pig and
chick (Gross, 2004; Gross and Lapiere, 1962); however the concept ’Matrix Metalloproteinase’ come
only to be forged in the late 80’s, early 90’s (Nagase et al., 1992). The impressive capacity of fibroblast
collagenase (HFC) to degrade triple-helical collagen at neutral pH, without the need of an external
source of energy (like ATP) (Eisen et al., 1968; Henning, 1987; Miller et al., 1976; Welgus et al., 1981)
pulled the research on MMPs to a rate of 1400 publications per year, as reported by Woessner, 2002,
and nowadays this rate must be much higher. It is historically important to realize that the concept of
collagenase is much older than 1962. It was defined back in the 40’s when the activity of exogenous
bacterial proteases was screened against collagen and differentiated from gelatinase degrading en-
zymes (Jennison, 1945) which could degrade gelatin but not triple-helical collagen. The collagenolytic
activity and somehow, the mechanism of collagen lysis, had been studied also during the 50’s (Hamit
and Upjohn, 1958; Nagai, 1961; Nagai and Noda, 1959; Tytell and Hewson, 1950).
The physiological relevance of MMPs soon became the focus of much attention (Section 2.4), as
enzymes of such peculiar action could not be left without a biological role of proportional significance
(Klein and Bischoff, 2011). It was consequently understood that MMPs were subject to strict regu-
latory mechanisms (Section 2.6), because the slightest misbehavior of these enzymes could lead to
disastrous diseases (Section 2.5) mostly related with tissue degradation (Amălinei et al., 2010). By
these means, MMPs were envisaged as potential therapeutic targets, and many efforts were invested
in the research of MMPs inhibitors (MMPIs, Section 2.6.5). Nowadays, the research onMMPs has by no
means decreased its intensity. The biotechnology, spectroscopic and computational techniques avail-
able today feed the search for unveiling, at the atomic level, the peculiar collagenolytic mechanism of
collagenases, such as MMP-1, so important in biology (Section 2.7).
2.2 The Matrix Metalloproteinase Family
Matrix Metalloproteinases (MMPs) are part of a larger family of zinc(II)-dependent endopeptidases:
the ubiquitously expressed ’Metzincins’. This family encompasses also ADAMs (White, 2003), ADAMTs
(Tang, 2001), bacterial serralysins (Nakahama et al., 1986) and other proteases such as astacins (Bode
et al., 1992; Butler et al., 1987). However, this work will focus solely on MMPs.
The human fibroblast collagenase (HFC) was the first MMP to be sequenced (Goldberg et al., 1986)
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and consequently baptized as MMP-1. The overwhelming research performed on the field of Matrix
Metalloproteinases (MMPs) led, in few years, to the identification of a total of 25 members of this
family, with respectivehomologues, ofwhich24areexpressed inhuman tissues (Sbardella et al., 2012).
MMPs aremultidomain proteinswith a verywell defineddomain organizationwhich share highprotein
sequence homology (Section 2.3). Table 2.1 lists the known MMPs, their historical alternative names
and refers the studieswhere theywere first discovered. Woessner, 2002,made a remarkable historical
review on the different MMPmembers, a paper from where additional references can be extracted.
The alternative names attributed to each MMP, as detailed in Table 2.1, suggest a connection be-
tween the different members of the family. In fact, MMPs are generally grouped according the their
substrate specificities. In this way four main groups can be described: i) collagenases, ii) gelatinases
iii) stromelysins and iv) matrilysins. An extra group is considered v) the Membrane-type MMPs (MT-
MMPs) to refer toMMPs that are secreted bound to the outer surface of the cellularmembrane. Some
MMPs don’t fit the standard groups and are considered separately. These are MMP-12, -19, -21 and
-28 (Sbardella et al., 2012).
The Collagenase group encompasses MMPs -1, -8 and -13, which are capable, and mostly active,
to degrade fibrillar collagen. The collagen molecule and the different mechanistic hypothesis of col-
lagenolysis are reviewed in Section 2.7.2. Gelatinases, i.e. MMP-2 and MMP-9, are effective in degrad-
ing gelatine (denaturated collagen), having a complementary role to that of the collagenases (Tam et
al., 2004). Stromelysins are able to degrade type-IV collagen but do not cleave fibrillar collagen (Na-
gase andWoessner, 1999). Matrilysins act in the sameway as Stromelysins but lack the hemopexin-like
domain (Wilson and Matrisian, 1996). MT-MMPs are able to perform roles of collagenases and gelati-
nases and are actively involved in MMP activation (Sabeh et al., 2009).
The missing in action enzymes A fair question that might be asked by new students of the Matrix
Metalloproteinase researchfield is, what happened toMMP-4, -5 and -6 (Woessner, 2002)? These three
enzymeswhere named right after novel biochemical actionswere discovered (Nakano and Scott, 1987;
Overall and Sodek, 1987; Sapolsky et al., 1976; Scott andGoldberg, 1983). However, itwas soonproved
that the newly found MMPs were actually identical to already known members of the family (Gunja-
Smith et al., 1989; Nagase et al., 1992; Wu et al., 1991), and so, these three names were discarded.
2.3 The Structural Features of MMPs
The Overall Structure of MMPs Matrix metalloproteinaes are multidomain proteins with at least
thirteen domains/domain variations identified (Bertini et al., 2009a). All the domains found in MMPs
have independent folding, functioning as buildingblocks that and canbeexpressed, purified, and stud-
ied as individual domains. For this reason, MMPs are designated as mosaic proteins (Das et al., 2003).
The members of the family present different organization of their domains but there is an arrange-
ment that defines virtually all MMPs: a catalytic domain bounded to a hemopexin-like domain via a
flexible proline-rich linker, and a pro-domain attached to the catalytic domain during the zymogen
form. Figure 2.1 shows the domain distribution of the MMP family members. Human Fibroblast Col-
lagenase (MMP-1) is considered an archetypal type MMP because it has solely the three characteristic
domains, and its tertiary structure is shown in Figure 2.2. This enzyme is the focus of the research
here presented and hence its structure will be treated in detail. Notice that the domain organization
of MMPs indicates the evolutionary relationship among the members (Andreini et al., 2004; Das et al.,
2003; Massova et al., 1998; Murphy and Reynolds, 1991).
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Figure 2.1: The domain distribution of the members of the MMP family, according to Bertini et al.,
2009a. MMP-22 was added and MMP-18 is not represented because there is no human orthologue.
Figure 2.2: X-ray structure of proMMP-1 as published under the PDB Code 1SU3. The pro-domain is in
white, the catalytic domain in gray and the hemopexin domain in darker gray. Spheres represent the
metal ions, the catalytic zinc(II) is in black.
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Differences in the domain distribution of MMPs As is evident from Figure 2.1, the linker lengths
in MMPs change pronouncedly across the members, spanning from 14 residues in MMP-1 (Goldberg
et al., 1986; Jozic et al., 2005) to as much as 68 residues in MMP-9, constituting a domain by itself
(Van den Steen et al., 2006). This feature can be envisaged as of strong impact in the catalytic role of
the enzymes (addressed in Section 2.7.2.6 - The role of the hinge region). Only MMP-21 is devoid of
linker. MMP-7 andMMP-26 are simply catalytic domains but all other MMPs have an extra domain, the
hemopexin-like domain, which performs a crucial aid in the activity of the enzymes. MMP-23 differs
from the others and has an Ig-like domain instead of hemopexin-like domain.
Other domains that are not present in the MMP-1 structure but should be highlighted are the
fibronectin-like domains, in MMP-2 (Steffensen et al., 2002) and MMP-9 (Rosenblum et al., 2007),
and the anchoring domains on membrane-type MMPs (Sohail et al., 2008; Zucker et al., 2003). The
fibronectin-like domain strongly emphasizes the concept of MMPs as mosaic proteins. This domain of
about 200 residues projects itself from theMMP-2 catalytic domain loop 7 between the fifth β-strand
and the second α-helix without disrupting the tertiary fold of the catalytic domain (Morgunova et al.,
1999). All MMPs are secreted enzymes, therefore they have an initial signal peptide that drives their
transcription to the Golgi aparatus and the following vesicles up to the extracellular environment.
Historical Perspective of MMP-1 Lovejoy et al., 1994a, crystallized for the first time in history the
truncated catalytic domain of human fibroblast collagenase (HFC, MMP-1). In this study, the enzyme
was inhibited with a peptide-based inhibitor (CPLX) in its catalytic site and the X-ray structure of the
complex was obtained at 2.40 Å of resolution, the PDB structure was deposit under the code 1CGL.
In a closely related work, the crystal structure of the catalytic domain (19 kDa) complexed to itself at
the N-terminus was published (Hassell et al., 1994; Lovejoy et al., 1994b). The X-ray structure of the
catalytic domain of HFC with the highest resolution known to date (1.56 Å) was published also in 1994
(Spurlino et al., 1994). After thesemodels of the truncated catalytic domain, several others have been
published (Borkakoti et al., 1994; Lovejoy et al., 1999), some were NMR structural ensembles (Moy et
al., 1997, 1998, 1999).
By 1995, the importance of the C-terminal domain, the hemopexin-like domain, in the collagenoly-
sis mechanism of HFC had been already hypothesized (Section 2.7.2, Murphy et al., 1992). Therefore,
it urged to resolve the still unknown C-terminal domain of such important collagenase as HFC. In 1995,
the full length X-ray structure of porcine synovial collagenase was published (Li et al., 1995). After
that, two other historically important structures were unveiled: the full length MMP-1 in its zymogen
form (Jozic et al., 2005) and in its active form (Iyer et al., 2006). These were the first studies were the
pro-domain, the linker and the hemopexin domain of MMP-1 were revealed and new insights were
hypothesized in the activation and collagenolytic mechanism of MMP-1 and MMPs in general.
The discovery of MMP-1 structures occurred alongside with the publication of models for many
other MMPs, one triggering the others. The first publication reviewing the structural aspects of ma-
trix metalloproteinases concerned not only MMP-1 but also the other collagenases, like MMP-8 and
MMP-13 (Bode et al., 1999). Over the years, different reviews have been published on the structural
details of MMP-1 and MMPs in general (Borkakoti, 1998; Das et al., 2003; Gomis-Rüth et al., 2012;
Maskos, 2005; Maskos and Bode, 2003; Massova et al., 1998; Tallant et al., 2010). This chapter details
the primary, secondary and tertiary structure of the Matrix Metalloproteinase-1.
Addressing the residue nomenclature Themultitude ofworks onMMP-1 generated some diversity
in the used residue nomenclatures. There are two main tendencies used nowadays, one that starts at
the first residue of the signaling domain of MMP-1 (Goldberg et al., 1986), and other that starts that
the first residue of the pro-domain (Jozic et al., 2005). In this work, the former nomenclature is used
52 CHAPTER 2. MATRIX METALLOPROTEINASES
Figure 2.3: The primary sequence of the catalytic domain of MMP-1. β-strands are highlighted with a
square, and α-helices with a dashed square, in bold the consensus sequence.
Table 2.2: Summary of MMP-1 catalytic domain secondary structures
Sec. Struct. Residues Abbreviation Alternative Name
Loop 1 Phe100-Gln111 L1 (see Pro-domainL3) -
Beta-strand Thr112-Glu119 sI -
Loop 2 Asn120-Leu125 L2 -
A-helix Pro126-Asn143 hA Amphipathic helix
Loop 3 Val144-Leu147 L3 -
Beta-strand Thr148-Val152 sII -
Loop 4 Ser153-Asp158 L4 Short loop sII-sIII
Beta-strand Ile159-Val164 sIII -
Loop 5 Arg165-Asn180 L5 S-shaped doubleloop
Beta-strand Leu181-Phe185 sIV
Cleft-sided
antiparallel ’edge
strand’
Loop 6 Gln186-Gly192 L6 -
Beta-strand Gly193-Glu199 sV -
Loop 7 Asp200-Tyr210 L7
Large open loop,
collagenase
cis-peptide bond
alpha-helix Asn211-Gly225 hB Active site helix
Loop 8 Leu226-Leu248 L8 Specificity loop
alpha-helix Ala249-Gly261 hC C-terminal helix
where residue 1 is the first Methionine residue of the signaling domain and it is also the nomenclature
found in the MEROPS data base1. The signaling domain has 19 amino acids, so the conversion from
one nomenclature to the other is also straightforward.
2.3.1 The Catalytic Domain of MMP-1
Primary and Secondary Structures The catalytic domain (CAT) of human fibroblast collagenase has
162 residues, from Phe100-Gly261 and its primary sequence is as described in Figure 2.3 (Goldberg et
al., 1986). Usually, the six first residues of the catalytic domain are auto cleaved during protein prepa-
ration and the domain is obtained starting from Pro107. This domain is constituted by three α-helices
and five highly twisted β-strands, historically named hA-hC and sI-sV, respectively, with the helices
and strands connected together by eight protein loops. Alternative names were attributed to some
of the secondary structures and loops according to their function, such names are more human read-
able and used to better identify the region. Table 2.2 summarizes the boundaries of each secondary
structure and loop as well as their nomenclature and artificial names (note that residue numbering is
as described above in 2.3 - Addressing the residue nomenclature).
The Metals within the structure It was found that the catalytic domain of MMP-1 envelops four
structural metal ions of which three calcium(II) ions and one zinc(II) ion and one additional catalytic
zinc(II) ion (Table 2.3). The structural metals have main importance in the fold of the protein, holding
1http://merops.sanger.ac.uk/cgi-bin/pepsum?mid=M10.001
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Table 2.3: Summary of the metal sites in the catalytic domain of MMP-1.
Catalytic ion Structural ions
Zn(II) Zn(II) 1st Ca(II) 2nd Ca(II) 3rd Ca(II)
M
···
L
His218 NE2 His168 NE2 Asp175 OD2 Asp158 O Asp124 OD2
His222 NE2 Asp170 OD2 Gly176 O Gly190 O Glu199 O
His228 NE2 His183 NE2 Gly178 O Gly192 O Glu199 OE2
Catalytic water His196 ND1 Asn180 O Asp194 OD2 Glu201 O
Asp198 OD2 Water
Glu201 OE2
tight the loops and secondary structural elements that ligate them, and are not permissive to metal
substitution (Lowry et al., 1992). On the other hand, the catalytic zinc is strategically positioned to
drive the proteolytic catalysis (Section 2.7.1). The ligation network that encompasses the five metals
causes a collaborative binding among them (Springman et al., 1995). For instance, the lack of the
structural zinc devoids MMP-8 of its catalytic activity (Cha et al., 1996).
The tertiary structure The catalytic-domain was described in the literature as having the shape of
an oblate ellipsoid of about 35 x 30 x 30 Å with one creased face. The overall shape of the catalytic
domain canbedivided into anupper and a lower subdomainwhoseboundaries aremarkedby the small
active sitewhich, in the ‘standard’ orientation (Gomis-Rüth et al., 2012; Tallant et al., 2010), is engraved
into the flat ellipsoid surface and extends horizontally across the domain. Figure (2.4) represents the
catalytic domain of MMP-1.
In detail, the tertiary structure of the catalytic domain of MMP-1 can be described as follows. The
initial loop, L1, embraces the domain at the left site of the catalytic site (detailed bellow). Follows
the β-sheet sI which is in between and parallel to β-sheets sII and sIII. From it, the second loop twists
back to the amphipathic (hA) α-helix, giving Asp124 as ligand to the 3rd calcium ion. The amphipathic
helix is a very large structural element that resembles the vertebrate column of the domain, spanning
it from the top to the bottom. A 180º turn in loop 3 initiates the twisted β-sheet sII. A short fourth
loop bridges sII and sIII over sI and shares Asp158 to the coordination sphere of the second calcium
ion. The very large and higly twisted β-sheet sIII is followed by the large S-shaped double loop. This
loop forms the site cleft ’bulge’ edge segment (Maskos and Bode, 2003) which is of prime importance
in binding peptidic substrates and inhibitors. It also shares ligands with the first calcium ion and the
structural zinc (Table 2.3). The β-sheet sIV forms the ceiling of the active site cleft. A sixth loop turn
right near the loop 4 thus providing Gly190 and Gly192 to the binding of the second structural calcium
and redirects the β-sheet sV to tether parallel to sIII and anti-parallel to sIV. Its strategic position al-
lows it to contribute to the binding of all three calcium ions. The large open loop L7 forms the right
surface of the domain; it contributes to the ligation of the three calcium ions and plays a major role in
single-chain substrate recognition (Chung et al., 2000). The second α-helix forms the inside wall of the
catalytic cleft, spanning it from the entry to the exit sites. This helix contributes with two histidines
to the ligation of the catalytic zinc(II) ion and it possesses the catalytic glutamate (Glu219). This helix
stops abruptly starting the large “specificity loop” L8 which constitutes a large part of the lower down
subdomain and holds the floor and the outer wall of the catalytic site cleft. It encondes the third zinc-
chelating histidine and also the MMP invariant Ser229. This loop forms the 1,4-tight ’Met-turn’ at the
highly conserved sequenceAla-Leu-Met238-Tyr, characteristic of the ’metzincins’ (Bodeet al., 1993) and
the “wall-forming” segment (Pro238-X-Tyr240) that constitutes the outerwall of the binding site and the
S’1 pocket (Bode et al., 1999, see next paragraph The catalytic site). Also, the residues that follow con-
stitute the “specificity-loop” which diverges considerably among MMPs. This loop defines the shape
and characteristics of the subsite S’1 (Overall and Kleifeld, 2006), having great impact on the speci-
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Figure 2.4: On the top left the catalytic domain of MMP-1 as determined in the CERM laboratories
(PDB Code 3SHI), the labels indicate the secondary structure elements nomenclature as described in
the text. On the top right the domain is rotated by 90 degrees. Bellow a zoom of the catalytic site
cleft with the catalytic Zn(II) in white and some of the most relevant residues highlighted.
ficity of the enzyme, hence its name. A network of residue connectivities within these regions hold
tight the structural arrangement of the active site. The interface between helix hB and the L8 loop
encondes the MMP consensus region, which is detailed later. A final helix hC supports the structure
of the large loop L8 and hence the consistency of the binding pocket. The structure ends with Gly261
from where the linker peptide starts. Note that the first (Phe100) and the last residues are placed at
the bottom part of the domain, which is a further indication of the mosaic nature of MMPs, in which
the domains were added during the evolutionary process in a way that they can fold independently
forming a complex of several building blocks (recall Figure 2.1).
The catalytic site The catalytic domain of MMP-1 has a small catalytic site cleft where only a single
peptidic chain is able to fit (Chung et al., 2004). As it has been detailed above, the active site is formed
by helix hB, strand sIV and the loops L5 and L7. The active site performs the function of endopepti-
dase, cleaving a specific peptidic bond of a peptide that sits inside. To perform this task it counts with
the action of a catalytic zinc ion ligated by the Nε2 protons of three histidine residues (His218, His222
and His228) and also with the action of a glutame residue that activates the catalytic water as nucle-
ophilic agent in the reaction mechanism (Section 2.7.1). These residues form the consensus sequence
H218EXXHXXGXXH228 (McKerrow, 1987; Vallee andAuld, 1990)which is conserved acrossMMPs (Das et
al., 2003) and other zinc-dependent endopeptidases, the ’metzincins’ superfamily (Bode et al., 1993).
Note the conserved Gly225 at the end of the β-sheet, necessary to allow the almost 180º twist to the
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Figure 2.5: Representation of the active site nomenclature considering the enzyme–peptide residues
interaction. Scheme adapted from Schechter and Berger, 1968.
loop L8, which shape the bottom and outer walls of the site cleft.
Within the catalytic pocket, several residues are available to interact with the substrate, forming
a significant network of hydrogen bonds, salt and hydrophobic interactions. The substrate and the
pocket residues at the proteolytic site cleft were historically denominated according to the pioneer
works in papain protease (Schechter and Berger, 1967, 1968). In this way, the peptide bond that is
cleaved sets the origin of the numeration; the residues that are upstream towards the N-terminus are
termed P1, P2, P3, etc... and the residues that follow downwards to the C-terminus are termed P’1, P’2,
P’3, etc... The active site of the enzyme can be divided into different subsites that accommodate the
different residues of the substrate peptide. These are accordingly termed S1, S2, S3 and S’1, S’2, S’3,
etc... This nomenclature was also reviewed elsewhere (Gomis-Rüth et al., 2012). A scheme is repre-
sented in Figure 2.5.
2.3.2 The Flexible Linker
All MMPs except for MMP-7, -21 and -26, have a linker segment, also called hinge region, which is vari-
able in length (from 14 to 68 residues) and holds together the catalytic and the hemopexin domains
(recall Figure 2.1). In MMP-1 the linker spans fourteen residues, with a proline-rich sequence as char-
acteristic of MMPs:
262 ··· RSQPVQPIGPQTP ··· 274
Note the proline pattern PXXPXXPXXP and theGly residue in themiddle of the sequence. The crys-
tallographic structures of the full length MMP-1 show a large network of connectivities between the
linker and both the catalytic and the hemopexin domain (Iyer et al., 2006; Jozic et al., 2005), which fos-
tered the hypothesis that the nature of the linker would be crucial for the collagenolytic mechanism,
and this is indeed the case, as will be referred later in Section 2.7.2.6.
2.3.3 The Hemopexin-like Domain
The hemopexin-like, or C-terminal, domain ofMMP-1 is a circular domain that starts and endswith two
cysteine residues that are bridged (Cys278-Cys466) which are solvent exposed and responsible to hold
tight the circular architecture of the domain (Figure 2.6).
Hence, theC-terminal domain is a four-bladedβ-propeller (Chenet al., 2011) inwhicheachbladehas
four anti-parallel β-strands and, in between, small loops are present so to position the strands in phase
with each other (Iyer et al., 2006; Jozic et al., 2005; Li et al., 1995), and also one small α-helix per blade
is observable. Figure 2.7 represents the hemopexin domain as extracted from the full length active
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Figure 2.6: The primary sequence of the hemopexin-like domain of MMP-1. β-strands are highlighted
with a square, and α-helix with a dashed square, the cysteines are contrasted.
Figure 2.7: The hemopexin domain of active human matrix metalloproteinase-1, extracted from PDB:
2CLT (Iyer et al., 2006). Highlighted the structural cysteine bridge and the circular symmetry of the
domain. The left and right panels are two different perspectives.
enzyme model (PDB: 2CLT). A calcium and a zinc ion were found in the center channel of the domain
in some of the crystallographic preparations and, although the metal ligation has been described, it is
still unknown if they are an artifact of the crystallographic preparation or if they hold any biological
relevance. The hemopexin domain was found to be of crucial aid in the collagenolytic mechanism of
collagenases; its role is detailed in Section 2.7.
2.3.4 The Pro-Domain
The activity of Matrix Metalloproteinases is regulated at many levels, after DNA translation, the first
regulatory step is at the zymogen level becauseMMPs are expressed as latent enzymes (Harper et al.,
1971). At this stage, all MMPs carry what is named the pro-domain, which is responsible to render the
enzyme inactive. The regulatory pro-domain corresponds to a protein segment that is consecutive
to the signaling peptide and prior to the catalytic domain. In MMP-1, the pro-domain is composed
of 81 amino acids (Goldberg et al., 1986) spanning from Phe20 to Gln99. This protein segment has an
independent fold, as all domains ofMMPs, and a shape similar to an ellipsoid. From the X-ray structure
(Jozic et al., 2005) (PDB: 1SU3) it is not possible to observe the first twelve residues of this domain in
the electron density map, Phe20-Val31, which were characterized as flexible.
The pro-domain is constituted by three α-helices named H1-3, and three loops named L1-3. The
α-helices and the loops are arranged in an interspersed mode with H1 starting from Asp32 to Tyr42.
Figure 2.8 represents the primary structure of the pro-domain with the residues corresponding to
each secondary structure highlighted. Figure 2.9 represents the pro-domain inhibiting the catalytic
domain in MMP-1.
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Figure 2.8: Primary sequence of the pro-domain. The secondary structural elements are highlighted.
The three α-helices fold upon each other creating the surface of the domain together with the
three loops. This arrangement is stabilized by the hydrophobic core that is composed by the internal
residues of the helices and the loops which interact to maintain the tertiary structure of the domain.
Moreover, other salt-bridges and hydrogen bonding interactions take place between the pro-domain,
the catalytic-domain and the hemopexin domain so that the domain conformation of the zymogen can
be stabilized and the inhibition strategy successful.
H1 spans from Asp32-Tyr42, it comprises three tyrosines of key importance in the domain structural
stability, these are Tyr37, Tyr41 and Tyr42. Tyr37 interacts with Arg91 through a hydrogen bridge provid-
ing extra stabilization of the cysteine switch region in the L3 (see later). Tyr41 follows Tyr37 forming
a “lid” on top of Arg91, as described by the authors (Jozic et al., 2005). Tyr42 forms a hydrogen bridge
with Asp96 that is also connected to Arg91 through a salt-bridge. It is to be noted that Arg91 and Asp96
are both highly conserved throughout MMPs.
The loops in the pro-domain have characteristics that tightly relate them with the function of the
domain itself. In loop 1 – Ans43-Gly58 – is present a “bait region”, consisting in the sequence EKRRN56.
The L1 and in particular the “bait region” is placed distal to the catalytic domain and fully exposed to
the solvent and is anessential target for proteolytic activity that leads toMMP-1 (andMMPs) activation
(Atkinson et al., 1995; Nagase, 1997; Nagase et al., 1990; Suzuki et al., 1990). Inside L1, the region
Asn46-Ser57 is not visible in the X-ray structure and was therefore also considered flexible. Helix 2
follows L1, it comprehends residues from Pro59 to Phe71 and mainly interacts with H1, H3 and L2. It
also interacts with the catalytic domain through Phe70 and Phe71 at the level of His228-Ser229-Thr230
and Tyr237 and Pro238. Loop 2, Gly71-Asp80, is a visible loop in the X-ray structure which points to be
rigid. Such rigidity can be due to its several interactions with H2 and H3 through both hydrophobic
groups and hydrogen bonding, with highlight on the intradomain side-chain interaction of Asp80 with
Gln68. Helix 3, Ala81-Met87, interacts mainly with H1, H2 and L2, pointing towards the catalytic site
cleft at an angle of about 45°.
Right after the helix 3 the “cysteine switch” motif is present. The sequence where this motif is
present is termed C loop and precedes the last loop L3 of the pro-domain. The cysteine switch motif
is composed by the aminoacid sequence P90RCGVPD96 which is highly conserved among all MMPs (Das
et al., 2003). This loop enters the active site in the right-hand side considering the standard orientation
(Gomis-Rüth et al., 2012), recall Figure 2.4 on the catalytic domain, and has an orientation opposite to
a possible bound peptide substrate (Figure 2.9). Pro90, the first residue in the switch motif, strongly
stabilizes the inactivation of the enzyme by entering a hydrophobic pocket in the catalytic domain
composed of Leu181, Tyr210 and Tyr240. Very importantly, the MMP strictly conserved Arg91 residue is
found in the C loop; it is turned to the core of the pro-domain and strongly interacts with Tyr37 and
Asp96. The inhibitory region makes β-sheet backbone contacts with the loop and beta-strand sIV of
the catalytic domain. It is in parallel orientation with residues Gly179, Leu181, Ala182 and in antiparallel
orientationwith Pro238 and Tyr240. All these interactions stabilize the conformation of the pro-domain
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Figure 2.9: Representation of the zymogen state. The domains were extracted from PDB 1SU3 (Jozic
et al., 2005). The pro-domain is colored in white with the side-chain of Cys92 represented as sticks
and chelating the catalytic zinc(II) ion displayed as a black sphere. The catalytic domain is in gray, the
other spheres are the metals. Dashed lines are simply a representation of the interactions between
the chains of the two domains and have no atomic resolution. The hemopexin-like domain is not rep-
resented.
towards the catalytic domain, finally orienting theCys92 towards its inhibitorypositionwhere it directly
coordinates the catalytic Zn(II) ionwith the Sγ atomas the fourth ligand in the tetrahedral coordination
sphere. The relative orientations of Cys92 and Arg91 render the S’1 and the S’2 substrate specificity
pockets empty in comparison to when the catalytic domain interacts with the natural substrate. Aside
from the S’1 pocket, no water molecules can enter the catalytic site cleft when the enzyme is is its
zymogen form. The disruption of the pro-domain and the consequent activation of MMPs is discussed
in Section 2.2.
Loop L3, part of the Pro- and Catalytic Domains The final pro-domain loop, L3, spans from Val97-
Pro107 and was not detectable in the X-ray structure (Jozic et al., 2005) thus forcing the conclusion
that it is somewhat mobile. This loop is part of both the pro- and the catalytic-domain. When the
pro-domain is cleaved at Gln99-Phe100 the catalytic-domain already expresses enzymatic activity. In
fact, Phe100 forms a hydrogenbridgewithAsp252 and the loopPhe100-Pro107 confers “super-peptidase”
activity to the catalytic domains (Reinemer et al., 1994; Suzuki et al., 1990). This loop can be observed
in the structure of the full length active MMP-1 (PDB 2CLT). However, this small sequence is usually
auto-cleaved during preparation and the reported catalytic domains generally start at Pro107.
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2.4 MMPs in Physiology
Matrix Metalloproteinases operate in the proteolytic processing of proteins with structural functions,
such as the components of Extracellular Matrix (ECM), like collagen, gelatins, fribronectins, aggrecan,
laminins, andmany others (Sbardella et al., 2012; Van den Steen et al., 2001). However, they also inter-
fere in cellular signaling pathways because of their action on agents like the insulin-like growth factor
binding protein (Manes, 1997) or in the modulation of cytokine and chemokine activity (Mehra et al.,
2010). Therefore, MMPs are involved in practically any biological events of tissue remodeling, degra-
dation, turnover (Page-McCaw et al., 2007) such as wound healing (Gibson et al., 2009), menstruation
(Marbaix, 2005; Salamonsen and Woolley, 1996), embryonic development (Keow et al., 2012; Tomlin-
son et al., 2008) and bone homeostasis (Hou et al., 2004). The physiological role of MMPs have been
extensively reviewed in the literature (Kessenbrock et al., 2010; Klein and Bischoff, 2011; Rodríguez
et al., 2010; Stamenkovic, 2003; Vu and Werb, 2000).
Along with the vast interplay of roles performed by MMPs, there is a vast library of substrates
uponwhichMMPs can interact, some examples follow. Themost commonly known and studied action
of MMP-1 is its processing of triple helical type-I collagen which is addressed in Section 2.7.2. How-
ever, besides that role, MMP-1 can act on other structural molecules including versican, perlecan, ca-
sein, nidogen, serpins, and tenascin-C (McCawley andMatrisian, 2001), and also cell surfacemolecules
like antichymotrypsin, antitrypsin, insulin-growth factor binding protein (IGFBP)-3, IGFBP-5, IL- Ib, L-
selectin, ovostatin, tumor necrosis factor-α and stromal cell-derived factor-1 (McCawley andMatrisian,
2001). Stromelysin-1, for instance, is not able to cleave type-I collagen like collagenases but can indeed
degrade collagens of many other types (Chin et al., 1985). New techniques in proteomics are unveiling
new substrates of MMPs (Morrison et al., 2009).
MMPs are expressed as latent zymogens that can be activated by several mechanisms. Within
these, the intrinsic activation ofMMPs by otherMMPs is crucial in the biochemistry of the living tissues
(Section 2.6.3). Hence, MMPs are also substrates of themselves.
2.5 MMPs in Pathology
“Withgreat power comesgreat responsibility”, this sayingapplies thebest forMatrixMetalloproteinases.
The crucial roles and vast spectrum of action of MMPs in the tissue and body homeostasis demands
regulatory mechanisms of equal quality (Section 2.6). When imbalances in the regulatory mechanisms
ofMMPs occur, and consequently the pool ofMMPactivity rises or, on the contrary, is depleted, severe
pathological conditions are prone todevelop. MMPshavebeen associatedwith virtually any pathology
related to structural impair or cell signaling misregulation. The associated pathologies are mainly due
to i) tissue destruction, such as rheumatoid arthritis, osteoarthritis, gastric ulcer, neuroinflamatory
diseases, ii) fibrosis, like cirrhosis, artherosclerosis, fibrotic lung disease, iii) weakening of the matrix,
as in epidermylosis bulbosa, aortic aneurism, restenotic lesions. A large spectrum of other patholo-
gies has been enumerated (Amălinei et al., 2010; Klein and Bischoff, 2011; Murphy and Nagase, 2008;
Sbardella et al., 2012).
Probably the most severe and studied MMP-related pathology is cancer and specially tumor inva-
sion (metastasis). In brief, the over-expression of MMPs in cancerous cells leads to the fast degrada-
tion of the extracellular matrix components, specially through the action of collagenases (Ala-aho and
Kähäri, 2005), allowing for the adhesion-independent tumor cells to escape from the core of the tumor
(Stetler-Stevenson andYu, 2001). An enormous amount of data regarding the action ofMMPs in tumor
development has been gathered, mainly from knockout mice experiments (Butcher et al., 2009; Ege-
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blad and Werb, 2002; Johansson et al., 2000; Kessenbrock et al., 2010; Kleiner and Stetler-Stevenson,
1999; Rundhaug, 2003).
However, the study of the role of MMPs in disease isn’t in absolutely straightforward. The prote-
olytic network (Krüger et al., 2010) inwhichMMPsare involved result in very intricate and complexdata
from mice models: depletion of a MMP can be compensated by others without significant changes in
homeostasis, or it can foster the development of a pathology or hinder the progression of another
(Murphy and Nagase, 2008). Nonetheless, MMPs continue to be a fundamental target of medical and
pharmaceutical research (Section 2.6.5) as the efforts to fully understand the MMP biochemistry are
as vigorous as ever (Shuman Moss et al., 2012).
2.6 Regulation of MMPs
The activity of MMPs is regulated at three main levels (Stamenkovic, 2003): i) at the genetic level,
where a multitude of factors act upon the DNA expression and the turnover of mRNA, ii) at the zymo-
gen level, where the pro-domain blocks the interaction with the substrates and, at last, iii) the activity
of MMPs is regulated by the presence of the Tissue Inhibitors of MMPs which form protein-protein
complexes with MMPs.
2.6.1 Genetic Regulation
The regulation of MMPs is crucial for the healthy condition of the systems they regulate. Moreover,
MMP function in a joint cooperation to perform their roles, many times sharing substrates. For this
reason, the first step in MMP regulation is at the gene expression level (Sternlicht and Werb, 2001).
Several regulatorymechanisms intersect andhavebeen extensively reviewed (Chakraborti et al., 2003;
Fanjul-Fernández et al., 2010; Yan and Boyd, 2007), such as the action of small metabolites (Kitahara
et al., 2001; Yeung and Hurta, 2001) and/or macromolecular agents (Ilyas, 2005; Van den Steen et
al., 2002) at the transcription stage. The regulatory forces act also in the post-transcription phase by
affecting mRNA stability and turnover (Bao et al., 2006; Hsu et al., 1992; Murphy et al., 2004; Overall
et al., 1991). Curiously, and importantly, the expression of MMP-1 can be regulated by one of its own
substrates, type-I collagen, which acting through a signaling pathway induces the expression of MMP-
1 when present and inhibits it when absent (Shrivastava et al., 1997; Vogel et al., 1997). More recently
the influence of epigenetics in the regulation of MMP expression started to be studied (Chicoine et
al., 2002; Couillard et al., 2006).
2.6.2 Regulation by the Pro-Domain: the “cysteine switch”
MMPs are expressed as zymogens (Harper et al., 1971), which means that, without structural activa-
tion, these enzymes are unable to perform their catalytic activity. As Figure 2.1 on Section 2.3 shows,
the regulatory pro-domain is omnipresent in theMMP family, it is responsible for conferring the struc-
tural inhibition at this stage of the enzymes, and its structure has been elucidated (Section 2.3.4). The
81 residues of the pro-domain fold independently and fall over the enzymatic site of the catalytic do-
main (Jozic et al., 2005). Its conserved cysteine residue, Cys92, blocks the catalytic zinc ion having its
thiol group occupying the place of the catalytic water that is present in the active enzyme (Section
2.3.1 - The catalytic site). The fold of the pro-domain further blocks the entry of any substrate to the
enzymatic site.
A pioneer study baptized theMMP regulation by the pro-domain the “cysteine-switch” mechanism
(VanWart andBirkedal-Hansen, 1990). This “cysteine-switch” hypothesis satisfied all the data acquired
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in the multitude of conditions that lead to proMMP activation in vitro (Springman et al., 1990): i) ac-
tivation by proteases (e.g. in vivo, plasmin, trypsin, kallikrein, chymase, and mast cell tryptase), ii)
organomercurials and thiol reactive compounds (a finding that dates back to 1930’s (Weil and Ko-
cholaty, 1937, 1939) and iii) detergent treatment. In summary, a disruptive action on the stability
of the Pro·Cat complex caused by direct proteolytic action of the pro-domain (refer to the “bait re-
gion” in Section 2.3.4), or by other agents, fosters posterior cleavage of the domain and consequent
autocatalytic separation of the pro- and the catalytic domains (Grant et al., 1987). Analogously, if the
Cysteine-Zn(II) ligation is undone, the quaternary fold of the pro-domain over the catalytic domain is
lost and the interface L3 loop is prone for autocatalysis, resulting in, e.g., an active 42 kDa MMP-1.
Although this hypothesis was proposed in 1990, the Cys92 thiol-Zn(II) ligation required for latency, and
the basis of the “cysteine-switch”, was observed experimentally only later in stromelysin (Becker et
al., 1995; Salowe et al., 1992) and finally with the crystallographic structure of proMMP-1, Figure 2.9.
The biochemistry of the inhibitorymechanismwas posteriorly assessed by other studieswhich demon-
strated also the crucial role of the highly conserved Arg91 in the pro-domain function (Park et al., 1991)
and the possibility to generate MMP inhibitors derived from the pro-domain (Stetler-Stevenson et al.,
1991) that blocked tumor progression (Melchiori et al., 1992).
Additionally to thewhole set of interactions that occur between the pro- and the catalytic domains,
very important interactions were found between the pro- and the hemopexin-like domains. The sur-
face of this interaction has an area of 265 Å2 and occurs mainly through residues Phe289-Tyr290-Pro291
of the loop between β-sheets 3 and 4 of blade I of the HPX domain and Gly53-Leu54-Lys55 in L2 and
Asp61-Glu63 of H2 in the pro-domain (Jozic et al., 2005). This interaction cause a significant shift in the
interacting hemopexin loop (Met303-Glu313) when compared to the active form of MMP-1 (Iyer et al.,
2006), rendering the proenzyme in a closed state and hindering themovements between the catalytic
and the hemopexin domains (discussed in I.B.7.2.2 - The mobility of MMPs) which further inhibits the
enzyme by not allowing the interaction with the triple helical collagen (Welgus et al., 1985).
2.6.3 MMP-dependent Activation
As discussed in the previous section, the MMP zymogen activation is accomplished in vivo by prote-
olytic action by several proteases on the pro-domain. However, MMPs are also themselves proteases
and, therefore, they have alsomechanismsof auto-activation. In fact, themechanismsof intrinsicMMP
activition are an intricate network of connections. For example, MMP- 1 zymogen is fully activated by
MMP-3,MMP-7, orMMP-10 (Imai et al., 1995; Ito andNagase, 1988; Suzuki et al., 1990). MMP-13 can be
activated by MT1-MMP (MMP-14) either directly or indirectly by MMP-2 after it has been activated by
MT1-MMP. MMP-13 can activate the progelatinases proMMP-2 and proMMP-9 (Knäuper et al., 1997a)
and is, by itself, activated by MMP-3, MMP-10, and MT2-MMP (d’Ortho et al., 1997; Knäuper et al.,
1996; L pez-Otin, 1996). A large network of MMP interactions interplay to regulate and activate each
other in the different extracellular environments and situations (Ala-aho and Kähäri, 2005; Visse and
Nagase, 2003).
2.6.4 Tissue Inhibitors of MMPs
At the end of the whole regulatory cascade that controls the healthy activity of MMPs is the inhibitory
action of the endogenous Tissue Inhibitors of MMPs (TIMPs). To date, 4 different TIMPs have been
identified. The first one, TIMP-1, was noted in human fibroblasts (Bauer et al., 1975; Welgus et al.,
1979) and serum (Woolley et al., 1975). A chronological and historical review regarding TIMP discovery
can be found in the literature (Woessner, 2002).
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The four members of the TIMP family have a sequence identity of 40-50% (Pohar et al., 1999) and
they are composed of twodomains, anN-terminal domain (N-TIMP)which has 120 amino acids, and a C-
terminal domain (C-TIMP) that is a third of the total protein (~60 amino acids). Three disulfide bridges
help the folding of the structure in each domain (Murphy et al., 1991), and a total of 12 cysteines are
present in the whole protein. Similarly to MMPs, the N-TIMP domain can fold independently and still
perform full inhibition of its MMP target (Huang et al., 1997; Murphy and Willenbrock, 1995). Other
reviews are important to highlight, that explain the inhibitory action of TIMP, their structure and other
biological roles (BrewandNagase, 2010; Brewet al., 2000; Maskos, 2005; Maskos andBode, 2003). The
question follows: how do the TIMPs perform their inhibitory action on MMPs?
It has been found that the four knownTIMPs are able to jointly inhibit thewhole spectrumofMMPs
(Brew and Nagase, 2010; Hamze et al., 2007), and a comprehensive table can be found in a review
(Diaz et al., 2005). The N-TIMPs form 1:1 non-covalent tight complexes with their respective MMP
targets, usually with a Ki ~ 1 nM (Brew et al., 2000; Will et al., 1996) with some exceptions like theweak
interaction between MMP-14·TIMP-1 (Ki ~ 100 nM, Lee et al., 2003) and the really strong interaction
of MMP-2·TIMP-2 (Ki ~ 1 fM, Hutton et al., 1998). It is necessary to reference here three important
crystallographic TIMP·MMP complexes (Fernandez-Catalan et al., 1998; Gomis-Rüth et al., 1997; Iyer
et al., 2007). It has also been found that C-TIMPsmay interactwith other domains of proMMPs forming
larger complexes (Morgunova et al., 2002; Ogata et al., 1995).
At the level of the active site, the first five amino acids of the N-TIMP enter and interact in a quasi-
substrate fashion with the binding pocket of the MMP. The Cys1 of TIMP chelates the catalytic zinc(II)
with its carboxyl and amide groups, contrarily to the pro-domain that ligates the zincwith the Cys92-SH
goups. Cys1 occupies the position P1, interacting also with the catalytic Glu219. The four consecutive
residues in the TIMP sequence occupy the positions S’1-4 of the binding pocket. Externally to the bind-
ing site, theTIMP·MMP interaction is stabilizedby loopsofbothmolecules. Thedifferences in affinities
between TIMPs andMMPs come from localized differences in the sequence of the variousmembers of
the families that fine tune the interaction mode. TIMPs can also adapt to some extent to the surface
of the MMP target (Nagase and Brew, 2003).
It was also shown that the C-TIMP domain is favored to interact with the hemopexin domain, possi-
bly strengthening the inhibitory interaction (Knäuper et al., 1997b; Overall et al., 1999). Finaly, TIMPs
have been also proposed as active parts in complex MMP activation, which increases the importance
of these proteins in MMP regulation (Itoh et al., 2001; Visse and Nagase, 2003).
2.6.5 Artificial Inhibitors
The important role that MMPs possess in tissue homeostasis (Section 2.4, Klein and Bischoff, 2011;
Mott and Werb, 2004; Rodríguez et al., 2010) makes them protagonists in the development of se-
vere diseases when regulatory mechanisms fail (Section 2.5, Amălinei et al., 2010; Chen and Parks,
2009; Deryugina and Quigley, 2010). For this reason, MMPs have for long been preferential targets
for artificial drugs (MMPIs) for fighting such pathological processes (Fisher andMobashery, 2006; Roy
et al., 2009). Vast libraries of MMP inhibitors targeting the catalytic zinc(II) ion were synthesized as
good drug candidates but, unfortunately, three decades of clinical trials proved all these unsuccess-
ful (Greenwald, 1999). The structural similarity of the MMPs binding site along with the multitude of
roles performed by these enzymes (McCawley and Matrisian, 2001; Rodríguez et al., 2010) generated
severe undesired secondary effects upon the treatment with these drugs. Therefore, pharmaceutical
companies lost interest for MMPIs (Coussens et al., 2002).
Recently, the identification of allosteric exosites inMMPactivity opened newdoors to the develop-
ment of a newgeneration of drugs (Sela-Passwell et al., 2010; Udi et al., 2013). The increasing evidence
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of the relationship between MMPs and severe diseases also contributed to the renewed interest on
MMPs. Nevertheless, the dynamic proteolytic network in which MMPs are involved (Krüger, 2009;
Krüger et al., 2010) strongly hinders the task of finding highly selective and accurate MMP inhibitors.
Nowadays, new strategies are siring which approach inhibition by binding the active pocket with-
out targeting the catalytic zinc (Jacobsen et al., 2010). A very recent and more bold approach fo-
cuses on the combined role of MMPs and galectins in tumor progression and how to explore this with
oligosaccharide-conjugate drugs (Bartoloni et al., 2013).
2.7 The Catalytic Mechanism of MMP-1
Two mechanisms of action can be differentiated in the catalytic activity of MMPs: i) the proteolytic
cleavage, which occurs inside the active pocket of the catalytic domain and is responsible for the di-
gestion of the singular peptidic chains and ii) the collagenolytic action, which is the large structural
rearrangements that occur in the protein and in the substrate upon interaction and that drive the posi-
tioning of the correct scissile bond into the active pocket. Recall that not all MMPs have collagenolytic
activity, only the subfamily of collagenases and few other exceptions (Section 2.2). The two mecha-
nisms are independent from each other, hence each one can be inhibited separately. The nature of
the proteolytic mechanism is virtually equal throughout the MMP familly, consisting in the rupture of
a specific peptidic bond and has been extensively studied during the development of MMP inhibitors,
aidedby the resolvedX-ray structures and theknownsimilarity tootherproteins (Solomonet al., 2007).
Recently, the snapshots on the proteolytic mechanism were unveiled from X-ray studies on MMP-12
(Bertini et al., 2006). However, the molecular details of the collagenolytic activity still remain not fully
known.
2.7.1 The Proteolytic Mechanism - Inside the Active Site
Recall Figure 2.5 on page 55 which describes the nomenclature attributed to each subsite in the cat-
alytic cleft and the corresponding bound substrate residue (S1→ P1). The catalytic Zn(II) is ligated by
three Nε2 histidine protons and other water molecule in an approximately tetrahedral manner, but in
some cases two additional water molecules were observed (Bertini et al., 2006). One of the solvent
molecules is hydrogen bonded to the active Glu219, which is part of the consensus sequence (Section
2.3.1), and is said to be “activated” for catalysis. Figure 2.10 depicts themechanism as described in the
following text. When the peptide enters the catalytic cleft it displaces the other water molecules and
a pentameric adduct is formed between the Zn(II) ion and the oxygen of the residue P1, the oxygen of
the activatedwatermolecule and the three histidines – this is termed theMichaelis complex (Bertini et
al., 2009a; Tallant et al., 2010). As much as nine hydrogen bonds are formed between the peptide and
the cleft walls at sites S2, S3, S’2, S’3 and S’4. Is important to highlight the lipophilic patch that occurs
with the Ile P’1 at the site S’1. Recall that the S’1 subsite is also termed the “specificity pocket” ofMMPs,
because it diverges themost acrossMMPs, strongly influencing the substrate specificity (Tallant et al.,
2010). The “buldge-edge segment” is also important in this interaction.
The pentameric coordination of the zinc forces the activatedwater to become extremely polarized
between the glutamate base and the zinc Lewis acid and the electrophilicy of the scissile carbon in-
creases. At the climax, the glumate base takes the proton from the water molecule which becomes
a hydroxide and by its turn attacks the electrophilic carbon. An intermediate tetrahedral form is sta-
bilized in the pentameric coordination with the zinc. The Glu219 then acts as a general acid catalyst,
delivering the proton acquired from the catalytic water to the amide nitrogen of residue P’1, which
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Figure 2.10: The proteolytic mechanism of MMPs, with the catalytic zinc(II) represented as a gray
sphere. Details of the reaction mechanism are explained in the main text. The graphical aspect of
the figure was inspired from Tallant et al., 2010.
becomes a secondary ammonium. A last shuffling occurs where the proton that was initially on the
water is now transferred to the amide of residue P’1, either directly or via the Glu219. This last step re-
sults in the separation of the peptide chain, where the newly formed carboxyl group remains ligated
to the zinc(II) ion (Bertini et al., 2006). The final products are eventually released from the binding site
and a new water molecule enters to close the cycle.
2.7.2 The Collagenolytic Mechanism - Structural Rearrangements
With the proteolytic mechanisms understood, the scientific community faces a much harder puzzle to
solve: the collagenolytic action. CollagenasesMMPs are capable of degrading natural triple helical col-
lagen at neutral pH and without the need for external sources of energy, like ATP or a proton electric
gradien. However, despite the strong similarity in the domain arrangements of MMPs (Section 2.3),
only this restrict group of can perform collagenolysis (Section 2.2). MMP-1 is the most studied colla-
genase and has been the focus in the study of the collagenolytic process, and here MMP-1 is referred
as model.
Triple helical collagen (consecutive section) does not fit inside the catalytic cleft of the collage-
nases, which can only accommodate a single peptidic chain, and therefore, its degradation implies a
priori large structural changes in both the substrate and the enzyme itself. The experimentalists face
since decades crucial questions about this collagenolytic mechanism. Does the collagen suffer struc-
tural changes? If yes, how? Do they occur naturally, or are they provoked? Does MMP-1 cause the
changes in collagen? Yes? So, from where does the energy come from? Why does MMP-1 cleave col-
lagen and other structurally related MMPs cannot? Which specific amino acids are key in the whole
process? Are MMPs intrinsically dynamic? Some of these questions have been answered and many
clues can now be gathered to help to assemble the picture of collagenolysis. However, despite the
many clues obtained, the full understanding of the process still remains unclear, as some steps have
not yet been observed experimentally and the data might not always point in a single direction. This
chapter gathers a general picture of what is known in the literature about the collagenolytic action
of MMP-1, it explains the most relevant hypothesis and finally prepares the reader to the upcoming
chapters on the results obtained in this thesis.
2.7.2.1 Molecular Determinants of the Collagen Molecule
Collagens constitute the most abundant proteins in animals and are protagonists as the major struc-
tural proteins in all connective tissues, e.g. skin, bone, tendon, cartilage, blood vessels and basement
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membrane (Shoulders and Raines, 2009). Several types of collagen exist and the threemost abundant,
types-I, -II and -III, are called interstitial collagens. These are constituted by three chains, designated
α chains (Kadler et al., 2007). Each α chain is approximately 1000 residues long and is constituted by
Gly-X-Y triplet repeats, where X and Y are most often Proline and Hydroxyproline residues, respec-
tively. Only at the terminal edges the sequence identity differs from this pattern (Gelse, 2003). The
Gly-X-Y repeats force the sequence to acquire a left-handed poly-Pro II helix conformation. Three α
chains consequently form a right-handed supra molecular triple-helix: the collagen molecule (Figure
2.11). The structure of the collagen triple helix is such that only the carbon α protons of the glycine
point to the inner core of the macromolecule and all other side chains point to the outside, otherwise
the supramolecular structure would be impaired. Two collagens are important to highlight: type-I and
type-III collagens. Type-I collagen is a heterotrimer formed by two α1(I) chains and one α2(I) chain,
while type-III collagen is formed by three α1(III) chains (Gelse, 2003). The collagen molecules can still
organize themselves into supra-molecular tether of fibrillar collagen (Perumal et al., 2008). The struc-
ture of triple helical collagen is highly resistant to the proteolytic action of virtually all proteases with
the peculiar exception of the collagenase group of MMPs and few other proteases.
Because the collagen molecule has hundreds of residues and relatively low solubility, it is worth
noticing that themajority of the biochemical assays on collagenolysis uses synthetic triple helical pep-
tides (THP) that accurately mimic the collagen molecule (Fields, 2010; Fields and Prockop, 1996). The
use of synthetic collagen analogues also introduced the possibility to study the effect of mutations
on the catalysis of the proteolysis of collagen.
Collagenases catalyze the lysis of the triple helical peptide by selectively attacking the sequence
Gly-[Ile or Leu]-[Ala or Leu] that is situated approximately at ¼ from the N-terminal site, cleaving the
bond after theGly residue (Gross, 2004). A vast library of experimentswere performedbefore the 90’s
trying to assess the molecular determinants of the triple-helix lysis by collagenases. Experimentalists
were trying to understand why collagenases are selective to that particular site when several other
Gly-[Ile or Leu]-[Ala or Leu] sequences were found across the collagen chains. Fields, 1991, thoroughly
reviewed the work performed to that date and consequently concluded that the cleaved site by mam-
malian collagenases in interstitial collagens shared the following characteristics that no other relevant
site possessed: a) a low side-chain molal volume, high imino acid (>33%) content in the four GIy-X-Y
triplets preceding the cleavage site, forming a tight triple-helical structure, (b) low imino acid content
(< 17%) in the four GIy-X-Y triplets following the cleavage site, loose triple-helix, (c) a maximum of one
charged residue in the 25 residue cleavage site region, which is always anArg that follows the cleavage
site in subsite P’5 or P’8 and d) the absence of an imino acid at position P2. These studies constituted
the first clue in solving the collagenolytic mechanism. However, amajor question remained. The triple
helical collagen has a structure too large to fit inside the active site of the catalytic domain of MMPs,
which suggested that an unwinding of the triple-helical collagen had to occur prior to the proteolytic
cleavage of the α chains.
2.7.2.2 The Mobility of MMPs
A feature of MMPs that had always caught the scientists attention was the presence of a linker with
different lengths across the members of the MMP family (Section 2.3). When the X-ray structures of
the Full Length enzymes started to be unveiled, the nature of the linker was put into question. It was
important to assess if the linker that connects the catalytic domain and the hemopexin domain had
some intrinsic flexibility that would allow the enzyme to better fold onto the substrate conformation
(Overall and Butler, 2007). Some conclusive works focused in answering this question. The intrinsic
freedomofMMP-9, theMMPwith the largest linker (68 residues), was assessed using SAXS and single-
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Figure 2.11: The tridimentional structure of the collagen molecule as depicted from PDB 1BKV. The
backbone is displayed in carton and the side-chains in lines. Note that no bulk side-chain points to the
inner core of the molecule.
molecule imaging data (Rosenblum et al., 2007). It was concluded that, indeed, the CAT and HPX do-
mains of MMP-9 are connected by an unstructured flexible linker which constituted a whole different
domain in this case. Using another set of techniques, SAXS and NMR relaxation data, the flexibility in
MMP-1 and MMP-12 was investigated (Bertini et al., 2008b, 2009a, 2009b). Again, the authors found
that the acquired data could only fit MMP models which considered flexibility of the linker. Because
MMP-1 has the shortest linker of theMMP family and still exhibits flexibility, it was postulated that all
membersof this familywouldpresent intrinsicmobility, proportionatedby the linker, between theCAT
and the HPX domains. A computational work using pyDock also supported the existence of mobility
in MMPs (Valdés et al., 2010). Thereafter, the flexibility of MMPs became an ever present factor in the
collagenolysis equation. Could the flexibility ofMMPs drive the unwinding of the collagen triple-helix?
Figure 2.12: Schematic representation
of the helicase activity of MMP prior to
the proteolytic cleavage of the single
chains.
2.7.2.3 The Helicase Activity of MMPs
How could MMPs perform helicase activity? To answer this
question a major suspect came into scene, the hemopexin-
like domain. The role of the hemopexin domain had always
been a mistery and focus of much attention (Bode, 1995;
Murphy and Knäuper, 1997; Tam et al., 2002).
It was firstly identified that the HPX domain does have
affinity to the collagen triple-helix and that does favor the
binding of collagenase MMPs to it (Netzel-Arnett et al.,
1994; Welgus et al., 1985). Later the collagenolytic ef-
ficiency of MMPs was assessed in the absence of the C-
terminal domain. A study on MMP-13 revealed that with-
out the C-terminal domain (HPX-like domain) this enzyme
was unable to cleave natural collagen but, nevertheless,
maintained its activity towards single chain substrates,
like denaturated collagen and fribronectin (Knäuper et al.,
1997b). Interestingly, chimera enzymes carrying the cat-
alytic domain of MMP-1 and a hemopexin domain of the non collagenolytic MMP-3, and vice-versa,
were unable to cleave collagen (Murphy et al., 1992; Sanchez-Lopez et al., 1993). Anotherwork showed
that the truncated catalytic domain inunable toperformcollagenolytic activitywithout thehemopexin
domain. However, interestingly and importantly, this study showed that the inactive full length en-
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zyme E219A can’t cleave collagen but it nevertheless can favor the collagenolysis by other truncated
CATdomains that otherwisewould not occur (Chung et al., 2004). Similar findingswere obtainedwhen
studying the MMP-14/MMP-2 coordinated collagenolysis (Tam et al., 2004).
These works threw light on the need of the hemopexin domain for the collagenolytic mechanism
and amajor hypothesis rose from these studies (Figure 2.12). The initial binding of the hemopexin do-
main to the collagenmoleculewouldbe followedbymovements in thewhole enzyme, that are allowed
by the flexible linker, and that would cause the unwinding of the collagen triple helix. Thereupon, the
catalytic domain would bind a single α-chain, that was then unwound, and perform the proteolytic
action according to the mechanism explained in Section 2.7.1. This theory supports the perspective
of conformational induced binding mode and states that the sole movement of the MMP domains is
enough todrive the ruptureof the triple-helix superstructure. Amore recentwork fromthe colleagues
of CERM addressed this same hypothesis using NMR and computational tools (Section 2.7.2.4). A spe-
cial focus is given to it because many of the results obtained by them were used later in the studies
presented in this thesis.
2.7.2.4 Structural basis for MMP 1 catalyzed collagenolysis.
In this work (Bertini et al., 2012c) the authors aimed at modeling the collagenolysis mechanism of
MMP-1 and assessing its energetic needs. For this, the authors studied by NMR the interaction of dif-
ferentMMP-1 constructswith a triple helical collagen analogue abbreviated as THP. The studiedMMP-
1 constructs comprehend the truncated catalytic and hemopexin domains and also the full length pro-
tein. The complete peak assignment of all the protein constructs and the THP itself necessary to carry
the studies was accomplished successfully. Two THP species were found to be present in solution: a
trimeric structurewhose chains were designated 1T, 2T and 3T, and amonomeric structure designated
as 4M that accounted for 30% of the spectral density. The trimeric structure of THPwas characterized
as being a left-handed superhelix as in the case of collagen. The macromolecular helical structure
was completely stable at 310K, the temperature at which the experiments were run, but was found
to be very disrupted at 316K (the melting point for THP is Tm = 313 K). In all MMP-1/THP interactions
presented in the work no chemical shift perturbations were observed, only peak intensities were lost.
MMP-1·THP Interaction (MMP-1 labeled) Adding THP to the full length MMP-1 resulted in reduc-
tion of the peak intensity for several residues that restrained the zone of interaction, in both the
catalytic domain and the hemopexin domain. The peaks that suffered the largest decrease in inten-
sity and that had a solvent accessibility over 50% were reported as active residues: for the catalytic
domain) N171, G178, N180, F207, R208, E209, H218, H222, H228, G233, Y237, S239, T241, for the
hemopexin domain) R291, G292, E311, E313, N315, F316, I317, S318, V319, F320, Q323, N326 and
for the THP chains) 1TP14, 1TQ15, 1TG16, 1TI17, 1TA18, 1TG19, 1TQ20, 1TR21, 1TV23, 1TV24, 1TG25,
1TL26, 2TV23, 2TV24, 2TG25, 2TL26, 3TV23, 3TV24, 3TG25, 3TL26.
The truncated HPX domain in the presence of the THP revealed peak intensity loss in the same
regions as for the full length MMP-1 but to a lesser degree. The catalytic domain also revealed peak
intensity loss in the region of the active site but showedmuch lesser affinity to the THPmolecule than
the truncated HPX domain, in consistence with the higher affinity of the HPX domain to the α1(I)772-
786 THP (Han et al., 2010).
MMP-1·THP Interaction (THP labeled) When probing the interaction with the truncated HPX do-
main, the peak intensity loss was immediate across all THP peaks but much more pronounced at the
C-terminal region, Val23 to Leu26. The monomeric chain 4M was not affected. In the presence of the
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truncated catalytic domain the peak intensity loss of the THP was milder and more generalized, but
the strongest decreasewas at themonomeric chain 4M. The signals of triple helical THP decreased the
most when interacting with the full length MMP-1 construct in comparison to the truncated domains.
The decrease in 4M peak height in the presence of the full length enzyme was negligible.
The unwinding of THP In the presence of the full length MMP-1, the whole THP helical structure
showed loosening of its compactness but, 71 specific interchain NOEs presented a more accentuated
decrease in intensity. The loosening of the helical structures was pronounced for 3T at the C-terminal
region whereas for the N-terminal region (bound to the catalytic domain) the loosening was observed
in chains 2T and 3T. The same unwinding behavior was observed for the interaction of the truncated
HPX domain and the THP, however to a lower extent.
Experimentally guided docking of theMMP-1·THP adduct The truncated HPX domain was docked
against the THP imposing the experimental observations, between one, two and all the three chains of
THP. Only the output of the HPX interacting with a pair of two chains of the THP was plausible. Then,
the interaction with the different pairs of two chains in THP, that is, 1T-2T, 2T-3T, 3T-1T, was probed
by HADDOCK (Dominguez et al., 2003). From the three combinations, only the interface 1T-2T and
HPX adduct could orient the residues Gly16-Ile17 in chain 1T to the catalytic site, as suggested by the
reduction in NOEs intensity.
When docking the full length MMP-1 to the THP, the same experimental restraints were used as
for the truncated HPX domain, plus the restraints obtained in the catalytic domain region as well as
others from previous X-ray data (Section 2.7.1) in order to guide the chain 1T to and in the active site.
Theproposed catalyticmechanism These results triggered the authors to suggest snapshots of the
mechanismof the collagenolytic action ofMMP-1. They considered that the closed structure found for
MMP-1 in the crystal form had to be that with the lowest energy. Therefore, additional restraints at
the proximity between the catalytic and the hemopexin domains were imposed to the MMP-1 FL·THP
adduct in order to force a back rotation of the hemopexin domain. When these, together with all the
previous restraints, were imposed to generate the docked model of the full length MMP-1 with the
THP, the result was a closed MMP-1 conformation, similar to the X-ray structure, complexed to an un-
wound THP. The THPwas in contact with theMMP-1 at all experimentally found regions. Interestingly,
their chains where loosened accordingly to the reductions observed in NOE intensities.
The back rotation movement of the hemopexin domain drove the 1T chain at the N-terminal part
of the THP into the active site of MMP-1, allowing the formation of the connections that occur inside
the active pocket. Moreover, chain 3T at the C-terminal part was also detached from chains 1T and
2T that create the adduct between the THP and the HPX domains. Such behaviour was again found in
agreementwith theobservedNOEs. So, the authorsproposed that themechanismof collagenolysis by
MMP-1 couldbedescribedby the following steps: 1) bindingof the1T-2T chains of theTHP to a specific
region of the HPX domain, 2) this binding would cause the loosening of the triple helical structure, 3)
the binding frame 1T-2T at the hemopexin domain would position the chain 1T in the catalytic pocket,
4) after binding the THP the two domains would move towards a lower energy conformation which
would be that found in the crystalographic structures and 5) thismovementwould drive the unwinding
of the THP and further place the chain 1T inside the catalytic cleft for proper cleavage.
To increase the detail of the proposed model and to assess its energetic validity, the authors per-
formed two intermediate docking steps between the initial MMP-1·THP complex and the X-ray similar
closed complex. These four steps were designated “steps 1 to 4” and reprepresent snapshots of the
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unfolding collagenolytic process. At the end, the authors found that the energy of the system drasti-
cally decreases by 300 kcal/mol along with the RMSD to the crystal structure from the initial ”open”
step to the last ”closed” step. Strikingly, the energy necessary for the MMP-1 to drive the collagenol-
ysis of soluble type I collagen and fibrilar type I collagen was found experimentally to be bellow 100
kcal/mol (Han et al., 2010; Welgus et al., 1981). It was therefore concluded that the sole movement of
the MMP-1 domains after THP binding is enough to drive the unwinding of the latter with consequent
peptidic cleavage at Gly16-Ile17, an event also termed as “molecular-tectonics”.
2.7.2.5 Collagen’s Natural Unwinding
As is usual, and beneficial, in science one hypothesis does not normally come alone. In fact, another
school of thought arose fromevidence stating that the unwinding of the collagen triple helixwould oc-
cur spontaneously at specific loci of the chain and that the hemopexin domain of collagenases would
have affinity to these loosed regions and consequently shifting the equilibrium to a completely un-
wound state and stabilizing it. The presence of the linked catalytic domain would readily drive it to
the proteolysis of the single chains. This theory is also known as “vulnerable sites” mechanism.
Several evidences point, indeed, to a loosening of the triple helical chain in natural conditions.
Molecular dynamics showed that the imino-poor regions on the cleavage site (Section 2.7.2.1) can ex-
perience partial unfold exposing a single chain to be cleaved (Stultz, 2002). Several studies confirmed
that the cleavage of the collagen chains can be easily hindered by point mutations that rigidify the
helix character of the collagen, but that do not alter the binding affinities of the enzymes (Minond et
al., 2004; Williams and Olsen, 2009). Also collagenases were found to be ineffective against the more
tight homotrimer type-III collagen (Han et al., 2010). Interestingly, the catalytic activity of the trun-
cated CAT domains of collagenases was reassessed and it was found that the typical collagenolytic
degradation at ¼ in the collagen triple-helical chain still occurs in the absence of the hemopexin do-
main though being residual (Salsas-Escat et al., 2010). These evidences point towards a conformation
selective mechanism. The results that were obtained in support for the hellicase mechanism were
reinterpreted coherently according to the “vulnerable sites” hypothesis (Nerenberg et al., 2008). It is
necessary also to considered in the collagenolytic equation, that strong forces act in the extracellu-
lar environment that could distort a theoretically perfect triple helical structure (Butcher et al., 2009)
thus favoring its cleavage (Adhikari et al., 2011).
2.7.2.6 The Role of the Hinge Region
The hinge region (Section 2.3.2) connects the catalytic to the hemopexin domain and hence deter-
mines the dynamics between the latter two (Section 2.7.2.2 - The Mobility of MMPs on page 65). The
importance of the linker in the collagenolytic activity has been assessed experimentally, and compu-
tationally (De Souza et al., 1996), and it was found that the collagenolytic action is very sensitive to
mutations in the hinge region, specially if the proline configuration becomes affected (Knäuper et al.,
1997c; Tsukada and Pourmotabbed, 2002). The altered mobility of the linker and its interaction with
the CAT domain would hinder the correct positioning of the latter onto the collagen chains for prote-
olysis (Fasciglione et al., 2012).
2.8 Remarks
The above sections aimed at introducing thefield ofMatrixMetalloproteinases. Firstly, they explained
the historical relevance of MMPs and how the interest for these proteins grew in the last 60 years.
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An overview of the whole MMP family was accompanied by an historical report on all the respective
members. Because this thesis focuses on analyzing details at the atomic level, it was imperative to
understand the anatomy on the full lengthMMP-1 enzyme and to gain a general understanding of the
rest of the members of the family. The inhibitory pro-domain, the catalytic and the hemopexin-like
domains and the flexible hinge region were detailed. The role of MMPs in physiology and pathology
was also introduced, as well as a brief overview on the regulatory mechanisms of MMPs. Finally, the
proteolytic and the so important collagenolyticmechanismswere reviewed and the twomost relevant
hypothesis were introduced and explained. Additional studies onMMPswill be referred and discussed
at appropriate occasions in later sections.
Part II
The Projects
71

Chapter 3
Objectives of the Thesis
In science, the biochemical assays unveil the chemical pathways that compose life, revealing the cross-
roads of interactions between biological molecules. Structural biology beautifully complements the
biochemical research by “popping the hood” to discover the atomic details of the molecular motors
that drive the homeostasis of life. Proteins are certainly the machinery of life and, therefore, under-
standing the details of their behavior is a crucial step in human knowledge if we are to dare to control
life to a deeper extent. The constant improvement of the empirical and computational tools have led
us to enter where we are now, the era of protein design (from scratch!).
Before, it was common understanding that proteins constituted solid bodies of a precise structure
determined by their monomeric building blocks, the amino acids. Nowadays, the opposite is true, we
have understood that motions within proteins are a fact and are essential to the well functioning of
these molecular motors. The study of the proteins’ dynamics became a priority in this new era of
knowledge.
Matrix Metalloproteinases, specially the subfamily of collagenases, are enzymes whose conforma-
tional dynamics in the performance of their catalytic activity has intrigued scientists for more than
two decades. The complex biochemical network in which MMPs operate make them key players in
tissue homeostasis and, at the same time, protagonists in severe diseases such as metastatic tumor
progression.
Nuclear Magnetic Resonance presents itself as a technique able to reveal the dynamic movements
of the biological molecules at atomic detail, whose potentialities can be further increased when com-
bined with the effect of the paramagnetic ions naturally available.
In the Thesis here presented, the most advanced techniques in Paramagnetic NMR served the
means to study the dynamic behavior of Matrix Metalloproteinase-1, an enzyme which by dynamic
joint action of its two domains can catalyze the peculiar and crucial mechanisms of extracellular ma-
trix degradation.
To achieve the these purposes the following specific aims were proposed, to:
• Select of themost suitedparamagneticNMRprobe,whichwas theLanthanide(III) bearingCLaNP-
5. The probe was also synthesized by the candidate as part of his training.
• Functionalize the catalytic domain of Matrix Metalloproteinase-1 with the probe (Ln)CLaNP-5.
Two different constructs were prepared, the truncated domain and the full length enzyme.
• AcquireparamagneticNMRrestraints (PCSandRDC)on thedifferent (Ln)MMP-1 constructsbear-
ingfivedifferent Lanthanides. In theprocesswe aimedat obtaining completeNMRpeak lists and
determine the respective paramagnetic Δχ-tensors.
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• Obtain the paramagnetic solution refinedmodels of the two domains of theMMP-1 enzyme: the
catalytic domain and the hemopexin-like domain.
• Determine the complete and detailed 3D map of the conformational space explored by MMP-1
in solution. This map must have resolved information on the maximum percentage of time that
each possible conformation of MMP-1 can exist.
• Analise an obtained map on the basis of the collagenolytic action of the enzyme and perform
detailed comparison with the previously published crystallographic models. This map must thus
carry high resolution information on the prologue steps of the collagenolytic interaction.
• Finally, to acquire paramagnetic NMR data on the complex formed between MMP-1 and a triple
helical collagen analogue. We expect with this data to reveal the conformation acquired by the
enzyme in the presence of the substrate and, in combination with a large body of previously
published data, to determine an empirically drivenmodel of the latest step of the collagenolytic
mechanism, which is the MMP-1·THP complex in the instant prior to the proteolytic cleavage of
the scissile bond.
During theprogress of the studies here proposed the candidate has theobjective andduty to learn and
understand each single step of the project in order to gain expertise on how to design, plan, develop
and present, projects in the area of paramagnetic NMR structural biology.
Chapter 4
Materials and Methods
4.1 Validating the Cysteine Mutants
The introduction of a paramagnetic tag into amacromolecular structuremay lead to underised effects
of structural modifications or blocking of the biological activity. Therefore it is necessary to analyze
carefully the structure of themacromolecule to be functionalized in order to place the tag in a position
where it won’t interfere with its biological activity. We have designed the double cysteine mutations
for the catalytic domainofMMP-1bearing inmind the concepts discussed in Section 1.6.1.1, namely for
(Ln)CLaNP-5. We concluded that the long amphipathic α-helix hA and the second β-sheets sII were the
most favorable target positions. We also envisaged a mutation on the Hemopexin domain. The wild
type sequences of all the regions proposed for mutation were tested with the different bioinformatic
tools to validate the initial condition. The integrity of α-helix residues 126 to 143 after mutations
was evaluated with tools PSIPRED, SCRATCH, PROF, EsyPred3D, HNN and GOR4, and the integrity of
β-sheets residues 148 to 151 and Hemopexin residues 453 to 459 was evaluated with PSIPRED and
PSIPRED and PORTER, respectively. The software used is freely available and can be found in the
respective links:
• EsyPred3D (http://www.unamur.be/sciences/biologie/urbm/bioinfo/esypred/)
• GOR4 (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_gor4.html)
• HNN (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_hnn.html)
• PORTER (http://distill.ucd.ie/porter/)
• PROF (http://www.aber.ac.uk/~phiwww/prof/)
• SCRATCH (http://scratch.proteomics.ics.uci.edu/)
• PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/)
With the wild type sequence all the programs correctly predict the native secondary structure. Five
different mutations were tested on the selected secondary structures: (1) A128C // H132C (α-helix),
H132C // K136C (α-helix) (2), K136C // L140C (α-helix) (3), T148C // T150C (β-sheet) (4) and R453C
// L455C (β-sheet) (5). After validation with the bioinformatic tools and laboratory experimentation
we concluded that the mutation H132C/K136C was that which performed better. This mutation is
placed in themidle of the helix hA and distal to the catalytic site which renders it highly improbable to
affect the biological activity of theMMP-1 enzyme. The other mutations on the catalytic domain were
discarded. The mutation on the hemopexin-like domain was also discarded because it conflicted with
the structural cysteine bridge that is naturally present in the domain.
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4.2 CLaNP-5
4.2.1 CLaNP-5 Synthesis
The synthesis of the CLaNP-5.2 tag followed the steps of the authors’ publication (Keizers et al., 2008)
except for the last step which was developed in the lab. Figure 4.1 summarizes the synthesis scheme.
Trans-protection of cyclen with benzyl chloroformate was achieved by dissolving 5 g of cyclen (1) in
750 mL of chloroform. 2.2 equivalents of benzyl-chloroformate were added dropwise to the reac-
tion which started in ice bath and stirred for 16h. After reaction, a white precipitate was formed
corresponding to the monoderivated Cbz2-cyclen. The reaction mixture was filtered and the soluble
fraction was extracted by evaporation under reduced pressure. Solid trans-Cbz2-cyclen was dissolved
in H2O/EtOH 20% with addition of NaOH and stirred overnight to obtain the compound’s pure basic
form. Trans-Cbz2-cyclen was extracted against chloroform and consecutively dried with Na2SO4 (2).
Alkylation with tert-butyl bromoacetate was achieved by dissolving the trans-Cbz2-cyclen in dried ace-
tonitrile with addition of 8-10 equivalents of K2CO3 and slight excess of tert-butyl bromoacetate, 20%,
overnight stirring. Product purificationwas performedusing Silica 60 columnequilibratedwith chloro-
form to elute the unreacted tert-butyl bromoacetate. Trans-tBuAc2-Cbz2-cyclen elution was achieved
with pure methanol (3). To hydrogenate the Cbz2 groups, the previously obtained product was dis-
solved in methanol under argon atmosphere, active palladium on carbon was added as catalyst, 20-
25% of the reagent mass. Hydrogen was pumped overnight directly inside the solution. The product,
trans-tBu2DO2A (4a), was purified using Silica 60 as solid phase and a 1:6 NH3:EtOH liquid phase mix-
ture for elution. Elutions were coevapored and washed twice with dichloromethane under reduced
pressure. Functionalization with the pyridine-N-oxide rings (4b) was achieved in dried acetonitrile in
the presence of 8-10 equivalents of K2CO3 in oil bath at 80ºC during 18h stirring. The reaction mix-
ture was purified through several extractions in dichloromethane/H2O to remove the soluble colored
impurities and in the presence of N(CH3)4 to obtain better phase separation. Complete drying of the
organic phase was achieved with Na2SO4 yielding satisfactory pure trans-tBuAc2-pyNox2-cyclen (5).
The tert-butyl groups were hydrolysed in a mixture of 1:3 (v/v) DCM:TFA stirring overnight at 40ºC.
The reaction was coevaporated with toluene to obtain the trans-pyNox2-DO2A (6).
Thefinal stepof synthesis, couplingof2-(aminoethyl)methanethiosulphate (MTS) arms,was achieved
by reacting the precursor with 2.3 equivalents of MTS in the presence of 1 equivalent of DMAP1, 1
equivalent of HOBT2, 4 equivalents of TBTU3, and 5–6 equivalents of DIPEA4, stirring overnight at
room temperature in dried acetonitrile. A HPLC purification step was necessary to achieve purifica-
tion of the final product. The setup and optimization of the HPLC method was performed using a
Phenomenex C8 analytical column and the peak of interest was identified by HR-MS as the correct
product [C30H48N8O8S4], with 777Da. After optimization of theHPLCmethod, a PhenomenexC8 semi-
preparative column was used with the following program: starting mixture of 40/50/10 (H2O/0.1%
TFA/MeCN) during 1.6 column volumeswith consecutive gradient flow to thefinalmixture of 30/50/20
(H2O/0.1%TFA/MeCN)during4 columnvolumes. Theobtainedproduct (1,4,7,10-Tetraazacyclododecane-
1,7-[di-(N-oxido-pyridine-2-yl)methyl]-4,10-bis[2-(acetylamino)ethylmethane-sulfonothioate)] (7) was
lyophilized and its purification was confirmed by analytical HPLC. A thick and slightly green colored oil
was obtained, and the compound was stored at -20ºC.
14-dimethylaminopyridine
21-hydroxybenzotriazole
3O-(Benzotriazol-1-yl)-N,N,N￿,N￿-tetramethyluronium tetrafluoroborate
4N,N-Diisopropylethylamine
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Figure 4.1: Schematic representation of the synthesis of CLaNP-5.2. a) benzyl chloroformate in
chloroform b) tert-butyl bromoacetate in dried acetonitrile c) hydrogenation of Cbz2 in methanol
d) Pyridine-N-oxide in dried acetonitrile e) hydrolysis of the tert-butyl groups, DCM and TFA f)
(aminoethyl)methanethiosulphate (MTS), DMAP, HOBT, TBTU, DIPAE in dried acetonitrile.
4.2.1.1 Pyridine-N-Oxide Synthesis
Commercially available 2-(chloromethyl)pyridine hydrochloridewasdissolved andpurified frombrown
impurities by elution with chloroform in a short alumina column. 5 g of 2-picolyl chloride were dis-
solved in 300 mL of chloroform and 200 mL of chloroform containing equimolar quantities of MCPBA
acid (m-chloroperoxobenzoic acid) were added dropwise to the stirring solution of 2-(chloromethyl)-
pyridine hydrochloride reaction occurred overnight. Pyridine-N-oxide was purified by eluting the re-
action mixture through alumina column with a mixture of 95:5 CHCl3/MeOH. An yellowish oil was ob-
tained which crystallized spontaneously, Figure 4.1 - (4b) (Polásek et al., 2009).
4.2.2 Lanthanide binding to CLaNP-5
Batches of 15mgof the obtainedCLaNP-5 gelwere dissolved in 400 μL ofDMF. TheDMF tag batchwas
separated in aliquots of 100 μL and a strong excess of lanthanide(III) acetate salt [Ln = Lu(III), Tb(III),
Dy(III), Tm(III) and Yb(III)] were added to each batch. The 100 μL batches of LnOAc-/CLaNP-5 were
shaken for 3 days at 32ºC with some vortex resuspention steps over the day to avoid sedimentation of
the salts. The insoluble excess of Lanthanide(III) salt was centrifuged but left in the reaction mixture.
The yield of the protocol described was confirmed by ESI analysis – during the optimization proce-
dure several protocols were tried with more mild conditions of chelation, either lower temperature
or reduced shacking time, with no successful results. In Figure 4.2, two ESI spectra are represented:
panel A corresponds to the free tag and panel B to the tag quantitatively chelatedwith Yb(III). In panel
A a strong single peak is present at 777 Da, that is exactly the molecular mass of free CLaNP-5. On
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Figure 4.2: The ESI spectra of A) free CLaNP-5 and B) (Yb)CLaNP-5.
the other hand, in panel B a single strong peak is present at 948 Da (z=1), in approximation, 948 mi-
nus 777 is 171 that corresponds to the atomic mass of Yb(III), 173 Da. The second peak on the left
of the panel B ESI spectrum represents the (Yb)CLaNP-5 measured with two charges, z=2, which give
the halved molecular mass. In conclusion, the efficiency of the protocol described for Ln(III)/CLaNP-5
functionalization can be qualified as quantitative considering the obtained ESI spectra.
4.3 MMP-1 Constructs
4.3.1 Plasmid Preparation
4.3.1.1 Inactive MMP-1 mutants E219A
The plasmids of MMP-1 E219A inactive mutants used during the studies here presented were pre-
viously prepared by CERM colleagues. Here a very brief summary is given for the sake of clarity, the
completedetails canbe found in literature (Bertini et al., 2009b). The cDNAencoding sequence (Asn106
– Gly261) of the catalytic domain, Hemopexin domain (Thr274 - Arg469) and Full-lenght MMP-1 (Asn106 -
Arg469) were generated by polymerase chain reaction (PCR) using the inactive full length MMP-1 gene
(E219A) as template which was then cloned into pET21a(+) plasmid using NdeI and XhoI as restriction
enzymes.
4.3.1.2 Engineering Double Cysteine Mutants
The plannedmutationswere engineered during a single PCR step using theQuickChange SiteDirected
Mutagenesis Kit (Stratagene - Catalog #200518 (30 reactions) and #200519 (10 reactions) Revision B);
the primers used to perform the H132C/K136C pair of mutations are the following: (F) 5’ - GCC AAG
AGC AGA TGT GGA CTG TGC CAT TGA GTG TGC CTT CCA ACT CTG GAG - 3’, (R) 5’ - CTC CAG AGT TGG
AAGGCACACTCAATGGCACAGTCCACATCTGCTCTTGGC - 3’. The PCR cycle usedwas the following:
step 1) 95ºC for 30 seconds, step 2) for 18 cycles, 95ºC for 30 seconds, 55ºC for 1 minute, 68ºC for 14
minutes, 3) stop the reaction at 4ºC. Plasmid templates were digested by Dpn I for 1h30 hours at 37ºC.
The mutations were confirmed by nucleotide sequencing at PRIMMMilano.
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4.3.1.3 Expressed MMP-1 constructs
Truncated Catalytic Domain (MW: 17,453.1 Da):
• MNPRWEQTHLTYRIENYTPDLPRADVDCAIECAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPF
DGPGGNLAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHALGHSLGLSHSTDIGALMYPSYTFS
GDVQLAQDDIDGIQAIYG
Full Length MMP-1 (MW: 42,060.1 Da):
• MNPRWEQTHLTYRIENYTPDLPRADVDCAIECAFQLWSNVTPLTFTKVSEGQADIMISFVRGDHRDNSPF
DGPGGNLAHAFQPGPGIGGDAHFDEDERWTNNFREYNLHRVAAHALGHSLGLSHSTDIGALMYPSYTFS
GDVQLAQDDIDGIQAIYGRSQNPVQPIGPQTPKACDSKLTFDAITTIRGEVMFFKDRFYMRTNPFYPEVEL
NFISVFWPQLPNGLEAAYEFADRDEVRFFKGNKYWAVQGQNVLHGYPKDIYSSFGFPRTVKHIDAALSEE
NTGKTYFFVANKYWRYDEYKRSMDPGYPKMIAHDFPGIGHKVDAVFMKDGFFYFFHGTRQYKFDPKTK
RILTLQKANSWFNCRKN
4.3.2 MMP-1 Preparation
4.3.2.1 MMP-1 Expression
The expression vectors corresponding to each MMP-1 construct were inserted into competent Es-
cherichia coli BL21(DE3) CodonPlus RIPL strain cells, and the colonies were selected for ampicillin
and chloramphenicol resistance. Overnight pre-culture steps of cellular growth in 11 mL preceded
the large growth steps. Single-labeled 15N and double-labeled 13C/15Nmutants were expressed using
minimal medium (M9) containing 1.2 g/L of 15N-enriched (NH4)2SO4 and 2 g/L of 13C-enriched glucose
(Cambridge Isotope Laboratories) or 3g/L in case of 15Nmonolabeling. Cell growth occurred at 37 °C,
with induction at 0.6O.D.with 500μMof IPTGandharvested after 5 h expression, allMMP-1 constructs
precipitated as inclusion bodies. The expression of non labeled protein constructs was performed the
same way as described above except that LB rich medium was used instead of M9. The expression of
triple labeled (2H/13C/15N) constructs was conducted with the same protocol as for non rich samples
but the medium used was E.coli-OD2 CDN (2H > 95%, 13C, 15N), 110701402, from Silantes.com. Pre-
culture steps were also performed in OD2 medium. All steps were performed in sterile conditions.
4.3.2.2 MMP-1 Extraction From Inclusion Bodies
The extraction of all MMP-1 constructs can be performed in the same way. The following steps were
performed in cold room at 4°C. The cell pellet was resuspended using strong agitation in buffer con-
taining 25% sucrose, 50 mM Trizma-base at pH 8, 0.1 M NaCl, 0.2 mM EDTA and 1 mM dithiothreitol
(DTT), 10 ml of buffer/1L of expression followed by addition in the same proportions of buffer 2% Tri-
ton, 50 mM Trizma-base pH 8, 0.1 M NaCl, 0.2 mM EDTA, 1 mMDTT prior to sonication. The sonication
cycle for cell lysis was carried out with 5 cycles of 3 x 30 seconds of sonication (big tip), with 5 minutes
of strong agitation between each cycle. In case of large expression pellets, 20-30mL of buffer per litre
of expression is advisable, larger volumes of buffer in addition to more sonication cycles are crucial
to help in the complete cell disruption at this stage; the larger the percentage of cell disruption the
better the next stepswill perform. The destructed cell mixturewas centrifuged at 20,000 r.p.m. for 20
minutes. A pellet with two phases was obtained, a proteic phase and a lipidic phase. The lipidic mem-
brane residues were mechanically removed and the pellet was resuspended using sonication (small
tip) with buffer 50 mM Trizma-base pH 8, EDTA 0.2 mM and 1 mM DTT, adding enough buffer to cover
the pellet. The centrifugation/resuspension cycle was repeated until the supernatant presented no
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color. For the case of OD2 protein, a single washing cycle of performed. The pellet was finally solu-
bilized using sonication (small tip) in buffer containing 8 M Urea and 50 mM Trizma-base pH 8, using
6 mL for each litter of expression. After solubilization, the solution was centrifuged at 20,000 r.p.m.
for 1 hour in order to deposit the remaining membrane lipids. The supernatant was fractionated into
3 mL fractions which were stored at -20°C, fast freezing of the samples at -80°C is advisable.
4.3.2.3 MMP-1 Refolding
Refolding of MMP-1 involved a decreasing urea gradient at 4 °C through sequential dialysis. For the
truncated catalytic domain of MMP-1: 10 mM DTT were added to the unfolded protein in the 8 M
fractions stock (3 mL). Unfolded protein was diluted into 500 mL buffer solution containing 6 M urea,
50 mM Trizma-base pH 8, 10 mM CaCl2, 0.1 mM ZnCl2 and 20 mM Cysteamine. The solution was then
dialyzed against a) overnight, 4 L of 4 M Urea, 50 mM Trizma-base pH 8.0, 10 mM CaCl2 and 0.1 mM
ZnCl2 b) 12h, 4 L of 2 M Urea, 50 mM Trizma-base pH 7.2, 10 mM CaCl2, 0.1 mM ZnCl2, and 0.3 M
NaCl c) three minimum 5h steps of 20 mM Trizma-base pH 7.2, 10 mM CaCl2, 0.1 mM ZnCl2, and 0.3 M
NaCl. The resulting 500 mL of protein sample were concentrated to 100 mL using MiniKros Modules
(Spectrumlabs). For the truncated hemopexin domain and full-lengthMMP-1 the refolding protocol is
the same as above described with the addition of 5 mM 2-Mercaptoethanol and 1 mM 2-Hydroxyethyl
Disulfide in the 4 M Urea buffer. If necessary or desirable, acetohydroxamic acid (AHA) can be used
onward the last three steps of dialysis as an inhibitor and protein stabilizer, however, if no AHA is
desired on the final NMR sample, avoid its use.
4.3.2.4 MMP-1 Purification
All constructs of MMP-1 were purified using HiLoad 26/60 Superdex 75 pg (AmershamBio-sciences) in
a AKTA Prime System using as running buffer: 20 mM Trizma-base pH 7.2, 10 mM CaCl2, 0.1 mM ZnCl2
and 300 mM NaCl, running at 1.5 mL/min. If the cases when the protein in preparation was not to be
latter functionalizedwith (Ln)CLaNP-5.2, theNaCl concentrationwas halved to 150mM. Stocks of pure
protein were stored at 4 °C. The chromatogram protein peaks, either for the truncated domains or the
full length construct, are well separated from other impurity peaks, rendering the separation of the
protein straightforward.
4.3.3 MMP-1 Functionalization with (Ln)CLaNP-5
4.3.3.1 Functionalization of the CatMMP-1 (H132C/K136C/E219A)
An aliquot of 5 ml of 10 mM protein was dialyzed against anaerobic buffer (20 mM Trizma-base pH
7.2, 10 mM CaCl2 and 0.1 mM ZnCl2, 0.3M NaCl) and under anaerobic atmosphere. The protein was
then treated with 5 mM of Dithiothreitol (DTT) to reduce the engineered cysteines. Still in anaerobic
conditions the DTT was removed using a PD10 desalting column, and the protein was concentrated
down to 1 mL. 10 equivalents of tag (Ln)CLaNP-5 [Ln = Lu(III), Tb(III), Dy(III), Tm(III) and Yb(III)] were
added to the sample; the reaction proceeded overnight at 4 ºC (20 mM Trizma-base pH 7.2, 10 mM
CaCl2 and 0.1 mM ZnCl2, 0.3 M NaCl). Precipitation was observed after overnight incubation. Final
NMR buffer conditions were obtained by washing the sample with PD10 desalting columns against 20
mM Trizma-base pH 7.2, 10mM CaCl2 and 0.1mM ZnCl2, 0.15M NaCl. The final yield of soluble protein
obtained approximates 60%. The NMR spectra and the MASS spectrometry showed that the protein
had quantitatively reacted with the metal complex.
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4.3.3.2 Functionalization of the full length MMP-1 (H132C/K136C/E219A)
2 mg of purified H132C/K136C/E219A full length MMP-1 were concentrated down to 1 mL in 2 M
Trizma-base, pH 7.2, 10mMCaCl2, 0.1mMZnCl2, and 0.3MNaCl buffer. 10 equivalents of (Ln)CLaNP-5
[Ln = Lu(III), Tb(III), Dy(III), Tm(III)] from DMF stock were added to the protein solution. The triple mu-
tantMMP-1/(Ln)CLaNP-5mixturewas left onmild stirring overnight at 4ºC. Someprotein precipitation
was observed after reaction. Contrary to the procedure for theMMP-1 truncated catalytic domain, no
DTT nor reductant of any kind was added to the protein at any stage of the preparation to avoid re-
duction of the structurally important and solvent exposed disulfide bridge present in the HPX domain
between residues Cys278 and Cys466. After reaction with (Ln)CLaNP-5, approximately 10-20% of unre-
acted MMP-1 remained, as estimated from the 1H-15N HSQC spectra acquired on these samples. The
overall yield of obtained paramagnetic (Ln)CLaNP-5·MMP-1was estimated to be ~60-70%, considering
precipitation occurring during (Ln)CLaNP-5 reaction and efficiency ofMMP-1 functionalization. Please
note the increase in overall yield on the ligation step due to reduced precipitation in comparison to
the experiments on the trucated catalytic domain. As a side product of the functionalization reaction
a sulfinic group is released, 2 M Tris helps buffering the strong localized acidic effects of this group,
maintaining the stability of the protein. On the perdeuterated samples of full lengthMMP-1, the yield
of reaction was superior to 90%, and diamagnetic species were practically absent in the NMR spectra.
4.4 Triple Helical Peptide (THP) Preparation
THP used in this project is the same used in the previous work from CERM colleagues (Bertini et al,
2012c). The THP was separated in batches of 1 mg and the pH was adjusted to 7.2 with subsequent
lyophilization. Each bath of 1 mg was dissolved in 10 µL of deionized water prior to addition to the
protein sample. The THPmolecule is a homotrimer with chains labelled as 1T, 2T and 2T. The sequence
of each chain is (GPO)4-G13PQGIA19GQRGVVG25LO-(GPO)4 (MW ~ 10,600 Da) and, as in the natural
collagen molecule, when in the triple helical conformation the chains are staggered by one residue.
4.5 NMR Sample Conditions
For all samples, the final NMR buffer conditions were obtained by washing the tag·protein reaction
mixture with PD10 desalting columns against 20 mM Trizma-base pH 7.2, 10mM CaCl2 and 0.1mM
ZnCl2, 0.15 M NaCl. (Ln)MMP-1 samples for interdomain mobility studies with MaxOcc had, addition-
ally, 200 mM of acetohydroxamic acid (AHA) for protein inhibition and sample stability. The final pro-
tein concentrations in the NMR test tube were of 150-200 µM for the truncated catalytic domain, 100
µM for free full length (Ln)MMP-1, while protein concentrations ranging 180-190 µM were obtained
for the interaction studies between (Ln)MMP-1·THP.
4.5.1 (Ln)MMP-1·THP Complex
2 mg of THP were added to each sample of perdeuterated full length MMP-1 bearing the different
Lanthanides as described in 4.2.2. The molar ratio obtained was 1:5 enzyme:THP. THP batches were
prepared as described in Section 4.4.
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4.6 NMRMeasurements
4.6.1 (Ln)MMP-1 Truncated Catalytic Domain
All experiments were performed on samples of H132C/K136C/E219A mutants of MMP-1 truncated
catalytic domain (CatMMP-1) which was functionalized with (Ln)CLaNP-5 [Ln = Lu(III), Tb(III), Dy(III),
Tm(III), Yb(III)], at concentrations ranging between 0.15 and 0.2mM (20mMTris, pH = 7.2, 0.15MNaCl,
0.1 mM ZnCl2, 10 mM CaCl2). All NMR experiments were performed at 310 K and acquired on Bruker
AVANCE 700 and DRX 500 spectrometers, equipped with a triple resonance cryo-probes. All spectra
wereprocessedwith theBruker TOPSPIN softwarepackages andanalyzedby theprogramCARA (Com-
puter Aided Resonance Assignment, ETH Zurich) (Keller, 2003). 1H-15N HSQC spectra were recorded
at 500 MHz. The assignment of the protein functionalized with (Lu)CLaNP-5 was obtained by the
comparison of the 1H-15N HSQC spectrum with the assignment reported on BMRB (Moy et al., 1997)
and the analysis of the 3D HNCA experiment performed at 700 MHz. The 1H-15N HSQC spectrum of
(Yb)CatMMP-1 was assigned with the help of the 3D HNCA and CBCA(CO)NH experiments performed
at 500MHz. The 1H-15NHSQC spectra of (Tm/Tb)CatMMP-1were assigned based on (Lu/Yb)CatMMP-1
assignments and pseudocontact shift predictions. 1H-15N residual dipolar couplingsweremeasured at
310K and700MHz for the (Tb/Tm)CatMMP-1 using the IPAPmethod. In the case of the (Yb)CatMMP-1,
due to the smallermagnetic susceptibility anisotropyof themetal, themeasurementswereperformed
on an Avance 900 MHz Bruker spectrometer to achieve a higher alignment, and thus larger RDC val-
ues. Figures of the spectra and the peak lists can be found in the Appendix Chapter, the final peaklists
were obtained by the iterative process of Section 4.7.
4.6.2 Free Full Length (Ln)MMP-1
All experimentswere performedon samples of triplemutant (H132C/K136C/E219A), full-lengthMMP-
1 functionalized with the (Ln)CLaNP-5 [Ln = Lu(III), Tb(III), Dy(III), Tm(III)], at concentrations of approx-
imately 0.10 mM in water buffered solution (20 mM Tris, pH 7.2, 0.15 M NaCl, 0.1 mM ZnCl2, 10 mM
CaCl2, and 200 mM AHA). All NMR experiments were performed at 310 K and acquired on a Bruker
AVANCE 700 spectrometer equipped with a triple resonance cryoprobe. All spectra were processed
with the Bruker TOPSPIN software packages and analyzed using the program CARA (Computer Aided
Resonance Assignment, ETH Zurich) (Keller, 2003). The 2D 1H-15N HSQC spectrum of (Lu)MMP-1 was
recorded as the diamagnetic reference to evaluate the PCSs and its assignment was based on the pre-
viously acquired experiments (Bertini et al, 2009b). The spectrum was easily reassigned because no
meaningful shifts with respect to the non-functionalized protein were observed, indicating that the
presence of the (Ln)CLaNP-5 does not alter the structure of the protein. The assignment of MMP-1
in the presence of the different paramagnetic Lanthanides was performed by comparison with the
assignments obtained for the truncated catalytic domain for the same metal ions (Section 4.6.1). 1H-
15N RDCs were measured for the (Tb/Dy/Tm)MMP-1 using the IPAP-HSQC method and (Lu)MMP-1 as
reference. Figures of the spectra and the peak lists can be found in the Appendix Chapter, the final
peaklists were obtained in the iterative process of Section 4.7.
4.6.3 (Ln)MMP-1·THP Complex
AllNMRexperimentswereperformedon samples of perdeuterated (2H/13C/15N) triplemutant (H132C
/ K136C / E219A) full lengthMMP-1 functionalizedwith (Ln)CLaNP-5 [Ln = Lu(III), Tb(III), Dy(III), Tm(III)],
at concentrations of 190 µM inwater buffer solutions (20mMTris, pH 7.2, 150mMNaCl, 0.1mMZnCl2,
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10 mM CaCl2). The experiments were performed in the presence of 5-fold concentration of the col-
lagen analogue triple helical peptide (THP), wich was described previously in Section 4.4. All NMR
experiments were recorded at 298 K and acquired on a Bruker AVANCE 700 spectrometer equipped
with triple resonance cryo-probe. 1H-15N HSQC and HSQC-IPAP experiments were recorded on each
(Ln)MMP-1·THP sample to obtain PCS and RDC, respectively, and (Lu)MMP-1·THP was used as refer-
ence. All spectra were processed with the Bruker TOPSPIN software packages and analyzed with the
program CARA (Computer Aided Resonance Assignment, ETH Zurich) (Keller, 2003). The assignment
of the different (Ln)MMP-1 diamagnetic and paramagnetic samples was based on the previously ob-
tainedassignmentsof both the truncated (Ln)Catalytic domain and the full length (Ln)MMP-1 (Sections
4.6.1 and 4.6.2). Figures of the spectra and the peak lists can be found in the Appendix Chapter, the
final peaklists were obtained in the iterative process of Section 4.7.
4.7 Δχ-tensor calculations
The Δχ-tensors were calculated following the iterative strategy of Figure 1.9. The software used was
the AnisoFIT program available in the WeNMR Web Portal (Section 1.5.2 - AnisoFIT and the WeNMR
GRID-Enabled Web Portal).
4.8 Maximum Occurrence Calculations
Aflexible linkerof 13 residues (fromArg262 toThr274)wasdefinedas alpha carbons andused to connect
the rigid structures of the previously refined catalytic domain (Chapter 5) and hemopexin domain (PDB
ID: 1SU3). These domains were input in the program RanCh (Bernadó et al., 2007; Bertini et al., 2010;
Petoukhov et al., 2012) which generated a pool of 50,000 CAT-HPX conformations that sampled all
conformational space allowed by the quasi-Ramachandran plot of linker’s Cα-atoms. Explanation on
the MaxOcc protocol can be found in Section 1.8. 1,000 conformations were randomly selected from
the large pool generated by RanCh for analysis with MaxOcc. The MaxOcc value of each of the 1,000
freeMMP-1 conformationswas obtained from the largestweight that it can havewhen included in any
best-fit ensemble togetherwith 50other conformationswith differentweights freely chosen from the
RanCh pool. These best-fit ensembles were found as families of structures in best agreement with
the experimental data by minimizing the target function (TF) which is defined as a measure of the
disagreement from the experimental data of the weighted average of PCS, RDC and SAXS, calculated
according to the ensemble itself (eq. 1.19). The weight of the observed conformation was sampled in
steps of 5% from 0% to 50%. The MaxOcc value for each of the 1,000 conformations was defined as
the largest weight for which the TF is smaller than a given threshold. The minimum value for the TF
was calculated by generating structural ensembles without any fixed conformation or weight, and it
was calculated to be ~0.253. The TF thresholdwas defined as 10% larger than this lowest value (0.278).
Calculations were performed through the web server accessible to WeNMR registered users (Section
1.8 - MaxOcc on the WeNMR Web Portal). The final weights of the restraints used in the calculations
were 1.0 for RDC andPCS and 0.1 for SAXS. Theweight of the different restraintswas chosen to obtain
a reasonable balance between them.
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4.9 Hemopexin Refinement and Reorientation
Protein structures in solution can be refined using the crystal structures as starting models and ap-
plying NMR solution restraints. We used here the same strategy that we developed in Chapter 5.
A pseudoprotein residue was created and included in the library of CYANA, composed by as many
“pseudoatoms” as the number of atoms of the protein, each labeled according to its residue number
and atom name. These pseudoatoms have coordinates equal to the coordinates of the corresponding
atoms in the crystal structure andwith no van derWaals radius. The pseudoprotein residuewas linked
to the protein sequence through dummy residues, which have the function to allow the pseudoprotein
residue to freelymovewith respect to the protein residues. RDCswere introduced as restraints under
the assumption that the tensor calculated from the PCSs and the crystal structure is also responsible
for these paramagnetic constraints, as it occurs in the absence of motion. The usual mobility of H-
HN vectors was considered using an order parameter SLS of 0.9 and the applied weights for the RDCs
of all the three metal ions (Tm, Tb, Dy) were 0.04. A simulated annealing calculation was performed
with PARAMAGNETIC-CYANA with upper distance limits of 0.1 Å (with weight 0.1) between all the
heteroatoms of the protein and the corresponding atoms of the pseudoprotein residue. A further
conjugate gradient minimization was then performed with the same restraints and weight of the up-
per distance limits reduced to 0.01. In this way, pseudoatoms are positioned as close as possible to
the crystal structure, being constrained to the bond lengths and angles defined in the internal library,
and restraint by the experimental NMR data.
To reorient theMMP-1 domains according to the paramagnetic data, a rigid bodyminimization was
performed with PARAMAGNETIC-CYANA using the PCS of CAT and HPX domain with a weight of 50
and 10, respectively, and the RDCs of the HPX domain with weight 0.1. The options “angle fix” was
used to maintain the CAT and HPX domains (residues 107-261 and 275-466, respectively) internally
rigid, allowing only full flexibility of the interdomain loop.
4.10 HADDOCK (Ln)MMP-1·THP Model Refinement
The HADDOCK runs were performed with the options presented by default. During the rigid docking
calculations, 1,000 complexes were generated, and then 200 structures were selected for the semi-
rigid simulated annealing in torsion angle space, and finally refined in Cartesian spacewith explicit sol-
vent. The weight of the paramagnetic constraints during the different annealing steps are as follows:
RDChot= 0.001; RDCcool1= 0.02; RDCcool2= 0.2; RDCcool3= 0.2; PCShot= 100.0; PCScool1= 100.0; PCScool2=
200.0; PCScool3=200. The ratios on the weights are set to compensate the absolute magnitude of the
restraints. The Δχ-tensors inputted were those of Table 7.1.
Chapter 5
The Catalytic Domain of MMP-1
Studied Through Lanthanide Tags
5.1 Introduction
Nuclear Magnetic Resonance (NMR) allows the experimentalist to acquire solution data with atomic
resolution. Nuclear Overhauser Effects (NOE) are likely the most commonly used NMR restraints for
macromolecular structure determination, as they carry information on the spatial distance between
two nuclei. However, over the last two decades, pseudocontact shifts (PCSs, Section 1.4.2) which de-
rive from the presence of a paramagnetic center and residual dipolar couplings (RDCs, Section 1.4.3)
which are originated uponmolecular alignment in the external magnetic field, have gained strong rel-
evance. Both PCSs and RDCs carry geometric information on the macromolecular coordinates to an
external frame (Figures 1.5 and 1.7).
Macromolecular structures can, and indeed, do undergo packing forces that may distort their ter-
tiary structure when compacted into a crystal state. This drawback of crystallography has been ad-
dressed by NMR spectroscopists that made use of different types of restraints. The information en-
coded inPCSs andRDCs is of valuable quality. Althoughby their own, PCSs andRDCs canhardly resolve
a structural model from an ab initio approach, they can, indeed, be used to “correct” or improve crys-
tallographic models towards liquid state accurateness (Bertini et al., 2001d, 2002d, 2004b, 2009c).
Strategies have been proposed that are able to cause large movements in the secondary structural
elements of the X-ray models in order to made them fit the liquid state derived PCSs and RDCs and, in
this way, overcome the condition imposed by the crystal packing forces (Chou et al., 2000, 2001).
In the following work we present an approach that is able to straightforwardly assess the accu-
rateness of a crystallographic structural model with respect to the liquid state solution. The approach
depends on the acquired PCSs and RDCs that serve as input in the program CYANA and PARAMAG-
NETIC CYANA (Section 1.5.2). Differently from the standard protocols, the input files for these tools
have been heremodified so that only very restrictedmovements of the atom coordinates are allowed.
Two situations may resolve as output. On one hand, if the crystal structure is coherent with the liquid
state structure, the PCSs and the RDCs given as input should be enough to refine the crystallographic
model just by minor changes in the structural coordinates, thus generating a solution refined struc-
tural model. On the other hand, if no direct refinement of the crystallographic structure is possible,
large scale rearrangements, like secondary structures movements, may be necessary for the model to
fit the PCS and RDC data. If this latter case occurs, other approaches (Section 1.8) are necessary to
modulate such structural rearrangements and produce accurate models. In either, the approach we
85
86 CHAPTER 5. THE CATALYTIC DOMAIN OF MMP-1 STUDIED THROUGH LANTHANIDE TAGS
present here is valuable because it can refine X-ray models according to solution state data or, other-
wise, it identifies biologically relevant X-ray models that may need further attention from structural
biologists.
To demonstrate and concretize our concept, we used the truncated catalytic domain of MMP-
1 (CatMMP-1, Section 2.3.1) as an example of proximity between the crystal model and the liquid-
state solution. The CatMMP-1 was functionalized with a paramagnetic tag, CLaNP-5 (Section 1.6.1.1
- CLaNPs developments and characterization), bearing different Lanthanide(III) ions (Section 1.3.1) to
extract informative PCSs and RDCs. At the end, we expose the case of two calmodulin models as ex-
amples of proteins that strongly suffer from crystal packing forces.
5.2 The Crystallographic Structures of the CatMMP-1 Construct
The structure of the truncated catalytic domain of thewild typeMMP-1was solved at 2.2 Å resolution,
and deposited in the PDB with code 3SHI. The structure 3SHI was determined by Dr. Vito Calderone1
and the corresponding “Materials andMethods” reported for the3SHI calculation canbe founddirectly
in the publication derived from this work.
Four CatMMP-1 structural models were used to implement the refinement protocol presented
here; threeX-ray structures, PDB IDs: 3SHI, 1HFC, 1CGE andoneNMRsolution structure, PDB ID: 2AYK.
Structures 3SHI and 2AYK are inhibitor free, and structures 1HFC and 1CGE have their active sites oc-
cupied by an inhibitor or by the structure segment. The description of the X-ray model 3SHI and its
comparison to the other X-ray models is straightforward and therefore a direct transcription of the
words reported in the publication is presented here.
The structure of the catalytic domain of wild type MMP-1 was solved at 2.2 Å resolution, and de-
posited in the PDBwith code 3SHI. The space group is C2 and threemolecules are present in the asym-
metric unit. The backbone RMSD between the different protein molecules in the unit cell is 0.25 Å.
There areno regions showing significant lackofdensity involving themain chainof the threemolecules
in the asymmetric unit. The Ramachandran plot is of good quality (90.8% core, 8.4% allowed, 0.8%
generously allowed and 0.0% disallowed residues). CatMMP-1 is a ‘‘spherical’’ molecule that contains
a twisted five-stranded β-sheet (sI, sII, sIII, sIV and sV) and three α-helices (hA, hB and hC). The β-sheet
contains four parallel strands and one antiparallel strand. The active site cleft is bordered by β-strand
IV, helix B, and a stretch of randomcoil adjacent to the COOH terminus of helix B. The catalytic zinc is at
the bottomof the cleft and is ligated byHis218, His222, andHis228. In addition to the catalytic zinc, there
is a second zinc ion that interacts with an extended loop between β-strand III and IV, and also three
calcium atoms. Although the model used for molecular replacement contained all residues in trans
conformation, the refinement provided two residues (Tyr A210 and Arg G108) in cis conformation.
The calculated structure 3SHI resulted similar to both the 1CGE crystal structure of the same pro-
tein without inhibitor already deposited in the PDB (the BB RMSD between the two structures is 0.44
Å in the residue range 108-261) and to the crystal structure at highest resolution (1HFC, resolution
1.56 Å), crystallized with a bulk hydroxamate inhibitor (with BB RMSD with 3SHI of 0.38 Å). The space
group of these two structures is different from the C2 space group of 3SHI, as a result of different
conditions of crystallization. The BB RMSD of 3SHI with the available solution structure (2AYK) is 1.34
Å. Also in 1HFC the residue Tyr A210 is in cis conformation, whereas in the other two structures all
residues are in trans conformation.
In 1HFC, the space group is P212121, with cell parameters different from those obtained in 3SHI.
There are two small regions with significantly high RMSD between the 3SHI and the 1HFC structures
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Figure 5.1: A) Superimposition of the four analyzed structures (the crystal structure 3SHI, determined
in the CERM laboratory, and the 1HFC, 1CGE and 2AYK structures). The bar plots represent the RMSD
between the 3SHI and the B) 1HFC, C) 1CGE and D) 2AYK structures.
(Figure 5.1): the first one involves residues 188–190 and shows an RMSD of about 1 Å and the second
one involves residues 242–245 with an RMSD which reaches 2.3 Å for residue 243 only. Both regions
belong to protein loops; the second region belongs to the long loop forming the S’1 cavity. The re-
gionswhichmight be affected by the binding of the inhibitor in 1HFC are 178–182 and 238–240. These
residues are not those with high RMSD, although they are adjacent. The high RMSD values can be de-
termined by the presence of the inhibitor in 1HFC and by the different crystal contacts with symmetry
relatedmolecules present in the two space groups. In the ligand-free 1CGE structure, the space group
is P41212, with one molecule in the asymmetric unit and different cell parameters with respect to the
othermentioned structures. The superposition between the 3SHI and the 1CGE structures shows that
residues 155–156 deviate by 1–2 Å, residues 243–244 deviate by 1–1.5 Å and residues 208 and 238
by slightly more than 1 Å. All other deviations are well below 1 Å. It is worth noticing that the region
involving residues 178–182 does not show significant deviations (BB RMSD 0.3–0.4 Å), and that the
deviations in the region 242–245 are much smaller than for the ligand-bound 1HFC structure.
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5.3 Translating The PDB Model To A CYANAModel
The protocol here presented consists in determining if an X-ray model can be refined in order to fit
solution paramagnetic data by just performing small localized structural rearrangements without ma-
jor global changes. Paramagnetic solution data (PCSs and RDCs) carry geometrical information on the
sample structure, and because of that, they can be used to assess the accuracy of the X-ray crystal-
lographic models to the solution state data. The CYANA software and its add-on package PARAMAG-
NETIC CYANA (Section 1.5.2) were the tools selected to materialize the concept here proposed.
Some modifications in the CYANA input routines are necessary to implement the approach, the
housemade scripts used for preparation of the files and details on the format of the input files can be
handled upon request. Firstly, the X-raymodels have to be converted to the CYANA input files in order
to be consistent with the chemical bond restraints (bond angles and lengths) that are implemented
in the CYANA libraries, where the H-HN vector length was defined to 1.02 Å. The convertion was ac-
complished by appending to the protein sequence a “pseudoprotein residue” that is a mirror of the
protein sequence itself, composed of as many atoms as atoms in the protein with the same matching
labels and coordinates, but, no van derWaals radius is defined for the “pseudoprotein residue”, mean-
ing that during the minimization procedure this pseudoresidue can freely move through the protein
structure without generating clashes. The pseudoprotein residue is actually the body upon which the
CYANA calculation will act, the X-ray protein structure serves here only as model, as it will be clarified
shortly. The protein sequence and the “pseudoprotein residue” were linked by dummy residues that
allow free movements of one with respect to the other.
The first calculation step consists in orienting the “pseudoprotein residue” to fit the coordinates of
the X-ray structure which have been defined a priori. For this, a simulated annealing calculation is per-
formed with CYANAwith upper distance limits of 0.1 Å, with weight 0.1, between all the heteroatoms
of the protein and the matching atoms of the “pseudoprotein residue”. The dihedral angles ψ and φ
are also restrained to vary within a fixed range of ± 90º around the value defined in the X-ray model.
This angle restrictionwill latter favor the RDC-based refinement as it will avoid angle flipping thatmay
derive due to the symmetric nature of the RDCs themselves (Section 1.4.3 - Geometric symmetry). Af-
terwards, a conjugate gradient minimization is performed with the same restraints as in the first step
of the simulated annealing but with the upper distance limit weight reduced to 0.01. The weight re-
duction at this stage allows for amore accurate positioning of the atoms of the pseudoprotein residue
over the X-raymodel atomswithout significant increasing of the target function. Please recall that the
target function is the sum of the restraints imposed times the weight given to each restraint, higher
values of target function relate to higher restraint violation. Note that in the present case the atom-
pseudoatom distance is imposed as restraint.
The above described procedure of converting the PDB models into CYANA models allows the pro-
tein atoms (pseudoatoms) to be positioned as close as possible to the starting structure (PDB coor-
dinates) maintaining at the same time the constraints of bond lengths and angles as defined by the
CYANA internal libraries. The combination of the constraints imposed in the CYANA libraries and the
distance restraints between themodels generates minute but necessary rearrangements in the struc-
tures.
The above referred approachwas applied to the four PDBmodels of the truncated catalytic domain
of MMP-1 under study here (PDB IDs: 3SHI, 1CGE, 1HFC and 2AYK). The backbone RMSD between the
starting models and the CYANA generated models range between 0.25-0.30 Å. The residues Tyr A210
and Arg G108 were found from the X-ray data to be in the cis conformation, to obtain full agreement
in the generated models it was necessary to manually flag those residues as cis in the input files.
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Table 5.1: PCS-derived magnetic susceptibility anisotropy parameters for the three Lanthanides and
for the 3SHI, 1HFC, 1CGE and 2AYK structures. Values are represented as Δχax (Δχrh) (10-32m3).
Tb(III) Tm(III) Yb(III)
3SHI -44.9 (-20.1) 49.3 (-8.7) 8.6 (-2.1)
1HFC -45.3 (-14.8) 47.4 (-8.6) 8.0 (-2.2)
1CGE 43.4 (-14.5) 45.9 (-8.0) 8.2 (-2.8)
2AYK -44.6 (11.5) 50.1 (-8.7) 9.0 (-3.0)
5.4 Experimental NMR Restraints
The truncated and inactive catalytic domain of MMP-1 (E219A) was mutated in H132C/K136C as de-
scribed in theMaterials AndMethods Sections 4.1 and 4.3.1. The double cysteinemutationswere used
to anchor the paramagnetic tag CLaNP-5 bearing four different Lanthanide(III) ions, namely, Lu(III),
Yb(III), Tm(III) and Tb(III). An introductory background on the use of paramagnetic tags for structural
biology can be read in section 1.6, and the specific case of CLaNP-5 is presented in Section 1.6.1.1
- CLaNPs developments and characterization. The experimental measurement of the PCS and RDC
data is described in Section 4.6 of the Materials AndMethods Chapter and the obtained restraints are
reported in the Appendix Chapter.
PCSswereused toderive theΔχ-tensors for eachLanthanide(III) ionprobed. PCS-derivedΔχ-tensors
can robustly characterize the paramagnetism of the systems (Δχax and Δχrh) because they do not vary
upon small localized mobility in the atomic structure of the protein as it happens for RDCs (recall Fig-
ure 1.8). The Δχ-tensors were derived by fitting the experimentally observed PCSs to each of the four
models in study through equation 1.12; for this, we used the iterative protocol as described in sec-
tion 1.5.2 (Figure 1.9). The minimization routine of FANTASIAN was used to determine the Δχ-tensor
in combination with the program CYANA and the package PARAMAGNETIC CYANA that positions the
metal ion in the protein frame. The PDB models were converted to CYANA models with the new pro-
tocol, as presented above, and the PCSs were added as restraints along with the distance restraints
to anchor the “pseudoprotein residue” to the protein model. The derived Δχ-tensors are reported for
each CYANA model in Table 5.1.
The positions for the different metals were found at distances of 7.5 and 8 Å from the Cα nuclei of
the tag-binding residues C132 and C136, respectively, which is in agreement with the previous reported
data for the (Ln)CLaNP-5-protein adduct structure (Keizers et al., 2008). The agreement between the
experimental and back-calculated PCSs for each of the four models is quite satisfactory and the Q
factors (equation 1.18) for all the structures range between 0.07-0.09. The corresponding PCS corre-
lations are plotted in Figure 5.2.
A question that usually arises at this stage is if the paramagnetic tag, in this case (Ln)CLaNP-5,
is rigidly held and fully attached to the protein construct. It was proved by the authors of CLaNP-5
(Keizers et al., 2007, 2008) that, because it is attached to the protein by two anchoring points, the tag
holds rigid to the protein frame and internal motions in the protein-tag adduct can be disregarded.
The previous considerations still remain valid in our present case: the PCSs derived for each of the
three metal ions used with the tag agree simultaneously with the same structure and the Δχ-tensors
obtained are as high as expected (Keizers et al., 2008). This reveals that mobility between the protein
and the tag frames does not occur. Moreover, the intensity of the Δχ-tensors shows that the catalytic
domain itself presents only very small internal motions that are not detected by the PCSs. Also, if
the tag would be attached by a single disulfide bridge by incomplete reaction, no agreement could be
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Figure 5.2: Agreement between measured and back-calculated PCSs obtained with the magnetic sus-
ceptibility anisotropyparameters reported in Table 5.1 and the structures determinedwith PARAMAG-
NETIC CYANA, after the introduction of PCSs and the upper distance limits for anchoring the protein
nuclei to the nuclear coordinates of the 3SHI, 1HFC, 1CGE and 2AYK structures.
found between the average tensors for the different PCS sets, because the metal-nucleus distances
would average differently depending on their motion with respect to the orientation of the magnetic
susceptibility tensors, which is unique for each Lanthanide(III) (Section 1.3.1).
After determining the PCS-derived Δχ-tensors, the experimentally observed RDCs were plotted
against the RDCs that were back-calculated using equation 1.14 and the very same PCS-derived ten-
sors, for both the original PDB models and the CYANA derived models. In both cases the correlation
was unsatisfactory (Q factor = 0.72 for 3SHI, equation 1.18). Generally, the RDC fittings are of lesser
quality than the PCS fits and they are expected not to be in full agreement with the PCS-derived Δχ-
tensors. Several factors contribute to such behavior of the RDCs: i) the local mobility of each residue
that is not sensed by the PCSs but is sensed by the RDCs (recall Figure 1.8) ii) the pronouncedmobility
of the paramagnetic tag in the protein frame and iii) inaccuracies in the H-HN vectors orientations on
the model itself. Please recall that RDCs represent a weighted average of the orientations that the H-
HN vectors express in solution (Sections 1.4.3 and 1.8). In themodels, the vectors are frozen in a single
orientation and the experimental RDCs are forced to fit those models which result in disagreement
and a consequent higher Q factor. The second referred case, tag-protein mobility, can be ruled out
by the reasons that were stated previously. At last, to address the local mobility of the H-HN vectors,
15N relaxation rate measurements can be performed. R1, R2 and NOE measurements for the catalytic
domain ofMMP-1 had been previously published by the CERM colleagues (Bertini et al., 2009b). These
studies indicate that sizable mobility is found for residues 108, 111, 116, 134, 135, 137, 145, 154, 157,
184, 191, 217, 227, 244, 245, 246, 249, 250, 260 and 261. The RDCs obtained for those residues were
consequently removed from all the calculations onward. The calculations were repeated and the new
foundQ factors CYANAmodels are as follows: 0.67, 0.52, 0.69 and 0.83 for 3SHI, 1HFC, 1CGE and 2AYK,
respectively, the plots of calculated versus experimental RDCs are represented in Figure 5.3A.One can
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Table 5.2: RDC-derived magnetic susceptibility anisotropy parameters for the three Lanthanides and
for the 3SHI, 1HFC structures. Values are reported as Δχax (Δχrh) (10-32m3)
Tb(III) Tm(III) Yb(III)
3SHI -38.7 (-10.4) 36.6 (-10.2) 7.0 (-1.2)
1HFC -39.4 (-16.7) -39.4 (-1.5) 7.1 (-0.8)
conclude from the lowest Q factor of 1HFC that this model is the closest to the liquid state structure.
The occurrence of small mobility of the H-HN vectors can be additionally taken into account by
including an order parameter SLS in equation 1.14 (Section 1.4.3 - The generalized order parameter,
here equation 5.1). The experimental RDCs (except those with considerable mobility) were fit to the
models according to eq. 5.1with anorder parameter SLS fixed to 0.9. TheobtainedΔχ-tensors for 1HFC
and 3SHI are reported in Table 5.2 and the plots of the fitted data are represented in Figure 5.3B.
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With the tensors derived for corrections for the localizedmobility, a comparison between the PCS-
derived and the RDC-derived tensors can be made. Both PCS-derived and RDC-derived tensors are of
similar size, which further indicates a rigid behavior of the tag. However, the disagreement between
the calculated and the experimental RDCs is still outside the error (2 Hz). The disagreement in the
best fits for the RDCs2 clearly represents, at this stage, inaccuracies of the H-HN vector orientation
within the PDBmodels (Figure 1.8). The RDC-derived tensors are expected to be smaller than the PCS-
derived tensors when H-HN vectors inaccuracies are present; which can be observed when comparing
the tensors reported in Table 5.2 with those reported in Table 5.1.
In conclusion, the better the experimental RDCs fit a proposed model using the PCS-derived Δχ
parameters, the closer the model is to the solution structure, i.e. the more accurate it is. As we will
analyze latter, the inconsistency of the RDCs to the observed model can be derived from local inaccu-
racies or large scale structural rearrangements.
Interestingly, worse fits were found for structures 1CGE and 2AYK, as represented in Figure 5.3B,
despite that these two structures were determined in the absence of inhibitors, in analogy to the
conditions in which the experimental paramagnetic data was acquired (Section 4.6.1) . This finding
indicates that 1CGE and 2AYK are less accurate models of the solution state of the MMP-1 truncated
catalytic domain.
In this subsection, we have determined the PCS- and RDC-derived Δχ-tensors for each Lanthanide
metal ion and for in each CatMMP-1 model. We have identified and explained, for the case being,
the inaccuracies that can be extracted from the RDC-tensors and the RDC data itself. And, lastly, we
have unveiled preliminary information on the degree of accurateness of the different CatMMP-1 X-ray
models byevaluating thequality of theRDCsfits obtained frombothPCS- andRDC-derivedΔχ-tensors.
5.5 The Protein Solution Structure
In this subsection we use the approach described initially to assess the degree of inaccuracy of the
differentmodels and to refine thosemodels if possible with the obtained solution paramagnetic data.
To implement the refinement strategy, the PDB structures were converted to the CYANA models
using the approach described above in Section 5.3 - Translating The PDBModel To A CYANAModel, in
2Meaning, the RDCs back-calculated on the RDC-derived Δχ-tensor.
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Figure 5.3: A) Agreement between experimental RDCs and the RDCs back-calculated from the PCS-
derived tensors and the 3SHI, 1HFC, 1CGE and 2AYK structures. B) Best fit of the experimental RDC
values to the 3SHI, 1HFC, 1CGE and 2AYK structures. C) Agreement between experimental RDCs and
the RDCs calculated from the PCS-derived tensors and the solution structures.
short, a “pseudoprotein residue” was appended to the protein sequence by a linker of dummy atoms
along with the three metal residues (one linker for each lanthanide). The PCS and RDC data for each
metal were introduced as restraints imposing their PCS-derived tensor. It is assumed that a single
tensor is responsible for all the observed data, PCSs and RDCs, as is the case in the absence of large
scale motions. The usual local mobility of the H-HN vectors was again corrected by using the order
parameter SLS fixed to 0.9 for the RDCs. CYANA considers the PCS and the RDC values as absolute
“numbers” and disregards their units; PCSs were found under 2 ppm and RDCs under 40 Hz. For this
reason it is necessary to balance the weights of the different paramagnetic restraints. The weights of
the restraints were consequently set to 0.20 for Yb-RDCs, 0.04 for the larger Tm- and Tb-RDCs and 100
for PCSs. The restraints of the sequence-”pseudoresidue” distances were kept equal to 0.1 Å (weight
equal to 0.1) as in Section 5.3 for the first simulated annealing step and their weight was reduced
to 0.01 in the subsequent gradient minimization. Calculations were performed with PARAMAGNETIC
CYANA.
In this procedure, CYANAwill fit the “pseudoresidue” to the sequence coordinates and at the same
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Figure 5.4: Crossed-eye stereoscopic view of the crystal 1HFC structure (black), the respective CYANA
structure before introducing the paramagnetic restraints (gray) and the solution structure (white) re-
finedwith the experimental PCSs and RDCs. Thewhite sphere shows the position of the paramagnetic
metals, the gray sphere represents the catalytic zinc, the other metals were omitted.
time perform the necessary readjustments in the atom positions (protein and metal) in order to opti-
mize the fitting of the back-calculated PCSs and RDCs to the input data and the PCS-derived Δχ-tensor.
However, the modifications in the atoms positions are small because of the upper limit distance re-
straint set to 0.1 Å and the dihedral angle restraints set between the sequence coordinates and the
“pseudoresidues”. The balance between the weight imposed to the solution restraints and to the dis-
tance restraints will dictate the flow of the calculation and the consequent nature of the final target
function. If higher weights are given to the paramagnetic experimental data, the structure might be
distorted by CYANA so to obey the restraints imposed. On the other hand, if too much weight is given
to the distance restraints, the paramagnetic datamay not be able tomodify the structure accordingly.
A meaningful balance between all the restraints’ weights is necessary to achieve accurateness and
coherence between all of them.
Please recall that the 1HFC model was that in higher agreement with the experimental RDC data,
and for the sake of clarity we will analyze this case first. Figure 5.4 represents the imposed crys-
tal structure 1HFC with the corresponding CYANA model before incorporating the paramagnetic re-
straints and the paramagnetically refined 1HFC structure (solution structure). The backbone (BB)
RMSD between the crystal model and the refined model is 0.29 Å. The Ramachandran plot of the so-
lution structure is still of very good quality (90.1% core, 9.9% allowed, 0.0% generously allowed and
disallowed residues) with no van der Waals contact violations and with the bond length and angle pa-
rameters in agreement with the CYANA library. Figure 5.3C depicts the good agreement between the
experimental and back-calculated RDC values. The Q factor decreasesfrom 0.52 previously obtained
in the CYANA model of 1HFC to 0.19 in this late solution model.
The solution models of 1CGE and 3SHI also present very good agreement between the calculated
and experimental RDCs. as Figure 5.3C shows, theQ factor decreased to 0.20 relatively to the previous
calculations of 0.67 and 0.69, and the RMSD between the crystal model and the solution model is
also lower than 0.4 Å. The fact that the obtained solution models are in so good agreement with the
experimental data and yet be similar to the X-ray crystal models indicates that the catalytic domain
of MMP-1 does not suffer from crystal packing forces when crystallized and, as consequence, only
small changes in the H-HN vectors’ orientation are enough to satisfy the solution restraints, as initially
predicted.
The solution models obtained from all the three X-ray structures nicely satisfy the experimental
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Figure 5.5: Dihedral φ angles of the solution structures (solid symbols) and of the crystal structures
(open symbols), after subtraction of the average of the angles calculated from the crystal structures.
The bars indicate the residues whose dihedral angles in solution are consistently outside the range of
the valuesobservedat the solid state. Theanalyzed structures are the1HFC, 3SHI and1CGE structures.
restraints and therefore no ensemble averaging approaches are necessary to achieve higher accurate-
ness or reliability. Although slight structural heterogeneity between themodelsmay likely be present,
considering all the models in an ensemble which represents the data won’t add any additional infor-
mation because all of them equally satisfy the experimental data. The concept that the number of
structures necessary to represent amolecule should be restricted to theminimum required by the ex-
perimental data (in our case a single structure is necessary) is referred as an application of theOccam’s
razor (Clore and Schwieters, 2004).
We can further analyze the proposed refinement strategy in terms of the accuracy improvement
of the solution models with respect to the X-ray crystallographic structures. Figure 5.5 shows the
differences in dihedral angles PHI (φ) among the crystallographic structures and their solution model
counterparts.
It can be observed that the changes in the φ angles are small but significant and, therefore, neces-
sary to satisfy the back-calculated RDCs to the experimentally obtained data. In many cases, the set
of φ angles were changed to values outside the angle range in the crystallographic structures and to-
wards the same direction, certifying that the paramagnetic restraints do force changes that aremean-
ingful and coherent. In support to this premise, other angles were gathered in the same orientation
even if still inside the X-ray angle range. Variations on the H-HN vectors have minor effects on the ψ
angles and those are oftenwithin the variability of the structures, and for these reasons the variations
in ψ were not represented. The average difference in the variation of the φ angles for the structures
represented in Figure 5.1 are 9.1º, 10.8º and 10.8º for 1HFC, 3SHI and 1CGE, respectively. It was shown
previously that the 1HFC X-ray structure was that the one in best agreement with the solution data,
and coherently, the 1HFC structure suffered less modification upon refinement, as expressed by the
above calculated averages.
It is important to assess the accuracy improvement of the solution structures by cross-validation
with data not used in the calculations. For the cases were RDCs of a single residue were measured for
all three metal ions (5 RDC values in total), one of the values for a single ion was removed from the
calculations and those were repeated. The Qfree for these RDCs was still small, 0.23 in the refined ver-
sus 0.34 in the crystal structure. The same agreement was observed when RDCs that were measured
for at least two metals were removed (8 RDCs in total).
Twomain conclusions can be drawn at this point. Firstly, we can conclude that the crystallographic
models of the catalytic domain of MMP-1 are good representations of the real structure in solution.
This can be said because only small structural changes were necessary to make the crystallographic
models satisfy the solution data. Secondly, the approach that he present in this work is able to refine
structural models accordingly to paramagnetic-derived solution NMR data whenever no large scale
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movements are needed. Consequently our protocol can assess if such large scale structural move-
ments are necessary to render the crystallographic models in agreement with the solution data. This
paradigm will be discussed in the following section.
5.6 Proteins With Solution Structure Different From The Crystal
Model
This section will demonstrate that the approach here presented and developed can differentiate be-
tween cases where only minor changes are necessary to satisfy the experimental solution data (as
seen in the previous section) and cases where large scale structural rearrangements are needed.
To demonstrate what we have proposed, two studied examples will be used: the case of calmod-
ulin and the case of the calmodulin adduct with DAPk (death-associated protein kinase). It is known
that the solution structure of the N-terminal domain of calmodulin differs from that of the crystal
structure (Chou et al., 2001). The crystal structure of calmodulin is available with 1 Å resolution (PDB
ID: 1EXR) as well as the RDC data for H-HN, Hα-Cα, C’-N, Cα-C’, Hα-C’ nuclear pairs, measured in liquid
crystallinemedium. Our approachwas applied to the calmodulin case. The best fit of the experimental
RDCs to the 1EXR structure was found to be unsatisfactory (Figure 5.6A). More interestingly, the poor
fit quality was maintained after introducing the RDC restraints in the CYANA calculation (Figure 5.6B):
the Q factor, equal to 0.39 for the crystal structure, remains as high as 0.32 after restrained minimiza-
tion. These findings, indicate that published crystallographic structure 1EXR cannot be refined to fit
experimental solution NMR data by applying only small changes in the structure coordinates as it was
done to the models of the catalytic domain structures. Thus, our approach is not able to, and is not
aimed at, generate the large scale movements necessary to accomplish such restraint minimization.
However it is, indeed, able to identify when a crystallographic model needs large scale refinements in
order to be in agreement with the solution data. In other words, it can assess the accurateness of the
given model based on liquid state acquired PCS and RDC data.
Similarly to 1EXR, we also assessed the accurateness of the adduct of the mutant N60D calmod-
ulin with the binding peptide DAPk (PDB ID: 1YR5). For this system we had available data on three
different Lanthanide(III) metal ions, Yb(III), Tb(III) and Tm(III), that substituted the naturally occurring
metal at the binding site of the N-terminal domain. This data was acquired previously, in the words of
the authors, ”to show the occurrence of a conformational rearrangement involving the first helix of the
N-terminal domain and the whole C-terminal domain with respect to the N-terminal domain” (Bertini et
al., 2009c). Despite that a considerable improvement in the best fit of the RDCs was possible when re-
fining the X-ray structure (Figure 5.6C) with the solution restraints, the agreement with the RDC data
is still modest (Figure 5.6D), the Q factor couldn’t be lowered from 0.28 with differences between ex-
perimental and calculated RDCs up to 10 Hz, where the limit of experimental error is 2 Hz. Once again,
the protocol points to the fact that sizable structural rearrangements are necessary to completely re-
fine the X-raymodel 1YR5 to the solution obtained data. In these cases, previously describedmethods
should be applied (Chou et al., 2000, 2001; Bertini et al., 2009c), where appropriate dihedral angle re-
straints are introduced with disregard of the distance restraints as imposed in our approach and also
the necessary force fields to keep the protein structure properly folded while allowing large scale
secondary structure movements.
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Figure 5.6: A) Best fit of the experimental RDC values to the crystal 1EXR structure of calmodulin
and B) to the structure calculated with the inclusion of the solution restraints. C) Agreement between
experimental RDCs and the RDCs calculated from the PCS-derived Δχ-tensors and the crystal 1YR5
structure of calmodulin bound to the binding peptide of DAPk or D) the structure calculated with the
inclusion of the paramagnetic restraints.
5.7 Discussion and Remarks
Solid state crystallographic structures can be solved nowadays beyond 1 Å resolution. However, when
compacted into a crystal state, some macromolecules may adopt conformations that are not favored
when in the solution state, as it is the case of calmodulin, that presents a flexible linker between its
two domains. When such cases occur, even very high resolution models do not reflect the real state
of the protein is a liquid environment. The accurateness of a crystallographic model can be assessed
by experimental restraints acquired in liquid conditions, such as the NMR observables pseudocontact
shifts (Section 1.4.2) and residual dipolar couplings (Section 1.4.3). Here, we presented an approach
based on previously available tools (CYANA, PARAMAGNETIC CYANA and FANTASIAN - Section 1.5.2)
that, given an X-ray model and available solution restraints, is able to assess the accurateness of the
crystallographic model, distinguishing those cases in which only small localized changes are necessary
to generate newmodels in agreement with the solution data, and those cases where large secondary
structure rearrangements are needed. In the former cases, our approach is also suited to perform
the necessary refinement driven by the solution data. This has been proven and accomplished for
three X-ray structures of the catalytic domain ofMMP-1, and also anNMR structure. Different starting
models converged to similar ends upon refinement,meaning that liquid-state geometric restraints can
coherently drive structural refinement.
Our approachwon’t be able to refine X-raymodels that present large scale differences from crystal
to liquid state, but is indeed able to identify them, as is the case of calmodulin. In those cases different
approaches that allow structure refinement with large scale movements should be instead used.
The approach here presented can be used together with the above referred approaches in a very
powerful combination. Once identified the mobile blocks/domains of a given protein, our approach
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can be used to refine such blocks in order to obtain the best possible fit with the experimental data.
Remember that RDCs do not depend on the position of the tensor respectively to the protein, just on
its orientation. In orderwords, our approachmight not be able to refine thewholeproteinmodelwhen
large scale motions occur, but is able to refine the rigid singular blocks once identified. Afterwards,
those singular refined blocks can be used as input in the other routines and the overall conformation
for the whole protein that best fits the experimental solution data can be determined. The latter
routines will simply perform better if the building protein blocks are already refined to the solution
data (Section 1.8).
As a final remark, we were able to quantitatively attach a Lanthanide(III) bearing tag (CLaNP-5) to
the truncated catalytic domain ofMMP-1 and characterize this system for different Lanthanides. Both
the refinement approach developed and the refinedmodel obtained for the (Ln)CatMMP-1 construct,
will be valuable resources for the works that are presented later in this thesis.

Chapter 6
Describing the Interdomain Mobility
Of MMP-1
6.1 Introduction
Matrix Metalloproteinases (MMPs) are a family of highly efficient enzymes that are able to process a
multitude of structurally unrelated substrates. Thus, MMPs are responsible for the activation, degra-
dation, transformation of other proteases, growth factors, structural proteins, and many other ex-
tracellular components (Section 2.4). The important role they perform in tissue homeostasis makes
them preferential targets in the control of diseases related with tissue degradation (Section 2.5). Ex-
perimentalists have for long tried to relate the structural features of MMPs (Section 2.3) with their
function, and, despite the similarities at the large scale, the catalytic activity of MMPs is strongly fine
tuned by small changes in their amino acid sequence.
Triple helical collagen (THC), described in Section 2.7.2.1, has amacromolecular superstructure that
renders it immune to proteases in general. However, within the family ofMMPS, there is the subfamily
of collagenases (Section 2.2), which members are able to degrade triple helical collagen, and even fib-
rillar collagen, andMMP-1 is oneof those. Other proteases exist that are capable of degrading THCbut
those lie outside the scope of this work. Indeed, the mechanism by which collagenase MMPs degrade
THC has been the focus of intense research by structural biologists (Section 2.7.2). The models of full
length MMPs that have been presented to date (Section 2.3) were acquired by X-ray crystallography
and they show a “closed” conformation between the two archetypal domains, the catalytic domain
and the hemopexin domain. However, the rigid model was discarded when it was necessary to intro-
duce the concept of intrinsic flexibility between two domains to explain the behavior of MMP-1 and
-12 in solution and also the collagenolytic behaviour of MMP-9 (Section 2.7.2.2). The unstructured and
flexible linker that connects the catalytic and the hemopexin domains is the sole responsible for the
mobility observed. The crystallographic structures of full lengthMMP-1 and otherMMPs are plausibly
those of the lowest energy conformation, induced by the crystallographic packing, which are closed
conformations that suggested only very minute motions (Iyer et al., 2006; Jozic et al., 2005). These
models served as drawing template for structural studies on the collagenolytic mechanism (Section
2.7.2), which were accompanied by the knowledge of existing mobility. However, a gap exists in the
structural and dynamical description of the full length MMPs (specially MMP-1): the conformational
behavior of the free enzyme in solution remains unkown, which corresponds to the state that precedes
the collagenolytic attack.
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Paramagnetic NMR (Chapter 1) was used for the purpose of fulfilling this gap. Three different long
range paramagnetic Lanthanide(III) ions (Section 1.3.1) were introduced in the tag CLaNP-5 (Section
1.6.1.1) and used to acquire high quality PCS and RDC data on the triple mutant H132C/K136C/E219A
inactive full length MMP-1. This data was processed and analyzed on the basis of the well established
Maximum Occurrence approach (described in Section 1.8) and a complete map of the conformational
space sampled in solution by the MMP-1 enzyme was obtained. The experimental process and the
results achieved are as follows.
6.2 Results
6.2.1 Paramagnetism-based NMR data
To obtain a consistent and coherent set of geometrical restraints from paramagnetic-derived pseu-
docontact shifts (Section 1.4.2), and self-orienting residual dipolar couplings (Section 1.4.3), at least
three different tensors are necessary (Section 1.5.2). The geometric information-rich PCSs and RDCs
are needed here to unveil the conformational space sampled by the full length MMP-1 enzyme when
in the liquid state. We had previously functionalized the truncated catalytic domain ofMMP-1with the
tag CLaNP-5 bearing three different Lanthanides, Tb(III), Tm(III) and Yb(III), and described these para-
magnetic systems and consequently derived the solution refined structure of the CatMMP-1 domain
(Chapter 5). A background introduction to the concept of paramagnetic functionalization of diamag-
netic proteins can be found in Section 1.6, specifically, CLaNP-5 is detailed in Section 1.6.1.1.
Analogously to the work on the truncated catalytic domain (Chapter 5), we functionalized the full
length MMP-1 with other three Lanthanide(III) ions, in this case: Dy(III), Tb(III) and Tm(III). We used
Dy(III) in disregard of Yb(III) because of the need to generate PCSs at the longer distances of the
hemopexin-domain and also to induce an higher degree of alignment to obtain larger RDCs and thus
reduce the error of measurement; recall from Section 1.3.1 the magnetic susceptibility of the differ-
ent Lanthanide(III) ions. For this, new data on (Dy)CatMMP-1 was generated and analyzed in the same
way as for the other Lanthanides in the previous work (Chapter 5), and the data on the truncated cat-
alytic domain helped and guided the complete analysis on the full length construct. The information
about sample preparation, spectra acquisition and data analysis can be found in Materials and Meth-
ods Chapter (Section ,4.5, 4.6, 4.7, and 4.8).
The magnetic susceptibility tensors for the full length (Ln)MMP-1 construct were determined by
fitting the acquired PCSs to the previously obtained solution refined CatMMP-1 structure (Chapter 5)
through equation 1.12 ( on page 12) and they are summarized in Table 6.1.
Table 6.1: PCS-derived Δχ-tensors (10-32m3) of the catalytic domain of the free full length MMP-1 for
the different Lanthanides(III) ions probed.
Tb(III) Dy(III) Tm(III)
Δχax -45.4 (± 1%) -40.4 (± 1%) 51.9 (±1%)
Δχrh 16.5 (± 23%) -13.2 (± 21%) -9.9 (± 12%)
Comparing both sets of tensors from Table 5.1 (CatMMP-1 construct) and Table 6.1 (full length
MMP-1 construct) we can see that the tensors are virtually equal. This finding does prove that the
structure of the catalytic domain is maintained when expressed truncated and that the analysis previ-
ously made on the single domain is valid for the complete protein.
To study the interdomain mobility of a two-domain protein it is necessary to use one domain as
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reference and then acquire information on the other (mobile) domain, as explained in Section 1.8.
With the tensors shown above, we have referenced the system to the catalytic domain. Consequently,
by acquiring RDCs on the hemopexin domain, it is possible to assess its relative mobility. In this way,
we have also evaluated the averaged anisotropy tensors obtained from the best fit of the RDCs of the
amide protons of the HPX domain, which was extracted from the available crystallographic structure
of the full length proMMP-1 (PDB ID: 1SU3). These tensors are presented in Table 6.2.
Table 6.2: RDC-derived Δχ-tensors (10-32m3) for the Hemopexin domain of the free full length MMP-1
for the different Lanthanides(III) probed. The X-ray model used was the HPX domain of PDB ID 1SU3.
Tb(III) Dy(III) Tm(III)
Δχax -12.7 (± 3%) -10.9 (± 4%) 15.0 (± 3%)
Δχrh 7.7 (± 4%) -2.3 (± 28%) -2.3 (± 19%)
Recall that the measured restraints, either PCSs or RDCs, are, in fact, weighted averages of all the
conformations that contribute to the observed data (Section 1.8). By these means, we could expect
that if the HPX and the CAT domain were holding rigid to each other, the RDC-derived Δχ-tensors for
the Hemopexin domain would be equal (or very similar) to those of the catalytic domain. As we ob-
serve, thehemopexinΔχ-tensors are reducedby70%with respect to thoseof thePCS-derived catalytic
domain. This simple analysis proves by itself that, in support to the previous studies (Section 2.7.2.2),
both domains of MMP-1 experience sizable independent motions. The internal motions of the H-HN
vectors (Figure 1.8) in the HPX domain are not responsible for the large reduction of the RDC-derived
Δχ-tensors because those were proven by relaxation measurements to have reduced mobility (Bertini
et al., 2009b). Despite the largemotions of a specific domain, if it moves as a rigid body it will be possi-
ble to fit the data (in this case the RDC sets) to an anisotropy χ-tensor, although of reducedmagnitude.
The good fitting obtained for the crystallographic structure of the hemopexin domain and the exper-
imental data (RDCs), plotted on Figure 6.1, indicates that this domain moves equally as a whole body
respectively to the catalytic domain.
Figure 6.1: Fit of the observed and calculated RDCs on the Hemopexin domain (PDB ID: 1SU3), using
the obtained averaged Δχ-tensors.
We have seen that in MMP-1, both CAT and HPX domains move as rigid bodies with some degree
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of independence, as represented by Figure 1.24 on page 40. To assess the extent of the interdomain
movements we present in the histograms of Figure 6.2 three different examples of the whole range
of RDC values that can be obtained given a structure and a Δχ-tensor. This king of representation is
also explained in Section 1.8 (Observing averaged paramagnetic NMR data (PCSs and RDCs)). Figure
6.2A left panel shows the range of RDCs back-calculated from the PCS-derived tensors (Table 6.1) con-
sidering the rigid conformation of PDB entry 1SU3. This distribution represents the case where the
RDC-derived Δχ-tensor is equal to the PCS-derived Δχ-tensor and the whole structure (both domains
together) behaves as a rigid body. The real case of (Ln)MMP-1 is represented in Figure 6.2B left panel,
were theRDCs rangewasback-calculated from the averagedRDC-derivedΔχ-tensors as shown in Table
6.2. The histograms in Figures 6.2A and 6.2B really look similar but, it is important to note the reduced
scale in the panel B. The spreading of RDCs is considerably reduced in this latter panel and this indi-
cates the extent by which the RDCs are averaged due to the intrinsic motion between the domains.
The same representation is shown on the right panels of Figure 6.2A and B but for (Ln)Calmodulin,
the studies on the internal motions of Calmodulin are indicated in Section 1.8, here we want to use
Calmodulin as a comparative example. We can see from the right panels that the decrease in the
RDCs distribution is much more accentuated in Calmodulin than in the full length MMP-1. For further
comparison purposes, the RDCs distributions for uniformly sampled, sterically allowed, conformations
were determined (Figure 6.2C). Comparing panels B and C, we see that Calmodulin (Figure 6.2B, right)
is closer to the situation of theoretically absolute mobility (Figure 6.2C, right). For the case of MMP-1,
the real distribution is somehow in between the complete rigidity and the absolutemobility. This does
not necessarilymean that the conformational space sampled by Calmodulin is vaster, but itmeans that
Calmodulin’s conformational distribution in space is more homogeneous. In comparison, MMP-1 is av-
eraged to a lesser degree, which drove us to conclude that within the conformational space sampled,
there are regions which are more favorable than others. This concept will be explored in the next
section when applying the MaxOcc analysis.
To conclude, the ratio between the real RDCs distribution and the RDCs distribution calculated on
the assumption of no motion can be considered as a generalized order parameter (Section 1.8) that
represents the extent of the motion itself. Those were calculated for MMP-1 to be 0.28, 0.27 and 0.29
for Tb(III), Dy(III) and Tm(III), respectively. The differences in generalized order parameters as well
as in scaling factors for the Ln(III) Δχ-tensors indicate that the HPX domain motion causes different
averaging for the different metals because of the different rhombicity and directions of the principal
axes of the anisotropy tensors.
6.2.2 SAXS Data
Small Angle X-ray scattering (SAXS) data acquired previously by Bertini et al., 2009b, corroborate the
findings obtained with the anisotropy χ-tensors that a single MMP-1 conformation is not enough to
satisfy the liquid state condition of the protein. SAXS reported that an open conformation needs to
exist for at least one third of the time and thus noticeable flexibility of the domains indeed exist. The
same SAXS data was also used for the following MacOcc analysis.
6.2.3 Mapping Conformational Space
TheMaximumOccurrence (MaxOcc) approach TheMaxOcc approach was developed by CERM col-
leagues and an explanatory summary on its theoretical background and applicability can be found
inSection 1.8. Nowadays, the MaxOcc analysis can be run directly in the WeNMR Web Portal (Bertini
et al., 2012b), facilitating its use to external users. The MaxOcc protocol was fine tuned in different
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Figure 6.2: Left panel) Distribution of the RDC values (in Hz) of the (Tm)MMP-1 HPX domain based on
the magnetic susceptibility tensors obtained from A) experimental PCSs of the CAT domain, B) exper-
imental RDCs of the HPX domain, and C) average RDCs of the HPX domain obtained from sterically
allowed uniformly sampled conformations – data acquired in this project. Right panel) Distribution
of the RDC values (in Hz) of the (Tm)CaM C-terminal structure based on the magnetic susceptibility
anisotropy values obtained from A) experimental PCSs of the N-terminal domain, B) experimental
RDCs of the C-terminal domain, and C) average RDCs of the C-terminal domain obtained from ster-
ically allowed uniformly sampled conformations - data extracted from references cited in 1.8 - The
studies with Calmodulin.
Calmodulin systems, showing itself tobeveryefficient indescribing the conformational space sampled
by a two domain protein. Here, MaxOcc is for the first time used to investigate a biological relevant
problem: the interdomainmobility of free full lengthMatrixMetalloproteinase-1. It is not the purpose
of this work to set up or prove the concept and capabilities of the software itself, because those have
been already well established.
Materials and Methods The details on the MaxOcc calculations and input data can be found in the
Materials and Methods Section (Section 4.8). Briefly, the MaxOcc analysis was performed using as
restraints the PCSs and RDCs collected for the hemopexin domain, the metal anisotropy tensors de-
termined from the PCSs of the catalytic domain, and the SAXS data, the latter was proven to be com-
plementary to the NMR data and of relevance to accurately assess the MO values of the different
conformations. 1,000 structures were randomly selected to be assessed by MaxOcc from the pool
of 50·000 MMP-1 conformations generated by Ranch, thus assuring that all the conformational space
allowed by the linker’s Ramachandran plot is investigated.
The1,000 conformations sampled Thedifferentweights atwhich thedifferent conformationsover-
came the threshold target function resulted in remarkably different MaxOcc values (see example on
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Figure 6.3: Histogram representation of the MaxOcc results of the 1·000 random conformations that
wereevaluated. Bars represent thenumberof conformations thatwere foundup to thegivenweights:
for example, 53 conformationswere found tohave aMaxOcc valuebetween0and0.05, while 173were
found between 0.1 inclusive and 0.15 exclusive. Two conformations overcame the TF threshold at zero
weight and therefore are not represented.
Figure 1.26 on page 44). We found that only 6% of the analyzed 1,000 conformations have a MaxOcc
smaller than 5%, while 80%of the conformations have aMaxOcc value under 20%. Only 3%of the con-
formations have a MaxOcc value larger than 30%, and only 0.3% have a value larger than 40% (Figure
6.3).
To visualize the results obtained from theMaxOcc analysis within the conformational space, all the
1,000 tested conformationswerefitted (superimposed) to their catalytic domainswhile thehemopexin
domain was schematized by a triad of vectors pointing along the axes of the PDB file and centered in
the center of mass of the HPX domain (Figure 6.4). The hemopexin axes representation is color-coded
with respect to the MaxOcc value of the corresponding conformation, from blue (MaxOcc lower than
5%) to red (highest MaxOcc, 47%); the different orientations and positions of the Cartesian axes sys-
temreflect thedifferentorientations andpositionsof theHPXdomainwith respect to theCATdomain.
The region in space that comprehends the hemopexin tensors clearly defines the boundaries of
the allowed interdomain mobility as dictated by the theoretical linker characteristics given by the Ra-
machandran plot (see Section 4.8). Within this mushroom-like distribution, it is possible to observe,
Figure 6.4, a region where only dark blue tensors are present. This region corresponds to the vicinity
of the (Ln)CLaNP-5 site, which means that those conformations, where the HPX domain falls on the
back of the catalytic domain, have a MaxOcc value under 5%, which was actually the minimum weight
tested, the real value could be actually lower, and thus, we conclude that such conformations are ab-
sent in solution. This behavior is actually quite expected because this position is distal to the catalytic
site, with no biological function considered, and this is why we chose to position the tag there in the
first place (mutations H132C/K136C; Section 4.1). Then, we can observe a ring of light blue tensors
in the regions near the catalytic domain, representing closed conformations. As the linker elongates,
the presence of green tensors dominates the distribution and some orange and red tensors start to
appear. From this brief analysis we can see that, when in the liquid state, the behavior ofMMP-1 favors
more open conformations with disregard of the closed ones.
The focus of our study is to understand where the orange and red tensors are present, because
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these, by the definition of the Maximum Occurrence (Section 1.8), correspond to those conforma-
tions that can contribute the most to the experimental data. Strikingly, the majority of the high Max-
Occ structures, values above 35%, are clustered in a well defined region, corresponding to relatively
elongated structures. Another lesser dense region of conformations with high MaxOcc value is also
present. Figure6.5depicts the sameas in Figure6.4butwith the conformationsfitted to thehemopexin
domain. When analyzing Figure 6.5, we see that the dark blue region is now more disperse, and this
is due to the resultant perspective which depends from where one looks. Concordantly, when ob-
serving from the HPX perspective, more detail is obtained about the region where the highest Max-
Occ conformations are present. The most prominent region appears at the upper left corner of the
mushroom-like distribution. Nevertheless, despite having changed the perspective it is once again
clear that closed conformations have lower MaxOcc values, blue tensors, than elongated conforma-
tions that have higher MaxOcc values, green to red tensors.
A different representation of the MaxOcc analyzis The MaxOcc values can be represented as a
function of the translational and rotational parameters of the corresponding structures with respect
to the structure with highest MaxOcc. Figure 6.6 represents such distribution as an alternative to
the mushroom-like representation. The translations are reported with respect to the center of mass
of a reference structure (see later). To simplify the distance calculations, rotations are represented
through the corresponding 4-components complex number (quaternion) and the distances were cal-
culated as the projection of one quaternion to the reference (Kuffner, 2004). Figure 6.6A has the
structure of highest MaxOcc value at coordinates (0, 0) where the most intense peak is present. Two
other peaks of lower intensity are also present, they represent the other lesser dense clusters as de-
scribed above. The continuity between the MaxOcc values and the structural parameters indicates a
direct relation between the position/orientation of the domains and the respective MaxOcc values.
Figure 6.6B is again centered at the structure with the highest MaxOcc value where only that same
structure is found, but more structures are found as we count the number of structures towards an
equatorial position with respect to the (0, 0) coordinates, describing the shape of a homogeneous
mushroom-like distribution. Figure 6.6B proves that the RanCh distribution is in fact random and no
artifacts derived from the generation of the large pool nor the choice of the 1,000 structures affect
the obtained results.
Resolving the high MaxOcc clusters The initial analysis was performed choosing 1,000 conforma-
tions from the RanCh generated pool of 50,000 conformations. The resolution of the conformational
space described can be increased if more conformations are taken from the RanCh pool and analyzed.
So, to further define the clusters where the highest MaxOcc conformations were found, 281 addi-
tional conformations were specifically selected from the large pool based on their translational and
rotational parameters to the structures of highest MaxOcc value, and their MaxOcc value was deter-
mined. These additional 281 structures did include conformations with high MaxOcc values, as ex-
pected. All conformations with a value larger than 35%were examined. Figure 6.7 represents the two
regions, that have been identified previously, for which additional structures were analyzed.
It is important to ascertain whether the two obtained clusters represent real solutions or, con-
versely, represent “ghost” solutions derived from the quadratic nature of the RDC equation (Section
1.4.3 - Geometric symmetry) which neither the PCS nor SAXS data could resolve (Fragai et al., 2013).
The nature of the two clusters was verified by performing two sets of calculations using only two of
the three sets of data, pairwise. In this way, only the real solutions were preserved equal along the
different combination of pairs while the “ghost” solutions became spread in the conformational space
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Figure 6.6: Representation ofMaxOcc values as a function of translational and rotational parameters.
Both plots are centered at the conformation with the highest MaxOcc value. A) 3D plot represen-
tation of the MaxOcc values as a function of the distance between the centers of mass of the HPX
domains in the different conformations and the angle between their quaternion representations. B)
The probability distribution in space of the conformations generated by RanCh.
and lostMaxOcc intensity. The real cluster was in this way identified and corresponds to that of higher
density in Figure 6.7.
Analysis of the real solution cluster One of the potentialities of the MaxOcc approach, which de-
rives from thenatureof theRDCs themselves, is its capability todiscriminatenot only different domain
translationsbut alsoorientations. Figure6.8depicts the conformations thatwere found tohaveaMax-
Occ value higher than 40% and that lie within the cluster that was identified as being the real solution.
In panel A, the already described mushroom-like representation centered at the hemopexin domain
with the catalytic domain depicted as three axes tensors. Panel B shows the same conformations as
in A but, instead of the typical tensors, the helices hA and hC of the catalytic domain are represented.
The helices are defined by residues 130-141 (hA) and residues 250-258 (hC) (recall Table 2.2) which are
almost perpendicular and serve as good references for the domain orientation and position. For the
sake of visualization, for one of the catalytic domain structures the cartoon representation is given.
The angles among these highest MaxOcc structures, for the hA and hB helices, change up to a
maximum of 26º and 18º, respectively. We can see that from all the conformational space allowed
to be sampled by MMP-1, which is represented by the 50,000 conformations generated by RanCh, a
single cluster with the highest MaxOcc structures can be individualized. This striking finding corrob-
orates the conclusion from Figure 6.2, where the Δχ-tensor averaging for MMP-1 was compared to
that of Calmodulin and a more heterogeneous distribution was expected for the former. Recall that
for Calmodulin no particular cluster of higher values was found, with the spreading of the MaxOcc
intensity being homogeneous along the conformational space with the highest MaxOcc found of 35%
(Section 1.8 - The studies with Calmodulin). Thismeans that, contrarily to Calmodulin, the interdomain
mobility of MMP-1 is selective towards certain conformations. To conclude, and always considering
the physical meaning of the MaximumOccurrence analysis, the above detailed cluster does represent
those conformations that can be present for the longest amount of time in solution, which, in this
case, is a maximum of 47% of the time. We can also imagine the cluster as the boundaries of the
region (including orientation) that is sampled for the longest time.
Two questions do arise from the obtained results. First, are the full length MMP-1 conformations
represented in the highestMaxOcc cluster similar to those obtained by X-ray crystallography? Second,
how do the highest MaxOcc conformations relate to the binding mode of MMP-1 towards a triple
helical peptide? Now we focus on answering such questions.
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Figure 6.7: From the 1,281 conformations analyzed, those with MaxOcc value > 35% are shown fitted
to the catalytic domain. Twomain clusters canbeobserved, only themoredense clusterwas confirmed
to be the true spot of high MaxOcc values.
Figure 6.8: Results of the MaxOcc calculations for the 1,281 MMP-1 conformations, only conforma-
tions with MO higher than 40% which are real solutions are reported. A) One main cluster is distin-
guishable containing conformations with the highest MaxOcc value. B) CAT domain α-helices hA and
hC are in light gray and dark gray, respectively. The complete structure of one of the CAT domains is
also displayed in gray along with the colored helices for reference.
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Analysis of the availableX-ray structures of full lengthMMP-1 All availableX-ray structures of the
human full-length MMP-1 [PDB ID: 1SU3 (Jozic et al., 2005), 2CLT (Iyer et al., 2006) and 4AUO (Manka
et al., 2012)] display closed conformations of the archetypal domains. It is important to evaluate these
conformations based on the experimental data acquired in this study. In order to calculate their Max-
Occ values, these structures were included in the pool of structures analyzed. The MaxOcc values
obtained for the structures 1SU3 (proMMP-1) and 2CLT (active MMP-1) were 20% and 19%, respec-
tively. The recently reported X-ray complex betweenMMP-1 and a triple helical peptide shows amore
closed conformation of the CAT and HPX domains compared to 1SU3 and 2CLT. Interestingly, but, nev-
ertheless, expected, due to its closed nature, the 4AUO conformation has a lower MaxOcc value of
18%. Recall that lower MaxOcc values were found for closed conformations (Figure 6.4 and 6.5).
The radii of gyration (Rg) of the 1SU3 and 2CLT crystallographic structures are 25.5 and 25.7 Å,
respectively, whereas those conformations with highest MaxOcc (>35%) had Rg of 29 ± 1.3 Å. This
latter range obtained for the highest MaxOcc structures is in better agreement with the Rg derived
from the SAXS data alone (Bertini et al., 2009b), 29 ± 1 Å, which further corroborates the accurateness
of the MaxOcc results presented here.
To conclude, and to answer our previously posed question, the conformations found with highest
MaxOcc value are clearly different from those reported from X-ray crystallographic data. In Figure 6.9
the crystallographic structures are superimposed to the model with the highest MaxOcc value. The
latter is clearlymore elongated anddevoid of interaction between the twodomains, as opposed to the
X-ray structures, which are not able to contribute inmore than 20% to the solution experimental data.
Only 2CLT corresponds to the active full length enzyme, the other two structures, 1SU3 and 4AUO,
represent, respectively, the closed proMMP-1 and the closed interaction complex. This consequently
points to the fact that in the crystal form, themultidomainMMP-1 (or otherMMP) is forced to a closed
conformation due to the crystal packing forces that does not represent the real state of the enzyme
when free in solution.
The exosites of MMP-1 Several exosites in both catalytic and hemopexin domains have been iden-
tified for theMMP-1·triple helical collagen interaction (Bertini et al., 2012c; Manka et al., 2012). These
are known to guide and strengthen the interaction between the enzyme and the triple helical sub-
strate. It is therefore imperative that, in the structures foundwith highestMaxOcc value, such exosites
are correctly positioned and exposed to promote the interaction. In fact, in the high MaxOcc cluster
that has been presented here (Figure 6.8), the exosites of the hemopexin domain and the active site
of the catalytic domain face the same side and are solvent exposed, which indicates that these con-
formations are prone to interact with the triple helical peptide. Also, the residues Phe301 and Val319
and Asp338 that were reported to play a crucial role inminimizing the energy of theMMP-1 closed con-
formation are solvent exposed and detached from the catalytic domain (Arnold et al., 2011). Figure
6.10 represents the conformation obtained with the highest MaxOcc value (47%) and the prominent
exosite region that corresponds mainly to the blade 1 of the hemopexin domain (recall Figure 2.7).
It is clearly visible that the hemopexin’s collagen binding residues are solvent exposed and face the
same side as the active pocket of the catalytic domain, and this is a corroboration of the accurateness
of the conformations found in this study. Those are presented open as opposed to the X-ray models
but, concordantly to the literature knowledge (Section 2.3), are favored to bind the triple helical colla-
gen substrate by an initial binding of the hemopexin domain with further positioning of the catalytic
domain.
The prologue of theMMP-1·Collagen Interaction The second question thatwe posed asks how the
cluster of the highest MaxOcc conformations relates to the event of binding of the collagen triple he-
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Figure 6.9: Superimposition of the structurewith the highestMaxOcc value (in black) and those of the
X-ray models colored from white to gray in the chronological order: 1SU3, 2CLT and 4AUO. Structures
were fitted to their catalytic domains and only that of the highest MaxOcc structure is represented.
The metals of the catalytic domain are represented as spheres with the catalytic Zn(II) ion in white.
lical molecule. To answer this question, we modeled the triple-helical structure of an analogue of the
collagenmolecule to the hemopexin domain respecting the interactions which were previously found
to be effective in catalysis (Section 2.7.2.4) . The catalytic domain and its active site cleft closely face
the cleavage site of the helical peptide. In fact, all the conformations with MaxOcc value higher than
35% either penetrate the collagen molecule or fall into the non-penetrating boundaries. Figure 6.11
shows from the 1,281 conformations tested only those with MaxOcc value over 35% and belonging
to the main cluster, the hemopexin domain is taken as reference. Panel A shows all the referred con-
formations, panel B shows those that do not penetrate the modeled collagen helix and panel C shows
only those that do penetrate it. It is clear that the tensors are clustered within well resolved bound-
aries. At the end, panel D shows a zoom of the catalytic domain representative tensors, clarifying that
the great majority of the conformations share the same orientation, as previously represented in Fig-
ure 6.8. These are important findings that, on one hand, despite that a theoretically infinite number of
conformations could be found in the represented region of space, theMaxOcc protocol can accurately
discriminate them and output a coherent set of conformations with highMaxOcc values. On the other
hand, Figure 6.11D shows that the morphology of MMP-1, most likely the morphology of the linker
itself (Section 2.3.2), forces the enzyme to acquire orientations that most favor the collagen binding
event and consequent catalysis, and,we have here unveiled them.
Figure 6.12 gives the same representation as Figure 6.11 but within the overall picture of the con-
formational space sampled. It is in the lower right region of the mushroom where the high MaxOcc
value conformations fall. When the conformations that penetrate the modeled triple helical collagen
are removed (right panel) it remains clear that it is on the lower right side of the mushroom where
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Figure 6.10: Two different views of the cartoon representation of the conformation found with the
highest MaxOcc value (47%). The blade 1 of the hemopexin-like domain is highlighted in white be-
cause it presents the collagen binding residues (exosites), additionally, Phe301 and Val319 and Asp338
are shown in sticks. The metal ions on the catalytic domain are represented as spheres, the catalytic
zinc(II) is in white. The linker is not shown as no experimental information is available.
the prominent conformations are found. Mainly low MaxOcc conformations are found on the oppo-
site side of the hole of removed conformations Again, the morphology of the free enzyme forces it
to acquire, in solution, conformations that are favorable to the collagen binding event and that dif-
fer from the crystal models previously published. The high MaxOcc conformations that do not collide
with the modeled collagen can be seen as an antecedent step of the collagenolytic mechanism. In
support of this hypothesis are the low MaxOcc values obtained for the conformations that do not di-
rect the enzyme towards the correct interaction with the triple helical collagen. The results that we
have presented so far, nicely correlate to each other, shedding light, for the first time, on the prologue
moments of the MMP-1 collagenolytic mechanism.
6.3 Discussion
With the MaxOcc analysis presented here we have explored the conformational space sampled in so-
lution by the free MMP-1 enzyme (Figure 6.4 and 6.5) and, moreover, we have shown that the crystal-
lographic models of full length MMPs are not faithful to the enzyme’s solution free state (Figure 6.9).
Thus, we provide a complete map of the conformational space sampled by the mobile enzyme, con-
sequently fulfilling an important gap that existed in the understanding of this collagenase. Despite
the amount of data acquired for the catalytic and the hemopexin domains, no information regarding
the state of the linker was possible to obtain because its peaks were absent in the NMR spectra. Nev-
ertheless, for the purpose of mapping the reciprocal orientation of the two domains treated as rigid
bodies using MaxOcc, information on the linker is neither required nor desirable.
For several years it was accepted that the unwinding of the collagenmolecule would be solely pro-
moted by the binding of MMPs, which is termed the induced fit mechanism and is discussed as the
helicase activity of MMPs (Section 2.7.2.3). However, recently a large body of data suggests the ex-
istance of spontaneously localized unwinding of the collagen molecule that favors and is stabilized
by the binding of the hemopexin domain – conformational selectionmechanism or vulnerable sites hy-
pothesis (Section 2.7.2.5). This hypothesis states that no MMP-1 induced structural rearrangements
6.3. DISCUSSION 113
Figure 6.11: Representation of the MMP-1 conformations fitted to the hemopexin domain with the
catalytic domain represented as a three axial tensor, in analogy to Figures 6.4 and 6.5. From the 1,281
conformations analyzed, only those conformations with a MaxOcc value above 35% are represented.
A) all the conformations that are congruent with the criteria. B) Only those that do not penetrate the
modeled collagen structure. C) only those that do penetrate the collagen structure. D) the same as
in A) but reoriented so to highlight the coherent orientation that is share by virtually all represented
conformations.
are necessary for the collagenolysis to occur. We suggest that, on the light of our findings, the induced
fit mechanism is not yet to be disregarded. We found that elongated conformations are favored in
solution and are accompanied by unstructured movements of the linker. Considering also the data
amassed in literature along with a recently published work (Bertini et al., 2012c), reviewed in Section
2.7.2.4, we might risk saying that a conformational selective mechanism initiates the specific binding
event and is followed by induced fit rearrangements that ultimately drive the collagenolytic mecha-
nism. In the elongatedmodels obtained with MaxOcc, the exosites necessary for hemopexin·collagen
binding are exposed (Figure 6.10). So, in detail, the hemopexin domain would bind to the collagen
molecule by its exosites with consequent stabilization of the partially unwound regions of the triple
helix. Upon HPX binding, the catalytic domain would be readily available, having the catalytic site fac-
ing the collagen triple helix, which would drastically promote collagen binding by the CAT domain’s
exosites (Figures 6.11 and 6.12). After this stage, the system would favor a back-rotation movement
of the CAT domain towards a closed and more stable conformation, similar to those of the X-ray data,
in a mechanism that can be represented to a high extent by data driven computational calculations
(Bertini et al., 2012c).
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The increase in stabilization would be favored by the linker’s structure, which would form a net-
work of interactions with both the CAT and the HPX domains, as previously reported (Section 2.3.2).
Additional stabilization would be given by the interaction of hemopexin residues Phe301 and Val318
with the catalytic domain (Arnold et al., 2011). The energy gain that can be envisaged from the back
rotationmovements of the catalytic domain towards the closed conformation, with consequent stabi-
lization of the linker and CAT·HPX interface, would give enough energy to complete the unwinding of
the alreadypartially unwound collagen. Again, previouswork supports this possibility (Section 2.7.2.4).
The mechanism presented differs from the original helicase hypothesis (Section 2.7.2.3) by consider-
ing that only the final steps of the unwinding are induced by the enzyme (induced fit) while a initial
unwinding does occur spontaneously because of the nature of the collagen molecule (conformational
selection). This new idea agreeswith the notion that the collagen portion upstream the scissile bond is
spontaneously prone to be loose and that, on the other hand, MMPs are not able to cleave completely
stable α1(III) homotrimer triple-III collagen (Section 2.7.2.1). A combination of both mechanisms can,
in the way described, be invoked to further explain the mysterious collagenolytic action.
Under the light of the hypothesis presented here, the linker might play two different and crucial
roles. On one hand, the unstructured nature of the linker is responsible to position the catalytic do-
main in the correct orientation for favorable catalysis. If the linker is granted different properties it
might favor an orientation of the catalytic domain in the enzyme’s free state that could be opposite
to the one found in this study. Consequently, upon HPX binding, the active site cleft would face the
solvent instead of the triple helix peptide and render the enzyme not prone for catalysis. On the other
hand, the nature of the linker also determines its propensity to gain structure and interact with both
the catalytic and hemopexin domains, contributing to the stabilization of the closed conformation as
suggested by pioneer X-ray data (Section 2.7.2.6). If bymeans of somemutation such nature is altered,
the back rotation of the catalytic domain and the simultaneous pulling of the collagen chain can be se-
riously impaired, an even absent. Again, on the light of this hypothesis, this would reduce drastically
the collagenolysis, but would not affect the binding affinity towards collagen nor the proteolytic ac-
tivity (explained in Section 2.7.1). On the light of the above assumptions, we can explain previously
obtained results (Knäuper et al., 1997c; Tsukada and Pourmotabbed, 2002). G272D mutants of colla-
genases showed collagenolytic activity reduced to 13% without affecting the proteolytic activity nor
the binding rate of the enzymes to triple helical collagen. Also, other point mutations, specially at
the proline sites, drastically reduced the collagenolytic activity of collagenases without altering their
binding or proteolytic activity.
It has been found that the MMP-1·collagen complex is favored with respect to the free MMP-1, as
shown by Manka et al., 2012, and by data obtained in our lab which is presented later in Chapter 7.
This is an additional support to the statement that the back rotation mechanism (induced fit) tends to
a more stable situation.
The cooperative action of the catalytic and the hemopexin domain in collagen binding and unfold-
ing is also supported by other recently published data (Bertini et al., 2012c; Manka et al., 2012). It
was shown that the full-length MMP-1 is effective in binding the collagen triple helix but that the two
truncated domains fail in having significant binding. The binding to the collagen is enhanced with the
increase in temperature, exclusively for the full length enzyme, up to nearly 40ºCwhen collagendenat-
urates, meaning that loosened conformations of the collagen are preferred by MMP-1. Both findings
point to a cooperative interaction of both domains. Additionally, the active site cleft inhibitor GM6001
reduced the binding affinity towards the collagen, meaning that the capturing of a single chain by the
catalytic domain is essential for collagen·MMP-1 adduct stabilization, which may only happen if in-
duced by a back rotation of the catalytic domain that further exposes the 1T chain. In this way, the
hypothesis that we have presented in this work nicely correlates thewhole set of results obtained and
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those already present in the literature. Oppositely to the past lines of thought, and on the light of the
new achievements, we are now directed to concluded that, indeed, conformational selection followed
by induced fit are necessary to explain the collagenolytic mechanism. Still, Manka et al., 2012, have
proposed, based on their X-ray model of the MMP-1·collagen adduct, that only minor movements of
the MMP’s domains are necessary for a single chain to enter the active site. The results obtained with
MaxOcc add that the movements from open to close conformations upon binding are not so minor,
as can be observed in Figure 6.9. We can suggest that in the case of the MMP-1·THP interation, the
energy gain with movements of such amplitude further favours the unwinding mechanism. Though,
it is necessary to stress that these movements are also not disparate because the intrinsic mobility of
the enzyme favors positions and orientations of its domains that are readily prone for catalysis. Our
data does not add any information to the actual collagenolytic steps and, therefore, we refrain, at this
state, from further discussion on the topic.
MMPswere found to travel though the collagen fibrils like trains in railroads (Saffarian et al., 2004),
where elongated MMP-9 structures were observed (Rosenblum et al., 2007), in analogy to those ob-
tained here for MMP-1. An “inchworm” mechanism has been proposed to explain the movement of
MMPs through the collagenmolecule (Overall and Butler, 2007). If the enzyme trulymoves in an “inch-
worm” manner through the collagen fibrils, our data can neither confirm nor disprove. However, it
confirms the existence of elongated structures that may support this theory.
To conclude, the data presented here sheds pioneering light on the prologue of the long studied
collagenolytic mechanism, and with this data we hope to help in unifying the knowledge that litera-
ture has amassed. A crucial step of the collagenolysis is still missing in the current overall picture: a
picture frame of the conformational state of theMMP-1·Collagen adduct in solution, prior to the chain
proteolysis. We aim at addressing this issue in the next Chapter.
6.4 Conclusion and Remarks
In this work we have functionalized the active form of the full length Matrix Metalloproteinase-1
(MMP-1) with a Lanthanide(III) bearing tag, CLaNP-5. NMR samples were prepared with the enzyme
free in solution and the necessary spectrawere acquired. From these spectra, paramagnetic restraints
that contain structural information were extracted, namely, PCSs and RDCs. These restraints were ini-
tially used to describe the paramagnetic properties of the system, that is, to calculate the respective
Δχ-tensors for each Lanthanide(III) ion, for each set of restraints (PCSs and RDCs) and for each domain
(catalytic and hemopexin). This analysis indicated us that the HPX domain could move somewhat in-
dependently (Figure 6.2) of the catalytic domain, in corroboration to what has been already published
in literature (Section 2.7.2.2).
The novelty of this work lies on the description of the reciprocal reorientation that both domains
experience in solution. For this, we used theMaximumOccurrence (MaxOcc) approach as it is available
in the WeNMRWeb Portal (Section 1.8). A complete map of the different MMP-1 conformations that
can exist in solution resolved by their possible maximum contribution to the experimental data was
obtained (Figure 6.4 and 6.5). The map clearly showed the conformations that are not sampled for
significant periods of time as well as those that can indeed be present for almost half of the time. The
former conformations corresponded to those of closed states of the domains, similar to the crystal-
lographic structures that have been published so far. The conformations with higher MaxOcc values
were themore elongated and, strikingly, those with the highest MaxOcc values (>35%) were together
in awell defined region of space and presented a specific orientation (Figure 6.8). Also, the hemopexin
exosites that have been found to be active in collagen binding are nicely oriented with the catalytic
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site cleft and are solvent exposed in these high MaxOcc value conformations. By modeling the colla-
gen structure to the exosites of HPX domain we found the cleavage site of collagen to be correctly
drawn to the catalytic cleft. All structures with MaxOcc value above 35% had their catalytic domains
in the near proximity or penetrate themodeled collagen. Thus, wewere led to the conclusion that the
MMP-1 enzyme presents in solution conformations that favor the collagenolytic process. Upon selec-
tive binding, structural movements can take place to unwind the triple helical collagen and proceed
to the consequent chain 1 cleavage, and such events have been named “molecular tectonics” (Overall,
2002).
In a one sentence conclusion, we can say that we have identified the relevant conformations that
MMP-1 acquires in the liquid state and we have shown how these are efficiently the prologue of the
collagenolytic mechanism. As much as the available data allows, we have humbly attempted to unify
the conformational selection and the induced fit mechanisms to explain the collagenolytic event.

Chapter 7
The MMP-1·THP Interaction
7.1 Introduction
Matrix metalloproteinases are a family of zinc-dependent endopeptidases that regulate a vast net-
work of signaling processes, tissue homeostasis and remodeling. The misbehavior of such enzymes
rapidly drives the tissue to a severe pathological condition. Within the family of MMPs, the subfamily
of collagenases is probably the most studied. Exceptionally to the majority of the proteases, colla-
genases degrade, in a very specific manner, the triple helical collagen molecules even in their fibrillar
state. The correct collagen turnover is crucial for tissue homeostasis, and uncontrolled collagenoly-
sis favors tumor progression and development of metastasis. The research of this enzymatic process
reaches as far as 40 years ago and a complete understanding of it was not yet achieved, as the molec-
ular mechanism and dynamics of this complex enzyme·substrate interaction are still unclear.
Uncovering the enzymatic processes is crucial for the understanding of the biochemical machinery
that constitutes the living bodies, aswith such understanding newpharmacological approaches can be
developed to promote health, hindering the development of any type of disease. Substrate·enzyme
interactions have been mainly studied by X-ray crystallography methods and classic NMR approaches,
which are very powerful methods to reveal at atomic resolution the adducts formed between the two
interacting molecules. However, for the study of catalytic processes that depend on large structural
movements such strategies may become incomplete and not able to describe the full picture of the
catalytic mechanism. In crystallographic conditions the interacting complex may be forced to a single
state due to the crystallographic packing forces whichmay even represent a local minimum instead of
a crucial step of the catalytic mechanism. Additionally, classic NMR restraints (like NOE and chemical
shift mapping analysis) add only poor information on mobile systems.
During the last decade complementary techniques based onparamagnetic NMRanalysis have been
under strong development and have become practically routine. NMR paramagnetic data like pseu-
docontact shifts (PCSs), residual dipolar couplings (RDCs) and paramagnetic relaxation enhancements
(PRE) convey long-range and high quality information on dynamics and positioning within a multibody
interaction, and in this way, they successfully complement the classical restraints obtained by X-ray
and NMR.
In this project, we used a large body of paramagnetic NMR restraints, together with X-ray and clas-
sic NMR data and computational approaches, to derive the interaction model of the two domain en-
zyme Matrix Metalloproteinase-1 (MMP-1) and an analogue of its collagen substrate. The successful
results obtained previously with paramagnetic NMR data on the study of free MMP-1 dynamics in so-
lution encouraged us to use this same approach on such a complex interaction. The model we were
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able to reproduce nicely agrees with all the independent data that was inputted. This is the first time
that a fully experimental data-driven model of an advanced step of the collagenolytic mechanism is
produced.
7.2 Results
7.2.1 Obtaining The Δχ-tensors
The aim of this project is to obtain a picture frame of the interaction state between the multidomain
MMP-1 enzymeand the triple-helical collagenduring the collagenolyticmechanismand at themoment
prior to the proteolytic step. The collagenmolecule itself (Section 2.7.2.1) is not favored to NMR stud-
ies due to its large molecular size and reduced solubility. For this reason, and analogously to what is
already common in the research of collagenolysis, we used a collagen analogue that mimics the natu-
ral collagen characteristics. The triple-helical collagen analogue used (THP) is detailed in Section 4.4,
and in short it can be said that the THP contains a specificity region of 14 amino acids which contains
the scissile Gly-Ile bond and is flanked by eight GPO groups, four on each side. It also acquires a triple-
helical conformation in solution up to 40ºC when it denaturates into single chains. The full length
(Ln)MMP-1 construct used is the same as in the previous project (Chapter 6) where the domain mo-
tions of the enzyme’s free state were analyzed. The details on the protein preparation process can be
found in the Materials and Methods section 4.3.
The interaction between theMMP-1 and this THPmoleculewas determined to be in the boundaries
between the slow and the fast exchange regimes (Bertini, et al, 2012c). For this reason, to obtain a
long lived (Ln)MMP-1·THP complex we forced the protein to the presence of 5-fold excess of THP,
thus shifting the interaction equilibrium towards the complexed state. The final sample conditions
can be found in Section 4.5. Because the MMP-1 construct is inactivated by the mutation E219A, we
expected that the complex would hold firm in the sample conditions without cleavage of the singular
chains of the THP and, as it will be shown later, this was indeed observed. To study this event, we
exploit the use of paramagnetic NMR in the sameway as previously (Chapters 5 and 6), functionalizing
theMMP-1with the tag CLaNP-5 (Section 1.6.1.1) carrying different Lanthanide(III) ions (Section 1.3.1).
The experimental details can be found in the Materials and Methods section for the NMR acquisition
(4.6.3) and data analysis (4.7).
We acquired PCSs and RDCs on both the catalytic and the hemopexin-like domains (Section 2.3)
and analyzed them (Section 1.5.2) on the light of the strategy explained in Section 1.8 to understand
if MMP-1 presented internal domain motions when complexed to the THP. A list of the experimental
data obtained can be found in the Appendix Chapter. Table 7.1 summarizes the relevant Δχ-tensors
obtained, while Figure 7.1 shows the agreement plots between the experimental and calculated data.
Table 7.1: The PCS-derived and RDC-derived Δχ-tensors for the CAT and HPX domains, respectively,
obtained from the MMP-1·THP adduct, in 10-32m3.
PCS·CAT RDC·HPX
Δχax Δχrh Δχax Δχrh
Tb(III) -49.99 17.54 -34.4 12.3
Dy(III) -46.31 25.28 -36.7 17.4
Tm(III) 55.81 5.91 39.3 -6.2
Δχ-tensor parameters obtained from the PCSs of the catalytic domain are of the same magnitude
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Figure 7.1: Fits between the experimental and back-calculated data using the tensors of Table 7.1.
The model of the catalytic domain used is the one refined with solution restraints during the project
of Chapter 5. The hemopexin model is that of the active form of MMP-1, PDB ID: 2CLT.
Figure 7.2: The spreadingof theRDCs (inHz) calculatedon thehemopexin domain extracted fromPDB
2CLT and based on different Δχ-tensors. A) the PCS-derived Tb(III) Δχ-tensor of the catalytic domain
from the MMP-1·THP complex at 298 K, B) RDC-derived Tb(III) Δχ-tensor of the hemopexin domain
from the free full length MMP-1 at 310 K and C) the RDC-derived Tb(III) Δχ-tensor of the hemopexin
domain from the MMP-1·THP complex at 298 K.
of those obtained for the truncated domain (Table 5.1) and the full length MMP-1 in the free state
(Table 6.1), which means that the previous data is reproducible and can be applied to this project.
The Q factors are 0.04 for the PCS-derived Δχ-tensor and 0.16 for the RDC-derived Δχ-tensor. Indeed,
the CAT domain model used in this calculation was that obtained after refinement with solution data
(Chapter 5). We have seen with the MaxOcc analysis of MMP-1 (Chapter 6) that, in the free state, the
two domains move to some extent independently to each other, in agreement with literature data
(Section 2.7.2.2). The mobility of the two domains was responsible for the reduced magnitude of the
RDC-derivedΔχ-tensors obtained for the hemopexin-like domainwhenMMP-1 is found free in solution
(Table 6.2). Very interestingly, the RDC-derived Δχ-tensors reported here for the hemopexin domain
in the presence of the THP triple-helix (Table 7.1) are no longer of reduced magnitude. Instead, their
magnitude is characteristic of a rigid body molecule that only expresses the natural motion of the H-
HN vectors and are comparable with the results obtained for the catalytic domain shown in Table 6.1
[recall also the explanation given in section 1.8 - Observing averaged paramagnetic NMR data (PCSs
and RDCs)].
Togainbetter understandingon the rigidity thatMMP-1acquires in thepresenceof theTHPmolecule,
we analyzed the RDCs spreading considering the different situations, analogously to Figure 6.2 on
page 103. Figure 7.2 shows the spreading of the RDC values on the hemopexin domain calculated
from the Tb(III) Δχ-tensors for different situations. Figure 7.2A represents the case of absence of in-
trinsicmobility of thedomains calculated considering thePCS-tensor obtained for the catalytic domain
122 CHAPTER 7. THE MMP-1·THP INTERACTION
Figure 7.3: Left) In black the X-ray model of the HPX domain as extracted from PDB ID 2CLT, in white
the solution refined model of the same domain. Right) the agreement between the experimental
RDCs and those derived from the refined model.
in the MMP-1·THP interaction at 298 K, Figure 7.2B represents the case of the natural mobility of free
MMP-1 calculated from the Tb(III) RDC Δχ-tensors obtained in the previous project (Chapter 6), analo-
gously to Tm(III) in Figure 6.2C. However, contrarily to the free state MMP-1, the spread of RDCs from
the RDC-derived Tb(III) Δχ-tensor of the hemopexin domain for the MMP-1·THP complex is very simi-
lar to the one calculated for a putative rigid system (Figure 7.2C). We can conclude from this analysis
that, when in the presence of 5-fold THP, MMP-1 does not experience reciprocal reorientation of its
domains, being frozen into a single conformation.
7.2.2 Refining The HPX Domain
The highmagnitude values obtained for the RDC-tensors on the Hemopexin domain encouraged us to
attempt the refinement of the crystallographic model. Having a refined model will facilitate the later
calculations necessary to derive theMMP-1·THP adduct, because the startingmodel will be optimized
to the data in use. For this, we used the refinement protocol we developed previously (Chapter 5)
using the HPX X-ray structure of the active form of MMP-1 (PDB ID: 2CLT) and the experimental data
obtained here in the presence of THP (sets of RDCs and PCSs and the corresponding paramagnetic
tensors). Figure 7.3A represents the superimposion of the X-ray and the refined model, and Figure
7.3B shows the agreement between the experimental and observed RDCs after the refinement. It is
clear frompanel A that the backbone structure of the twodomains do not present significant changes,
as it is expected for this domain and for the refinement protocol we have developed. Nevertheless,
the protocol is able to drive a significant improvement in the agreement between the experimental
and the calculated data, thus fine tuning the X-ray model towards the solution state. The RDCs fit
of the refined structure presents a Q factor of 0.22, which is higher than the Q factor for the HPX of
the 2CLT structure (0.16, Figure 7.1). This is due to the much larger quantity of RDCs used during the
refinement, 132 RDCs versus the 43 RDCs used for tensor calculation.
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Figure 7.4: Best solutions of the two different clusters obtained with CYANA for orienting the
CAT·HPX pairs with the experimental PCS and RDC sets. In gray the two hemopexin domains super-
imposed, in black the catalytic domain of the nearest to the mean structure of the real cluster and in
white the nearest to the mean structure of the “ghost” cluster solution. Metal ions are represented
as spheres, in black the catalytic zinc.
7.2.3 MMP-1 Interdomain Orientation When Complexed To THP
The magnitude of the calculated Δχ-tensors strongly point to the existence of a stable and fixed con-
formation of the MMP-1 domains when in the presence of 5-fold triple helical THP. If this is so, we
expect to find a single solution for the calculated paramagnetic tensors. Additional “ghost” solu-
tions must also be expected due to the symmetry dependency of RDCs (Section 1.4.3 - Geometric
symmetry), but such should be easily identifiable in this case. For this reason, there is no physical
meaning in using the Maximum Occurrence approach (Section 1.8 and Chapter 6) as it was the case
when studying the dynamics of the free MMP-1 enzyme. To determine the relative orientation of the
catalytic and the hemopexin domains when complexed to the THPmolecule, we directly used the pro-
gram PARAMAGNETIC CYANA (Section 1.5.2). Practical details of the calculations can be found in the
Materials and Methods section 4.9. In the CYANA calculations, the solution refined models of the cat-
alytic and hemopexin domainswere inputted alongwith the obtainedΔχ-tensors anddata sets. A total
of 100 structures with the lowest target function (TF) were selected. From these, 81 structures could
be clusteredwith a backboneRMSDof 0.068Å,while the remaining 19 structures belonged to another
cluster with a backbone RMSD of 0.038 Å. The nearest to the mean structures of the former and the
latter clusters were superimposed on their hemopexin domains and are represented in Figure 7.4, the
two catalytic domains differ from each other by a backbone RMSD of 41.38 Å.
The lower populated cluster is symmetric to the higher population cluster and was considered to
represent a “ghost” solution that derives from the quadratic nature of the RDC function (equation
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Figure 7.5: Fits of the measured and back calculated PCSs and RDCs for the catalytic (CAT) and the
hemopexin (HPX) domains after the data driven angle-fix reorientation with CYANA.
1.14), the nature of this latter cluster will be addressed later. The PCSs and RDCs were back calcu-
lated for the nearest to the mean structure of the large populated cluster and plotted against the
experimentally observed values that were obtained for (Ln)MMP-1·THP complex. Figure 7.5 depicts
the plots. The obtained overall Q factors were calculated based on equation 1.18 and, considering the
data for all the Lanthanides, the values are 0.06 and 0.23 for the PCSs of the catalytic and hemopexin
domains, respectively, and 0.28 for the RDCs of the hemopexin domain. The obtained orientation be-
tween the catalytic and the hemopexin domain is in very good agreement with the observed PCS and
RDC values, meaning, as expected, that a single orientation can fit the data. Therefore, this confor-
mation corresponds to that of the bound state of MMP-1 in the MMP-1·THP complex.
It is relevant to understand how similar the newly foundMMP-1 conformation is to “steps 1-4” pre-
viously described (Section 2.7.2.4). To recall, “steps 1-4” represent four different stages of theMMP-1-
driven THP unwinding induced by the back rotation of the MMP-1 domains; these stages comprehend
the MMP-1 and the THP molecule. A direct comparison reveals that the RMSDs found for the steps
“1 to 4” and the CYANA-derived MMP-1 orientation are 4.9, 4.7, 3.9 and 2.4 Å, respectively. The closer
proximity to the “step 4” points to the confirmation that our complex is indeed bound to the THP,
and strikingly points to a complex that is indeed stable at the step preliminar to the chain proteolysis,
where the triple helix is already unwound but the MMP-1 is still attached.
7.2.4 Model Refinement with HADDOCK
So farwe have obtained solid information on the domain orientation of the bound state of the protein.
Information has been previously reported in literature on the binding regions between the MMP-1
domains and the same THPmolecule (Section 2.7.2.4; Arnold et al., 2011; Bertini et al., 2012c) and also
on the binding epitope of an analogue single chain at the catalytic pocket of MMP-12 (Bertini et al.,
2006). In order to obtain a complete model of the collagenolytic instant before the proteolytic action
we compiled all the experimental information available and submitted it to a refinement with the
HADDOCKWeb Server (Dominguez et al., 2003) which has been recently updated to allow the input of
PCSs (Schmitz and Bonvin, 2011) and RDCs (van Dijk et al., 2005) to drive the domain orientation and
position during the flexible refinement step of the HADDOCK protocol. Therefore, the PCS and RDC
sets were used to restraint the orientation and position of theMMP-1model obtained experimentally
with CYANA (from the bigger cluster of 81 structures). The known interactions between the THP and
theMMP-1were inputted to drive the docking of the THPmodel to the experimentally obtainedMMP-
1 conformation. An important question arises at this point. Since the MMP-1 was found in a close
conformation and we expect that the data relates to that of the instant before the proteolysis, which
THP model should be used in the docking procedure? Is a straightly perfect triple helix able to fit the
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Figure 7.6: Plots of the HADDOCK Score versus the i-RMSD to the structure of lowest score within the
cluster. The plots for “steps 1-4” share the same scale but note that the “step 4 ghost” has a positive
scale.
acquired data? We decided to probe the four different conformations of the THPmolecule that relate
to the snapshots of the unwinding mechanism of the collagenolysis, as calculated previously by CERM
colleagues (Section 2.7.2.4). In this way, the THP models corresponding to the “step 1” to “step 4”
were docked in different calculations to the same experimentally obtainedMMP-1 model. The details
on the HADDOCK calculations can be found in the Materials and Methods section 4.10.
Theoutputof the runs TheHADDOCK results for the fourdifferent THPmodels (the variableparam-
eter), “step 1”, “step 2”, “step 3” and “step 4”, were clustered and analyzed using the scripts provided.
These can be considered as calculations of minimization and refinement, instead of docking searches,
becauseof the large amountof experimental data available as restrains. TheRMSD foundbetween the
200 structures outputted for each different run is therefore very reduced (< 2 Å). For this reason, clus-
tering the 200 structures to very low RMSD cutoffs, like 2 or 1.5 Å, is devoid of physical meaning. The
standard cutoff of 7.5 Å was used and all the 200 structures could fit a single cluster for all the runs.
In addition to the four “steps” explored, we wanted to address the less populated cluster obtained
previously with CYANA, which was considered a “ghost” representation of the solution data (Figure
7.4) and for which we expected very poor HADDOCK Scores. So, we inputted in HADDOCK the same
kind of run as for “step 4” but changing theMMP-1 model to that of the less populated cluster. Figure
7.6 plots the i-RMSD versus the HADDOCK Scores for the different runs and Table 7.2 summarizes the
standard HADDOCK output parameters. The analysis of both follow in the next subsection.
7.2.5 Analysis Of The “Steps 1 To 3” HADDOCK Runs
When docking the “steps 1 to 3” to the obtained MMP-1 complexed orientation (Section 7.2.3), the
HADDOCK outputted much poorer models. The differences in HADDOCK score for the runs “steps 1
to 3” are minimal, -140, -136 and -130, respectively, when compared with the large decrease in HAD-
DOCK score, -191, of the run “step 4” (Table 7.2). From “step 1” to “step 3” there is a clear increase,
although small, in the HADDOCK score. We can justify such behavior recalling the old key·lock model
for enzyme·substrate interaction. The “step 1” THP model is a straight triple helical molecule (stan-
dard key) that can fit to some extent a specific lock (MMP-1 complex conformation) without creat-
ing extraordinary hindrances. When the THP model starts to acquire specific conformations (“steps 2
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Table 7.2: The results obtained from the HADDOCK runs for the different THP models. “Steps 1 to 4”
share the sameMMP-1 domain orientation while in the “Step 4 ghost” run the THP “Step 4”model was
docked on the supposed “ghost” MMP-1 orientation (Figure 7.4).
Step 1 Step 2 Step 3 Step 4
Step 4
“ghost”
HADDOCK
Score -141.403 ± 6.890 -136.899 ± 4.544 -130.848 ± 5.897 -191.141 ± 2.811
39.111 ±
2.526
Cluster Size 200 200 200 200 200
RMSD from
the
lowest-energy
structure
0.645 ± 0.436 0.549 ± 0.318 1.591 ± 0.922 0.673 ± 0.413 0.633 ± 0.412
Van der Walls
energy -130.27 ± 8.37 -129.37 ± 10.51 -121.59 ± 9.60 -150.51 ± 5.35 -65.68 ± 8.29
Electrostatic
energy -342.82 ± 7.63 -317.48 ± 6.93 -344.56 ± 37.60 -455.31 ± 16.83
-230.00 ±
24.59
Desolvation
energy -4.087 ± 3.511 -7.740 ± 6.502 5.023 ± 9.328 -13.162 ± 5.11
7.598 ±
11.720
Restraints
violation
energy
15.75 ± 1.48 17.00 ± 1.00 13.75 ± 1.78 15.5 ± 0.5 30.00 ± 1.41
Buried Surface
Area 2970.727 ± 138.397 3027.165 ± 131.379 2574.602 ± 112.322 3466.2 ± -159.257
1889.093 ±
43.775
Z-Score 0 0 0 0 0
and 3”) it becomes more difficult to fit it into the differently specialized enzyme conformations. The
intermediate steps that the models “2 and 3” represent may create obstacles when modeling their
interaction with the final MMP-1 complexed orientation. In the collagenolytic action, the occurrence
of “steps 2” and “step 3” are accompanied by the corresponding MMP-1 conformations, which in this
case are not represented. Finally, when the THPmodel is ideal for the receptive enzyme conformation
the interaction occurs favorably. In conclusion, docking the initial stage of the substrate with the final
stage of the enzyme ismore favorable than docking the substrates’ intermediate stages. Nonetheless,
the models of the different runs show a progression of the interaction towards the final state. Recall
that the “step 1 to 3” HADDOCK runs (MMP-1 + THP) do not intent to represent intermediate steps of
the collagenolytic mechanism, they were performed to justify that the obtainedMMP-1 conformation
does represent the collagenolytic instant prior to the proteolysis, which gives much better HADDOCK
result with “step 4” run.
Figure 7.7 represents a general view of the four models obtained, as they were aligned to the HPX
domain and positioned in the same perspective. Panels A and B, “steps 1 and 2”, show that in these
models the chain 1T is not yet able to enter the catalytic site properly. The interactions at the level of
the HPX and the surface of the CAT do not comply also with all the restraints inputted because with
the still helical structure of THP such interactions are not favored to occur. At panel C, the triple helix
starts to become unwounded and mode interactions with the surface of the domains are possible,
specially at the HPX·CAT interface; the chain 1T is partially positioned at the catalytic site cleft. Finally
on panel D, the unwinding of the THPmodel is maximum, allowing for the active interactions to occur,
with emphasis to those at the HPX·CAT interface which are very pronounced and directly run the THP
1T chain to the catalytic site (as will be analyzed in the next sections). Panel C, “step 3”, shows that
the catalytic domain has suferred a tilt upwards with respect to the other three panels, possibly due
to the partially unwounded state of the THPmodel which distorted themodel of the complex because
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Figure 7.7: An overview of the models with the lowest HADDOCK score for the different runs, from A
to D, “steps 1 to 4”, respectively. In black the THP model, in white the MMP-1 model, calcium ions are
represented as large gray spheres and zinc ions as small spheres, the catalytic zinc is in black.
of undesired interactions, thus increasing the HADDOCK score.
The character of “ghost solution” of the less populated CYANA cluster was confirmed by the very
high HADDOCK score (+39) obtained. Figure 7.8 depicts the obtainedMMP-1·THP for the “ghost” con-
formation. The wrong interaction of the THP with the HPX domain is clear and, more importantly, the
model catalytic domain faces the site opposite to the THP molecule, as expected from its symmetric
nature, thus generating a completely unfeasible collagenolytic model.
Figure 7.8: Themodel of lowest HADDOCK score from the run with the “ghost” MMP-1 conformation.
THP is in black, MMP-1 inwhite, metal ions are represented as sphereswith the catalytic zinc is in black.
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Figure 7.9: Plots of experimental versus calculated PCSs and RDCs for the catalytic and hemopexin
domains obtained in the model with the lowest HADDOCK Score from the “step 4” run.
7.2.6 Validation Of The “Step 4” HADDOCK Models
Verifying the correctness of MMP-1 domain orientation In order to evaluate if the MMP-1 do-
mains on the HADDOCK models obtained remained in agreement with the experimentally acquired
restraints, both PCSs and RDCs were fitted to the catalytic and hemopexin domains of themodel with
lowest HADDOCK score from the “step 4” run. The plots from Figure 7.9 show that the experimental
data concordantly fits both domains, meaning that HADDOCK performed very well in the flexible re-
finement step (water ) maintaining the structures coherent with the experimental paramagnetic data,
respecting both the individual domain solution refinement and the domain-domain orientations found
for the MMP-1·THP complex. The overall Q factors for PCSs and RDCs were calculated from equation
1.18 considering the contribution of all the three metal ions and are shortly summarized in Table 7.3
in comparisonwith the Q factors found for the solutionMMP-1 conformation in the complex obtained
from CYANA (above section MMP-1 interdomain orientation when complexed to THP).
Table 7.3: Comparison of the Q factor values of A) MMP-1 derived orientation from the CYANA calcu-
lation (Figure 7.5) and B) MMP-1 domain orientation after HADDOCK (run “step 4”).
A B
HPX (RDC) 0.28 0.23
HPX (PCS) 0.23 0.20
CAT (PCS) 0.06 0.04
Validation of the models with SAXS data Additionally to all the NMR and X-ray data that was gath-
ered to generate the HADDOCK models, independent SAXS data was also acquired to validate the
state of the samples used and the models generated. Samples of 1:5 (Ln)MMP-1:THP were prepared
in the same conditions as for the NMR analysis and were analyzed with SAXS. The experimental SAXS
curve was fitted theoretically when considering the models generated by “step 4” run of HADDOCK
and an excess of 4-fold free THP (Figure 7.10), with a resultant chi of 1.03. The independent SAXS
analysis is in clear agreement with the expected (Ln)MMP-1:THP bound/free ratio in the NMR sam-
ples, meaning that the equilibrium has shifted completely into a frozen complexed state, and also is
in agreement with the shape of the models generated with HADDOCK “step 4” run. Although the in-
dividual models generated by this run have HADDOCK scores differing by as much as 100 units, the
SAXS data cannot discriminate between then since the overall molecular shape is the same (the 200
structures were clustered bellow 2 Å).
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Figure 7.10: The SAXS profile of the 1:5 (Ln)MMP-1:THP sample. In black dots the experimental data
and in the gray line the theoretical fit which was generated considering 4-fold excess of THP in the
free state and the models obtained from HADDOCK “step 4” run for the MMP-1·THP interaction; chi =
1.03.
7.2.7 Analysis of the Lowest HADDOCK Score Run of the MMP-1·THP Interac-
tion
The HADDOCK run for MMP-1 against the THP in the “step 4” gave, as expected from the previous
RMSD comparison, the best docking outcome. The models calculated in this run are those in best
agreement with the large amount of data acquired for the MMP-1·THP solution complex. It is, there-
fore, imperative to perform a detailed analysis of such models in order to understand the MMP-1·THP
interactions that drive and stabilize such large scale movements and energy demanding mechanisms.
The next Tables summarize the salt bridge interactions that occur between the THP and theMMP-1
domains and also between chains in the unwound THP regions, these constitute impressive networks
of interactions which result from the combination of the THP sequence and the ternary structure of
MMP-1 and drive and stabilize the unwinding of the THP molecule while positioning the prominent
chain (chain 1T) in the active site for the scissile Gly-Ile cleavage. As is default in the HADDOCK pro-
tocol, the best four structures are used to calculated the cluster’s average results, for this reason the
four best models of the HADDOCK cluster under study (“step 4” run) are analyzed here. It was found
that a single residue on a domain can and, indeed, does interact with several residues on the THP
chains. The tables are organized taking as reference the residues of the MMP-1 domains in order to
allow better visualization of the interaction networks in which they participate.
7.2.7.1 The 1T-2T chains adduct with the Hemopexin domain
Table 7.4 summarizes the salt bridge interactions that were found for the THP·HPX adduct. As ex-
pected from previous observations and from the input given to HADDOCK, chain 3T does not interact
directly with the hemopexin domain (Section 2.7.2.4; Bertini et al., 2012c). On the other hand, chains
1T and 2T do probe the hemopexin landscape. Figure 7.11 shows the THP chains on top of the do-
main. Strikingly, chain 2T interacts all over the HPX surface, as will be detailed shortly, and is forced
to open towards the left, while the chain 1T, creating a vast network of interactions, is led straight up
to the catalytic site where the Zn(II) ion lies. Chain 3T is shown in a lighter color and follows the path
in between the other two chains, see details on the next subsection.
In total, 9 salt bridge networks consisting in 7 residues of the HPX domain and 8 residues from
chains 1T and 2T were found for this interface. Amost interesting observation is that several residues
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Figure7.11: Inwhite surface representation theMMP-1enzyme. Thedomain in focus is thehemopexin
domain and part of the catalytic domain is seen in the upper region of the figure. In dark gray the chain
1T which interacts with the surface of the HPX domain and is led upwards directly to the catalytic site
cleft. In gray the chain 2Twhich interacts with the HPX surface but is driven to the left interactingwith
the interface between the HPX and the catalytic domain. In white the chain 3Twhich does not interact
with the MMP-1 at the hemopexin level. From the left to the right panel the figure is rotated by 50
degrees.
Table 7.4: Salt bridge interactions (in Å) between the Hemopexin domain and the THP molecule for
the four best models of the HADDOCK refinement between the THP “step 4” conformation and the
MMP-1 complex conformation.
Residue THP Residues Model 1 Model 2 Model 3 Model 4 Average distance
R291(O)
2TG28(NH) 3.3 3.5 3.4 2.9 3.3
R291(HNε)
2T-HyP27(O) 3.7 2.3 4.0 2.3 3.1
1T-HyP30(Oε) 2.0 2.6 2.7 2.2 2.4
R291(HNη)
1T-HyP30(Oε) 2.0 2.0 2.7 2.3 2.3
E293(Oε)
2T-L26(HN) 1.8 2.4 1.7 2.2 2.0
R304(HNη)
2T-L26(O) 1.9 2.0 2.0 1.7 1.9
2T-V24(O) 2.0 5.3 2.9 2.1 3.1
E311(Oε)
2T-G25(HN) 2.3 2.3 2.0 2.3 2.2
2T-R21(HNη) 3.7 5.2 2.0 2.0 3.6
E313(Oε)
2T-V24(HN) 1.7 1.6 1.8 1.7 1.7
2T-R21(HNη) 1.8 1.7 1.6 1.9 1.8
V319(O)
1T-G25(HN) 2.2 2.6 2.5 3.0 2.6
Q354(HNη)
1T-G25(O) 9.9 5.1 6.1 2.6 5.9
Average distance 2.9 3.0 2.7 2.3
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can form salt bridge “clusters” in which a number of charged residues is stabilized by less charges of
the opposite sign. An example of this behavior is the Arg291 that stabilizes both 1T-HyP30 and 2T-HyP27
forcing a considerable region of the chain to be attached to the HPX surface. This is in agreement
with previous findings, showing that the couple Ile290 and Arg291 ia an exosite for the collagen binding
(Lauer-Fields et al., 2009). Also, Glu313 “clusters” theηnitrogensofArg21 and theHN ofGly25 fromchain
2T. The distances presented in Table 7.4 may yet vary notably across the four models. For instance,
Gln345(HNη)-1T-G25(O) interaction is only present in model 4, the distances for the other models were
also reported for comparison. In this particular case, the large distances found for models 1 to 3 are
due to the side chain of Gln354 which was generated facing the opposite direction of 1T-Gly25(O). The
network created by Glu311 and Glu313 interact with three positive residues from the THP chain 2T in a
large cluster of charges. The variance in the reported distances for such residues is also due to side
chain movements in the models. Additionally to the salt-bridge interactions reported on the Table,
there are other very important hydrophobic interactions in the models obtained. Of special emphasis
is the positioning of the active collagen chain (1T) at the Phe320, which corresponds to the center of
the exosite pocket S’10. The Phe320 was identified as an extremely important exosite, as the mutation
F320Y has been recently reported to decrease the collagenolytic activity down to approximately 10%
(Manka et al., 2012). Also, the 1T chain and interactions with the entrance of the S’10 pocket [Manka
et al., 2012; residues Arg291, Glu293, Arg304, Gln354] are maintained in our HADDOCK model.
The reported models represent quick snapshots of the real state of the interaction. By analyzing
the distances found one has to assume that the real solution for the interaction is an equilibrium state
between the reportedmodels. To generate amore accurate picture of the adduct solution, themeans
of the reported distances were calculated for each model and across the different models. For the
THP·HPX interactions, model 4 has the lowest mean, while model 2 has the highest. The calculated
mean for model 1 is considerably increased because of the Gln354-1T-Gly25 distance. If this interaction
is removed from the mean calculation, the results follows: model 1, 2.4 Å, model 2, 2.8 Å, model 3,
2.4 Å and model 4, 2.2 Å and the similarity between the models is now more evident. Despite the
distance differences in the models across each interaction, the average distance is very similar for
the four models, which supports the previous statement that these models have to be seen has short
snapshots of an “average” interaction. This conclusion will become more evident when analyzing the
interaction at other regions of the domains.
7.2.7.2 The 1T-2T chains adduct with the Catalytic domain
This section reports the interactions that occur between the chain 1T and the surface of the catalytic
domain and unveil how the chain 1T is redirected from the hemopexin domain towards the catalytic
site cleft. Table 7.5 reports interactions found for the four best models and Figure 7.12 depicts the
path taken by chain 1T, which is revealed as being the only chain which interacts with the MMP-1 in
this region of domain interface. Glu209 plays a crucial role on the stabilization of chain 1T at this stage,
interacting closelywith four residues and adopting a configurationwhich is stronglymaintained across
the four models. Moreover, the side chain of Arg21 is further stabilized by the carbonyl of Tyr240 and
the side chain of Thr241. The calculated averages are presented in the same way as for the THP·HPX
interface (Table 7.4) and they further support the fact that the interactions are conserved in the four
models.
7.2.7.3 Chain 1T of THP at the catalytic site
Themost important interactions of the obtainedmodels are those that occur at the catalytic site cleft.
For the presented HADDOCK runs this data was extracted from previously published crystallographic
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Table 7.5: Salt bridge interactions (in Å) between residues on the surface of the catalytic domain and
the THPmolecule for the four bestmodels of theHADDOCK refinement for the runwith the THP “step
4” model.
Residue THP Residues Model 1 Model 2 Model 3 Model 4 Averagedistance
E209(Oε)
1T-G22(HN) 1.7 2.0 1.8 1.7 1.8
1T-R21(NH) 1.8 1.7 1.8 1.7 1.8
1T-Q20(HNε) 1.7 2.2 1.9 1.9 1.9
1T-V23(HN) 2.3 2.2 2.2 3.4 2.5
Y240(O)
1T-R21(HNε) 1.9 1.8 1.8 1.8 1.8
T241(Oγ)
1T-R21(HNη) 2.4 1.9 2.4 2.7 2.4
Average distance 2.0 2.0 2.0 2.2
Figure 7.12: In white, the surface the MMP-1 enzyme. At the bottom left, the hemopexin domain and
at the top right, the catalytic domain. The chain 1T is represented in black ribbon, it spans the surface
of the HPX domain and the interface with the catalytic domain and enters the catalytic site cleft. The
other chains are represented in dark gray.
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Table 7.6: Interactions (in Å) between residues at the catalytic site and the THP chain 1T for the four
best models of the HADDOCK refinement between the THP “step 4” conformation and the MMP-1
complexed conformation.
THP Residue Domain Residue Model 1 Model 2 Model 3 Model 4 Averagedistance
G19(HN) G179(O) 1.7 1.7 1.7 1.9 1.8
A18(HN) P238(O) 2.3 1.9 2.9 2.0 2.3
I17(O) L181(HN) 1.8 1.9 1.8 1.8 1.8
Q15(O) A184(HN) 2.1 2.4 2.7 2.4 2.4
I17(Cδ) V215(Cβ) 4.1 4.1 4.2 4.0 4.1
I17(Cγ2) L281(Cγ) 4.6 4.4 4.4 4.3 4.4
G16(O) Zn(II) 1.8 1.8 1.8 1.8 1.8
Average distance 2.6 2.6 2.8 2.6
studies (Bertini et al., 2006). The models presented here would be strongly validated if the X-ray data
on the proteolyticmechanism is reproducible alongwith all the other paramagnetic and chemical shift
perturbationdatawhich regards the collagenolyticmechanism. Analogously to the above subsections,
Table 7.6 identifies the interactions that take place between chain 1T of the THP and the catalytic
site of MMP-1 and shows that the interactions reported in the literature are maintained in the “step
4” HADDOCK models. Figure 7.13 depicts a zoom at the catalytic site of the four models analyzed.
Gly19(HN)-Gly179(O) and Ile17(O)-Leu181(HN) are kept tightly close across the four models. The same
can be said for the other interactions except formodel 3 that has theAla18(HN)-Pro238(O) andGln15(O)-
Ala184(HN) bridges slightly loosen. Table 7.6 also reports the hydrophobic patch interactions between
residue Ile17 of chain 1T and residues Val215 and Leu281 (site S’1), which are constant across themodels.
At last, the coordinationof the catalytic Zn(II) byGly16(O) is the same in the fourmodels, with adistance
of 1.8 Å. Models 1, 2 and 4 have the same average distance summing all the interactions, and only
model 3 has a higher average, as could be expected from the reasons stated above. In this way, we can
say that the interactions at the catalytic site are verywell conserved across the four bestmodels of the
“step 4” HADDOCK run andwell represent the knowndata on the proteolyticmechanism (summarized
previous in Figure 2.10, Section 2.7.1).
7.2.7.4 Interactions between the unwound chains
It is also very relevant to describe and understand the interactions that take place at the THP chains
upon unwinding as they give further insight on the unwinding mechanism itself. The most easily iden-
tifiable characteristic of the presentedmodels is the position and role of their single arginine residues.
In the collagen and in the THPmolecule, a single Arg residue in present in each chain at the scissile re-
gion; recall that chains are staggered to each other by one residue (Sections 2.7.2.1 and 4.4). As shown
in Table 7.5, Arg21 from chain 1T interacts with residues Tyr240 and Thr241 on the surface of the cat-
alytic domain further stabilizing the complex charges at the Glu209 and helping on guiding the chain
1T towards the catalytic site. The Glu209 charge cluster is also stabilized by the side chain of Arg21
from chain 3T. It is very interesting to realize that the length of the side chain of 3T-Arg21 perfectly
fits the tether of interactions that occur at the hemopexin level and the twist that chain 1T takes for
interacting with the catalytic domain. The side chain of Arg21 of chain 2T interacts with the couple
Glu311/Glu313, forcing the separation of chain 2T from chain 1T and pulling it outside the catalytic do-
main together with chain 3T. One can say that the arginine residues are those residues that less follow
the pattern of amino acids of the THPmolecule, but, it is, nevertheless, revealing that they perfectly fit
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Figure 7.13: A zoom of the catalytic site of MMP-1 with the chain 1T of the THP docked inside after
the “step 4” runs. A) the model with the lowest HADDOCK score, the amino acid residues are labeled
accordingly, in dash the reported interactions, B) 180º rotation of panel A, C) the same view of panel
A but with all the four lowest HADDOCK score models, D) the same as in panel C rotated by 180º.
and strengthen the interactionnetworks that occur between theTHPand theMMP-1 in thebound con-
formation. As previous analyzed by Fields, 1991, (Section 2.7.2.1) the presence of an arginine residue
is essential for the collagenolysis to occur.
The presence of the glutamine residues has also to be considered. Gln20 of chain 1T contributes to
the stabilization of the charge cluster with Glu209 at the entrance of the active site. The Gln20 at chain
3T initiates the tether between chains 2T-3T after the unwinding that occur at the HPX surface. In this
way, Gln20 of chain 3T has a conjugate role with Arg21 of chain 2T. No relevant interaction was found
for Gln20 of chain 2T.
The interactions between chains 2T and 3T at the outside of the catalytic domain are very well
defined in all four models, leading us to conclude that these two chains are well stabilized when the
proteolysis takes place. Here, the role of Gln15 is highlighted. Gln15 from chains 2T and 3T strengthens
the interaction between both chains along the catalytic domain. On the other hand, Gln15 at the P2
site is shown in themodels stabilizing the chain 1T at the S2 site against residues Gln186(Oe) and Ser227
(Oγ), and the rings of His222 and His228.
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7.3 Discussion
Revisiting the work We have obtained and experimetally observed, for the first time, a stable com-
plex in solution between MMP-1 and a collagen analogue (THP) (Section 4.5.1). The combined con-
ditions of inactive MMP-1 (E219A) and 5-fold THP concentration shifted the interaction equilibrium
to a permanent binding state on the NMR time scale. From this state we have acquired pseudocon-
tact shifts and residual dipolar couplings that were induced by the presence of the paramagnetic tag
CLaNP-5 bearing three strongly paramagnetic Lanthanides (4.6.3, Figure 7.1). The tag position was
the same as in the previous projects and is known not to interfere with the binding event. The para-
magnetic Δχ-tensors were recalculated for both domains (Table 7.1). Concordantly, we found that
the RDCs spreading for the hemopexin tensor was consistent with a rigid body, i.e., the two domains
of MMP-1 were holding rigid to a single conformation (Figure 7.2), which allowed us to refine the
hemopexin domain using the strategy developed in the first project (Figure 7.3). With the solution
refined catalytic and hemopexin domains and the paramagnetic data available, it was possible with
CYANA to spatially reorient the domains in order to nicely fit the derived Δχ-tensors, thus obtaining
the model of the MMP-1 conformation when complexed to the THP molecule in the instant prior to
the proteolysis step (Figures 7.4 and 7.5). Four different models of triple helical THP molecule, cor-
responding to four different phases of unwinding (Section 2.7.2.4), were HADDOCKed to the CYANA
derived model of the complexed MMP-1, whose orientation was always imposed by the PCS and RDC
data. A large pool of data derived from previous work was added to the paramagnetic information to
drive the active residues of the THP binding to the MMP-1 surface. The HADDOCK results were con-
clusive, the CYANAMMP-1 domain orientation found for the complex perfectly accepts the unwound
model of the THP (Figure 7.6). In this way, we have obtained here for the first time a model of the
MMP-1·THP interaction at the moment prior to the chain proteolysis, all driven by experimental data.
We can assure that no artifacts from other species interfered with the data because no significant
peaks of free enzymewere found in the 1H-15H-HSQC and IPAP-[1H15N]-HSQC spectra, PCSs and RDCs
measured were clearly from a single species which was not consistent with the free MMP-1 enzyme.
Also, the free MMP-1 samples always showed high level of autoproteolysis at the hinge region, even
at 298 K, but in the presence of THP noMMP-1 degradation was ever observed, which means that the
THP was bound to the enzyme inhibiting the autoproteolysis.
In our model, the inputted THP interactions at the hemopexin level are respected and even favor
the other chain-protein interactions at the catalytic domain surface and active site, creating a vast net-
work of charged and hydrophobic interactions that we have detailed here. Moreover, the THP inter-
acts with the HPX domain concordantly with what has been previously reported for the most relevant
hemopexin exosites in the collagenolytic activity. Our model seems to be in agreement with all the
independent data extracted and published for the collagenolytic mechanism. It also unveiled new in-
formation on the THP residues interaction with the enzyme surface, with special emphasis on the role
of the Arg residues at P’5 position that perfectly stabilize clusters of charges and the position of the
unwound THP chains.
Solution driven model vs X-ray driven model The first crystallographic model of the MMP-1 colla-
gen interaction was obtained recently (Manka et al., 2012). The authors argued that the X-ray model
doesnot represent aproductive interactionbut thatwith slight conformational changeson thedomain
orientation and THP rotation a productive model could be obtained. We compare here the reported
crystallographic model with our solution data driven model.
Firstly, the collagen analogues used are different. For the X-ray model (PDB ID: 4AUO) a 36 amino
acid analogue was used, which contained the target region followed by another specific region at the
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C-terminal (1). Instead, our THP analogue has only a specificity region flanked by GPO groups (2).
(1) - (GPO)3-GPQGLAGQRGIVGL-O-GQRGERGP-O
(2) - (GPO)4-GPQGIAGQRGVVGL-(OGP)4
The triple helix is maintained in the 4AUO model while in our model the triple helix is clearly un-
wound which causes an increase in the curvature performed by the chain. Nevertheless, at the di-
rection of the chains’ edges is the same or very similar which strongly suggested that the unwound
state proposed can occur locally at the surface of the MMP-1 enzyme and still be compatible with a
continuation of the triple helical structure from each edge. The surface of the collagen analogue that
interacts with MMP-1 is therefore much smaller in the X-ray model than in our model, which, as an-
alyzed previously, shows chains 1T and 2T unwound and strongly interacting with the surface of the
hemopexin domain in a pattern that correctly leads the 1T chain through the CAT·HPX interface up to
the catalytic site cleft. The conformation of the unwound THP allows for the three arginine residues
at position P’5 to strategically interact with the MMP-1 surface or other chains of the THP to stabilize
the unwound state, which does not occur in the X-ray model of 4AUO where only the arginine from
chain 1T interacts with the MMP-1 domain interface and the other two have their side-chains facing
the solvent.
Another prominent difference is the domain opening between the two models. Overlapping the
three MMP-1 full length crystallographic models (1SU3, 2CLT and 4AUO) and the solution model to
their hemopexin domains it is clearly observable that X-ray models have virtually the same open-
ing, while, on the contrary, the solution driven model has the catalytic domain displaced towards a
more open position. To measure the apperture of the models, the four were superimposed on their
hemopexin domains and the distances between the Cα of the Lys136 residues were measured taking
the 4AUO model as reference and are as follows: 1.6 Å to the 1SU3, 2.3 Å to 2CLT and 6.7 Å to our
HADDOCK solution model. The similar aperture of the 4AUO model to the X-ray models may lead to
the conclusion that the orientation and position of the domains in the 4AUOmodel does not reflect a
strong interaction with the collagen analogue but simply the standard conformation that is observed
in crystallographic conditions. On the other hand, the more open conformation of the solution model
reflects the large network of interaction with the THPmolecule which include the positioning of chain
1T into the active site, thus, the presence of the THPdrives/influences theMMP-1 to stabilize at amore
open conformation. In conclusion, while the 4AUO model may represent, after some modifications,
the initial steps of the collagenolytic mechanism, our model, obtained with the joint contribution of
several independently obtained data sets, represents the final step of the collagenolytic mechanism,
afterwhich theproteolytic cleavage takesplace and theMMP-1 leaves, the collagen triple helical chain.
We have suggested in the previous Chapter 6 that the back rotationmovement of theMMP-1 from
the elongated conformation to the closed conformation would drive the energy necessary to partially
unwind the triple helical collagen, in similarity towhat had been already proposed by CERM colleagues
and has been again recently proposed by the authors of the 4AUOmodel (Manka et al., 2012). Despite
that there is no experimental information on the transient steps from the free state or initial binding
to the final step, we can say that our model does support the back rotation hypothesis because of
the differences in domain position and orientation from the model of highest MaxOcc value and the
complexedmodel when interacting with the collagenmolecule (Figure 7.7). It is known that the patch
Arg300·Phe301·Phe316 is crucial to force the free MMP-1 to remain into a transient closed state which
is acquired spontaneously with the MMP-1 intrinsic domain movements. With this information and
based on the model drawn in this project, we can say that upon initial binding to the collagen triple
helix, the spontaneous back rotation of the MMP-1 (Bertini et al., 2012c) initiates a cascade of inter-
actions between the enzyme and the substrate that progress, favorable in energy, towards the state
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represented by our model, which is ultimately stabilized by the Arg·Phe·Phe patch. The results from
this work point again to a situation where conformational selection and induced fit have to be invoked
to explain and understand the complexity of the collagenolytic mechanism.
7.4 Conclusion
In this project we functionalized the full length inactive (E219A) MMP-1 enzyme with the tag CLaNP-5
bearing three long range paramagnetic Lanthanide(III) ions. By adjusting the absolute and the relative
concentrations of (Ln)MMP-1 and triple helical peptide substrate (THP), we were able to observe for
the first time in solution the MMP-1·THP complex, which was highly stable, allowing us to extract a
large pool of paramagnetic NMR data. Such data showed that in the complexed form, the MMP-1
acquires a rigid behavior and no longer expressed the intrinsic mobility observed in Chapter 6. Using
PARAMAGNETIC CYANA we were able to determine the orientation of the archetypal domains of the
enzyme when complexed to the THP substrate and use it to dock a previously determined model of
the unwound triple helix. Several other independent data was considered to guide the docking runs,
and at the endwe obtained very high quality models that nicely converge all the inputted data: classic
and paramagnetic NMR restraints and X-ray data. This is the first time that a model of the interaction
between MMP collagenase and a triple helical peptide is produced solely based on empirical data,
and mostly from liquid state experiments. The results obtained here represent the sumit of the two
projects previously presented (Chapters 5 and 6) and open a new path to the understading of the so
long studied collagenolytic mechanism.

Chapter 8
Final Conclusions and Future
Perspectives
Objectives The aim of this project was to study the dynamic behavior of Matrix Metalloproteinase-1
(MMP-1) in solution and to obtain new information on the catalysis performed by this protein on the
lysis of the triple helical collagen molecule. We decided to use paramagnetic NMR strategies in our
approach because these can generate high quality data at the atomic level, which is exclusive from
these techniques.
Strategy For our purposes, we chose the paramagnetic probe CLaNP-5 which could be functional-
ized with several Lanthanide(III) ions endowed with paramagnetic shift capacities of different magni-
tudes, and the respective diamagnetic references. CLaNP-5 is known to have no significant mobility
within the protein frame and to generate large Δχ-tensors. Both features were crucial to correctly
perform the NMRmeasurements because MMP-1 is, indeed, a large molecular weight system. We en-
gineered triplemutants of different constructs ofMMP-1 (H132C/K136C/E219A) towhichweattached
the (Ln)CLaNP-5 tag. Pseudo-contact shifts and residual dipolar couplings were measured in 1H-15N-
HSQC and IPAP-[1H-15N]-HSQC spectra, respectively, for the different (Ln)MMP-1 constructs and the
corresponding Δχ-tensors were calculated. The Maximum Occurrence analysis was used to generate
the 3D map of the conformations that MMP-1 samples when free in solution, and a combination of
PARAMAGNETIC CYANA and HADDOCK were used to produce a model of the MMP-1·THP interaction
in the instant prior to the proteolytic lysis of the collagenolytic mechanism.
Achievements In an initial stepweacquiredparamagneticNMRdata (PCS andRDC) on the truncated
catalytic domain of MMP-1 using different Lanthanide(III) ions. Using such data, we developed a strat-
egy within PARAMAGNETIC CYANA that is capable of refining an X-ray model according to liquid-state
acquired paramagnetic NMR data. In this way, we generated a solution refined model of the catalytic
domain of MMP-1, which can be used to obtain more accurate Δχ-tensors and serves as a basis for
posterior approaches that combine PDB models with solution paramagnetic NMR data.
PCS and RDC were posteriorly acquired on samples of full length (Ln)MMP-1 when free in solution
and when in the presence of 5-fold concentration excess of the triple helical peptide substrate (THP).
The paramagnetic NMR data from the free (Ln)MMP-1was used, alongwith SAXS data, in theMaxi-
mumOccurrence (MaxOcc) analysis. With this method we revealed the 3Dmap of the conformational
space sampled by MMP-1. The map is composed of more than 1,000 conformations, and each of it is
marked with a MaxOcc value, indicating themaximum percentage of time that such conformation can
exist in solution. We found out, in this way, that, before binding the triple helical substrate, MMP-1
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exploresopen conformations, that significantly differ fromtheX-raymodels, and that those conforma-
tions exist for the longest periods of time (up to47%), while closed conformations, such as thoseof the
X-ray models, were calculated to exist only for short periods of time (up to 20 %). Strikingly, the dom-
inant conformations are effective for collagen binding and cleavage, having the hemopexin exosites
exposed to the solvent and the catalytic site cleft posing to the same site as these exosites. Our Max-
Occ results revealed in detail the dynamics ofMMP-1 in solution. It was previously known thatMMP-1,
like mostly other MMPs, have intrinsic and reciprocal flexibility of their catalytic and hemopexin do-
mains, but such have never been described before to an extended detail. With this information on
the prologue steps of the collagenolytic mechanism we could draw new insights on the collagenolytic
mechanism and better explain other data that have been previously published.
The PCS and RDC data obtained for the samples of the MMP-1·THP complex (1:5 concentration
ratio) showed that we were able to obtain stable complexes that were considered permanent on the
NMR time scale. A single MMP-1 conformation (of the CAT·HPX pair), determined with PARAMAG-
NETIC CYANA, could justify the obtained Δχ-tensors, which further indicated the presence of a single
complexed species. The calculated complexedMMP-1 conformation was inputted in HADDOCK along
with amodel of the unwound THPmolecule, which had been generated in a previously publishedwork.
The paramagnetic NMR data, along with classical NMR data and X-ray data were also inputted to drive
the docking calculations. The inputted substrate model was nicely docked to the protein model ac-
cording to all the considered experimental data, and, thus, we obtained a high resolution model of
the MMP-1·THP interaction. The model we generated represents the MMP-1 bound to the unwound
THP molecule and with the scissile peptide chain inside the catalytic site cleft of the catalytic domain
- this is the step prior to the proteolytic lysis. Interestingly, our interaction model consistently agrees
with other published data deriving mainly from mutagenesis analysis. The same HADDOCK calcula-
tions were repeatedwithmodels of the THPmolecule that were not in an unwound conformation and
those gave very poor results. The combination of all the analysis performed strongly supports the ac-
curateness of the model. This is the first time that such a model is presented which is derived from a
large body of independent sets of data, mainly from liquid state measurements.
Learning The projects developed throughout this thesis have used several methodologies which are
vanguard in their respective fields. Therefore, this thesis has, undoubtedly, solidified its use and ap-
plicability.
We have improved the use of paramagnetic NMR restraints by developing amethod to refine X-ray
models. Moreover, this method, which only performs localized changes in the atoms coordinates, can
beused to identify systems inwhich their X-raymodels do not accurately express their state in solution
(as is the case of Calmodulin), thus identifying the systems in which large scale dynamic movements
are crucial in the biological role they play. Potential targets for research in the structural biology field
can be identified in this way.
The conformational 3D map we have generated for MMP-1 completely describes the dynamics of
the free protein. This data has filled a very important gap that existed in the research of MMP-1 activ-
ity, as we now understand that the conformational states which occur for longer periods of time are
those crucial tomaintain the freeMMP-1 enzyme ready to perform its collagenolytic activity. Mutage-
nesis analysis had already proven the relevance of key residues in the flexible linker of MMP-1 to the
collagenolytic process, but with these new results we were able to suggest a very plausible mechanis-
tic reason for such behavior, and we gained, in this way, a better understanding of the catalytic role
played by the flexible hinge region which connects both archetypal domains in the MMP family.
The model of the MMP-1·THP interaction that we have presented shows how a very large body of
independent data can begathered into a single solutionwhich, in our opinion, represents an important
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step into the unification of the literature knowledge regarding the MMP-1 collagenolytic mechanism.
Through the use of paramagnetic NMR techniques it was possible to clearly identify the conformation
acquired by the enzyme in one of the latest moments of the collagen catalysis, and this result, along
with the 3DMaxOccmapping, strongly point to the conclusion that the collagenolytic action ofMMP-1
is regulated firstly by a conformational selection mechanism, at the level of both the substrate triple
helix and the enzyme free state, and secondly by an induced fit mechanism that results from the pas-
sage from the most prevalent conformation in the protein’s free state to the conformation acquired
at the moment of the proteolytic step.
In the future Proteins inwhose structures andX-raymodels suggest large scalemobility of different
blocks (or domains), as is the case of MMPs and Calmodulin, can be proposed for paramagnetic NMR
analysis. The increasing availability of paramagnetic probes and the experience that is being gathered
in the literature and in the projects presented here render the paramagnetic NMR strategies, year
by year, more straightforward. New relevant systems can be refined to their solution models with
the strategy we have presented. Also, in the case that large scale motions are detected, the refined
domains can be used inmore complex strategies that can resolve the intrinsic dynamics of the proteins
under study.
We believe that the conclusions we achieved for MMP-1 with the conformational 3Dmap obtained
with MaxOcc can be extrapolated to virtually all MMPs, and the same strategy used for MMP-1 can
be applied to perform the same kind of studies in any other MMP or protein that may function as a
binary domain system. Understanding the nature of the protein movements in its active, but free,
state has shown to be crucial for the understanding of the mechanistic events that comprehend the
protein action. Therefore, future projects that study a catalytic event dependent on complex domain
movements must not disregard the prologue steps of the catalytic process itself.
A study that could be performed is that of analysingwithMaxOcc the free (Ln)MMP-1 after specific
mutations had been engineered in the hinge region. It would be interesting to understand how the
conformational map changes upon such mutations. This would give further indications on the role of
the linker in the collagenolytic process. The same measurements could be performed in the presence
of compounds that would aim at binding the linker, and thus, the induced effects on the mobility of
MMP-1 could be easily tracked with MaxOcc.
The model of the MMP-1·THP interaction that we have presented is a pioneer step towards the
unification of all the independent data acquired on the collagenolytic process of MMP-1 and MMPs in
general. We foresee thatourmodelwould serveas abasis todevelop counter collagenolytic drugs that
could act simultaneously on the two domains of MMP-1 or between a domain and a substrate chain
or chains. Unfortunately, the model we generated does not contain paramagnetic NMR information
on the actual conformation of the THP molecule. To complete our model, it would be interesting to
add to it paramagnetic NMRdata about the THPmolecule, which could be acquired bymeasuring PCSs
and RDCs in samples of 15N labeled THP in the presence of non-labeled (Ln)MMP-1. Nonetheless, we
strongly believe ourmodel is accurate andprecise because it concordantly unifies several independent
sets of data from different techniques and approaches.
It would be also interesting to study by paramagnetic NMR the interaction between (Ln)MMP-1
and a THP molecule of longer length, to see up to which extent is the obtained MMP-1 complexed
conformation, and the accurateness of the model itself towards the a real collagenolytic situation,
dictated by the length of the THP substrate.
Although such projects are time consuming and cost demanding due to the necessary labellings,
we are positive to think that the peak-lists, the data and the experience amassed during the projects
here presented can significantly boost future projects.

Chapter 9
Appendix
9.1 Peak Lists of the NMR spectra
9.1.1 (Ln)CatMMP-1 Samples
Table 9.1: Peak lists (in ppm) of 1H-15N HSQC spectra for the (Ln)CatMMP-1 samples.
Lu(III) Tb(III) Dy(III) Tm(III) Yb(III)
res 1H 15N res 1H 15N res 1H 15N res 1H 15N res 1H 15N
A128 8.777 117.419 A157 6.500 125.472 A157 6.670 125.643 A157 9.051 127.964 A157 7.966 126.888
A133 8.197 122.332 A184 7.267 120.334 A184 7.261 120.163 A182 8.233 115.453 A182 7.614 115.054
A137 7.580 123.103 D158 6.763 119.801 D158 6.932 119.777 A219 10.734 122.854 A184 8.439 121.802
A157 7.729 126.655 D170 6.605 115.372 D170 6.688 115.406 A258 7.799 121.043 A195 8.823 119.330
A182 7.445 114.860 D175 8.116 115.422 D175 8.190 115.416 D158 9.594 122.603 A219 9.537 121.657
A184 8.226 121.579 D200 8.247 118.049 D194 7.254 121.467 D170 7.826 116.534 A234 7.932 123.781
A195 8.428 118.983 E110 8.706 123.757 D198 7.008 121.312 D175 9.022 116.308 A249 9.815 126.399
A216 9.841 122.982 E119 7.317 126.485 E110 8.753 123.668 D194 9.745 124.579 A258 7.817 121.082
A217 8.469 116.756 E154 6.497 117.054 E119 7.344 125.837 D231 8.660 125.415 D124 9.159 121.970
A219 9.127 121.277 E199 8.948 129.782 E154 6.651 117.184 D251 8.187 114.605 D129 8.136 118.833
A234 8.042 123.900 E201 6.752 114.979 E199 9.115 129.844 E110 9.663 124.506 D158 8.371 121.382
A249 9.967 126.608 F174 7.715 119.885 F174 7.798 119.905 E119 12.303 131.119 D170 7.318 116.071
A258 7.809 121.078 G166 8.879 107.161 G155 7.789 107.012 G155 9.444 108.716 D175 8.639 115.929
C132 8.233 118.630 G176 8.416 110.125 G166 8.968 107.138 G166 9.959 108.353 D194 8.618 123.178
C136 8.643 117.037 G178 11.589 119.675 G176 8.491 110.142 G176 9.240 110.761 D198 8.251 122.667
D124 8.954 121.827 G179 8.539 110.185 G178 11.646 119.679 G179 8.710 110.504 D200 9.050 118.770
D129 7.393 117.587 G192 6.887 105.504 G179 8.580 110.170 G188 6.637 108.499 D231 8.855 125.603
D131 8.658 118.886 G261 8.015 115.487 G192 6.993 105.483 G192 8.560 107.360 D251 8.642 114.995
D158 8.111 121.116 H113 6.894 119.815 I118 6.636 125.435 G193 8.783 120.065 D252 7.051 115.067
D167 9.112 128.082 H168 8.782 124.198 I259 6.942 114.552 G225 9.200 108.297 D254 9.165 119.622
D170 7.201 115.939 L114 7.269 126.008 L114 7.395 125.956 G233 8.068 108.989 E110 9.305 124.338
D175 8.550 115.865 N180 10.718 128.257 L147 6.723 117.380 G255 7.988 107.356 E119 10.243 129.260
D194 8.370 122.886 Q111 7.895 118.100 N180 10.777 128.261 G261 8.147 115.537 E154 7.752 118.343
D198 8.019 122.430 Q156 7.516 117.833 Q111 7.938 118.052 H113 7.917 120.996 E199 10.120 131.044
D200 8.916 118.644 Q186 7.518 117.676 Q156 7.603 117.855 H168 9.977 125.244 E201 7.527 115.605
D231 8.893 125.660 R108 7.319 113.814 R108 7.373 113.697 I118 12.290 131.290 E209 8.331 121.185
D245 7.635 120.646 R165 7.862 116.825 R165 7.985 116.871 I159 10.876 126.301 F149 8.675 119.699
D251 8.748 115.090 R169 7.656 111.183 R169 7.735 111.252 I161 11.711 129.096 F163 9.504 122.519
D252 7.131 115.218 R202 7.739 126.023 R202 7.799 126.060 I232 7.491 124.355 F174 8.391 120.518
D254 9.224 119.668 S172 7.064 114.462 T115 8.175 110.209 I259 7.283 115.062 F185 8.407 120.628
E110 9.205 124.242 T112 7.665 106.692 V164 7.865 115.833 L114 9.531 128.284 F197 9.219 121.985
E119 9.788 128.827 T115 8.020 110.092 W109 7.440 121.480 L147 7.497 118.203 F207 6.712 112.082
E135 8.842 121.950 V164 7.675 115.776 M160 9.432 128.757 G155 8.697 107.938
E154 7.548 118.124 W109 7.365 121.559 N180 11.391 128.991 G166 9.504 107.880
E199 9.937 130.836 W203 8.598 129.466 Q156 9.157 119.530 G176 8.889 110.502
E201 7.398 115.498 Y260 7.632 114.921 Q186 9.152 119.453 G178 11.818 119.804
E209 8.537 121.384 A234 8.444 124.270 Q250 8.628 122.559 G179 8.609 110.339
F138 7.927 114.741 D194 7.080 121.531 Q257 8.765 124.260 G188 5.916 107.810
F149 8.370 119.356 D198 7.087 121.412 R108 8.238 114.912 G190 9.137 111.169
F163 9.160 122.171 E209 9.791 122.725 R165 9.417 118.326 G192 7.856 106.574
F174 8.273 120.397 F185 6.912 119.074 R169 8.743 112.260 G193 7.855 119.059
F185 8.172 120.396 F197 7.015 119.859 S162 11.028 120.460 G221 7.775 106.532
F197 8.862 121.628 G190 8.248 110.406 S223 8.936 119.009 G225 8.341 107.528
F207 7.568 112.793 G225 7.575 106.655 S227 8.861 117.738 G233 8.551 109.568
G155 8.532 107.792 I118 6.498 125.551 T112 8.407 107.444 G255 8.118 107.387
G166 9.394 107.761 I159 7.040 122.779 T115 10.789 113.207 G261 8.130 115.533
G176 8.811 110.445 I232 8.242 125.188 T148 9.033 114.619 H113 7.454 120.412
G178 11.782 119.794 L147 6.728 117.490 T150 10.733 122.672 H168 9.483 124.834
G179 8.594 110.320 L181 8.762 125.355 V152 11.207 124.511 H183 9.028 111.620
G188 5.744 107.662 S162 6.320 115.798 V164 10.322 118.353 H196 9.259 121.191
G190 9.002 111.026 T150 6.910 118.856 W109 8.694 122.747 H222 7.420 119.846
G192 7.700 106.383 Y116 6.254 115.206 Y116 11.174 120.089 I118 9.794 128.997
G193 7.646 118.832 Y260 8.054 115.278 I159 9.242 124.806
G221 7.402 106.212 I161 9.758 127.287
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G225 8.152 107.493 I232 7.819 124.766
G233 8.668 109.726 I253 7.761 119.946
G244 6.141 108.884 I256 8.630 122.565
G255 8.142 107.311 I259 7.166 114.930
G261 8.116 115.532 K151 8.868 130.185
H113 7.351 120.311 L114 8.514 127.239
H168 9.369 124.725 L125 7.305 116.723
H183 8.770 111.404 L147 7.187 117.932
H196 8.934 120.876 L181 9.433 126.041
H213 8.875 119.522 L212 9.234 130.253
H218 7.134 114.439 L220 9.176 114.260
H222 7.148 119.641 L224 7.423 114.214
H228 8.444 117.085 L226 8.305 120.129
I118 9.191 128.403 M160 7.910 127.056
I134 7.925 116.214 N120 8.236 115.137
I159 8.889 124.472 N180 11.078 128.673
I161 9.274 126.833 N211 8.241 123.744
I191 9.074 134.704 Q156 8.459 118.745
I232 7.898 124.858 Q186 8.475 118.607
I253 7.842 120.022 Q250 8.895 122.934
I256 8.614 122.534 Q257 8.824 124.285
I259 7.129 114.869 R108 7.854 114.464
K151 8.398 129.694 R117 8.892 119.870
L114 8.296 127.024 R127 8.937 126.244
L125 7.066 116.533 R165 8.782 117.706
L140 7.319 117.494 R169 8.296 111.821
L147 7.104 117.822 R202 7.923 126.299
L181 9.324 125.946 R208 7.508 122.762
L212 8.919 129.958 S142 9.634 117.859
L220 8.614 113.774 S153 9.024 116.429
L224 7.147 113.920 S162 9.055 118.589
L226 8.154 120.042 S172 7.739 114.970
L235 12.232 132.668 S223 7.955 118.026
L248 8.469 120.210 S227 8.539 117.405
M160 7.571 126.691 T112 8.077 107.060
M236 8.560 112.139 T115 9.579 111.849
N120 7.826 114.775 T145 7.575 111.176
N143 7.965 116.234 T148 8.367 113.837
N171 7.480 112.734 T150 9.019 121.052
N180 11.015 128.600 T204 9.349 112.027
N205 8.372 117.443 T230 8.608 114.725
N206 7.874 119.114 V130 9.006 125.697
N211 8.399 123.783 V144 7.165 106.009
Q111 8.388 118.489 V152 9.191 122.758
Q139 8.170 118.581 V164 9.219 117.283
Q156 8.299 118.635 W109 8.144 122.209
Q186 8.301 118.396 W141 7.414 115.999
Q247 8.397 124.523 W203 9.372 130.135
Q250 9.062 123.185 Y116 9.042 117.962
Q257 8.826 124.284 Y121 8.760 114.937
R108 7.771 114.363 Y210 8.189 124.123
R117 8.416 119.226 Y237 8.058 128.615
R127 8.687 125.884 Y260 7.907 115.156
R165 8.629 117.567
R169 8.190 111.722
R202 7.883 126.235
R208 8.016 123.221
R214 8.718 117.535
S142 9.219 117.589
S153 8.780 116.074
S162 8.629 118.112
S172 7.635 114.894
S223 7.645 117.758
S227 8.463 117.333
S229 7.143 114.593
S239 8.179 116.471
T112 7.998 106.979
T115 9.312 111.558
T145 7.583 111.192
T148 8.218 113.703
T150 8.656 120.656
T204 9.293 111.943
T230 8.620 114.747
T241 6.848 119.774
V130 7.737 124.096
V144 7.188 106.053
V152 8.760 122.420
V164 8.967 117.083
V215 8.274 119.808
V246 8.409 123.903
W109 8.021 122.150
W141 6.827 115.633
W203 9.243 130.017
Y116 8.588 117.521
Y121 8.427 114.529
Y210 8.210 124.173
Y237 8.079 128.607
Y240 9.241 127.008
Y260 7.864 115.136
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Table 9.2: Peak list (in ppm) of the IPAP-[15N, 1H]-HSQC spectra for the (Ln)CatMMP-1 samples, at 700
MHz.
Lu(III) Tb(III) Dy(III) Tm(III)
Downfield Downfield Downfield Downfield
res 1H 15N res 1H 15N res 1H 15N res 1H 15N
A128 8.780 116.759 A157 6.506 126.058 A184 7.265 119.592 A157 9.060 127.204
A133 8.195 121.648 D158 6.775 120.454 D158 6.936 119.066 D170 7.832 115.865
A157 7.729 125.996 D170 6.606 115.996 D170 6.688 114.775 D194 9.751 124.108
A182 7.445 114.255 D175 8.108 116.150 D175 8.195 114.717 G192 8.565 106.839
A184 8.227 120.926 D200 8.265 118.733 D194 7.248 120.602 G261 8.151 114.806
A195 8.432 118.322 E199 8.965 130.518 D198 6.995 120.661 H113 7.920 120.470
A216 9.844 122.331 E201 6.769 115.553 E110 8.754 122.975 I232 7.499 123.528
A217 8.462 116.123 G166 8.875 107.869 E154 6.649 116.597 I259 7.282 114.523
A219 9.127 120.619 G176 8.412 110.698 E199 9.109 129.038 L114 9.532 127.809
A234 8.040 123.243 G178 11.589 120.273 G155 7.783 106.401 L147 7.505 117.468
A249 9.967 125.940 G179 8.539 110.806 G166 8.964 106.431 Q156 9.177 118.786
A258 7.812 120.381 G192 6.898 106.176 G176 8.491 109.615 Q186 9.149 118.790
D124 8.956 121.161 G261 8.009 116.078 G178 11.645 119.108 Q257 8.774 123.556
D129 7.394 116.952 H113 6.895 120.498 G192 6.992 104.772 R108 8.243 114.419
D131 8.661 118.210 H168 8.794 124.825 L114 7.393 125.126 R169 8.750 111.463
D158 8.110 120.470 L114 7.269 126.747 L147 6.715 116.837 S223 8.941 118.272
D170 7.205 115.318 N180 10.703 129.001 N180 10.776 127.467 T115 10.786 112.751
D175 8.553 115.218 Q111 7.895 118.694 Q111 7.937 117.449 W109 8.704 122.219
D194 8.372 122.223 Q156 7.515 118.401 Q156 7.607 117.316 Y260 8.083 114.642
D198 8.018 121.748 Q186 7.507 118.359 R108 7.373 113.042
D200 8.916 118.006 R108 7.332 114.502 R165 7.986 116.240
D231 8.893 124.999 R165 7.865 117.497 R169 7.733 110.697 Upfield
D245 7.638 119.948 R169 7.656 111.813 T115 8.175 109.387 res 1H 15N
D251 8.747 114.448 R202 7.747 126.597 V164 7.865 115.246 A157 9.062 128.619
D254 9.225 119.021 S172 7.061 115.018 W109 7.446 120.723 A258 7.818 121.741
E110 9.206 123.554 T112 7.649 107.149 D170 7.834 117.206
E119 9.789 128.163 V164 7.691 116.394 D194 9.751 125.309
E154 7.548 117.478 Y260 7.638 115.586 Upfield G192 8.560 108.004
E199 9.936 130.151 res 1H 15N G261 8.150 116.249
E201 7.397 114.848 A184 7.264 120.712 H113 7.926 121.569
E209 8.539 120.740 Upfield D158 6.932 120.534 I232 7.498 125.102
F149 8.379 118.698 res 1H 15N D170 6.688 116.034 I259 7.289 115.717
F163 9.149 121.526 A157 6.500 124.804 D175 8.190 116.167 L114 9.527 128.776
F174 8.268 119.751 D158 6.773 119.057 D194 7.251 122.293 L147 7.510 118.908
F185 8.172 119.762 D170 6.615 114.748 D198 7.002 121.951 Q257 8.779 124.847
F197 8.868 121.002 D175 8.108 114.793 E110 8.755 124.421 R108 8.243 115.536
G155 8.532 107.125 D200 8.269 117.320 E154 6.648 117.784 R169 8.743 112.950
G166 9.401 107.098 E199 8.962 128.898 E199 9.110 130.629 S223 8.942 119.666
G176 8.810 109.768 E201 6.757 114.444 G155 7.784 107.651 T115 10.783 113.693
G178 11.778 119.127 G166 8.857 106.281 G166 8.968 107.883 W109 8.701 123.279
G179 8.591 109.658 G176 8.412 109.636 G176 8.491 110.725 Y260 8.072 115.907
G188 5.752 107.047 G178 11.590 119.127 G178 11.644 120.245
G192 7.701 105.738 G179 8.526 109.470 G192 6.990 106.223
G193 7.652 118.175 G192 6.893 104.678 L114 7.374 126.757
G221 7.406 105.538 G261 8.019 114.893 L147 6.717 117.996
G233 8.668 109.075 H113 6.895 119.030 N180 10.774 128.973
G261 8.113 114.878 H168 8.810 123.607 Q111 7.936 118.663
H113 7.350 119.671 L114 7.246 125.050 Q156 7.605 118.449
H168 9.369 124.096 N180 10.712 127.472 R108 7.375 114.470
H183 8.771 110.765 Q111 7.895 117.487 R165 7.988 117.583
H196 8.936 120.212 Q156 7.517 117.370 R169 7.730 111.835
H222 7.153 118.961 Q186 7.505 117.261 T115 8.175 111.027
I118 9.190 127.742 R108 7.320 113.035 V164 7.863 116.505
I159 8.889 123.808 R165 7.864 116.162 W109 7.437 122.255
I161 9.270 126.155 R169 7.668 110.669
I232 7.900 124.186 R202 7.743 125.495
I253 7.845 119.353 S172 7.070 113.965
I256 8.616 121.871 V164 7.690 115.163
K151 8.398 129.031 Y260 7.638 114.311
L114 8.298 126.364
L125 7.068 115.880
L140 7.340 116.800
L147 7.107 117.169
L181 9.324 125.290
L212 8.924 129.272
L220 8.617 113.124
L224 7.149 113.287
L226 8.155 119.379
L235 12.233 132.056
L248 8.470 119.590
M160 7.570 126.018
M236 8.563 111.544
N120 7.824 114.139
N143 7.964 115.562
N180 11.016 127.945
N206 7.877 118.457
Q111 8.385 117.861
Q250 9.064 122.430
Q257 8.828 123.618
R108 7.769 113.703
R127 8.685 125.217
R165 8.633 116.917
R169 8.192 111.061
R202 7.887 125.595
R208 8.015 122.567
R214 8.721 116.844
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S162 8.632 117.428
S172 7.634 114.295
S223 7.644 117.079
S227 8.463 116.675
T112 7.998 106.333
T115 9.316 110.899
T145 7.582 110.557
T148 8.220 113.047
T150 8.660 120.014
T204 9.295 111.347
T230 8.619 114.079
T241 6.849 119.099
V130 7.737 123.442
V144 7.194 105.450
V152 8.761 121.748
V164 8.970 116.396
V215 8.283 119.127
W109 8.017 121.456
W141 6.826 114.982
W203 9.242 129.320
Y116 8.588 116.852
Y121 8.424 113.897
Y210 8.211 123.560
Y237 8.080 127.957
Y260 7.867 114.493
Upfield
res 1H 15N
A128 8.780 118.083
A133 8.196 122.975
A157 7.729 127.307
A182 7.445 115.540
A184 8.227 122.234
A195 8.430 119.630
A216 9.843 123.661
A219 9.127 121.943
A234 8.040 124.571
A249 9.967 127.254
A258 7.812 121.716
D124 8.957 122.472
D129 7.394 118.246
D131 8.663 119.534
D158 8.110 121.805
D170 7.204 116.619
D175 8.554 116.468
D194 8.371 123.564
D198 8.020 123.077
D200 8.916 119.337
D231 8.894 126.323
D245 7.638 121.259
D251 8.747 115.766
D254 9.226 120.345
E110 9.203 124.865
E119 9.789 129.496
E154 7.549 118.779
E199 9.936 131.489
E201 7.397 116.149
E209 8.541 122.058
F149 8.380 120.009
F163 9.158 122.831
F174 8.270 121.048
F185 8.172 121.093
F197 8.867 122.316
F207 7.571 113.453
G155 8.535 108.456
G166 9.400 108.436
G176 8.813 111.126
G178 11.779 120.427
G179 8.592 110.999
G188 5.755 108.360
G192 7.701 107.082
G193 7.653 119.505
G221 7.404 106.874
G233 8.667 110.386
G261 8.114 116.203
H113 7.350 120.969
H168 9.369 125.377
H183 8.772 112.088
H196 8.937 121.521
H222 7.153 120.260
I118 9.192 129.053
I159 8.889 125.122
I161 9.272 127.479
I232 7.898 125.497
I253 7.847 120.663
I256 8.616 123.207
K151 8.399 130.347
L114 8.298 127.695
L125 7.069 117.190
L140 7.340 118.136
L147 7.107 118.480
L181 9.324 126.587
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L212 8.924 130.622
L220 8.615 114.445
L224 7.150 114.606
L226 8.153 120.695
L235 12.232 133.348
L248 8.471 120.886
M160 7.573 127.346
M236 8.563 112.844
N120 7.824 115.455
N143 7.965 116.876
N180 11.017 129.245
N206 7.877 119.777
Q111 8.386 119.153
Q250 9.059 123.755
Q257 8.827 124.949
R108 7.770 115.014
R127 8.688 126.513
R165 8.634 118.222
R169 8.194 112.386
R202 7.885 126.889
R208 8.014 123.898
R214 8.721 118.182
S162 8.631 118.756
S172 7.634 115.597
S223 7.646 118.415
S227 8.463 117.961
T112 7.998 107.635
T115 9.316 112.235
T145 7.582 111.873
T148 8.219 114.377
T150 8.660 121.324
T204 9.295 112.650
T230 8.619 115.392
T241 6.847 120.415
V130 7.737 124.758
V144 7.194 106.732
V152 8.762 123.067
V164 8.971 117.713
V215 8.276 120.462
W109 8.019 122.780
W141 6.826 116.298
W203 9.242 130.659
Y116 8.588 118.183
Y121 8.425 115.197
Y210 8.212 124.832
Y237 8.081 129.284
Y260 7.867 115.781
Table 9.3: Peak list (in ppm) of the IPAP-[15N, 1H]-HSQC spectra for the (Ln)CatMMP-1 samples, at 900
MHz.
Lu(III) Yb(III)
Downfield Downfield
res 1H 15N res 1H 15N
A128 8.777 116.893 A128 9.117 117.354
A133 8.199 121.753 A157 7.962 126.270
A157 7.731 126.125 A182 7.631 114.395
A182 7.452 114.389 A184 8.434 121.256
A184 8.228 121.076 A195 8.827 118.699
A195 8.436 118.466 A216 10.605 123.068
A216 9.844 122.458 A219 9.533 121.104
A219 9.128 120.756 A234 7.934 123.151
A234 8.043 123.378 A249 9.823 125.844
A249 9.973 126.065 A258 7.818 120.403
A258 7.815 120.501 D124 9.148 121.460
D124 8.960 121.269 D129 8.152 118.141
D129 7.399 117.083 D158 8.373 120.827
D131 8.666 118.350 D170 7.317 115.456
D158 8.114 120.610 D175 8.637 115.393
D170 7.208 115.441 D194 8.609 122.614
D175 8.558 115.340 D198 8.248 122.064
D194 8.374 122.347 D200 9.046 118.207
D198 8.023 121.894 D231 8.852 125.005
D200 8.923 118.137 D251 8.641 114.415
D231 8.898 125.130 D252 7.054 114.607
D245 7.644 120.103 D254 9.157 119.011
D251 8.747 114.574 E110 9.298 123.722
D254 9.229 119.160 E119 10.238 128.608
E110 9.204 123.688 E154 7.748 117.737
E119 9.790 128.302 E199 10.106 130.492
E154 7.553 117.618 E201 7.521 114.999
E199 9.935 130.270 E209 8.332 120.558
E201 7.402 114.976 F149 8.662 119.175
E209 8.546 120.890 F163 9.500 121.959
F149 8.385 118.833 F174 8.370 119.904
F163 9.162 121.694 F185 8.418 120.035
F174 8.272 119.885 F197 9.215 121.397
F185 8.174 119.899 F207 6.724 111.431
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F197 8.872 121.144 G155 8.692 107.338
F207 7.573 112.295 G166 9.497 107.341
G155 8.532 107.256 G176 8.887 109.855
G166 9.406 107.243 G178 11.802 119.144
G176 8.813 109.904 G179 8.599 109.783
G178 11.779 119.243 G188 5.909 107.276
G179 8.593 109.776 G190 9.128 110.554
G188 5.759 107.168 G192 7.854 106.008
G192 7.706 105.881 G193 7.856 118.434
G193 7.659 118.319 G221 7.788 105.999
G221 7.409 105.681 G225 8.345 106.975
G233 8.673 109.193 G233 8.549 108.976
G261 8.110 115.005 G255 8.120 106.832
H113 7.345 119.851 G261 8.130 114.930
H168 9.373 124.212 H113 7.444 119.880
H183 8.778 110.929 H168 9.474 124.203
H196 8.940 120.336 H183 9.034 111.079
H222 7.158 119.083 H196 9.257 120.569
I118 9.188 127.865 H222 7.425 119.300
I159 8.897 123.953 I118 9.785 128.357
I161 9.271 126.273 I159 9.237 124.208
I232 7.895 124.301 I161 9.753 126.591
I253 7.849 119.475 I191 9.215 134.337
I256 8.616 121.997 I232 7.813 124.105
K151 8.397 129.146 I253 7.753 119.356
L114 8.305 126.510 I256 8.619 121.937
L125 7.074 116.018 K151 8.854 129.640
L140 7.339 116.962 L114 8.508 126.708
L147 7.115 117.332 L125 7.298 116.166
L181 9.322 125.418 L147 7.194 117.311
L212 8.929 129.414 L181 9.560 124.944
L220 8.621 113.263 L220 9.189 113.698
L224 7.158 113.452 L224 7.430 113.671
L226 8.160 119.506 L226 8.301 119.562
L235 12.232 132.180 L235 12.145 131.904
L248 8.469 119.720 L248 8.105 119.302
M160 7.575 126.159 M160 7.905 126.478
M236 8.573 111.672 N120 8.233 114.543
N120 7.828 114.265 N180 11.066 128.015
N143 7.964 115.657 N206 7.221 117.663
N180 11.021 128.065 N211 8.246 123.137
N206 7.882 118.582 Q111 8.312 117.876
Q111 8.384 117.971 Q156 8.450 118.185
Q156 8.299 118.155 Q186 8.470 117.973
Q186 8.305 117.917 Q250 8.883 122.330
Q250 9.058 122.532 Q257 8.816 123.716
Q257 8.830 123.751 R108 7.852 113.895
R108 7.767 113.820 R117 8.889 119.248
R127 8.688 125.311 R127 8.926 125.586
R165 8.630 117.046 R165 8.769 117.133
R169 8.197 111.198 R169 8.292 111.198
R202 7.889 125.705 R202 7.923 125.651
R208 8.018 122.690 R208 7.513 122.175
R214 8.726 116.988 S142 9.614 117.141
S162 8.635 117.571 S153 9.018 115.780
S172 7.636 114.414 S162 9.060 117.898
S223 7.655 117.262 S172 7.736 114.373
S227 8.464 116.797 S223 7.967 117.531
T112 8.001 106.493 S227 8.527 116.806
T115 9.315 111.022 T112 8.064 106.387
T145 7.588 110.714 T115 9.570 111.315
T148 8.222 113.234 T145 7.579 110.681
T150 8.664 120.147 T148 8.363 113.334
T204 9.297 111.477 T150 9.014 120.500
T230 8.620 114.199 T204 9.343 111.396
T241 6.852 119.272 T230 8.598 114.061
V130 7.742 123.563 V130 9.007 125.036
V144 7.201 105.600 V144 7.161 105.354
V152 8.764 121.875 V152 9.183 122.149
V164 8.974 116.535 V164 9.205 116.673
V215 8.280 119.255 W109 8.143 121.674
W109 8.021 121.578 W141 7.404 115.375
W141 6.832 115.117 W203 9.375 129.522
W203 9.240 129.457 Y116 9.037 117.367
Y116 8.597 116.993 Y121 8.750 114.359
Y121 8.424 114.037 Y210 8.183 123.475
Y210 8.213 123.660 Y237 8.059 128.023
Y237 8.085 128.079 Y260 7.901 114.569
Y260 7.873 114.629
Upfield
Upfield res 1H 15N
res 1H 15N A128 9.118 118.413
A128 8.777 117.919 A157 7.963 127.308
A133 8.199 122.780 A182 7.633 115.449
A157 7.731 127.140 A184 8.435 122.335
A182 7.452 115.391 A195 8.827 119.770
A184 8.227 122.092 A216 10.608 124.071
A195 8.437 119.478 A219 9.532 122.123
A216 9.844 123.500 A234 7.934 124.198
A219 9.128 121.790 A249 9.820 126.773
A234 8.043 124.418 A258 7.818 121.473
A249 9.972 127.091 D124 9.149 122.455
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A258 7.814 121.539 D129 8.155 119.163
D124 8.958 122.303 D158 8.373 121.822
D129 7.400 118.095 D170 7.317 116.479
D131 8.664 119.386 D175 8.637 116.305
D158 8.114 121.650 D194 8.609 123.569
D170 7.208 116.455 D198 8.248 123.111
D175 8.558 116.318 D200 9.046 119.199
D194 8.374 123.397 D231 8.853 126.077
D198 8.023 122.926 D251 8.643 115.452
D200 8.924 119.179 D252 7.054 115.524
D231 8.898 126.166 D254 9.157 120.057
D245 7.644 121.107 E110 9.298 124.708
D251 8.748 115.600 E119 10.238 129.693
D254 9.230 120.197 E154 7.748 118.783
E110 9.205 124.708 E199 10.107 131.458
E119 9.790 129.335 E201 7.522 116.058
E154 7.553 118.630 E209 8.332 121.633
E199 9.935 131.327 F149 8.661 120.092
E201 7.402 115.990 F163 9.500 123.012
E209 8.546 121.910 F174 8.370 120.943
F149 8.385 119.851 F185 8.418 121.116
F163 9.162 122.696 F197 9.217 122.476
F174 8.270 120.889 F207 6.732 112.375
F185 8.176 120.929 G155 8.692 108.394
F197 8.871 122.167 G166 9.497 108.336
F207 7.570 113.303 G176 8.888 110.964
G155 8.532 108.292 G178 11.802 120.190
G166 9.406 108.279 G179 8.599 110.822
G176 8.813 110.952 G188 5.909 108.282
G178 11.779 120.248 G190 9.128 111.651
G179 8.593 110.828 G192 7.854 107.017
G188 5.758 108.191 G193 7.857 119.525
G192 7.706 106.923 G221 7.787 107.051
G193 7.659 119.357 G225 8.345 108.022
G221 7.408 106.731 G233 8.549 110.037
G233 8.672 110.221 G255 8.120 107.874
G261 8.114 116.045 G261 8.130 115.984
H113 7.345 120.862 H113 7.444 120.848
H168 9.370 125.219 H168 9.474 125.261
H183 8.778 111.961 H183 9.036 112.161
H196 8.941 121.364 H196 9.256 121.649
H222 7.158 120.109 H222 7.425 120.339
I118 9.188 128.878 I118 9.785 129.388
I159 8.897 124.975 I159 9.237 125.212
I161 9.271 127.293 I161 9.753 127.661
I232 7.896 125.328 I191 9.214 135.295
I253 7.846 120.499 I232 7.813 125.179
I256 8.616 123.036 I253 7.752 120.354
K151 8.397 130.178 I256 8.619 122.929
L114 8.306 127.554 K151 8.854 130.584
L125 7.074 117.038 L114 8.508 127.663
L140 7.341 117.980 L125 7.298 117.131
L147 7.113 118.350 L147 7.194 118.361
L181 9.320 126.417 L181 9.559 125.928
L212 8.929 130.447 L220 9.190 114.671
L220 8.621 114.299 L224 7.430 114.689
L224 7.157 114.476 L226 8.300 120.616
L226 8.157 120.551 L235 12.145 132.972
L235 12.232 133.172 L248 8.106 120.340
L248 8.469 120.742 M160 7.906 127.476
M160 7.575 127.189 N120 8.233 115.597
M236 8.574 112.709 N180 11.066 128.977
N120 7.828 115.293 N206 7.219 118.622
N143 7.964 116.703 N211 8.247 124.208
N180 11.020 129.092 Q111 8.315 118.882
N206 7.884 119.622 Q156 8.448 119.268
Q111 8.384 118.981 Q186 8.470 118.995
Q156 8.300 119.174 Q250 8.884 123.332
Q186 8.304 118.937 Q257 8.816 124.754
Q250 9.056 123.566 R108 7.852 114.875
Q257 8.830 124.788 R117 8.889 120.283
R108 7.768 114.842 R127 8.926 126.645
R127 8.686 126.339 R165 8.769 118.143
R165 8.631 118.060 R169 8.292 112.255
R169 8.195 112.224 R202 7.924 126.718
R202 7.888 126.723 R208 7.513 123.253
R208 8.017 123.718 S142 9.614 118.210
R214 8.725 118.019 S153 9.018 116.846
S162 8.634 118.609 S162 9.060 118.992
S172 7.636 115.434 S172 7.736 115.451
S223 7.656 118.288 S223 7.969 118.539
S227 8.463 117.798 S227 8.526 117.826
T112 8.002 107.492 T112 8.064 107.449
T115 9.315 112.055 T115 9.570 112.262
T145 7.582 111.750 T145 7.579 111.725
T148 8.223 114.274 T148 8.363 114.289
T150 8.665 121.174 T150 9.015 121.447
T204 9.297 112.488 T204 9.343 112.449
T230 8.620 115.219 T230 8.598 115.118
T241 6.855 120.268 V130 9.007 126.117
V130 7.741 124.573 V144 7.160 106.336
V144 7.200 106.587 V152 9.183 123.221
V152 8.763 122.906 V164 9.205 117.723
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V164 8.974 117.562 W109 8.143 122.638
V215 8.281 120.266 W141 7.405 116.418
W109 8.020 122.596 W203 9.375 130.561
W141 6.832 116.139 Y116 9.037 118.385
W203 9.240 130.498 Y121 8.750 115.402
Y116 8.597 118.024 Y210 8.182 124.479
Y121 8.424 115.038 Y237 8.059 128.991
Y210 8.212 124.650 Y260 7.901 115.573
Y237 8.084 129.113
Y260 7.872 115.642
9.1.2 (Ln)MMP-1 Full Length
Table 9.4: Peak list (in ppm) of the 1H-15N HSQC spectra for the free (Ln)MMP-1 full length.
Lu(III) Tb(III) Dy(III) Tm(III)
res 1H 15N res 1H 15N res 1H 15N res 1H 15N
A157 7.720 126.474 A157 6.523 125.314 A157 6.667 125.422 A157 8.993 127.689
A182 7.437 114.835 A277 8.057 123.745 A335 9.374 130.516 A182 8.372 115.924
A184 8.236 121.687 A286 7.873 118.735 A394 8.457 118.725 A335 9.271 130.426
A195 8.422 119.022 A335 9.388 130.525 A428 7.993 119.673 A394 8.436 118.795
A216 9.844 123.109 A394 8.453 118.745 A460 8.439 124.839 A428 8.008 119.748
A234 8.042 123.887 A428 8.011 119.703 D170 6.676 115.420 A460 8.384 124.797
A249 9.893 125.959 A460 8.448 124.855 D279 7.635 122.518 C278 7.745 107.893
A277 8.082 123.907 D170 6.606 115.291 D336 8.088 116.441 D158 9.559 122.633
A286 7.875 118.740 D200 8.316 117.845 D338 8.096 120.480 D170 7.822 116.390
A330 7.835 116.950 D279 7.644 122.490 D401 7.764 127.123 D194 9.742 124.641
A335 9.334 130.507 D336 8.101 116.436 D448 8.437 127.926 D231 8.870 125.687
A379 8.013 118.333 D338 8.100 120.493 E333 7.899 121.861 D279 7.404 122.271
A380 8.940 124.114 D363 8.183 117.561 E383 9.211 130.619 D336 8.002 116.333
A394 8.461 118.812 D401 7.768 127.128 E384 8.240 129.190 D338 7.930 120.292
A416 9.068 117.697 D418 6.827 115.815 F174 7.768 119.949 D363 8.258 117.580
A428 8.024 119.740 D448 8.426 127.972 F284 9.274 114.332 D401 7.749 127.099
A460 8.386 124.778 E154 6.583 117.170 F308 8.561 116.501 D448 8.410 127.884
D124 8.947 121.805 E333 7.915 121.905 F370 6.391 115.432 E313 8.319 129.008
D131 8.669 118.547 E383 9.191 130.650 F391 8.713 118.881 E333 7.757 121.718
D170 7.201 115.929 E384 8.242 129.196 F436 8.861 119.225 E383 9.172 130.578
D194 8.383 122.966 F284 9.289 114.320 F439 8.993 119.232 E384 8.228 129.144
D231 8.845 125.556 F297 8.826 117.901 F447 9.856 131.708 F284 9.051 114.132
D251 8.758 115.121 F308 8.568 116.612 F464 7.323 116.484 F334 9.376 128.555
D252 7.106 115.233 F342 8.727 119.327 G155 7.808 107.180 F342 8.607 119.214
D254 9.212 119.444 F343 8.830 119.417 G176 8.440 110.160 F370 6.454 115.523
D279 7.546 122.415 F370 6.402 115.403 G178 11.600 119.660 F391 8.701 118.943
D299 10.219 129.010 F391 8.725 118.881 G179 8.530 110.190 F430 7.859 118.535
D336 8.049 116.416 F392 9.398 122.142 G192 6.991 105.563 F435 7.882 117.210
D338 8.031 120.408 F435 7.851 117.076 G292 9.400 106.321 F436 8.825 119.175
D363 8.206 117.577 F436 8.858 119.248 G353 9.650 118.229 F438 8.716 120.235
D401 7.764 127.123 F439 9.007 119.279 G387 8.469 110.375 F447 9.798 131.586
D448 8.437 127.915 F447 9.848 131.730 G423 7.428 107.862 F464 7.184 116.365
E110 9.244 124.185 F464 7.332 116.439 G434 8.596 102.122 G155 9.379 108.684
E119 9.795 128.779 G155 7.704 107.098 I454 8.466 121.239 G166 9.965 108.406
E154 7.548 118.159 G176 8.380 110.102 K281 8.628 120.869 G179 8.779 110.448
E199 9.941 130.763 G178 11.550 119.754 K347 7.893 118.939 G188 6.567 108.498
E201 7.387 115.478 G179 8.525 110.309 K388 7.751 115.524 G192 8.540 107.386
E209 8.516 121.318 G190 8.280 110.352 K404 8.813 120.373 G255 8.012 107.236
E293 7.879 119.915 G192 6.880 105.597 K432 8.896 124.796 G292 9.226 106.142
E311 7.888 119.535 G292 9.416 106.236 K450 8.062 117.709 G327 7.848 109.046
E313 8.421 129.004 G353 9.660 118.279 L114 7.399 125.647 G353 9.309 117.993
E333 7.838 121.799 G387 8.468 110.281 L282 7.304 123.550 G387 8.454 110.375
E383 9.201 130.668 G410 8.182 109.076 L455 9.252 128.439 G410 8.166 109.095
E384 8.237 129.205 G423 7.411 107.856 L457 8.200 126.452 G423 7.388 107.841
F149 8.382 119.346 G434 8.598 102.142 M295 8.630 126.254 G434 8.585 102.111
F174 8.268 120.394 H113 6.863 119.424 M303 9.219 118.358 H113 7.846 120.496
F185 8.179 120.577 I290 8.662 118.245 M407 8.995 125.416 H168 9.938 125.180
F197 8.871 121.712 I415 8.565 125.833 M431 8.858 120.795 I159 10.777 126.303
F207 7.561 112.819 I454 8.463 121.243 N385 9.126 115.544 I232 7.501 124.317
F284 9.207 114.234 K281 8.624 120.881 N395 8.367 116.306 I259 7.325 114.876
F297 8.840 117.952 K347 7.898 118.910 N465 8.231 117.073 I290 8.444 118.050
F308 8.457 116.407 K388 7.745 115.544 Q111 7.936 117.927 I454 8.443 121.272
F320 7.212 120.939 K404 8.819 120.408 Q458 9.045 123.888 K347 7.973 118.995
F342 8.727 119.362 K432 8.897 124.754 R108 7.400 113.731 K388 7.728 115.471
F343 8.825 119.562 K450 8.061 117.716 R165 7.944 116.959 K432 8.846 124.743
F370 6.416 115.516 K459 8.601 120.269 R169 7.715 111.298 K450 8.047 117.759
F391 8.713 119.051 L114 7.402 125.647 R291 10.511 130.912 K459 8.546 120.320
F430 7.902 118.504 L282 7.309 123.577 R337 6.383 112.900 L282 7.063 123.276
F435 7.852 117.072 L324 7.325 120.415 R341 8.920 125.968 L324 7.332 120.384
F436 8.853 119.211 L328 8.410 121.166 R453 6.590 114.553 L357 8.086 129.512
F438 8.769 120.384 L357 8.249 129.820 S382 8.697 118.195 L455 9.226 128.393
F439 8.993 119.263 L381 8.163 115.990 T115 8.145 110.177 L457 8.145 126.374
F447 9.859 131.639 L455 9.250 128.455 T289 7.060 114.794 M295 8.417 126.077
F464 7.274 116.457 L457 8.193 126.434 T386 7.856 107.788 M303 9.021 118.311
G155 8.522 107.853 M295 8.641 126.346 T389 9.347 122.286 N326 7.444 110.491
G166 9.401 107.757 M303 9.229 118.276 T451 6.878 105.624 N385 9.148 115.592
G176 8.804 110.442 M407 8.981 125.391 T456 7.208 109.115 N395 8.371 116.286
G178 11.796 119.772 N180 10.671 128.316 V164 7.829 115.866 N465 8.081 116.994
G179 8.587 110.286 N326 7.448 110.530 V294 8.439 120.790 Q111 8.907 118.764
G188 5.725 107.626 N385 9.122 115.553 V312 8.525 123.693 Q156 9.099 119.584
G190 8.989 111.109 N395 8.362 116.299 V351 9.092 117.826 Q186 9.110 119.328
G192 7.705 106.417 N465 8.226 117.028 V374 7.773 123.881 Q458 9.035 123.839
G193 7.648 118.823 Q111 7.906 117.884 V429 8.562 119.080 R108 8.263 114.823
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G221 7.419 106.333 Q156 7.528 117.954 Y332 9.106 115.364 R165 9.428 118.245
G225 8.213 107.871 Q186 7.540 117.743 Y365 7.568 124.913 R169 8.720 112.218
G233 8.662 109.736 Q323 8.296 113.709 Y390 8.992 125.747 R300 7.552 121.686
G255 8.145 107.227 Q458 9.142 123.905 Y403 8.122 117.130 R337 6.266 112.726
G292 9.329 106.238 R108 7.365 113.706 Y445 9.711 126.554 R341 8.728 125.720
G327 7.843 109.082 R291 10.528 130.900 R453 6.562 114.464
G353 9.483 118.114 R300 7.647 121.779 S406 6.983 109.891
G387 8.472 110.388 R337 6.395 112.851 S462 7.396 114.930
G410 8.198 109.191 R405 7.972 116.103 T112 8.342 106.609
G423 7.386 107.803 R453 6.583 114.557 T115 10.706 113.061
G434 8.616 102.138 S406 7.007 109.884 T289 6.959 114.652
G441 9.845 120.749 S462 7.464 114.976 T373 7.113 105.339
H113 7.263 120.193 T112 7.631 105.892 T386 7.857 107.854
H168 9.364 124.731 T373 6.924 105.250 T389 9.330 122.318
H183 8.781 111.686 T386 7.836 107.776 T442 8.469 115.963
H196 8.931 120.872 T389 9.349 122.261 T451 6.860 105.663
H222 7.181 119.736 T442 8.467 115.873 T456 7.164 109.061
I118 9.202 128.422 T456 7.206 109.108 V294 8.275 120.693
I159 8.853 124.574 V294 8.445 120.610 V312 8.307 123.679
I161 9.265 126.904 V312 8.525 123.659 V319 7.468 119.469
I232 7.913 124.899 V319 7.476 119.556 V340 8.744 123.731
I256 8.637 121.997 V351 9.080 117.877 V351 8.914 117.567
I259 7.140 114.920 V356 8.646 124.968 V356 8.641 125.007
I290 8.547 118.159 V374 7.772 123.918 V374 7.993 124.283
I415 8.567 125.808 V393 9.516 125.474 V393 9.511 125.446
I454 8.486 121.247 V429 8.559 119.051 W463 7.930 121.477
K151 8.402 129.670 W203 8.512 129.172 Y116 11.075 119.878
K281 8.539 120.860 W349 9.145 120.541 Y302 8.686 115.950
K298 9.193 123.967 W463 8.056 121.645 Y309 7.947 119.615
K347 7.908 118.919 Y121 6.691 112.852 Y332 8.937 115.145
K388 7.749 115.529 Y309 7.983 119.633 Y390 8.955 125.776
K404 8.823 120.382 Y332 9.025 115.279 Y400 9.569 130.062
K432 8.872 124.735 Y365 7.578 124.912 Y445 9.634 126.421
K450 8.072 117.761 Y390 8.978 125.836
K452 7.979 118.341 Y400 9.594 130.128
K459 8.601 120.392 Y403 8.145 117.139
L114 8.230 127.265 Y445 9.714 126.538
L125 7.055 116.493
L181 9.312 126.025
L220 8.690 113.871
L224 7.164 113.931
L226 8.170 119.951
L282 7.215 123.438
L324 7.341 120.468
L328 8.410 121.220
L357 8.273 129.823
L381 8.148 116.088
L455 9.258 128.424
L457 8.189 126.425
M160 7.561 126.673
M236 8.516 112.198
M295 8.533 126.175
M303 9.141 118.292
M407 9.006 125.458
M431 8.816 120.725
N120 7.823 114.770
N143 7.950 115.741
N180 11.008 128.579
N206 7.850 119.144
N211 8.390 123.927
N306 8.974 123.805
N326 7.473 110.481
N355 8.103 117.536
N385 9.146 115.597
N395 8.374 116.437
N465 8.179 117.068
Q111 8.408 118.280
Q257 8.841 124.134
Q323 8.291 113.599
Q352 8.464 123.341
Q458 9.113 123.928
R108 7.811 114.251
R127 8.664 125.738
R165 8.625 117.483
R169 8.190 111.699
R202 7.878 126.312
R208 7.990 123.317
R291 10.421 130.848
R300 7.650 121.717
R337 6.350 112.849
R341 8.822 125.891
R405 7.978 116.116
R453 6.586 114.511
S162 8.629 118.068
S172 7.630 114.918
S382 8.685 118.190
S406 7.016 109.899
S462 7.416 114.920
T112 7.978 106.366
T115 9.244 111.303
T148 8.227 113.307
T150 8.620 120.476
T204 9.308 112.024
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T230 8.604 114.712
T289 7.022 114.734
T373 7.033 105.296
T386 7.861 107.859
T389 9.356 122.347
T442 8.473 115.889
T451 6.882 105.669
T456 7.197 109.133
V130 7.720 123.999
V144 7.092 104.688
V164 8.965 117.042
V294 8.378 120.743
V312 8.434 123.645
V319 7.470 119.640
V340 8.769 123.778
V351 9.098 117.849
V356 8.662 124.999
V374 7.787 124.019
V393 9.485 125.226
V429 8.503 119.005
W203 9.240 129.970
W321 8.166 114.247
W349 9.152 120.520
W463 7.993 121.621
Y116 8.579 117.458
Y121 8.398 114.314
Y210 8.176 124.242
Y237 8.068 128.453
Y260 7.869 115.269
Y302 9.022 116.162
Y309 7.987 119.510
Y332 9.025 115.253
Y365 7.644 124.927
Y390 8.984 125.801
Y400 9.585 130.014
Y403 8.110 117.144
Y445 9.687 126.483
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Table 9.5: Peak lists (in ppm) of the IPAP-[15N, 1H]-HSQC for free (Ln)MMP-1.
Lu(III) Tb(III) Dy(III) Tm(III)
Downfield Downfield Downfield Downfield
res 1H 15N res 1H 15N res 1H 15N res 1H 15N
A157 7.720 125.791 A157 6.535 124.675 A157 6.663 124.784 A157 8.991 126.983
A182 7.429 114.214 A277 8.047 122.963 A394 8.452 118.114 A335 9.276 129.757
A184 8.229 121.026 A335 9.386 129.890 A460 8.429 124.192 A394 8.437 118.125
A195 8.419 118.389 A394 8.455 118.092 D170 6.673 114.786 A428 7.998 119.052
A216 9.857 122.511 A428 8.026 119.684 D279 7.629 121.860 A460 8.298 123.938
A249 9.913 125.365 A460 8.444 124.178 D336 8.093 115.769 D158 9.559 122.035
A286 7.881 118.130 D170 6.595 114.764 D338 8.113 119.835 D170 7.813 115.787
A330 7.824 116.341 D200 8.333 117.204 D401 7.761 126.455 D194 9.747 124.051
A335 9.327 129.793 D279 7.638 121.859 D448 8.427 127.258 D279 7.403 121.557
A428 8.024 119.094 D336 8.089 115.737 E333 7.901 121.211 D336 8.005 115.714
A460 8.389 124.132 D338 8.098 119.774 E383 9.199 129.918 D338 7.942 119.617
D124 8.948 121.153 D363 8.189 116.937 E384 8.243 128.516 D363 8.242 116.909
D170 7.198 115.293 D401 7.755 126.475 F174 7.764 119.382 D401 7.745 126.441
D194 8.382 122.290 D448 8.428 127.231 F284 9.297 113.677 D448 8.411 127.203
D231 8.849 124.992 E154 6.573 116.559 F308 8.570 115.861 E313 8.332 128.292
D252 7.109 114.486 E333 7.908 121.272 F343 8.935 118.907 E333 7.754 121.099
D279 7.548 121.753 E383 9.196 129.914 F370 6.381 114.731 E383 9.181 129.910
D336 8.051 115.731 E384 8.237 128.543 F436 8.856 118.578 E384 8.230 128.485
D338 8.032 119.723 F284 9.290 113.612 F439 8.995 118.560 F284 9.056 113.563
D363 8.203 116.818 F297 8.836 117.304 F447 9.848 131.022 F308 8.420 115.706
D401 7.760 126.424 F308 8.575 115.924 F464 7.318 115.866 F334 9.311 127.967
D448 8.449 127.185 F342 8.744 118.698 G155 7.800 106.607 F342 8.623 118.470
E119 9.807 128.060 F370 6.395 114.806 G176 8.437 109.639 F370 6.456 114.984
E154 7.548 117.473 F391 8.723 118.144 G178 11.603 119.060 F391 8.698 118.316
E199 9.927 130.067 F392 9.413 121.480 G179 8.529 109.524 F430 7.859 117.789
E201 7.391 114.831 F436 8.848 118.564 G192 6.989 104.852 F435 7.884 116.550
E311 7.887 118.877 F439 8.983 118.621 G292 9.406 105.606 F436 8.826 118.556
E313 8.409 128.279 F447 9.845 130.983 G353 9.633 117.568 F438 8.722 119.602
E333 7.835 121.181 G155 7.703 106.434 G410 8.194 108.444 F447 9.806 130.919
E383 9.210 130.060 G176 8.370 109.593 G423 7.416 107.223 F464 7.185 115.748
E384 8.233 128.480 G178 11.546 119.043 G434 8.593 101.461 G155 9.378 107.981
F149 8.387 118.684 G190 8.272 109.850 I290 8.521 117.470 G188 6.565 107.887
F174 8.269 119.712 G292 9.416 105.554 I415 8.581 125.198 G192 8.536 106.831
F185 8.185 119.935 G353 9.657 117.515 I454 8.463 120.593 G255 7.996 106.611
F197 8.867 121.034 G387 8.466 109.704 K281 8.629 120.197 G292 9.229 105.570
F207 7.561 111.588 G410 8.190 108.376 K298 9.119 123.197 G327 7.850 108.384
F284 9.204 113.567 G423 7.407 107.215 K347 7.896 118.263 G353 9.313 117.288
F297 8.834 117.284 G434 8.601 101.454 K388 7.747 114.881 G387 8.447 109.743
F308 8.453 115.732 I290 8.643 117.517 K404 8.807 119.715 G410 8.168 108.441
F320 7.208 120.342 I415 8.578 125.092 K432 8.886 124.081 G423 7.392 107.223
F334 9.371 127.854 I454 8.466 120.585 K450 8.059 117.062 G434 8.585 101.468
F342 8.709 118.679 K281 8.626 120.164 L114 7.399 125.006 H113 7.851 119.955
F370 6.415 114.784 K388 7.743 114.862 L282 7.303 122.820 I159 10.773 125.711
F391 8.713 118.324 K404 8.817 119.745 L455 9.239 127.774 I232 7.491 123.601
F430 7.896 117.813 K432 8.897 124.101 L457 8.193 125.795 I259 7.323 114.288
F435 7.853 116.398 K450 8.057 117.058 M295 8.629 125.426 I290 8.447 117.374
F436 8.849 118.661 K459 8.587 119.710 M303 9.216 117.651 I454 8.443 120.609
F438 8.778 119.631 L282 7.313 122.870 M407 8.999 124.524 K281 8.555 120.683
F439 8.995 118.607 L324 7.330 119.745 M431 8.804 120.101 K347 7.972 118.288
F447 9.855 130.940 L328 8.418 120.461 N395 8.366 115.634 K388 7.718 114.873
F464 7.277 115.777 L357 8.257 129.036 Q111 7.935 117.326 K404 8.816 120.370
G155 8.523 107.216 L381 8.131 115.364 Q458 9.044 123.234 K432 8.845 124.062
G176 8.797 109.784 L455 9.235 127.736 R108 7.396 113.064 K450 8.046 117.131
G179 8.586 109.641 L457 8.189 125.781 R165 7.945 116.302 K459 8.533 119.692
G188 5.726 107.028 M295 8.646 125.557 R169 7.724 110.753 L282 7.063 122.617
G192 7.705 105.779 M303 9.233 117.571 R291 10.508 130.108 L324 7.342 119.744
G193 7.643 118.172 N355 8.087 116.876 R300 7.689 121.121 L328 8.394 121.167
G221 7.413 105.675 N385 9.125 114.842 R337 6.395 112.265 L455 9.220 127.710
G225 8.211 107.273 N395 8.363 115.614 R341 8.851 124.967 L457 8.152 125.692
G255 8.146 106.559 N465 8.230 116.351 R453 6.585 113.921 M295 8.406 125.459
G292 9.333 105.664 Q111 7.910 117.281 T115 8.148 109.415 M303 9.023 117.702
G327 7.841 108.444 Q458 9.135 123.270 T373 6.918 104.608 M431 8.797 120.706
G353 9.485 117.388 R108 7.368 112.983 T386 7.839 107.152 N326 7.448 109.755
G387 8.465 109.763 R291 10.529 130.212 T389 9.350 121.625 N355 8.103 117.536
G410 8.214 108.482 R337 6.400 112.269 T442 8.471 115.269 N385 9.142 114.926
G423 7.387 107.187 R405 7.971 115.445 T451 6.877 104.947 N395 8.370 115.630
G434 8.618 101.510 R453 6.584 113.905 T456 7.203 108.475 N465 8.082 116.367
H113 7.259 119.553 S382 8.711 118.146 V164 7.826 115.228 Q111 8.908 118.095
H183 8.779 111.038 S406 6.998 109.196 V294 8.443 120.097 Q156 9.091 118.929
H196 8.937 120.177 S462 7.469 114.161 V312 8.519 123.035 Q186 9.135 118.639
H222 7.182 119.078 T112 7.644 105.392 V374 7.757 123.175 Q352 8.472 123.462
I118 9.202 127.754 T373 6.936 104.550 V429 8.556 118.466 Q458 9.033 123.144
I161 9.276 126.226 T386 7.840 107.165 W463 8.057 121.035 R108 8.282 114.284
I232 7.910 124.202 T389 9.350 121.662 Y390 8.992 124.963 R165 9.421 117.493
I256 8.633 121.306 T442 8.448 115.256 Y403 8.116 116.472 R169 8.719 111.496
I270 8.104 119.057 T456 7.199 108.485 Y445 9.712 125.886 R337 6.271 112.138
I290 8.568 117.637 V294 8.443 120.064 R341 8.734 125.082
I454 8.481 120.658 V312 8.525 123.004 R405 7.948 115.448
K151 8.401 129.015 V319 7.451 118.956 Upfield R453 6.565 113.826
K281 8.538 120.165 V351 9.084 117.225 res 1H 15N S406 6.982 109.207
K347 7.912 118.246 V356 8.649 124.306 A157 6.664 126.035 T112 8.335 105.828
K388 7.748 114.852 V374 7.775 123.242 A394 8.455 119.392 T115 10.706 112.635
K404 8.813 119.729 V393 9.524 124.739 A460 8.436 125.479 T289 7.003 114.722
K450 8.073 117.128 V429 8.571 118.440 D170 6.671 116.068 T373 7.112 104.749
L114 8.241 126.480 W203 8.513 128.576 D279 7.628 123.143 T386 7.856 107.204
L181 9.312 125.326 W463 8.048 120.981 D336 8.083 117.167 T389 9.332 121.653
L220 8.677 113.140 Y121 6.695 111.693 D338 8.108 121.112 T442 8.474 115.254
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L224 7.175 113.286 Y309 7.984 118.945 D401 7.758 127.779 T451 6.861 105.052
L226 8.150 119.294 Y332 9.017 114.583 D448 8.430 128.581 T456 7.166 108.399
L282 7.215 122.800 Y390 8.988 124.925 E333 7.901 122.471 V294 8.279 120.057
L324 7.343 119.820 Y403 8.125 116.502 E383 9.199 131.279 V312 8.317 122.947
L328 8.414 120.536 Y445 9.724 125.809 E384 8.238 129.826 V319 7.446 118.942
L357 8.268 129.095 F174 7.767 120.599 V340 8.756 123.079
L381 8.140 115.407 F284 9.281 115.007 V351 8.893 116.985
L455 9.252 127.816 Upfield F308 8.562 117.159 V356 8.640 124.346
L457 8.188 125.720 res 1H 15N F343 8.938 120.247 V374 7.864 123.169
M160 7.569 126.031 A157 6.527 125.895 F370 6.394 116.150 V393 9.510 124.772
M295 8.536 125.540 A277 8.034 124.490 F436 8.854 119.880 V429 8.504 119.008
M303 9.148 117.605 A335 9.379 131.185 F439 8.991 119.851 W463 7.936 120.867
M431 8.813 120.136 A394 8.453 119.372 F447 9.847 132.304 Y116 11.080 119.292
N120 7.826 114.118 A428 8.028 121.024 F464 7.321 117.165 Y302 8.998 115.541
N143 7.928 115.031 A460 8.438 125.452 G155 7.806 107.833 Y309 7.941 118.870
N180 11.007 127.931 D170 6.598 115.965 G176 8.439 110.699 Y332 8.930 114.481
N306 8.973 123.137 D279 7.640 123.139 G178 11.602 120.200 Y365 7.630 124.264
N326 7.469 109.825 D336 8.089 117.156 G179 8.534 110.844 Y390 8.957 125.055
N355 8.103 116.911 D338 8.107 121.105 G192 6.990 106.315 Y400 9.572 129.409
N395 8.371 115.747 D363 8.197 118.232 G292 9.399 107.027 Y403 8.109 117.141
N465 8.177 116.467 D401 7.758 127.774 G353 9.649 118.952 Y445 9.641 125.703
Q111 8.410 117.640 D448 8.429 128.579 G410 8.182 109.741
Q257 8.849 123.521 E154 6.570 117.762 G423 7.417 108.586
Q352 8.460 122.652 E333 7.908 122.496 G434 8.597 102.767 Upfield
Q458 9.122 123.250 E383 9.198 131.284 I290 8.515 118.818 res 1H 15N
R108 7.812 113.576 E384 8.237 129.827 I415 8.585 126.433 A157 8.993 128.363
R165 8.623 116.832 F284 9.296 114.996 I454 8.465 121.906 A335 9.274 131.108
R169 8.195 111.074 F297 8.840 118.610 K281 8.617 121.565 A428 7.996 120.363
R202 7.878 125.640 F308 8.560 117.182 K298 9.119 124.546 A460 8.289 125.377
R291 10.412 130.152 F342 8.727 120.023 K347 7.889 119.588 C278 7.742 108.529
R337 6.351 112.258 F370 6.398 116.127 K388 7.743 116.168 D158 9.559 123.189
R341 8.818 125.256 F391 8.723 119.626 K404 8.809 121.009 D194 9.751 125.219
R405 7.969 115.415 F392 9.413 122.831 K432 8.886 125.420 D279 7.401 122.945
R453 6.587 113.886 F436 8.855 119.874 K450 8.057 118.423 D336 8.004 116.999
S162 8.631 117.359 F439 8.996 119.890 L114 7.398 126.274 D338 7.931 120.974
S382 8.701 117.545 F447 9.852 132.301 L282 7.300 124.201 D363 8.252 118.242
S406 7.000 109.258 F464 7.324 117.161 L455 9.251 129.083 D401 7.745 127.758
T112 7.973 105.725 G155 7.702 107.672 L457 8.191 127.078 D448 8.408 128.551
T115 9.230 110.625 G176 8.379 110.626 M295 8.631 126.960 E313 8.333 129.566
T148 8.226 112.661 G178 11.552 120.142 M303 9.217 119.081 E333 7.764 122.400
T150 8.616 119.771 G190 8.265 111.049 M407 8.991 125.955 E383 9.182 131.214
T204 9.303 111.372 G292 9.413 106.995 M431 8.804 121.411 E384 8.231 129.798
T230 8.614 114.038 G353 9.658 118.971 N395 8.363 116.965 F284 9.044 114.732
T373 7.023 104.678 G387 8.469 111.078 Q111 7.933 118.535 F308 8.421 117.024
T386 7.859 107.205 G410 8.186 109.727 Q458 9.047 124.543 F334 9.318 129.283
T389 9.345 121.575 G423 7.407 108.555 R108 7.403 114.463 F342 8.616 119.942
T451 6.885 105.027 G434 8.601 102.783 R165 7.943 117.656 F370 6.447 116.175
T456 7.197 108.468 I290 8.643 118.846 R169 7.705 111.894 F391 8.700 119.577
V130 7.719 123.335 I415 8.578 126.425 R291 10.519 131.554 F430 7.865 119.115
V144 7.081 104.131 I454 8.465 121.899 R300 7.663 122.387 F435 7.876 117.895
V164 8.971 116.337 K281 8.642 121.571 R337 6.412 113.586 F436 8.827 119.839
V294 8.375 120.065 K388 7.746 116.172 R341 8.834 126.532 F438 8.721 120.949
V312 8.431 122.944 K404 8.814 121.010 R453 6.585 115.212 F447 9.819 132.284
V319 7.460 118.956 K432 8.865 125.404 T115 8.141 110.976 F464 7.185 117.067
V340 8.766 123.165 K450 8.057 118.424 T373 6.934 105.827 G155 9.376 109.440
V351 9.087 117.146 K459 8.599 121.035 T386 7.847 108.451 G188 6.567 109.149
V356 8.658 124.331 L282 7.314 124.236 T389 9.350 122.987 G192 8.533 107.999
V374 7.787 123.327 L324 7.344 121.096 T442 8.471 116.594 G255 8.000 107.935
V393 9.479 124.540 L328 8.411 121.842 T451 6.877 106.297 G292 9.231 106.778
V429 8.496 118.292 L357 8.273 130.309 T456 7.203 109.774 G327 7.852 109.720
W203 9.245 129.322 L381 8.131 116.637 V164 7.819 116.457 G353 9.315 118.662
W321 8.168 113.633 L455 9.248 129.091 V294 8.448 121.437 G387 8.449 111.037
W349 9.135 119.873 L457 8.191 127.054 V312 8.521 124.363 G410 8.167 109.738
W463 7.992 120.981 M295 8.640 126.976 V374 7.763 124.520 G423 7.389 108.520
Y116 8.573 116.708 M303 9.247 119.057 V429 8.560 119.712 G434 8.584 102.795
Y121 8.400 113.653 N355 8.095 118.209 W463 8.046 122.330 H113 7.859 121.044
Y210 8.181 123.636 N385 9.125 116.223 Y390 8.992 126.441 I159 10.776 126.907
Y237 8.070 127.781 N395 8.364 116.943 Y403 8.120 117.776 I232 7.497 125.131
Y302 9.018 115.498 N465 8.227 117.792 Y445 9.703 127.180 I259 7.324 115.480
Y309 7.986 118.859 Q111 7.908 118.519 I290 8.445 118.676
Y332 9.028 114.642 Q458 9.136 124.573 I454 8.443 121.913
Y348 8.542 115.221 R108 7.364 114.382 K281 8.536 121.351
Y365 7.646 124.234 R291 10.524 131.596 K347 7.970 119.582
Y390 8.985 124.993 R337 6.400 113.545 K388 7.726 116.152
Y403 8.111 116.572 R405 7.970 116.763 K432 8.844 125.382
Y445 9.702 125.919 R453 6.585 115.194 K450 8.045 118.378
S382 8.719 118.146 K459 8.540 120.970
S406 6.995 110.558 L282 7.062 123.939
Upfield S462 7.463 115.677 L324 7.341 121.083
res 1H 15N T112 7.635 106.435 L455 9.219 129.044
A157 7.719 127.102 T373 6.928 105.807 L457 8.146 127.018
A184 8.236 122.346 T386 7.843 108.456 M295 8.405 126.665
A195 8.423 119.705 T389 9.355 122.987 M303 9.022 118.906
A216 9.848 123.866 T442 8.464 116.555 N385 9.140 116.250
A277 8.080 124.588 T456 7.202 109.750 N395 8.368 116.944
A286 7.879 119.414 V294 8.448 121.432 Q111 8.908 119.465
A335 9.329 131.167 V312 8.519 124.325 Q458 9.032 124.477
A428 8.025 120.390 V319 7.458 120.255 R108 8.261 115.449
A460 8.381 125.456 V351 9.089 118.524 R169 8.718 112.972
D124 8.948 122.446 V356 8.649 125.639 R300 7.576 122.527
D170 7.199 116.576 V374 7.765 124.530 R337 6.270 113.458
D194 8.384 123.615 V393 9.522 126.109 R341 8.716 126.413
D231 8.845 126.237 V429 8.564 119.687 R405 7.947 116.746
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D279 7.548 123.075 W203 8.498 129.857 R453 6.563 115.152
D336 8.050 117.084 W463 8.056 122.319 S406 6.986 110.480
D338 8.031 121.068 Y309 7.982 120.218 S462 7.394 115.618
D363 8.206 118.215 Y332 9.016 115.919 T112 8.337 107.343
D401 7.766 127.770 Y390 8.981 126.441 T115 10.703 113.588
D448 8.424 128.567 Y403 8.121 117.778 T373 7.122 106.030
E119 9.801 129.384 Y445 9.721 127.214 T386 7.854 108.516
E154 7.550 118.820 T389 9.331 122.965
E201 7.387 116.100 T442 8.470 116.569
E311 7.891 120.180 T451 6.860 106.290
E313 8.421 129.627 T456 7.165 109.742
E333 7.843 122.414 V294 8.274 121.274
E383 9.192 131.283 V312 8.315 124.273
E384 8.228 129.834 V340 8.759 124.350
F149 8.384 119.985 V351 8.899 118.214
F174 8.261 121.052 V356 8.642 125.624
F185 8.185 121.252 V393 9.512 126.075
F197 8.870 122.310 W463 7.929 122.157
F207 7.562 114.111 Y116 11.073 120.511
F284 9.198 114.861 Y302 8.998 116.788
F297 8.830 118.620 Y309 7.943 120.202
F308 8.455 117.048 Y332 8.937 115.858
F320 7.209 121.548 Y365 7.634 125.642
F334 9.372 129.316 Y390 8.957 126.345
F342 8.731 120.043 Y400 9.574 130.700
F370 6.415 116.172
F430 7.899 119.135
F436 8.857 119.825
F438 8.771 120.971
F439 8.989 119.873
F447 9.849 132.295
F464 7.265 117.134
G155 8.525 108.526
G179 8.585 111.016
G188 5.720 108.311
G192 7.706 107.106
G193 7.654 119.494
G221 7.415 107.030
G225 8.223 108.611
G255 8.150 107.919
G292 9.333 106.929
G327 7.837 109.775
G353 9.490 118.829
G387 8.459 111.089
G410 8.198 109.818
G423 7.389 108.483
G434 8.614 102.842
H113 7.261 120.870
H183 8.783 112.416
H196 8.925 121.542
H222 7.176 120.435
I161 9.266 127.580
I232 7.913 125.521
I256 8.635 122.651
I270 8.104 120.383
I290 8.546 118.799
I454 8.477 121.905
K151 8.395 130.322
K281 8.541 121.536
K347 7.908 119.588
K388 7.748 116.192
K404 8.812 120.982
K450 8.072 118.415
K452 7.977 119.023
L114 8.224 127.960
L125 7.055 117.153
L181 9.334 126.658
L220 8.690 114.560
L224 7.168 114.603
L282 7.215 124.091
L324 7.344 121.152
L328 8.417 121.869
L357 8.268 130.484
L381 8.140 116.776
L455 9.253 129.091
L457 8.194 127.024
M160 7.570 127.242
M295 8.531 126.864
M303 9.152 118.977
M431 8.814 121.400
N120 7.825 115.446
N143 7.946 116.319
N180 11.010 129.255
N306 8.975 124.465
N326 7.473 111.170
N355 8.101 118.214
N395 8.369 117.114
N465 8.185 117.761
Q111 8.407 118.917
Q257 8.847 124.806
Q323 8.294 114.316
Q352 8.467 124.001
Q458 9.107 124.613
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R108 7.811 114.918
R165 8.622 118.152
R169 8.186 112.348
R202 7.882 126.956
R291 10.425 131.508
R337 6.347 113.520
R341 8.820 126.522
R405 7.972 116.741
R453 6.586 115.197
S162 8.631 118.728
S382 8.692 118.848
S406 7.000 110.597
T112 7.980 107.046
T115 9.243 111.979
T148 8.221 113.962
T204 9.306 112.740
T230 8.600 115.379
T373 7.032 105.995
T386 7.860 108.539
T389 9.353 122.963
T451 6.881 106.332
T456 7.197 109.749
V130 7.720 124.575
V144 7.084 105.408
V164 8.963 117.702
V294 8.374 121.392
V312 8.431 124.254
V319 7.468 120.305
V340 8.761 124.399
V351 9.083 118.446
V356 8.661 125.660
V374 7.778 124.686
V393 9.488 125.943
V429 8.498 119.640
W203 9.244 130.588
W321 8.151 114.914
W349 9.139 121.166
W463 7.999 122.275
Y116 8.581 118.104
Y210 8.175 125.015
Y237 8.067 129.102
Y302 9.010 116.849
Y309 7.986 120.181
Y332 9.024 115.927
Y348 8.550 116.513
Y365 7.641 125.572
Y390 8.984 126.388
Y403 8.113 117.782
9.1.3 (Ln)MMP-1·THP Interaction
Table 9.6: Peak list (in ppm) of the 1H-15N HSQC spectra for the (Ln)MMP-1·THP interaction.
Lu(III) Tb(III) Dy(III) Tm(III)
res 1H 15N res 1H 15N res 1H 15N res 1H 15N
A128 8.695 116.873 A157 6.307 124.704 A157 6.438 124.865 A157 9.104 127.501
A133 7.918 120.675 A335 9.513 130.546 A335 9.515 130.561 A277 7.713 123.954
A157 7.618 125.992 A460 8.400 124.646 A460 8.377 124.603 A335 9.146 130.296
A182 7.298 114.775 C278 7.883 107.702 C278 7.831 107.772 C278 7.587 107.025
A184 8.167 120.870 D279 7.608 122.380 D170 6.500 114.864 D170 7.776 115.967
A195 8.333 118.518 D401 7.683 126.615 D279 7.576 122.313 D279 7.091 121.816
A234 7.983 123.325 D448 8.405 127.677 D401 7.716 126.684 D401 7.618 126.585
A249 9.773 125.479 E383 9.235 130.396 D448 8.404 127.675 D448 8.261 127.459
A258 7.891 121.919 E384 8.194 129.235 E383 9.227 130.405 E110 9.808 124.471
A277 8.079 124.216 F301 8.786 120.131 E384 8.186 129.259 E383 8.977 130.285
A286 7.725 118.634 F370 6.271 115.139 F284 9.390 113.753 E384 7.957 128.938
A331 8.753 122.905 F392 9.311 122.133 F370 6.286 115.134 F370 6.398 115.398
A335 9.316 130.421 F430 7.790 117.960 F392 9.335 121.995 F392 9.140 122.036
A379 7.946 117.462 F435 7.822 116.690 F435 7.818 116.670 F436 8.726 118.835
A394 8.379 118.369 F436 8.829 118.813 F436 8.827 118.800 F439 8.851 118.710
A416 8.998 116.597 F447 9.862 131.378 F439 9.029 118.757 F447 9.634 131.267
A428 7.814 118.821 G155 7.567 106.605 F447 9.858 131.357 G155 9.485 108.388
A460 8.230 124.445 G190 8.189 110.215 G166 8.791 106.721 G166 9.770 107.986
C278 7.866 107.275 G387 8.322 110.023 G176 8.335 110.040 G178 12.083 120.395
C466 8.419 119.881 G410 8.114 108.719 G190 8.250 110.285 G188 6.507 108.488
D124 8.832 121.436 G434 8.727 101.814 G192 6.788 104.943 G190 9.771 111.571
D129 7.237 116.615 G441 9.845 120.656 G410 8.127 108.720 G192 8.510 107.488
D131 8.574 118.325 H113 6.679 119.317 G423 7.332 107.702 G255 7.790 106.592
D158 8.001 120.756 I364 7.968 112.503 G434 8.711 101.905 G261 8.296 108.781
D170 7.066 115.553 I415 8.455 125.494 G441 9.845 120.563 G387 8.321 110.103
D175 8.386 115.575 K298 9.122 123.769 H113 6.698 119.246 G410 8.033 108.859
D194 8.290 122.637 K347 7.806 118.766 I191 8.307 133.421 G434 8.498 101.624
D198 7.842 121.842 K388 7.758 115.329 I364 7.977 112.966 G441 9.452 120.124
D231 8.747 125.171 K425 7.241 117.079 I415 8.478 125.525 H113 7.822 120.468
D245 7.462 119.867 K446 8.278 124.952 K388 7.750 115.295 I415 8.451 125.419
D251 8.643 114.672 K452 7.958 118.461 K432 8.876 124.389 K388 7.577 115.063
D252 7.022 114.927 K459 8.673 120.164 K446 8.287 124.995 K432 8.747 124.240
D254 8.857 119.150 L114 7.119 125.967 K452 7.904 118.408 K446 8.101 124.753
D279 7.370 122.111 L282 7.425 123.674 K459 8.649 120.188 K459 8.543 120.016
D285 8.982 121.453 L457 8.202 125.902 L282 7.353 123.578 L282 6.851 123.070
9.1. PEAK LISTS OF THE NMR SPECTRA 157
D299 10.030 128.571 M295 8.433 125.481 L455 9.274 128.108 L357 8.088 129.146
D336 7.985 116.243 M407 8.981 125.122 L457 8.195 125.906 L455 9.045 127.804
D338 7.964 119.968 N180 10.575 127.825 M160 5.825 124.239 L457 8.040 125.576
D363 8.086 117.217 N385 9.239 115.825 M407 8.992 125.112 M295 8.126 125.778
D401 7.642 126.591 N465 8.141 116.671 N180 10.557 127.803 M407 8.983 124.964
D418 6.784 116.141 N469 8.052 125.258 N385 9.227 115.789 N385 9.026 115.621
D427 9.106 124.388 Q458 9.013 123.827 N465 8.150 116.752 N461 7.585 111.380
D448 8.336 127.613 R202 7.617 125.926 N469 8.042 125.254 N469 7.835 125.068
E110 9.180 123.898 R337 6.235 112.447 Q458 9.114 123.777 Q156 9.203 119.181
E119 9.684 128.185 R405 7.851 115.741 R108 7.306 113.618 Q186 9.188 119.049
E135 8.665 120.954 R453 6.515 114.269 R262 7.899 113.226 Q458 8.878 123.686
E154 7.436 117.729 S406 6.933 109.722 R337 6.274 112.495 R108 8.314 114.766
E199 9.830 130.563 T112 7.540 105.842 R405 7.912 115.885 R169 8.675 111.884
E201 7.290 114.963 T145 7.534 110.893 R453 6.507 114.244 R405 7.819 115.661
E209 8.392 120.558 T373 6.840 105.307 S406 6.947 109.718 R443 8.037 122.598
E293 7.834 119.836 T386 7.827 107.513 T112 7.571 105.941 R453 6.400 114.008
E311 7.807 119.040 T451 6.718 105.327 T145 7.607 111.030 S406 6.872 109.603
E329 8.433 116.475 T456 7.134 108.532 T373 6.844 105.243 T112 8.324 106.561
E333 7.713 120.871 V294 8.246 120.786 T451 6.817 105.439 T115 10.765 112.594
E339 6.994 113.900 V340 8.643 123.902 T456 7.134 108.527 T386 7.693 107.883
E383 9.081 130.360 V374 7.522 123.533 V374 7.533 123.541 T451 6.728 105.493
E402 8.800 122.899 V393 9.414 124.956 V429 8.562 118.669 T456 6.960 108.275
F138 7.612 113.741 W463 8.061 121.554 Y332 9.146 114.868 W463 7.784 121.401
F149 8.314 118.007 Y400 9.508 129.836 Y400 9.516 129.737 Y210 8.053 124.191
F163 8.802 121.441 Y445 9.711 126.633 Y445 9.718 126.767 Y400 9.432 129.751
F174 8.206 120.062 Y411 7.577 117.528
F185 8.118 120.429 Y437 8.678 122.630
F242 8.278 118.970
F284 9.117 113.601
F296 8.801 122.699
F301 8.845 120.476
F308 8.412 116.366
F368 6.962 114.088
F370 6.306 115.196
F392 9.218 121.976
F430 7.775 118.012
F435 7.711 116.669
F436 8.732 118.703
F438 8.670 119.902
F439 8.882 118.675
F447 9.759 131.194
F464 7.127 116.157
G155 8.467 107.460
G166 9.288 107.223
G176 8.707 110.265
G179 8.516 110.068
G188 5.579 107.208
G190 8.924 110.848
G192 7.574 105.942
G193 7.513 118.444
G255 8.029 106.926
G261 8.248 108.755
G271 8.408 111.740
G292 9.398 103.717
G369 7.346 102.847
G387 8.320 110.067
G410 8.085 108.812
G423 7.270 107.637
G434 8.596 101.741
G441 9.682 120.357
H113 7.148 119.731
H132 8.180 118.033
H168 9.286 124.440
H200 8.788 118.108
H213 8.729 119.241
H218 6.923 114.099
H228 8.401 116.859
H358 8.375 120.038
H417 6.896 111.899
H424 7.749 114.834
H440 9.108 122.672
I118 9.119 128.102
I159 8.747 124.190
I161 9.223 126.884
I191 9.014 134.473
I253 7.693 119.446
I256 8.594 121.994
I259 6.867 114.056
I287 8.653 121.108
I290 8.437 118.051
I317 8.868 125.153
I364 7.985 112.629
I415 8.441 125.367
I422 6.901 114.095
I454 8.409 120.799
K151 8.326 129.108
K276 7.894 119.236
K281 8.427 120.614
K298 9.182 123.365
K344 8.665 120.805
K347 7.750 118.597
K388 7.660 115.185
K404 8.747 120.017
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K425 7.267 117.152
K432 8.728 124.384
K446 8.197 124.751
K450 7.956 117.097
K452 7.942 118.236
K459 8.530 120.048
K468 8.456 122.552
L114 8.122 127.021
L125 6.925 116.050
L140 7.219 116.807
L147 7.115 116.706
L224 7.008 113.755
L248 8.435 120.003
L282 7.147 123.408
L328 8.353 120.788
L455 9.181 128.028
L457 8.127 125.742
M160 7.494 126.047
M295 8.435 125.505
M303 9.033 116.791
M407 8.974 125.025
M414 8.667 116.926
N120 7.676 114.185
N143 8.067 115.718
N205 8.322 116.895
N206 7.741 118.445
N211 8.295 123.345
N265 8.076 120.609
N315 7.842 121.723
N346 7.985 120.913
N355 7.985 116.882
N385 9.114 115.668
N461 7.647 111.627
N465 8.082 117.037
N469 7.954 125.178
Q111 8.408 118.207
Q139 7.950 117.259
Q156 8.242 118.129
Q186 8.224 117.880
Q257 8.781 123.485
Q264 8.716 121.649
Q268 8.342 125.859
Q323 8.218 112.699
Q352 8.349 122.998
Q444 7.971 120.714
Q458 8.993 123.855
R108 7.769 114.089
R117 8.310 119.112
R127 8.609 125.580
R202 7.781 125.886
R214 8.722 116.947
R262 7.815 113.189
R337 6.021 112.028
R341 8.788 125.725
R372 8.580 117.648
R405 7.838 115.773
R443 8.162 122.790
R453 6.448 114.207
S153 8.737 116.086
S162 8.636 117.741
S172 7.541 114.727
S223 7.541 117.363
S227 8.409 117.084
S229 6.964 114.667
S263 7.411 113.392
S382 8.651 118.176
S406 6.882 109.661
S462 7.173 114.195
T112 7.871 106.220
T115 9.143 111.040
T148 8.213 113.032
T150 8.578 120.181
T204 9.169 111.444
T208 7.917 123.055
T230 8.610 114.744
T283 6.660 111.971
T288 8.475 116.672
T289 6.926 114.770
T373 6.873 104.957
T386 7.762 107.690
T442 8.376 115.769
T451 6.756 105.381
T456 7.048 108.483
V130 7.615 123.835
V144 6.935 104.490
V152 8.665 122.564
V164 8.871 116.669
V246 8.435 123.777
V267 7.906 119.360
V294 8.300 120.294
V312 8.365 123.772
V340 8.607 122.971
V351 9.015 116.694
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V374 7.674 123.774
V393 9.395 124.871
V429 8.503 118.912
W109 7.986 121.985
W141 6.669 115.225
W203 9.177 129.607
W463 8.015 121.621
Y116 8.456 117.043
Y121 8.391 114.848
Y210 8.118 124.283
Y260 7.656 112.782
Y302 8.994 115.668
Y309 7.793 118.857
Y332 8.837 114.520
Y348 8.396 115.441
Y360 7.246 116.750
Y390 8.878 125.294
Y400 9.478 129.632
Y403 7.938 116.590
Y411 7.543 117.542
Y437 8.653 122.405
Y445 9.605 126.511
Table 9.7: Peak lists (in ppm) of the IPAP-[15N, 1H]-HSQC for the (Ln)MMP-1·THP interaction.
Lu(III) Tb(III) Dy(III) Tm(III)
Downfield Downfield Downfield Downfield
res 1H 15N res 1H 15N res 1H 15N res 1H 15N
A128 8.711 116.249 A157 6.301 124.032 A157 6.440 124.218 A157 9.109 126.723
A133 7.941 120.058 A335 9.500 129.882 A335 9.503 130.018 A335 9.152 129.524
A157 7.627 125.395 A460 8.409 123.896 A460 8.376 124.142 A460 8.218 123.771
A182 7.294 114.369 C278 7.880 107.199 C278 7.837 107.054 D170 7.790 115.671
A184 8.164 120.232 D279 7.613 121.747 D170 6.496 114.162 D279 7.123 121.089
A195 8.363 117.822 D401 7.661 125.791 D279 7.596 121.800 D363 8.196 116.276
A234 7.980 122.540 D448 8.404 126.921 D401 7.735 126.032 D401 7.615 125.996
A258 7.876 121.235 E384 8.199 128.629 D448 8.412 127.045 D448 8.269 126.760
A277 8.097 123.631 F301 8.816 119.355 E383 9.221 129.554 E110 9.808 123.913
A286 7.727 118.069 F370 6.288 114.365 E384 8.186 128.651 E293 7.718 118.443
A331 8.786 122.210 F435 7.850 115.910 F435 7.816 115.952 E383 8.970 129.684
A335 9.325 129.727 F436 8.840 118.264 F436 8.848 118.318 E384 7.955 128.168
A379 7.942 117.298 F447 9.878 130.669 F439 9.029 118.112 F316 9.071 117.991
A394 8.395 117.575 G155 7.557 105.971 F447 9.856 130.681 F436 8.727 118.269
A416 8.933 115.734 G190 8.181 109.263 G190 8.233 109.749 F439 8.884 117.973
A428 7.816 118.137 G387 8.317 109.424 G192 6.727 104.326 G155 9.486 107.680
A460 8.227 123.731 G410 8.135 108.156 G410 8.119 107.972 G188 6.602 107.646
C278 7.873 106.691 G434 8.712 101.360 G423 7.316 107.237 G190 9.826 110.889
C466 8.414 119.161 G441 9.828 120.104 G434 8.706 101.264 G192 8.559 106.858
D124 8.832 120.768 I364 8.033 111.928 G441 9.848 119.875 G255 7.792 105.941
D129 7.236 116.023 I415 8.465 124.944 I364 7.974 111.857 G261 8.270 108.138
D131 8.563 119.045 K298 9.139 123.327 I415 8.465 124.891 G387 8.317 109.443
D158 8.003 119.978 K347 7.836 118.165 K388 7.758 114.520 G410 8.041 108.201
D170 7.059 114.945 K425 7.222 116.510 K432 8.871 123.740 G434 8.486 101.021
D175 8.382 114.945 K446 8.279 124.325 K446 8.273 124.314 G441 9.466 119.371
D194 8.299 121.893 K452 7.954 117.848 K452 7.931 118.014 H113 7.847 119.803
D198 7.834 121.185 K459 8.676 119.477 K459 8.646 119.513 I415 8.453 124.688
D231 8.746 124.361 L282 7.372 123.009 L282 7.356 122.839 K388 7.587 114.331
D245 7.451 119.120 L457 8.197 125.277 L457 8.194 125.160 K432 8.734 123.616
D251 8.708 114.100 M407 8.995 124.533 M160 5.765 123.411 K446 8.091 123.934
D254 8.862 118.354 N385 9.127 115.109 M407 8.990 124.507 K459 8.541 119.246
D279 7.376 121.474 N465 8.141 116.671 N469 8.036 124.556 L282 6.871 122.596
D285 8.970 120.724 N469 8.053 124.569 Q458 9.122 123.172 L357 8.094 128.540
D299 10.032 127.895 Q268 8.347 125.069 R108 7.328 112.757 L455 9.097 126.852
D338 7.952 119.207 Q458 8.989 123.187 R262 7.891 112.770 L457 8.037 124.985
D363 8.087 116.551 R202 7.608 125.325 R453 6.504 113.640 M295 8.132 125.037
D401 7.645 125.879 R453 6.505 113.604 S406 6.941 109.088 N385 9.006 115.013
D427 9.124 123.758 S406 6.914 109.114 T373 6.811 104.712 N469 7.836 124.427
D448 8.331 126.892 T112 7.517 105.320 T451 6.790 104.648 Q156 9.211 118.499
E110 9.180 123.243 T145 7.551 110.272 T456 7.136 107.976 Q186 9.191 118.385
E119 9.692 127.579 T386 7.799 107.078 V374 7.537 122.957 Q458 8.877 123.123
E135 8.670 120.342 T456 7.133 107.942 V429 8.564 118.153 R108 8.307 114.259
E154 7.434 117.069 V294 8.245 120.160 Y445 9.718 126.244 R169 8.679 111.277
E199 9.825 129.863 V340 8.644 123.353 R405 7.820 115.338
E201 7.277 114.512 V374 7.559 122.995 R443 8.062 122.062
E209 8.392 119.943 V393 9.389 124.029 Upfield R453 6.395 113.335
E293 7.821 119.332 W463 8.081 120.874 res 1H 15N T115 10.768 112.026
E311 7.811 118.290 Y400 9.526 129.412 A157 6.438 125.402 T386 7.702 106.942
E329 8.425 116.121 Y445 9.715 126.018 A335 9.506 131.237 V429 8.310 118.544
E333 7.711 120.197 A460 8.385 125.178 W463 7.814 120.922
E339 6.974 113.004 C278 7.858 108.360 Y210 8.049 123.413
E383 9.085 129.547 Upfield D170 6.496 115.593 Y411 7.576 117.038
E384 8.066 128.498 res 1H 15N D279 7.563 122.957 Y437 8.653 122.024
E402 8.832 122.274 A157 6.307 125.265 D401 7.691 127.328
F138 7.610 113.178 A335 9.516 131.233 D448 8.400 128.322
F149 8.302 117.453 A460 8.394 125.205 E383 9.223 131.188 Upfield
F163 8.797 120.720 C278 7.862 108.379 E384 8.195 129.899 res 1H 15N
F174 8.195 119.357 D279 7.603 122.986 F370 6.290 115.852 A157 9.105 128.149
F185 8.123 119.827 D401 7.687 127.326 F392 9.317 122.693 A277 7.719 124.420
F242 8.288 118.333 D448 8.400 128.324 F435 7.824 117.578 A335 9.146 130.975
F296 8.803 122.103 E383 9.221 131.215 F436 8.843 119.467 A460 8.201 125.024
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F301 8.845 119.803 E384 8.201 129.888 F439 9.027 119.401 D170 7.794 116.451
F308 8.423 116.012 F301 8.804 120.617 F447 9.853 131.968 D279 7.097 122.538
F368 6.941 113.025 F370 6.293 115.847 G179 8.505 110.678 D363 8.176 117.482
F370 6.301 114.556 F392 9.308 122.775 G190 8.246 110.822 D401 7.612 127.174
F392 9.222 121.298 F435 7.842 117.538 G192 6.722 105.511 D448 8.273 128.171
F430 7.781 117.293 F436 8.826 119.480 G410 8.118 109.456 E110 9.808 125.036
F435 7.720 116.078 F447 9.863 131.939 G423 7.319 108.402 E293 7.718 119.745
F436 8.743 118.108 G155 7.569 107.204 G434 8.714 102.515 E383 8.967 130.783
F438 8.682 119.202 G190 8.165 110.806 G441 9.842 121.167 E384 7.956 129.601
F439 8.889 117.989 G387 8.319 110.749 I364 7.999 113.314 F316 9.074 119.401
F447 9.753 130.711 G410 8.131 109.468 I415 8.457 126.035 F370 6.392 115.843
F464 7.135 115.643 G434 8.713 102.480 K388 7.746 115.957 F392 9.131 122.564
G155 8.470 106.817 G441 9.855 121.170 K432 8.871 125.107 F436 8.717 119.225
G166 9.297 106.614 H113 6.645 119.899 K446 8.277 125.572 F439 8.870 119.302
G176 8.706 109.648 I364 7.975 113.317 K452 7.900 118.829 F447 9.663 131.856
G179 8.512 109.451 I415 8.453 126.047 K459 8.653 120.859 G155 9.484 109.161
G188 5.632 106.550 K298 9.123 124.498 L282 7.344 124.285 G178 11.788 120.457
G190 8.921 110.197 K347 7.800 119.368 L455 9.518 129.075 G188 6.609 108.966
G192 7.574 105.269 K388 7.762 115.921 L457 8.194 126.452 G190 9.785 112.440
G193 7.516 117.755 K425 7.230 117.672 M160 5.819 124.910 G192 8.546 108.261
G255 8.010 106.358 K446 8.281 125.571 M407 8.988 125.689 G255 7.789 107.290
G261 8.254 108.133 K452 7.954 119.327 N180 10.519 128.702 G261 8.281 109.550
G271 8.408 111.014 K459 8.668 120.898 N385 9.140 115.454 G387 8.322 110.771
G292 9.407 103.059 L282 7.365 124.333 N465 8.157 117.745 G410 8.028 109.429
G353 9.288 116.113 L457 8.202 126.463 N469 8.038 125.898 G434 8.483 102.436
G387 8.320 109.448 M407 8.977 125.673 Q458 9.111 124.495 G441 9.468 120.912
G410 8.083 108.152 N385 9.130 116.343 R108 7.322 114.249 H113 7.834 121.088
G423 7.261 107.017 N469 8.053 125.908 R262 7.891 113.882 I415 8.452 126.111
G434 8.592 101.149 Q268 8.345 126.514 R337 6.274 113.815 K388 7.584 115.815
G441 9.687 119.718 Q458 9.007 124.464 R405 7.876 116.581 K432 8.736 124.975
H113 7.157 119.120 R202 7.624 126.717 R453 6.506 114.908 K446 8.088 125.445
H132 8.140 117.591 R337 6.217 112.943 S406 6.933 110.341 K452 7.807 118.683
H168 9.287 123.746 R405 7.864 116.564 T373 6.837 106.174 K459 8.530 120.736
H200 8.790 117.480 R453 6.514 114.941 T451 6.799 106.159 L282 6.862 123.729
H218 6.902 113.037 S406 6.938 110.366 T456 7.102 109.133 L357 8.071 129.738
H228 8.413 116.211 T112 7.564 106.656 V374 7.569 124.205 L455 9.109 128.615
H358 8.368 119.264 T145 7.520 111.534 V429 8.563 119.307 L457 8.034 126.338
H417 6.896 111.286 T373 6.840 106.185 Y400 9.558 130.431 M295 8.119 126.360
H424 7.752 114.203 T386 7.749 108.335 Y445 9.719 127.267 M407 8.991 125.742
H440 9.113 122.065 T456 7.116 109.164 N385 9.013 116.300
I118 9.125 127.409 V294 8.245 121.465 N461 7.571 112.166
I159 8.750 123.558 V340 8.647 124.521 N469 7.836 125.695
I161 9.232 126.157 V374 7.543 124.176 Q156 9.211 119.971
I191 9.023 133.858 V393 9.436 125.763 Q186 9.192 119.852
I253 7.706 118.941 W463 8.051 122.248 Q458 8.876 124.398
I256 8.593 121.250 Y400 9.546 130.410 R108 8.300 115.372
I259 6.870 113.102 Y445 9.735 127.232 R169 8.693 112.771
I287 8.703 120.936 R405 7.825 116.480
I290 8.429 117.484 R443 8.067 123.244
I317 8.855 124.632 R453 6.392 114.699
I364 7.983 111.972 S406 6.864 110.412
I415 8.434 124.768 T112 8.345 107.311
I422 6.880 113.074 T115 10.725 113.129
I454 8.425 120.169 T386 7.702 108.377
K151 8.330 128.451 T451 6.739 106.019
K276 7.901 118.600 V393 9.372 125.597
K281 8.411 120.005 V429 8.302 119.674
K298 9.189 122.829 W463 7.815 122.049
K344 8.694 120.367 Y116 11.370 120.360
K347 7.762 118.034 Y210 8.044 124.891
K388 7.658 114.520 Y400 9.407 130.160
K404 8.734 119.210 Y411 7.569 118.209
K425 7.270 116.557 Y437 8.697 123.225
K432 8.727 123.750
K446 8.195 124.181
K450 7.948 116.480
K452 7.946 117.521
K459 8.524 119.408
K468 8.461 121.872
L114 8.122 126.373
L125 6.935 115.440
L140 7.245 116.267
L147 7.117 116.030
L224 6.985 112.976
L248 8.429 119.311
L282 7.158 122.740
L314 8.009 128.362
L328 8.370 120.084
L455 9.188 127.465
L457 8.126 125.088
M160 7.490 125.386
M295 8.455 124.857
M303 9.042 116.278
M407 8.979 124.431
M414 8.685 116.320
N120 7.672 113.517
N143 8.066 115.325
N180 10.895 127.391
N205 8.315 116.649
N206 7.737 117.884
N211 8.317 123.238
N265 8.083 119.939
N315 7.855 121.174
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N346 7.993 120.215
N355 7.998 116.167
N385 9.109 114.981
N461 7.632 110.896
N465 8.083 116.314
N469 7.954 124.512
Q111 8.415 117.542
Q139 7.967 116.637
Q156 8.246 117.503
Q186 8.228 117.252
Q257 8.769 123.070
Q264 8.734 121.174
Q268 8.346 125.184
Q323 8.220 111.953
Q352 8.350 122.334
Q444 7.970 119.978
Q458 9.009 123.069
R108 7.767 113.445
R117 8.314 118.501
R127 8.612 124.951
R169 8.085 110.774
R202 7.776 125.201
R214 8.725 116.331
R262 7.817 112.600
R337 6.024 111.379
R341 8.785 125.171
R372 8.582 117.158
R405 7.841 115.197
R443 8.158 122.107
R453 6.450 113.490
S153 8.742 115.377
S162 8.634 117.246
S172 7.521 114.191
S223 7.551 116.883
S227 8.417 116.381
S229 6.982 114.122
S263 7.415 113.070
S382 8.654 117.519
S406 6.883 109.048
S462 7.170 113.835
T112 7.871 105.568
T115 9.151 110.359
T148 8.215 112.480
T150 8.584 119.488
T204 9.173 110.828
T208 7.916 122.395
T230 8.609 114.147
T283 6.667 111.564
T288 8.469 116.158
T289 6.963 114.165
T373 6.866 104.426
T386 7.778 107.092
T442 8.350 115.063
T451 6.783 104.822
T456 7.038 107.851
V130 7.615 123.253
V152 8.602 122.330
V164 8.864 116.006
V246 8.438 123.079
V267 7.915 118.719
V294 8.285 119.588
V312 8.371 123.061
V340 8.563 122.336
V351 9.009 116.136
V374 7.658 123.083
V393 9.425 124.375
V429 8.500 118.363
W109 7.986 121.314
W141 6.675 114.680
W203 9.186 128.846
W463 7.999 120.933
Y116 8.458 116.306
Y210 8.139 123.560
Y260 7.680 112.262
Y302 9.019 115.027
Y309 7.786 118.129
Y348 8.397 114.904
Y360 7.256 116.096
Y390 8.865 124.442
Y400 9.475 129.013
Y403 7.953 116.133
Y411 7.538 116.944
Y437 8.672 121.888
Y445 9.613 125.903
Upfield
res 1H 15N
A128 8.698 117.514
A133 7.941 121.405
A157 7.619 126.621
A182 7.301 115.273
A184 8.165 121.505
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A195 8.367 119.190
A234 7.983 123.827
A258 7.873 122.579
A277 8.065 124.802
A286 7.720 119.327
A331 8.762 123.535
A335 9.321 131.068
A379 7.947 118.406
A394 8.399 118.898
A416 8.943 116.999
A428 7.820 119.485
A460 8.236 125.063
C278 7.878 107.994
C466 8.424 120.462
D124 8.832 122.041
D129 7.235 117.314
D131 8.563 119.045
D158 8.006 121.358
D170 7.058 116.192
D175 8.371 116.234
D194 8.290 123.247
D198 7.826 122.497
D231 8.747 125.758
D245 7.445 120.482
D251 8.636 115.327
D254 8.861 119.759
D279 7.370 122.773
D285 8.979 122.012
D299 10.034 129.248
D338 7.951 120.578
D363 8.093 117.837
D401 7.642 127.223
D427 9.119 125.044
D448 8.335 128.224
E110 9.181 124.556
E119 9.690 128.896
E135 8.670 121.625
E154 7.435 118.371
E199 9.825 131.199
E201 7.282 115.813
E209 8.389 121.261
E293 7.843 120.578
E311 7.815 119.604
E329 8.429 117.444
E333 7.713 121.500
E339 6.976 114.620
E383 9.089 130.974
E384 8.069 129.771
E402 8.823 123.563
F138 7.618 114.255
F149 8.308 118.659
F163 8.795 122.026
F174 8.208 120.623
F185 8.128 121.110
F242 8.282 119.652
F284 9.122 114.287
F296 8.789 123.442
F301 8.844 121.109
F308 8.424 117.253
F368 6.941 114.670
F370 6.307 115.836
F392 9.216 122.702
F430 7.772 118.633
F435 7.720 117.361
F436 8.740 119.338
F438 8.679 120.508
F439 8.884 119.291
F447 9.760 131.891
F464 7.129 116.776
G155 8.469 108.125
G166 9.297 107.927
G176 8.712 110.947
G179 8.496 111.084
G188 5.652 107.955
G190 8.928 111.537
G192 7.574 106.644
G193 7.513 119.101
G255 8.020 107.640
G261 8.255 109.459
G271 8.405 112.348
G292 9.407 104.419
G353 9.282 117.567
G387 8.323 110.791
G410 8.087 109.466
G423 7.276 108.290
G434 8.596 102.440
G441 9.688 121.066
H113 7.153 120.413
H132 8.150 118.886
H168 9.294 125.093
H200 8.792 118.764
H213 8.740 119.891
H218 6.903 114.655
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H228 8.404 117.580
H358 8.374 120.828
H417 6.890 112.587
H424 7.745 115.423
H440 9.110 123.322
I118 9.121 128.762
I159 8.746 124.908
I161 9.228 127.449
I191 9.017 135.123
I253 7.699 120.194
I256 8.604 122.617
I259 6.874 114.790
I287 8.662 122.060
I290 8.434 118.764
I317 8.857 125.803
I364 7.985 113.281
I415 8.433 125.972
I422 6.891 114.697
I454 8.427 121.467
K151 8.329 129.783
K276 7.892 119.902
K281 8.418 121.338
K298 9.195 123.978
K344 8.684 121.511
K347 7.754 119.283
K388 7.664 115.873
K404 8.748 120.604
K425 7.272 117.844
K432 8.728 125.021
K446 8.191 125.516
K450 7.954 117.832
K452 7.944 118.882
K459 8.535 120.672
K468 8.462 123.177
L114 8.124 127.676
L125 6.928 116.733
L140 7.200 117.366
L147 7.113 117.368
L224 6.994 114.550
L248 8.437 120.625
L282 7.147 124.073
L314 8.016 129.818
L328 8.363 121.404
L455 9.189 128.657
L457 8.125 126.406
M160 7.497 126.708
M295 8.446 126.112
M303 9.043 117.459
M407 8.976 125.693
M414 8.668 117.518
N120 7.676 114.955
N143 8.061 116.553
N205 8.308 117.743
N206 7.724 119.159
N211 8.287 124.128
N265 8.081 121.253
N315 7.844 122.471
N346 7.991 121.505
N355 8.001 117.419
N385 9.115 116.340
N461 7.638 112.362
N465 8.083 117.677
N469 7.955 125.811
Q111 8.419 118.811
Q139 7.955 117.992
Q156 8.245 118.836
Q186 8.224 118.490
Q257 8.760 124.265
Q264 8.720 122.302
Q268 8.347 126.502
Q323 8.220 113.246
Q352 8.351 123.644
Q444 7.975 121.341
Q458 9.006 124.442
R108 7.769 114.771
R117 8.306 119.675
R127 8.617 126.231
R169 8.085 112.080
R202 7.774 126.540
R214 8.718 117.573
R262 7.816 113.860
R337 6.018 112.754
R341 8.783 126.480
R372 8.580 118.314
R405 7.845 116.469
R443 8.157 123.475
R453 6.454 114.811
S153 8.736 116.734
S162 8.629 118.187
S172 7.525 115.388
S223 7.548 118.064
S227 8.405 117.668
S229 6.973 115.476
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S263 7.411 113.924
S382 8.657 118.766
S406 6.886 110.364
S462 7.183 114.786
T112 7.872 106.790
T115 9.152 111.636
T148 8.217 113.737
T150 8.594 120.859
T204 9.152 112.103
T208 7.903 123.716
T230 8.614 115.448
T283 6.667 112.468
T288 8.476 117.376
T289 6.946 115.489
T305 9.125 118.169
T373 6.855 105.563
T386 7.765 108.384
T442 8.359 116.370
T451 6.763 106.090
T456 7.042 109.129
V130 7.612 124.436
V152 8.619 123.604
V164 8.868 117.301
V246 8.439 124.366
V267 7.915 119.985
V294 8.285 120.986
V312 8.370 124.346
V340 8.570 123.683
V351 9.019 117.403
V374 7.679 124.357
V393 9.417 125.656
V429 8.500 119.569
W109 7.986 122.635
W141 6.673 115.888
W203 9.183 130.193
W463 8.023 122.184
Y116 8.456 117.614
Y121 8.398 115.608
Y210 8.113 124.975
Y260 7.689 113.363
Y302 8.999 116.393
Y309 7.793 119.472
Y332 8.842 115.208
Y348 8.401 116.145
Y360 7.253 117.393
Y390 8.877 125.883
Y400 9.483 130.280
Y403 7.940 117.304
Y411 7.534 118.198
Y437 8.674 123.235
Y445 9.620 127.169
9.2 PCS and RDC values used in Chapter 5
9.2.1 Table 5.1 and Figure 5.2
Table 9.8: PCS values (in ppm) used to generate the Δχ-tensors of Table 5.1 and the plot of Figure 5.2
for the model 1HFC.
Tb(III) Tm(III) Yb(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
108 -0.450 -0.494 108 0.460 0.529 108 0.080 0.105
109 -0.650 -0.587 109 0.670 0.638 109 0.120 0.128
110 -0.490 -0.480 112 0.400 0.440 110 0.100 0.103
111 -0.490 -0.478 113 0.560 0.580 112 0.070 0.087
112 -0.330 -0.334 114 1.230 1.193 113 0.100 0.110
113 -0.450 -0.435 147 0.390 0.337 114 0.210 0.218
114 -1.020 -0.970 148 0.810 0.853 115 0.260 0.261
115 -1.290 -1.332 155 0.910 0.901 116 0.450 0.433
119 -2.470 -2.540 156 0.850 0.844 117 0.470 0.480
154 -1.050 -0.992 157 1.320 1.363 118 0.600 0.556
156 -0.780 -0.795 165 0.780 0.830 119 0.450 0.411
157 -1.220 -1.286 166 0.560 0.606 120 0.400 0.356
158 -1.340 -1.417 168 0.600 0.640 121 0.330 0.296
164 -1.290 -1.351 169 0.550 0.564 124 0.200 0.163
165 -0.760 -0.795 170 0.620 0.574 125 0.230 0.221
166 -0.510 -0.541 176 0.420 0.470 127 0.250 0.200
168 -0.580 -0.601 179 0.110 0.160 141 0.580 0.508
169 -0.530 -0.540 186 0.850 0.795 142 0.410 0.396
170 -0.590 -0.540 188 0.890 0.860 144 -0.020 0.052
172 -0.570 -0.505 192 0.860 0.823 145 0.000 0.050
174 -0.550 -0.570 193 1.130 1.096 147 0.080 0.107
175 -0.430 -0.412 194 1.370 1.295 148 0.140 0.175
176 -0.390 -0.383 232 -0.400 -0.452 149 0.300 0.353
178 -0.190 -0.136 233 -0.600 -0.651 150 0.360 0.368
179 -0.050 -0.007 255 -0.150 -0.165 151 0.470 0.453
180 -0.290 -0.253 257 -0.060 -0.069 152 0.430 0.390
184 -0.950 -1.006 259 0.150 0.125 153 0.240 0.167
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186 -0.780 -0.731 260 0.190 0.183 154 0.200 0.141
192 -0.810 -0.764 261 0.030 0.063 155 0.160 0.136
199 -0.980 -0.982 156 0.160 0.132
200 -0.660 -0.693 157 0.230 0.221
201 -0.640 -0.676 158 0.260 0.262
202 -0.140 -0.113 159 0.350 0.333
203 -0.640 -0.627 160 0.330 0.416
260 -0.230 -0.229 161 0.480 0.478
261 -0.100 -0.118 162 0.420 0.418
163 0.340 0.328
164 0.250 0.233
165 0.150 0.135
166 0.110 0.098
168 0.110 0.106
169 0.100 0.093
170 0.110 0.096
172 0.100 0.093
174 0.110 0.105
175 0.080 0.082
176 0.070 0.074
178 0.030 0.043
179 0.010 0.019
180 0.060 0.060
181 0.110 0.107
182 0.160 0.159
183 0.250 0.233
184 0.210 0.200
185 0.230 0.229
186 0.170 0.145
188 0.170 0.155
190 0.130 0.120
192 0.150 0.143
193 0.200 0.195
194 0.240 0.225
195 0.390 0.355
196 0.320 0.284
197 0.350 0.313
198 0.230 0.221
199 0.180 0.173
200 0.130 0.126
201 0.120 0.129
202 0.040 0.048
203 0.120 0.134
204 0.050 0.062
205 -0.370 -0.432
206 -0.680 -0.621
207 -0.850 -0.840
208 -0.500 -0.480
209 -0.200 -0.194
210 -0.020 -0.011
211 -0.150 -0.104
212 0.310 0.283
219 0.410 0.384
220 0.560 0.522
221 0.370 0.356
222 0.270 0.248
223 0.300 0.286
224 0.270 0.248
225 0.180 0.182
226 0.150 0.156
227 0.070 0.082
230 -0.010 -0.008
231 -0.030 -0.027
232 -0.070 -0.068
233 -0.110 -0.098
234 -0.110 -0.082
237 -0.020 0.006
249 -0.150 -0.098
250 -0.160 -0.126
251 -0.100 -0.072
252 -0.080 -0.041
253 -0.080 -0.036
254 -0.050 -0.025
255 -0.020 0.012
256 0.010 0.052
257 0.000 0.034
258 0.000 0.035
259 0.030 0.053
260 0.040 0.065
261 0.010 0.041
Table 9.9: PCS values (in ppm) used to generate the Δχ-tensors of Table 5.1 and the plot of Figure 5.2
for the model 3SHI.
Tb(III) Tm(III) Yb(III)
# Measured Calculated # Measured Calculated # Measured Calculated
108 -0.450 -0.424 108 0.460 0.448 108 0.080 0.086
109 -0.650 -0.621 109 0.670 0.660 109 0.120 0.126
110 -0.490 -0.468 112 0.400 0.396 110 0.100 0.098
111 -0.490 -0.491 113 0.560 0.550 112 0.070 0.077
166 CHAPTER 9. APPENDIX
112 -0.330 -0.334 114 1.230 1.209 113 0.100 0.103
113 -0.450 -0.437 147 0.390 0.341 114 0.210 0.219
114 -1.020 -0.989 148 0.810 0.860 115 0.260 0.269
115 -1.290 -1.283 155 0.910 0.902 116 0.450 0.448
119 -2.470 -2.310 156 0.850 0.889 117 0.470 0.512
154 -1.050 -1.184 157 1.320 1.372 118 0.600 0.585
156 -0.780 -0.748 165 0.780 0.806 119 0.450 0.428
157 -1.220 -1.189 166 0.560 0.571 120 0.400 0.387
158 -1.340 -1.227 168 0.600 0.635 121 0.330 0.336
164 -1.290 -1.294 169 0.550 0.566 124 0.200 0.185
165 -0.760 -0.774 170 0.620 0.616 125 0.230 0.254
166 -0.510 -0.535 176 0.420 0.396 127 0.250 0.268
168 -0.580 -0.591 179 0.110 0.087 141 0.580 0.531
169 -0.530 -0.529 186 0.850 0.804 142 0.410 0.403
170 -0.590 -0.570 188 0.890 0.913 144 -0.020 0.018
172 -0.570 -0.510 192 0.860 0.847 145 0.000 0.017
174 -0.550 -0.555 193 1.130 1.138 147 0.080 0.089
175 -0.430 -0.409 194 1.370 1.345 148 0.140 0.167
176 -0.390 -0.360 232 -0.400 -0.447 149 0.300 0.350
178 -0.190 -0.134 233 -0.600 -0.634 150 0.360 0.382
179 -0.050 -0.015 255 -0.150 -0.110 151 0.470 0.481
180 -0.290 -0.267 257 -0.060 -0.011 152 0.430 0.455
184 -0.950 -1.025 259 0.150 0.151 153 0.240 0.226
186 -0.780 -0.737 260 0.190 0.207 154 0.200 0.226
192 -0.810 -0.762 261 0.030 0.076 155 0.160 0.145
199 -0.980 -0.981 156 0.160 0.148
200 -0.660 -0.700 157 0.230 0.234
201 -0.640 -0.672 158 0.260 0.250
202 -0.140 -0.136 159 0.350 0.346
203 -0.640 -0.712 160 0.330 0.328
260 -0.230 -0.300 161 0.480 0.496
261 -0.100 -0.178 162 0.420 0.432
163 0.340 0.353
164 0.250 0.243
165 0.150 0.143
166 0.110 0.103
168 0.110 0.113
169 0.100 0.100
170 0.110 0.109
172 0.100 0.100
174 0.110 0.109
175 0.080 0.085
176 0.070 0.073
178 0.030 0.041
179 0.010 0.019
180 0.060 0.063
181 0.110 0.108
182 0.160 0.165
183 0.250 0.245
184 0.210 0.209
185 0.230 0.237
186 0.170 0.148
188 0.170 0.166
190 0.130 0.135
192 0.150 0.151
193 0.200 0.206
194 0.240 0.241
195 0.390 0.378
196 0.320 0.296
197 0.350 0.330
198 0.230 0.229
199 0.180 0.185
200 0.130 0.134
201 0.120 0.133
202 0.040 0.044
203 0.120 0.141
204 0.050 0.073
205 -0.370 -0.407
206 -0.680 -0.632
207 -0.850 -0.941
208 -0.500 -0.550
209 -0.200 -0.212
210 -0.020 -0.009
211 -0.150 -0.108
212 0.310 0.323
219 0.410 0.397
220 0.560 0.540
221 0.370 0.366
222 0.270 0.253
223 0.300 0.293
224 0.270 0.253
225 0.180 0.184
226 0.150 0.157
227 0.070 0.079
230 -0.010 -0.012
231 -0.030 -0.033
232 -0.070 -0.075
233 -0.110 -0.107
234 -0.110 -0.093
237 -0.020 0.002
249 -0.150 -0.122
250 -0.160 -0.144
251 -0.100 -0.086
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252 -0.080 -0.054
253 -0.080 -0.054
254 -0.050 -0.040
255 -0.020 0.000
256 0.010 0.041
257 0.000 0.021
258 0.000 0.022
259 0.030 0.043
260 0.040 0.054
261 0.010 0.029
Table 9.10: PCS values (in ppm) used to generate the Δχ-tensors of Table 5.1 and the plot of Figure
5.2 for the model 1CGE.
Tb(III) Tm(III) Yb(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
108 -0.450 -0.433 108 0.460 0.481 108 0.080 0.096
109 -0.650 -0.584 109 0.670 0.653 109 0.120 0.131
110 -0.490 -0.477 112 0.400 0.428 110 0.100 0.104
111 -0.490 -0.487 113 0.560 0.590 112 0.070 0.084
112 -0.330 -0.342 114 1.230 1.301 113 0.100 0.109
113 -0.450 -0.467 147 0.390 0.333 114 0.210 0.233
114 -1.020 -1.078 148 0.810 0.870 115 0.260 0.271
115 -1.290 -1.377 155 0.910 0.998 116 0.450 0.477
119 -2.470 -2.566 156 0.850 0.842 117 0.470 0.538
154 -1.050 -1.121 157 1.320 1.184 118 0.600 0.623
156 -0.780 -0.741 165 0.780 0.795 119 0.450 0.451
157 -1.220 -1.067 166 0.560 0.549 120 0.400 0.392
158 -1.340 -1.358 168 0.600 0.624 121 0.330 0.333
164 -1.290 -1.357 169 0.550 0.561 124 0.200 0.201
165 -0.760 -0.798 170 0.620 0.701 125 0.230 0.276
166 -0.510 -0.538 176 0.420 0.394 127 0.250 0.242
168 -0.580 -0.604 179 0.110 0.070 141 0.580 0.519
169 -0.530 -0.546 186 0.850 0.801 142 0.410 0.399
170 -0.590 -0.672 188 0.890 0.931 144 -0.020 0.039
172 -0.570 -0.542 192 0.860 0.874 145 0.000 0.040
174 -0.550 -0.552 193 1.130 1.157 147 0.080 0.104
175 -0.430 -0.403 194 1.370 1.370 148 0.140 0.175
176 -0.390 -0.376 232 -0.400 -0.376 149 0.300 0.352
178 -0.190 -0.129 233 -0.600 -0.546 150 0.360 0.376
179 -0.050 -0.016 255 -0.150 -0.112 151 0.470 0.462
180 -0.290 -0.251 257 -0.060 -0.032 152 0.430 0.425
184 -0.950 -1.009 259 0.150 0.134 153 0.240 0.172
186 -0.780 -0.730 260 0.190 0.220 154 0.200 0.163
192 -0.810 -0.803 261 0.030 0.082 155 0.160 0.146
199 -0.980 -0.979 156 0.160 0.125
200 -0.660 -0.682 157 0.230 0.194
201 -0.640 -0.629 158 0.260 0.259
202 -0.140 -0.110 159 0.350 0.354
203 -0.640 -0.602 160 0.330 0.354
260 -0.230 -0.224 161 0.480 0.521
261 -0.100 -0.104 162 0.420 0.461
163 0.340 0.389
164 0.250 0.259
165 0.150 0.151
166 0.110 0.108
168 0.110 0.117
169 0.100 0.103
170 0.110 0.129
172 0.100 0.109
174 0.110 0.112
175 0.080 0.088
176 0.070 0.080
178 0.030 0.044
179 0.010 0.021
180 0.060 0.065
181 0.110 0.111
182 0.160 0.165
183 0.250 0.261
184 0.210 0.219
185 0.230 0.248
186 0.170 0.155
188 0.170 0.172
190 0.130 0.139
192 0.150 0.159
193 0.200 0.216
194 0.240 0.252
195 0.390 0.401
196 0.320 0.315
197 0.350 0.346
198 0.230 0.233
199 0.180 0.192
200 0.130 0.138
201 0.120 0.135
202 0.040 0.049
203 0.120 0.144
204 0.050 0.066
205 -0.370 -0.418
206 -0.680 -0.628
207 -0.850 -0.818
168 CHAPTER 9. APPENDIX
208 -0.500 -0.499
209 -0.200 -0.208
210 -0.020 -0.114
211 -0.150 -0.056
212 0.310 0.246
219 0.410 0.375
220 0.560 0.549
221 0.370 0.367
222 0.270 0.261
223 0.300 0.311
224 0.270 0.267
225 0.180 0.195
226 0.150 0.167
227 0.070 0.086
230 -0.010 -0.004
231 -0.030 -0.023
232 -0.070 -0.063
233 -0.110 -0.093
234 -0.110 -0.082
237 -0.020 0.003
249 -0.150 -0.110
250 -0.160 -0.123
251 -0.100 -0.072
252 -0.080 -0.042
253 -0.080 -0.039
254 -0.050 -0.026
255 -0.020 0.009
256 0.010 0.045
257 0.000 0.029
258 0.000 0.031
259 0.030 0.049
260 0.040 0.067
261 0.010 0.040
Table 9.11: PCS values (in ppm) used to generate the Δχ-tensors of Table 5.1 and the plot of Figure
5.2 for the model 2AYK.
Tb(III) Tm(III) Yb(III)
# Measured Calculated # Measured Calculated # Measured Calculated
108 -0.450 -0.406 108 0.460 0.463 108 0.080 0.096
109 -0.650 -0.602 109 0.670 0.691 109 0.120 0.143
110 -0.490 -0.461 112 0.400 0.440 110 0.100 0.110
111 -0.490 -0.476 113 0.560 0.611 112 0.070 0.096
112 -0.330 -0.341 114 1.230 1.240 113 0.100 0.128
113 -0.450 -0.475 147 0.390 0.338 114 0.210 0.247
114 -1.020 -0.981 148 0.810 0.825 115 0.260 0.301
115 -1.290 -1.367 155 0.910 0.845 116 0.450 0.482
119 -2.470 -2.568 156 0.850 0.894 117 0.470 0.548
154 -1.050 -0.992 157 1.320 1.405 118 0.600 0.611
156 -0.780 -0.745 165 0.780 0.847 119 0.450 0.466
157 -1.220 -1.203 166 0.560 0.613 120 0.400 0.432
158 -1.340 -1.296 168 0.600 0.629 121 0.330 0.338
164 -1.290 -1.342 169 0.550 0.545 124 0.200 0.212
165 -0.760 -0.792 170 0.620 0.555 125 0.230 0.286
166 -0.510 -0.566 176 0.420 0.332 127 0.250 0.242
168 -0.580 -0.575 179 0.110 0.182 141 0.580 0.488
169 -0.530 -0.500 186 0.850 0.790 142 0.410 0.378
170 -0.590 -0.504 188 0.890 0.925 144 -0.020 0.054
172 -0.570 -0.500 192 0.860 0.848 145 0.000 0.065
174 -0.550 -0.505 193 1.130 1.132 147 0.080 0.117
175 -0.430 -0.338 194 1.370 1.349 148 0.140 0.194
176 -0.390 -0.295 232 -0.400 -0.417 149 0.300 0.376
178 -0.190 -0.162 233 -0.600 -0.581 150 0.360 0.393
179 -0.050 -0.144 255 -0.150 -0.108 151 0.470 0.468
180 -0.290 -0.355 257 -0.060 -0.025 152 0.430 0.420
184 -0.950 -0.956 259 0.150 0.119 153 0.240 0.146
186 -0.780 -0.702 260 0.190 0.164 154 0.200 0.159
192 -0.810 -0.746 261 0.030 0.061 155 0.160 0.114
199 -0.980 -1.063 156 0.160 0.138
200 -0.660 -0.750 157 0.230 0.234
201 -0.640 -0.649 158 0.260 0.270
202 -0.140 -0.139 159 0.350 0.367
203 -0.640 -0.573 160 0.330 0.355
260 -0.230 -0.176 161 0.480 0.532
261 -0.100 -0.090 162 0.420 0.460
163 0.340 0.363
164 0.250 0.263
165 0.150 0.152
166 0.110 0.115
168 0.110 0.114
169 0.100 0.097
170 0.110 0.101
172 0.100 0.104
174 0.110 0.106
175 0.080 0.076
176 0.070 0.066
178 0.030 0.044
179 0.010 0.041
180 0.060 0.084
181 0.110 0.127
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182 0.160 0.174
183 0.250 0.260
184 0.210 0.207
185 0.230 0.229
186 0.170 0.151
188 0.170 0.174
190 0.130 0.132
192 0.150 0.154
193 0.200 0.212
194 0.240 0.246
195 0.390 0.378
196 0.320 0.314
197 0.350 0.358
198 0.230 0.268
199 0.180 0.215
200 0.130 0.157
201 0.120 0.146
202 0.040 0.060
203 0.120 0.158
204 0.050 0.081
205 -0.370 -0.437
206 -0.680 -0.614
207 -0.850 -0.862
208 -0.500 -0.514
209 -0.200 -0.196
210 -0.020 -0.106
211 -0.150 -0.070
212 0.310 0.279
219 0.410 0.403
220 0.560 0.506
221 0.370 0.346
222 0.270 0.262
223 0.300 0.292
224 0.270 0.250
225 0.180 0.183
226 0.150 0.157
227 0.070 0.081
230 -0.010 -0.008
231 -0.030 -0.026
232 -0.070 -0.072
233 -0.110 -0.101
234 -0.110 -0.081
237 -0.020 -0.001
249 -0.150 -0.088
250 -0.160 -0.117
251 -0.100 -0.065
252 -0.080 -0.035
253 -0.080 -0.033
254 -0.050 -0.026
255 -0.020 0.008
256 0.010 0.045
257 0.000 0.030
258 0.000 0.025
259 0.030 0.047
260 0.040 0.058
261 0.010 0.043
9.2.2 Figure 5.3
Table 9.12: RDC values (in Hz) used to generate the plots for the 3SHI model of Figure 5.3.
Tb(III) Tm(III) Dy(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
A B C A B C A B C
112 21.850 24.058 18.827 23.034 109 18.730 17.290 16.978 18.082 109 4.920 6.703 4.460 4.492
113 -12.060 -14.378 -11.427 -10.358 113 14.120 13.188 15.538 15.099 110 3.100 2.602 4.088 3.682
114 -25.970 -31.079 -25.478 -25.597 114 25.820 34.400 23.854 27.950 112 -5.740 -6.264 -5.008 -6.815
164 6.100 3.594 -1.035 3.830 115 27.950 27.075 24.880 27.596 113 3.920 5.153 3.725 4.041
165 -2.130 0.259 -5.676 -3.987 147 -9.150 -17.561 -12.275 -12.372 114 8.110 9.786 7.489 7.700
166 -17.740 -8.522 -11.560 -15.051 156 -9.150 -1.770 -9.613 -10.294 115 7.830 8.589 7.898 8.826
168 4.470 8.563 8.223 8.070 169 -11.490 -21.241 -7.349 -10.217 117 5.190 0.752 3.862 3.952
169 12.840 28.092 18.419 15.001 170 -2.840 -7.837 0.429 -4.614 118 -1.640 3.491 0.017 -1.564
170 3.760 -2.602 -2.080 7.201 186 9.790 4.802 6.575 6.922 119 -4.740 -4.546 -3.075 -3.350
172 17.660 22.505 13.625 14.766 192 12.700 31.808 15.347 14.840 120 -2.370 -3.645 -4.165 -4.107
176 21.000 29.611 18.037 18.783 194 9.930 38.809 16.012 14.759 121 -3.830 -1.552 -3.250 -3.497
178 10.930 7.218 5.167 13.363 232 -18.660 -16.423 -19.443 -19.990 124 3.550 6.828 4.576 4.778
179 0.350 17.700 7.064 1.216 257 3.190 -8.946 1.160 0.750 125 5.010 6.955 6.765 7.440
192 -10.930 -15.003 -15.086 -8.758 259 7.730 26.036 9.693 7.198 127 -2.820 -3.903 -3.094 -3.678
200 -5.820 -12.435 -5.472 -8.823 128 -3.010 -1.639 -2.682 -2.498
201 13.620 13.269 8.909 15.604 129 -0.910 -3.250 -2.923 -2.886
202 13.620 28.128 15.058 16.469 130 -6.470 -3.902 -3.349 -3.700
141 -1.910 -3.175 -2.423 -2.684
142 -1.090 -3.698 -3.089 -2.526
144 0.460 4.915 1.498 1.589
147 -2.920 -6.256 -3.918 -4.122
148 7.740 9.555 7.967 8.473
149 9.200 11.204 8.724 10.280
150 7.290 10.105 7.371 8.412
151 8.020 11.588 8.379 9.104
152 -3.740 -3.534 -4.763 -4.826
170 CHAPTER 9. APPENDIX
153 -4.650 -3.347 -5.448 -5.924
155 -1.820 -2.381 -3.060 -1.196
156 -5.830 0.927 -4.660 -4.751
158 4.100 2.012 2.810 3.073
159 1.640 2.791 0.413 1.534
160 2.920 5.061 3.780 3.259
161 -4.560 -5.117 -3.064 -3.558
162 -5.100 -5.447 -4.344 -5.296
163 -4.650 -6.603 -3.891 -4.833
164 -2.100 -2.701 -2.926 -3.147
165 0.360 -0.967 0.926 0.248
166 3.740 3.202 3.816 4.451
168 -4.650 -4.246 -3.259 -3.734
169 -2.820 -6.945 -3.883 -5.023
170 -0.820 1.593 -1.522 -2.025
172 -5.280 -5.764 -4.688 -4.925
174 -3.190 -6.637 -5.089 -5.038
175 6.010 9.423 6.907 6.954
176 -5.560 -7.484 -4.698 -4.676
178 -3.740 -0.844 -2.933 -2.496
179 1.180 -4.275 0.243 0.177
180 5.920 8.101 5.500 6.549
181 1.370 -3.689 -1.472 -1.163
182 -4.740 -5.587 -4.307 -4.390
183 -4.560 -6.486 -4.631 -5.395
185 -4.650 -5.251 -2.905 -3.405
186 -0.180 2.117 1.823 1.585
188 1.550 4.008 0.317 0.661
190 -1.000 -6.379 -1.778 -2.116
192 3.010 5.239 4.089 3.449
193 -4.830 -6.352 -4.217 -5.704
194 8.650 10.713 5.391 5.837
195 -5.380 -5.374 -4.400 -5.174
196 -4.740 -5.735 -3.533 -3.670
197 -5.100 -6.221 -4.764 -5.792
198 -1.370 -2.829 -2.417 -2.194
199 8.290 9.526 6.958 9.293
200 4.560 3.775 2.776 3.253
201 -4.100 -2.986 -3.000 -4.007
202 -4.460 -7.810 -5.037 -5.248
203 0.180 -1.681 1.633 1.514
204 -3.830 -2.262 -2.868 -2.598
206 7.380 8.045 5.881 6.453
207 5.830 6.081 6.136 7.422
208 -4.560 -0.397 -2.530 -3.062
209 -5.010 -6.132 -4.900 -6.925
210 -1.280 -2.902 -0.524 -0.130
211 -5.830 -5.848 -4.467 -4.886
216 3.550 1.828 3.363 3.585
219 1.370 3.173 1.772 1.576
220 5.740 6.037 4.889 5.521
221 -0.180 -0.784 -0.622 -0.753
222 -1.180 -2.185 -2.296 -2.806
223 1.640 0.249 2.747 2.732
224 0.550 -0.030 -0.855 -0.483
225 -3.640 -4.333 -3.476 -4.563
226 -0.820 -2.818 -2.593 -2.806
230 -3.370 -4.021 -3.805 -4.738
231 -3.280 -5.476 -2.785 -3.971
232 -4.280 -1.965 -4.342 -4.292
233 -3.010 -3.942 -2.704 -2.474
234 -0.640 -1.292 -1.017 -1.173
235 -6.920 -0.250 -4.284 -5.801
237 6.010 9.896 7.997 7.470
248 -1.460 -5.902 -1.949 -1.938
251 -1.000 -1.753 -0.962 -1.902
252 9.840 7.804 8.125 8.746
253 2.370 1.825 1.928 2.315
254 -0.820 -2.957 -1.544 -1.958
255 -0.730 -1.684 0.811 0.746
256 4.280 5.881 3.639 3.402
257 -0.090 0.637 -0.845 -1.017
258 -2.920 -5.060 -4.309 -5.027
259 0.820 2.353 2.205 2.409
Table 9.13: RDC values (in Hz) used to generate the plots for the 1HFC model of Figure 5.3.
Tb(III) Tm(III) Yb(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
A B C A B C A B C
112 21.850 25.045 22.021 24.070 109 18.730 26.666 17.523 20.109 109 4.920 6.720 5.836 4.402
113 -12.060 -20.606 -14.753 -10.078 113 14.120 23.130 13.718 14.945 110 3.100 0.778 2.340 2.988
114 -25.970 -26.007 -20.872 -27.029 114 25.820 29.807 21.341 27.504 112 -5.740 -3.961 -4.790 -6.864
164 6.100 9.397 2.855 7.706 115 27.950 34.421 22.016 29.884 113 3.920 5.975 5.342 3.079
165 -2.130 -4.992 -7.025 -4.339 147 -9.150 -12.788 -12.109 -11.944 114 8.110 7.413 6.475 7.090
166 -17.740 -16.471 -14.066 -14.749 156 -9.150 -5.596 -6.080 -9.011 115 7.830 9.998 7.386 8.806
168 4.470 13.534 6.484 8.011 169 -11.490 -11.816 -5.852 -11.628 117 5.190 1.367 -1.657 3.986
169 12.840 12.997 13.115 16.025 170 -2.840 -4.063 -4.886 -3.016 118 -1.640 2.921 -0.524 -0.705
170 3.760 4.470 5.409 7.176 186 9.790 9.723 5.643 6.799 119 -4.740 -3.373 -3.861 -3.149
172 17.660 24.043 18.250 14.682 192 12.700 22.175 13.488 15.106 120 -2.370 -5.300 -3.019 -3.915
176 21.000 23.615 19.952 18.254 194 9.930 35.754 23.262 15.271 121 -3.830 -4.807 -1.555 -2.585
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178 10.930 6.634 7.782 13.326 232 -18.660 -14.335 -12.502 -21.071 124 3.550 3.507 3.354 4.857
179 0.350 -0.974 -2.112 -1.974 257 3.190 4.121 0.810 0.707 125 5.010 7.036 6.094 7.794
192 -10.930 -18.273 -13.315 -10.870 259 7.730 13.419 5.645 7.919 127 -2.820 -6.805 -3.546 -2.902
200 -5.820 -11.141 -7.551 -8.023 128 -3.010 -4.710 -2.105 -2.907
201 13.620 13.219 12.469 14.908 129 -0.910 -7.560 -3.510 -2.191
202 13.620 25.051 17.944 17.375 130 -6.470 -6.710 -3.554 -4.074
141 -1.910 -5.838 -2.241 -1.791
142 -1.090 -7.522 -3.525 -2.698
144 0.460 1.637 2.193 1.744
147 -2.920 -3.144 -4.288 -4.616
148 7.740 9.149 7.621 8.352
149 9.200 10.596 8.458 8.972
150 7.290 9.460 6.693 8.340
151 8.020 10.189 7.221 9.305
152 -3.740 1.175 -2.059 -4.649
153 -4.650 -3.258 -4.812 -5.493
155 -1.820 -5.429 -2.220 -0.838
156 -5.830 -1.542 -1.717 -4.826
158 4.100 6.644 3.401 4.036
159 1.640 4.103 0.563 1.766
160 2.920 4.879 2.444 2.988
161 -4.560 0.365 -2.510 -4.840
162 -5.100 -3.764 -4.026 -4.969
163 -4.650 -4.384 -4.023 -5.472
164 -2.100 -3.315 -1.887 -3.076
165 0.360 1.454 1.769 -0.092
166 3.740 5.101 4.561 3.308
168 -4.650 -6.316 -3.616 -3.196
169 -2.820 -2.026 -3.179 -4.785
170 -0.820 -1.330 -0.458 -1.941
172 -5.280 -2.694 -4.333 -4.545
174 -3.190 -3.904 -3.644 -5.554
175 6.010 7.356 5.320 6.897
176 -5.560 -3.172 -4.032 -5.363
178 -3.740 2.486 -0.943 -2.850
179 1.180 1.786 1.428 -0.056
180 5.920 6.708 5.113 6.794
181 1.370 -6.637 -2.889 -0.646
182 -4.740 -3.756 -3.760 -4.273
183 -4.560 -4.424 -4.162 -5.392
185 -4.650 -0.258 -2.387 -3.360
186 -0.180 4.413 0.861 1.396
188 1.550 2.447 0.661 -0.132
190 -1.000 -3.253 -4.941 -2.051
192 3.010 5.600 4.970 2.778
193 -4.830 -2.159 -4.169 -5.771
194 8.650 9.900 7.898 5.256
195 -5.380 -2.859 -4.049 -5.411
196 -4.740 -4.338 -3.893 -4.176
197 -5.100 -4.179 -3.959 -5.222
198 -1.370 -3.590 -1.562 -2.160
199 8.290 8.411 7.160 9.225
200 4.560 1.989 2.467 3.235
201 -4.100 -3.209 -2.418 -4.389
202 -4.460 -3.579 -4.476 -5.212
203 0.180 -5.151 -2.541 1.436
204 -3.830 -4.474 -2.477 -2.785
206 7.380 6.339 4.192 6.752
207 5.830 6.765 5.549 7.660
208 -4.560 0.830 -1.637 -2.635
209 -5.010 -3.689 -3.987 -6.590
210 -1.280 -2.297 -0.743 0.100
211 -5.830 -4.061 -3.624 -5.622
216 3.550 2.516 2.841 2.923
219 1.370 -0.722 0.732 1.782
220 5.740 5.154 4.803 4.753
221 -0.180 -1.920 -0.788 -1.138
222 -1.180 -4.232 -1.809 -2.484
223 1.640 1.950 2.613 2.700
224 0.550 -0.393 -0.636 -0.567
225 -3.640 -7.064 -3.864 -3.831
226 -0.820 -1.946 -1.534 -2.789
230 -3.370 -6.621 -3.755 -4.231
231 -3.280 -1.819 -2.469 -4.148
232 -4.280 -4.214 -3.987 -4.623
233 -3.010 -6.708 -3.291 -1.953
234 -0.640 1.089 -1.842 -1.971
235 -6.920 -3.653 -2.816 -5.266
237 6.010 10.290 7.210 7.480
248 -1.460 -0.296 -3.183 -1.981
251 -1.000 -1.694 -1.231 -1.386
252 9.840 5.269 4.773 8.632
253 2.370 2.883 2.442 1.811
254 -0.820 -0.320 -0.502 -2.023
255 -0.730 -1.165 -0.167 0.816
256 4.280 5.114 4.699 3.229
257 -0.090 0.772 0.393 -1.756
258 -2.920 -4.753 -3.713 -4.900
259 0.820 3.555 3.679 2.340
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Table 9.14: RDC values (in Hz) used to generate the plots for the 1CGE model of Figure 5.3.
Tb(III) Tm(III) Tb(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
A B C A B C A B C
112 21.850 11.616 20.410 23.125 109 18.730 21.583 19.081 20.093 109 4.920 4.788 5.286 4.597
113 -12.060 -16.983 -8.537 -10.356 113 14.120 20.708 12.196 14.466 110 3.100 3.410 3.007 2.267
114 -25.970 -27.311 -19.184 -25.892 114 25.820 26.059 20.426 27.746 112 -5.740 -6.502 -4.724 -6.773
164 6.100 10.476 0.396 7.117 115 27.950 31.689 17.899 27.691 113 3.920 5.731 4.972 3.451
165 -2.130 -17.156 -13.213 -4.259 147 -9.150 -17.921 -7.915 -10.506 114 8.110 6.433 6.229 7.329
166 -17.740 -16.518 -10.610 -15.185 156 -9.150 -22.739 -11.308 -11.311 115 7.830 9.948 6.856 8.871
168 4.470 19.162 4.970 9.376 169 -11.490 -14.235 -5.855 -10.260 117 5.190 -0.952 -1.140 4.118
169 12.840 8.164 10.615 15.107 170 -2.840 18.797 8.093 -0.662 118 -1.640 2.464 1.037 -0.579
170 3.760 -11.091 -5.973 3.519 186 9.790 6.598 5.725 6.320 119 -4.740 -3.807 -2.991 -3.168
172 17.660 9.538 19.458 14.488 192 12.700 22.598 15.937 15.154 120 -2.370 -4.656 -2.687 -3.518
176 21.000 9.387 21.011 18.681 194 9.930 35.039 21.196 15.006 121 -3.830 -3.056 -2.152 -3.421
178 10.930 -9.204 5.058 13.388 232 -18.660 -20.594 -14.670 -20.838 124 3.550 6.547 4.068 4.959
179 0.350 -11.564 -2.135 -2.142 257 3.190 -2.105 1.446 0.515 125 5.010 6.395 5.710 6.621
192 -10.930 -22.157 -12.509 -11.180 259 7.730 6.529 -1.008 5.920 127 -2.820 -4.698 -3.638 -2.753
200 -5.820 -3.486 -2.760 -8.659 128 -3.010 -1.205 -2.197 -2.768
201 13.620 8.618 11.664 11.694 129 -0.910 -2.655 -3.277 -1.102
202 13.620 10.329 17.557 15.147 130 -6.470 -3.592 -3.353 -4.781
141 -1.910 -2.567 -2.311 -2.243
142 -1.090 -2.725 -3.246 -2.304
144 0.460 3.406 1.886 1.822
147 -2.920 -7.242 -3.329 -4.738
148 7.740 7.832 6.467 8.710
149 9.200 10.718 8.105 10.188
150 7.290 9.476 6.511 8.508
151 8.020 7.877 5.009 9.483
152 -3.740 -2.176 -1.901 -3.353
153 -4.650 -5.740 -4.335 -3.625
155 -1.820 -0.562 -1.722 -1.028
156 -5.830 -7.822 -4.689 -4.787
158 4.100 7.928 5.100 3.015
159 1.640 2.387 0.907 1.463
160 2.920 3.481 1.734 1.854
161 -4.560 -5.766 -3.923 -3.716
162 -5.100 -5.819 -3.903 -5.843
163 -4.650 -6.731 -4.267 -5.267
164 -2.100 -4.699 -2.384 -2.967
165 0.360 1.563 3.194 -0.033
166 3.740 1.280 3.004 3.790
168 -4.650 -5.143 -3.483 -2.987
169 -2.820 -3.649 -3.496 -4.198
170 -0.820 5.863 4.360 -0.539
172 -5.280 -5.772 -3.895 -5.076
174 -3.190 -7.119 -3.972 -4.567
175 6.010 7.505 4.964 7.169
176 -5.560 -6.874 -4.177 -5.858
178 -3.740 1.318 0.271 -3.588
179 1.180 -0.934 1.548 -0.139
180 5.920 7.757 5.157 6.787
181 1.370 -3.333 -2.929 -0.508
182 -4.740 -6.022 -4.010 -4.062
183 -4.560 -6.485 -4.145 -3.556
185 -4.650 -4.668 -3.310 -3.378
186 -0.180 2.517 1.003 1.762
188 1.550 3.815 1.980 1.248
190 -1.000 -7.286 -4.851 -2.019
192 3.010 5.735 5.467 2.894
193 -4.830 -6.128 -4.050 -5.779
194 8.650 10.708 7.635 5.663
195 -5.380 -6.204 -4.077 -6.360
196 -4.740 -5.655 -3.923 -3.976
197 -5.100 -7.204 -3.817 -5.977
198 -1.370 -4.420 -2.283 -2.377
199 8.290 8.437 7.406 7.855
200 4.560 5.421 3.231 3.470
201 -4.100 -2.317 -1.472 -3.399
202 -4.460 -7.661 -4.247 -5.418
203 0.180 -4.801 -2.372 1.684
204 -3.830 -2.699 -2.642 -2.767
206 7.380 6.952 4.330 6.954
207 5.830 9.416 6.461 7.430
208 -4.560 -2.062 -1.845 -3.012
209 -5.010 -5.329 -3.352 -4.696
210 -1.280 -3.294 -1.396 -4.036
211 -5.830 -7.291 -3.651 -3.877
216 3.550 5.128 2.989 2.734
219 1.370 0.972 -0.280 0.531
220 5.740 6.069 4.781 4.438
221 -0.180 -2.541 -1.791 -1.298
222 -1.180 -0.706 -1.218 -2.543
223 1.640 3.623 2.493 2.685
224 0.550 -2.140 -0.078 -0.573
225 -3.640 -3.030 -3.656 -3.734
226 -0.820 -0.780 -1.333 -2.249
230 -3.370 -2.513 -3.245 -3.815
231 -3.280 -6.250 -3.174 -4.620
232 -4.280 -6.987 -4.268 -5.279
233 -3.010 -1.314 -2.056 -2.172
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234 -0.640 1.101 0.138 -1.747
235 -6.920 -1.319 -2.331 -4.851
237 6.010 10.296 7.108 8.634
248 -1.460 -2.326 -2.220 -1.497
251 -1.000 -1.971 -0.732 -1.255
252 9.840 4.690 4.122 8.658
253 2.370 -0.813 1.150 1.330
254 -0.820 -4.690 -2.094 -2.121
255 -0.730 0.228 0.642 0.782
256 4.280 4.739 4.344 3.555
257 -0.090 -2.096 0.181 -1.949
258 -2.920 -4.698 -3.448 -5.074
259 0.820 2.615 1.598 2.185
Table 9.15: RDC values (in Hz) used to generate the plots for the 2AYK model of Figure 5.3.
Tb(III) Tm(III) Yb(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
A B C A B C A B C
112 21.850 11.573 16.025 20.001 109 18.730 9.340 8.466 16.507 109 4.920 3.349 1.928 5.043
113 -12.060 -26.759 -16.727 -10.383 113 14.120 30.259 16.620 15.961 110 3.100 0.194 2.433 4.488
114 -25.970 -34.930 -23.181 -23.936 114 25.820 39.524 20.504 27.598 112 -5.740 -4.448 -4.361 -7.275
164 6.100 9.506 8.674 5.875 115 27.950 36.465 21.127 26.380 113 3.920 9.036 5.757 2.997
165 -2.130 -10.732 -1.008 -1.944 147 -9.150 -16.578 -9.112 -6.737 114 8.110 11.470 7.458 7.357
166 -17.740 -25.026 -13.050 -17.368 156 -9.150 -8.352 2.435 -9.228 115 7.830 11.089 6.427 8.699
168 4.470 19.245 6.797 8.250 169 -11.490 -24.030 -8.864 -13.720 117 5.190 4.297 0.185 4.146
169 12.840 19.322 13.069 15.280 170 -2.840 -24.578 -6.574 -4.573 118 -1.640 4.556 0.748 -0.550
170 3.760 20.717 13.135 7.470 186 9.790 23.132 12.341 6.961 119 -4.740 -1.492 -4.155 -5.661
172 17.660 9.652 11.051 19.397 192 12.700 20.532 12.905 14.885 120 -2.370 -3.786 -4.041 -3.544
176 21.000 5.643 11.532 18.647 194 9.930 40.006 22.509 14.598 121 -3.830 -3.660 -4.000 -3.963
178 10.930 -2.928 -0.925 8.484 232 -18.660 -13.352 -15.509 -20.536 124 3.550 7.812 4.625 5.155
179 0.350 5.645 11.314 -2.117 257 3.190 -2.403 1.915 2.060 125 5.010 7.345 4.598 5.542
192 -10.930 -18.636 -10.670 -8.888 259 7.730 -5.771 4.440 5.479 127 -2.820 -5.408 -3.190 -2.341
200 -5.820 -0.255 -10.749 -7.421 128 -3.010 -6.618 -2.743 -3.192
201 13.620 11.162 4.535 15.315 129 -0.910 -7.874 -1.843 -1.126
202 13.620 11.045 14.912 17.587 130 -6.470 -5.666 -3.207 -4.511
141 -1.910 -6.870 -2.506 -2.041
142 -1.090 -7.221 -2.779 -3.212
144 0.460 -1.240 2.255 1.910
147 -2.920 -3.050 -4.186 -4.159
148 7.740 10.467 6.645 7.013
149 9.200 11.148 7.451 10.302
150 7.290 11.859 6.788 8.356
151 8.020 10.479 6.996 9.278
152 -3.740 -2.583 -3.019 -4.236
153 -4.650 -4.810 -3.084 -5.203
155 -1.820 -6.061 -1.538 -1.425
156 -5.830 -1.932 -1.021 -5.146
158 4.100 0.354 0.523 3.092
159 1.640 3.870 -0.052 0.631
160 2.920 8.371 3.167 3.896
161 -4.560 0.464 -2.705 -3.565
162 -5.100 -1.130 -3.772 -4.039
163 -4.650 -3.027 -4.438 -5.262
164 -2.100 -2.968 -2.306 -2.498
165 0.360 2.778 1.729 -0.163
166 3.740 7.796 5.177 5.156
168 -4.650 -4.276 -3.527 -2.821
169 -2.820 -8.449 -2.871 -5.106
170 -0.820 -7.992 -3.204 -1.947
172 -5.280 -2.098 -4.558 -6.842
174 -3.190 -2.927 -4.552 -5.122
175 6.010 -6.551 -1.596 4.780
176 -5.560 -1.847 -2.973 -6.997
178 -3.740 -1.476 2.008 -2.889
179 1.180 -1.827 -2.923 -0.098
180 5.920 11.679 7.594 7.250
181 1.370 -5.709 -1.033 -0.360
182 -4.740 -0.206 -3.143 -4.724
183 -4.560 -1.359 -3.948 -5.109
185 -4.650 1.110 -2.586 -3.344
186 -0.180 6.373 4.600 2.083
188 1.550 -3.597 -1.347 0.442
190 -1.000 -3.765 -4.451 -2.079
192 3.010 6.420 3.985 2.710
193 -4.830 -1.982 -4.381 -5.001
194 8.650 11.905 7.349 5.955
195 -5.380 -1.964 -4.095 -5.691
196 -4.740 0.563 -2.366 -3.627
197 -5.100 -3.429 -3.953 -6.084
198 -1.370 -4.528 -1.945 -0.340
199 8.290 8.552 5.595 7.641
200 4.560 3.052 1.287 3.442
201 -4.100 -3.336 -1.139 -5.058
202 -4.460 -3.339 -4.852 -5.992
203 0.180 -3.150 -2.453 0.479
204 -3.830 -1.097 -2.179 -2.764
206 7.380 -0.103 2.219 6.994
207 5.830 11.159 7.120 7.705
208 -4.560 -3.560 -4.749 -5.510
209 -5.010 -4.988 -2.920 -6.796
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210 -1.280 -3.227 -3.552 -2.454
211 -5.830 0.866 -1.655 -4.610
216 3.550 6.298 3.592 4.251
219 1.370 2.060 1.214 1.912
220 5.740 6.539 3.994 5.010
221 -0.180 -1.772 -0.354 -1.241
222 -1.180 -3.407 -1.018 -2.144
223 1.640 4.372 2.663 2.553
224 0.550 -0.296 -0.133 -0.528
225 -3.640 -8.385 -2.686 -4.353
226 -0.820 -0.722 -2.544 -1.977
230 -3.370 -7.226 -2.449 -4.023
231 -3.280 0.653 -0.488 -2.916
232 -4.280 -3.615 -3.477 -5.030
233 -3.010 -4.647 -3.535 -2.297
234 -0.640 -1.568 -3.432 -2.367
235 -6.920 -7.062 -3.124 -6.785
237 6.010 10.251 5.461 6.823
248 -1.460 -0.736 -1.995 -1.969
251 -1.000 -0.191 -0.073 -2.194
252 9.840 6.882 4.293 8.762
253 2.370 3.207 1.629 1.256
254 -0.820 -0.253 -0.782 -1.968
255 -0.730 0.266 0.518 0.596
256 4.280 4.459 2.860 3.170
257 -0.090 0.235 -0.433 -1.603
258 -2.920 -4.581 -2.595 -4.752
259 0.820 -1.738 -0.306 1.424
9.3 PCS and RDC values used in Chapter 6
9.3.1 Table 6.1
Table 9.16: PCS values (in ppm) used to calculate the Δχ-tensors of Table 6.1.
Tb(III) Dy(III) Tm(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
108 -0.464 -0.512 108 -0.411 -0.366 108 0.470 0.448
111 -0.435 -0.490 111 -0.472 -0.434 111 0.531 0.528
112 -0.797 -0.754 115 -1.099 -1.127 112 0.393 0.353
113 -1.182 -1.127 155 -0.714 -0.686 115 1.443 1.466
155 -0.582 -0.555 157 -1.053 -1.010 116 2.527 2.478
156 -0.415 -0.378 165 -0.681 -0.719 155 0.874 0.891
157 -0.691 -0.705 170 -0.525 -0.514 156 0.831 0.845
170 -0.798 -0.781 174 -0.500 -0.501 157 1.285 1.298
176 -0.591 -0.657 176 -0.364 -0.371 158 1.471 1.439
178 -0.699 -0.643 178 -0.196 -0.181 159 1.954 1.915
179 -0.503 -0.445 179 -0.057 -0.032 165 0.807 0.853
186 -0.312 -0.359 192 -0.714 -0.682 169 0.541 0.590
190 -0.743 -0.719 170 0.643 0.641
192 -0.064 -0.064 179 0.180 0.151
200 -0.752 -0.761 186 0.821 0.825
203 -0.229 -0.178 188 0.869 0.916
9.3.2 Table 6.2 and Figure 6.1
Table 9.17: RDC (in Hz) values used for Table 6.2 and Figure 6.1.
Tb(III) Dy(III) Tm(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
279 2.767 3.643 279 2.767 2.751 279 -4.682 -2.854
282 -2.554 -2.596 284 -2.554 -1.890 282 -2.199 -1.691
282 -4.398 -4.487 291 -6.385 -4.924 284 8.868 7.367
284 -6.243 -5.120 294 -0.922 -2.529 302 7.378 8.154
294 -2.341 -2.941 303 -4.115 -4.537 303 11.918 11.122
393 -8.088 -6.286 308 1.277 0.501 308 -0.142 1.149
312 -0.780 -1.192 335 0.922 -0.841 332 -6.527 -5.795
336 -4.540 -4.655 338 4.824 5.339 336 4.824 6.041
338 1.064 -0.260 347 1.206 2.602 338 -0.851 -2.434
342 2.767 4.317 383 -9.790 -8.433 356 3.618 4.048
351 0.071 -0.731 384 3.121 1.982 365 -2.838 -3.069
353 -1.064 -2.323 386 2.483 3.699 373 2.554 4.565
356 -0.284 -1.866 390 -5.888 -7.317 386 1.561 1.976
384 4.966 4.811 410 2.767 1.485 390 7.449 5.910
386 3.051 3.156 434 1.845 3.943 401 2.057 2.505
390 -8.584 -8.797 450 -5.250 -7.199 423 -0.071 1.528
406 -1.632 -1.532 451 -3.192 -4.106 447 -0.709 -0.928
410 -1.064 -1.924 545 -4.682 -5.403 453 -1.064 -2.448
423 -3.121 -1.391 457 1.490 1.284 455 -4.186 -4.278
434 0.213 0.996 458 3.831 2.610 456 -4.398 -4.273
445 -1.419 0.645 460 2.625 1.017 457 -1.561 -2.658
447 2.625 1.333 463 0.284 -0.998
453 1.561 1.896 464 2.696 1.593
457 2.199 0.283
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458 4.257 5.285
460 4.044 5.474
9.4 PCS and RDC values used in Chapter 7
9.4.1 Figure 7.1
Table 9.18: PCS values (in ppm) for the Catalytic Domain of (Ln)MMP-1 complexed with THP, Figure
7.1.
Tb(II) Dy(III) Tm(III)
# Measured Calculated # Measured Calculated # Measured Calculated
108 -0.468 -0.465 108 -0.463 -0.443 108 0.517 0.497
112 -0.326 -0.322 109 -0.637 -0.623 110 0.609 0.568
113 -0.465 -0.460 112 -0.304 -0.331 112 0.454 0.423
114 -1.071 -1.066 113 -0.414 -0.423 113 0.645 0.615
115 -1.360 -1.388 114 -0.962 -1.009 115 1.648 1.660
145 0.021 0.028 115 -1.248 -1.249 116 2.906 2.791
155 -0.882 -0.857 155 -0.759 -0.788 143 0.203 0.210
157 -1.274 -1.242 157 -1.118 -1.155 150 2.307 2.384
166 -0.564 -0.579 160 -1.620 -1.670 152 2.721 2.848
170 -0.619 -0.612 166 -0.516 -0.494 155 1.006 0.982
174 -0.586 -0.588 170 -0.561 -0.564 156 0.957 0.943
176 -0.426 -0.414 174 -0.528 -0.514 157 1.464 1.432
178 -0.235 -0.196 176 -0.353 -0.366 158 1.657 1.610
179 -0.105 -0.084 178 -0.109 -0.159 159 2.202 2.122
180 -0.330 -0.345 179 -0.020 -0.025 166 0.637 0.663
190 -0.743 -0.766 180 -0.284 -0.276 169 0.601 0.622
191 -0.754 -0.771 190 -0.704 -0.682 170 0.694 0.681
192 -0.849 -0.850 191 -0.713 -0.687 178 0.298 0.318
202 -0.194 -0.211 192 -0.790 -0.772 180 0.396 0.427
193 -1.073 -1.023 188 0.974 1.011
199 -0.890 -0.927 190 0.853 0.874
255 -0.296 -0.346 191 0.842 0.865
192 0.954 0.951
210 0.005 0.016
232 -0.421 -0.439
255 -0.074 -0.130
256 0.040 0.134
261 0.030 0.072
Table 9.19: RDC values (in Hz) used to generate the plots of the Hemopexin-like Domain of (Ln)MMP-1
complexed with THP, Figure 7.1.
Tb(III) Dy(III) Tm(III)
# Measured Calculated # Measured Calculated # Measured Calculated
278 8.726 7.022 279 10.074 9.007 282 14.189 15.431
279 4.257 3.693 335 8.655 8.452 383 30.577 29.194
282 0.638 -2.858 383 -14.685 -14.980 415 -15.537 -15.790
295 -12.841 -11.174 406 4.469 4.720 434 -8.868 -10.262
335 -0.709 1.413 434 3.122 -0.658 441 -13.690 -11.811
340 12.699 14.954 435 -24.334 -24.174 443 13.196 10.142
347 3.263 5.352 439 0.922 2.124 446 -12.486 -15.422
384 0.993 2.542 441 3.973 4.782 448 -5.605 -4.746
401 -13.550 -10.071 446 5.463 6.953 453 -3.051 -3.348
406 4.540 7.406 447 -7.591 -4.222 457 -2.483 -0.775
434 12.060 12.381 448 3.902 3.587 463 8.797 10.276
435 -24.476 -25.507 457 1.845 1.386
446 6.314 5.964 458 3.547 2.500
452 -8.371 -7.740 460 20.999 21.415
457 8.726 6.580
458 6.811 3.571
459 -11.138 -9.892
460 1.632 0.661
9.4.2 Figure 7.3
Table 9.20: RDC values (in Hz) used to generate the plots of the Hemopexin-like Domain of (Ln)MMP-1
complexed with THP, Figure 7.1.
Tb(III) Dy(III) Tm(III)
res # Measured Calculated # Measured Calculated res # Measured Calculated
278 8.730 10.284 279 10.070 7.667 279 -10.640 -11.005
279 4.260 7.892 282 -8.020 -6.752 282 14.190 10.693
282 0.640 -3.735 335 8.650 9.593 383 30.580 28.766
294 6.600 3.774 374 5.750 4.539 384 -11.350 -13.001
295 -12.840 -17.216 383 -14.690 -17.496 386 -10.140 -9.292
340 12.700 14.007 384 1.770 -0.419 405 9.220 10.597
347 3.260 0.316 388 -5.960 -7.202 410 6.100 3.587
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370 -14.330 -13.143 406 4.470 2.939 415 -15.540 -19.435
374 6.600 8.161 407 5.670 6.710 434 -8.870 -15.143
384 0.990 2.196 410 -12.060 -14.036 441 -13.690 -16.121
401 -13.550 -14.361 423 7.660 4.322 443 13.200 11.442
406 4.540 6.134 429 3.690 3.103 446 -12.490 -13.509
407 8.650 9.060 434 3.120 -0.154 448 -5.610 -5.926
425 3.550 7.522 435 -24.330 -24.311 453 -3.050 -2.009
434 12.060 12.442 439 0.920 -0.888 457 -2.480 -5.307
435 -24.480 -25.599 441 3.970 4.747 463 8.800 12.058
436 0.990 1.427 446 5.460 3.532
446 6.310 8.809 448 3.900 2.662
448 -5.040 -6.518 456 8.580 6.889
452 -8.370 -8.535 457 1.840 -1.334
453 -1.130 -2.175 458 3.550 3.188
456 3.970 7.190 459 -5.820 -7.469
457 8.730 6.849 460 21.000 20.601
458 6.810 5.130
459 -11.140 -14.735
460 1.630 3.877
463 -8.730 -5.429
9.4.3 Figure 7.5
Table 9.21: PCS values (in ppm) used in the plot regarding the Catalytic domain, Figure 7.5
Tb(III) Dy(III) Tm(III)
# Measured Calculated # Measured Calculated # Measured Calculated
108 -0.468 -0.404 108 -0.443 -0.440 108 0.517 0.501
112 -0.326 -0.311 109 -0.623 -0.607 110 0.609 0.559
113 -0.465 -0.455 112 -0.331 -0.293 112 0.454 0.386
114 -1.071 -1.053 113 -0.423 -0.421 113 0.645 0.572
115 -1.360 -1.380 114 -1.009 -1.007 115 1.648 1.650
145 0.021 0.140 115 -1.249 -1.329 116 2.906 2.799
155 -0.882 -0.896 155 -0.788 -0.874 143 0.203 0.096
157 -1.274 -1.263 157 -1.155 -1.205 150 2.307 2.338
166 -0.564 -0.604 160 -1.670 -1.661 152 2.721 2.836
170 -0.619 -0.614 166 -0.494 -0.467 155 1.006 0.960
174 -0.586 -0.589 170 -0.564 -0.548 156 0.957 0.925
176 -0.426 -0.430 174 -0.514 -0.484 157 1.464 1.432
178 -0.235 -0.209 176 -0.366 -0.294 158 1.657 1.607
179 -0.105 -0.053 178 -0.159 -0.009 159 2.202 2.145
180 -0.330 -0.301 179 -0.025 0.053 166 0.637 0.690
190 -0.743 -0.750 180 -0.276 -0.214 169 0.601 0.638
191 -0.754 -0.753 190 -0.682 -0.725 170 0.694 0.701
192 -0.849 -0.819 191 -0.687 -0.722 178 0.298 0.371
202 -0.194 -0.318 192 -0.772 -0.796 180 0.396 0.481
193 -1.023 -1.063 188 0.974 1.034
199 -0.927 -0.806 190 0.853 0.881
255 -0.346 -0.234 191 0.842 0.882
192 0.954 0.972
210 0.005 0.106
232 -0.421 -0.365
255 -0.074 -0.085
256 0.040 0.185
261 0.030 0.060
Table 9.22: PCS values (in ppm) used in the plot regarding the Hemopexin-like domain, Figure 7.5.
Tb(III) Dy(III) Tm(III)
# Measured Calculated # Measured Calculated # Measured Calculated
279 0.238 0.315 279 0.206 0.189 279 -0.279 -0.293
282 0.278 0.307 282 0.206 0.170 282 -0.296 -0.309
335 0.197 0.209 284 0.273 0.201 335 -0.170 -0.175
337 0.214 0.188 332 0.309 0.266 370 0.092 0.065
347 0.056 0.123 335 0.199 0.205 383 -0.104 -0.095
364 -0.017 0.022 370 -0.020 -0.036 384 -0.113 -0.096
370 -0.035 -0.030 374 -0.141 -0.162 388 -0.083 -0.073
374 -0.152 -0.146 383 0.146 0.101 392 -0.078 -0.075
383 0.154 0.116 384 0.116 0.100 400 -0.046 -0.043
384 0.124 0.115 385 0.113 0.095 401 -0.024 -0.030
385 0.125 0.104 388 0.090 0.083 405 -0.019 -0.042
386 0.065 0.101 392 0.117 0.057 406 -0.010 -0.025
388 0.098 0.092 400 0.038 0.051 407 0.009 0.010
392 0.093 0.095 401 0.074 0.045 410 -0.052 0.033
393 0.019 0.027 405 0.074 0.066 411 0.034 0.036
400 0.030 0.065 406 0.065 0.047 415 0.010 -0.008
401 0.041 0.051 407 0.018 0.009 434 -0.098 -0.109
405 0.013 0.064 410 0.042 -0.025 441 -0.230 -0.213
406 0.051 0.047 415 0.037 -0.022 446 -0.096 -0.105
407 0.007 0.012 432 0.148 0.120 447 -0.125 -0.100
410 0.029 -0.019 434 0.115 0.107 448 -0.075 -0.072
415 0.014 0.007 435 0.107 0.101 451 -0.028 -0.056
425 0.069 0.056 436 0.095 0.081 453 -0.048 -0.057
434 0.131 0.127 439 0.147 0.114 456 -0.088 -0.092
435 0.111 0.124 441 0.163 0.107 457 -0.087 -0.099
436 0.097 0.110 445 0.113 0.085 458 -0.115 -0.127
441 0.163 0.207 446 0.090 0.071 463 -0.231 -0.195
445 0.106 0.138 447 0.099 0.072
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446 0.081 0.111 448 0.068 0.052
447 0.103 0.108 451 0.061 0.044
448 0.069 0.079 453 0.059 0.039
452 0.016 0.060 455 0.093 0.056
453 0.067 0.062 456 0.086 0.063
456 0.086 0.097 457 0.068 0.061
457 0.075 0.101 458 0.121 0.082
459 0.143 0.162 459 0.119 0.100
460 0.170 0.202 460 0.147 0.120
Table 9.23: RDC values (in Hz) used in the plot regarding the Hemopexin-like domain, Figure 7.5.
Tb(III) Dy(III) Tm(III)
# Measured Calculated # Measured Calculated # Measured Calculated
278 8.730 8.203 279 10.070 6.677 279 -10.640 -12.363
279 4.260 7.195 282 -8.020 -8.159 282 14.190 9.810
282 0.640 -3.608 335 8.650 7.375 383 30.580 27.794
294 6.600 3.575 374 5.750 8.391 384 -11.350 -11.868
295 -12.840 -16.600 383 -14.690 -20.121 386 -10.140 -8.830
340 12.700 13.167 384 1.770 -1.441 405 9.220 9.268
347 3.260 -2.026 388 -5.960 -8.600 410 6.100 5.542
370 -14.330 -14.041 406 4.470 2.164 415 -15.540 -20.027
374 6.600 5.872 407 5.670 6.017 434 -8.870 -13.473
384 0.990 2.416 410 -12.060 -13.786 441 -13.690 -16.461
401 -13.550 -13.165 423 7.660 6.867 443 13.200 10.941
406 4.540 6.948 429 3.690 3.064 446 -12.490 -14.130
407 8.650 10.103 434 3.120 4.012 448 -5.610 -5.504
425 3.550 7.029 435 -24.330 -24.429 453 -3.050 -2.213
434 12.060 11.252 439 0.920 -1.488 457 -2.480 -5.923
435 -24.480 -25.679 441 3.970 3.611 463 8.800 11.723
436 0.990 0.755 446 5.460 2.600
446 6.310 8.345 448 3.900 -1.335
448 -5.040 -4.315 456 8.580 4.869
452 -8.370 -5.703 457 1.840 -1.663
453 -1.130 1.260 458 3.550 2.820
456 3.970 7.690 459 -5.820 -11.277
457 8.730 6.018 460 21.000 15.533
458 6.810 3.904
459 -11.140 -13.089
460 1.630 7.117
463 -8.730 -4.267
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Table 9.24: PCS values (in ppm) from the Catalytic Domain used for the plots of Figure 7.9.
Tb(III) Dy(III) Tm(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
108 -0.468 -0.404 108 -0.443 -0.440 108 0.517 0.501
112 -0.326 -0.311 109 -0.623 -0.607 110 0.609 0.559
113 -0.465 -0.455 112 -0.331 -0.293 112 0.454 0.386
114 -1.071 -1.053 113 -0.423 -0.421 113 0.645 0.572
115 -1.360 -1.380 114 -1.009 -1.007 115 1.648 1.650
145 0.021 0.140 115 -1.249 -1.329 116 2.906 2.799
155 -0.882 -0.896 155 -0.788 -0.874 143 0.203 0.096
157 -1.274 -1.263 157 -1.155 -1.205 150 2.307 2.338
166 -0.564 -0.604 160 -1.670 -1.661 152 2.721 2.836
170 -0.619 -0.614 166 -0.494 -0.467 155 1.006 0.960
174 -0.586 -0.589 170 -0.564 -0.548 156 0.957 0.925
176 -0.426 -0.430 174 -0.514 -0.484 157 1.464 1.432
178 -0.235 -0.209 176 -0.366 -0.294 158 1.657 1.607
179 -0.105 -0.053 178 -0.159 -0.009 159 2.202 2.145
180 -0.330 -0.301 179 -0.025 0.053 166 0.637 0.690
190 -0.743 -0.750 180 -0.276 -0.214 169 0.601 0.638
191 -0.754 -0.753 190 -0.682 -0.725 170 0.694 0.701
192 -0.849 -0.819 191 -0.687 -0.722 178 0.298 0.371
202 -0.194 -0.318 192 -0.772 -0.796 180 0.396 0.481
193 -1.023 -1.063 188 0.974 1.034
199 -0.927 -0.806 190 0.853 0.881
255 -0.346 -0.234 191 0.842 0.882
192 0.954 0.972
210 0.005 0.106
232 -0.421 -0.365
255 -0.074 -0.085
256 0.040 0.185
261 0.030 0.060
Table 9.25: PCS values (in ppm) from the Hemopexin Domain used for the plots of Figure 7.9.
Tb(III) Dy(III) Tm(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
279 0.238 0.315 279 0.206 0.189 279 -0.279 -0.293
282 0.278 0.307 282 0.206 0.170 282 -0.296 -0.309
335 0.197 0.209 284 0.273 0.201 335 -0.170 -0.175
337 0.214 0.188 332 0.309 0.266 370 0.092 0.065
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347 0.056 0.123 335 0.199 0.205 383 -0.104 -0.095
364 -0.017 0.022 370 -0.020 -0.036 384 -0.113 -0.096
370 -0.035 -0.030 374 -0.141 -0.162 388 -0.083 -0.073
374 -0.152 -0.146 383 0.146 0.101 392 -0.078 -0.075
383 0.154 0.116 384 0.116 0.100 400 -0.046 -0.043
384 0.124 0.115 385 0.113 0.095 401 -0.024 -0.030
385 0.125 0.104 388 0.090 0.083 405 -0.019 -0.042
386 0.065 0.101 392 0.117 0.057 406 -0.010 -0.025
388 0.098 0.092 400 0.038 0.051 407 0.009 0.010
392 0.093 0.095 401 0.074 0.045 410 -0.052 0.033
393 0.019 0.027 405 0.074 0.066 411 0.034 0.036
400 0.030 0.065 406 0.065 0.047 415 0.010 -0.008
401 0.041 0.051 407 0.018 0.009 434 -0.098 -0.109
405 0.013 0.064 410 0.042 -0.025 441 -0.230 -0.213
406 0.051 0.047 415 0.037 -0.022 446 -0.096 -0.105
407 0.007 0.012 432 0.148 0.120 447 -0.125 -0.100
410 0.029 -0.019 434 0.115 0.107 448 -0.075 -0.072
415 0.014 0.007 435 0.107 0.101 451 -0.028 -0.056
425 0.069 0.056 436 0.095 0.081 453 -0.048 -0.057
434 0.131 0.127 439 0.147 0.114 456 -0.088 -0.092
435 0.111 0.124 441 0.163 0.107 457 -0.087 -0.099
436 0.097 0.110 445 0.113 0.085 458 -0.115 -0.127
441 0.163 0.207 446 0.090 0.071 463 -0.231 -0.195
445 0.106 0.138 447 0.099 0.072
446 0.081 0.111 448 0.068 0.052
447 0.103 0.108 451 0.061 0.044
448 0.069 0.079 453 0.059 0.039
452 0.016 0.060 455 0.093 0.056
453 0.067 0.062 456 0.086 0.063
456 0.086 0.097 457 0.068 0.061
457 0.075 0.101 458 0.121 0.082
459 0.143 0.162 459 0.119 0.100
460 0.170 0.202 460 0.147 0.120
Table 9.26: RDC values (in Hz) from the Hemopexin Domain used for the plots of Figure 7.9.
Tb(III) Dy(III) Tm(III)
res # Measured Calculated res # Measured Calculated res # Measured Calculated
278 8.730 8.203 279 10.070 6.677 279 -10.640 -12.363
279 4.260 7.195 282 -8.020 -8.159 282 14.190 9.810
282 0.640 -3.608 335 8.650 7.375 383 30.580 27.794
294 6.600 3.575 374 5.750 8.391 384 -11.350 -11.868
295 -12.840 -16.600 383 -14.690 -20.121 386 -10.140 -8.830
340 12.700 13.167 384 1.770 -1.441 405 9.220 9.268
347 3.260 -2.026 388 -5.960 -8.600 410 6.100 5.542
370 -14.330 -14.041 406 4.470 2.164 415 -15.540 -20.027
374 6.600 5.872 407 5.670 6.017 434 -8.870 -13.473
384 0.990 2.416 410 -12.060 -13.786 441 -13.690 -16.461
401 -13.550 -13.165 423 7.660 6.867 443 13.200 10.941
406 4.540 6.948 429 3.690 3.064 446 -12.490 -14.130
407 8.650 10.103 434 3.120 4.012 448 -5.610 -5.504
425 3.550 7.029 435 -24.330 -24.429 453 -3.050 -2.213
434 12.060 11.252 439 0.920 -1.488 457 -2.480 -5.923
435 -24.480 -25.679 441 3.970 3.611 463 8.800 11.723
436 0.990 0.755 446 5.460 2.600
446 6.310 8.345 448 3.900 -1.335
448 -5.040 -4.315 456 8.580 4.869
452 -8.370 -5.703 457 1.840 -1.663
453 -1.130 1.260 458 3.550 2.820
456 3.970 7.690 459 -5.820 -11.277
457 8.730 6.018 460 21.000 15.533
458 6.810 3.904
459 -11.140 -13.089
460 1.630 7.117
463 -8.730 -4.267
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9.5 Spectra of (Ln)CatMMP-1
9.5.1 1H-15N HSQC spectra for the different Ln(III) ions
Figure 9.1: 1H-15N HSQC spectrum of (Lu)CatMMP-1 at 500 MHz.
Figure 9.2: 1H-15N HSQC spectrum of (Tb)CatMMP-1 at 500 MHz.
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Figure 9.3: 1H-15N HSQC spectrum of (Dy)CatMMP-1 at 500 MHz.
Figure 9.4: 1H-15N HSQC spectrum of (Tm)CatMMP-1 at 500 MHz.
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Figure 9.5: 1H-15N HSQC spectrum of (Yb)CatMMP-1 at 500 MHz.
9.5.2 IPAP-[15N, 1H]-HSQC spectra for the different Ln(III) ions
Figure 9.6: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Lu)CatMMP-1 at
700 MHz.
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Figure 9.7: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrumof (Lu)CatMMP-1 at 700
MHz.
Figure 9.8: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Tb)CatMMP-1 at
700 MHz.
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Figure 9.9: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrumof (Tb)CatMMP-1 at 700
MHz.
Figure 9.10: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Dy)CatMMP-1
at 700 MHz.
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Figure 9.11: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Dy)CatMMP-1 at
700 MHz.
Figure 9.12: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Tm)CatMMP-1
at 700 MHz.
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Figure 9.13: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Tm)CatMMP-1 at
700 MHz.
Figure 9.14: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Lu)CatMMP-1
at 900 MHz.
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Figure 9.15: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Lu)CatMMP-1 at
900 MHz.
Figure 9.16: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Yb)CatMMP-1
at 900 MHz.
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Figure 9.17: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Yb)CatMMP-1 at
900 MHz.
9.6 Spectra of the (Ln)MMP-1 full length
9.6.1 1H-15N HSQC spectra for the different Ln(III) ions
Figure 9.18: 1H-15N HSQC spectrum of (Lu)MMP-1 full length at 700 MHz.
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Figure 9.19: 1H-15N HSQC spectrum of (Tb)MMP-1 full length at 700 MHz.
Figure 9.20: 1H-15N HSQC spectrum of (Dy)MMP-1 full length at 700 MHz.
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Figure 9.21: 1H-15N HSQC spectrum of (Tm)MMP-1 full length at 700 MHz.
9.6.2 IPAP-[1H-15N]-HSQC spectra for the different Ln(III) ions
Figure 9.22: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Lu)MMP-1 full
length at 700 MHz.
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Figure 9.23: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Lu)MMP-1 full
length at 700 MHz.
Figure 9.24: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Tb)MMP-1 full
length at 700 MHz.
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Figure 9.25: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Tb)MMP-1 full
length at 700 MHz.
Figure 9.26: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Dy)MMP-1 full
length at 700 MHz.
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Figure 9.27: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Dy)MMP-1 full
length at 700 MHz.
Figure 9.28: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Tm)MMP-1 full
length at 700 MHz.
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Figure 9.29: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of (Tm)MMP-1 full
length at 700 MHz.
9.7 Spectra of the (Ln)MMP-1·THP interaction
9.7.1 1H-15N HSQC spectra for the different Ln(III) ions
Figure 9.30: 1H-15N HSQC spectrum of the (Lu)MMP-1·THP interaction at 700 MHz.
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Figure 9.31: 1H-15N HSQC spectrum of the (Tb)MMP-1·THP interaction at 700 MHz.
Figure 9.32: 1H-15N HSQC spectrum of the (Dy)MMP-1·THP interaction at 700 MHz.
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Figure 9.33: 1H-15N HSQC spectrum of the (Tm)MMP-1·THP interaction at 700 MHz.
9.7.2 IPAP-[1H-15N]-HSQC spectra for the different Ln(III) ions
Figure 9.34: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of the (Lu)MMP-
1·THP interaction at 700 MHz.
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Figure 9.35: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of the (Lu)MMP-1·THP
interaction at 700 MHz.
Figure 9.36: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of the (Tb)MMP-
1·THP interaction at 700 MHz.
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Figure 9.37: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of the (Tb)MMP-
1·THP interaction at 700 MHz.
Figure 9.38: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrumof the (Tb)MMP-1·THP
interaction at 700 MHz.
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Figure 9.39: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of the (Dy)MMP-
1·THP interaction at 700 MHz.
Figure 9.40: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrumof the (Dy)MMP-1·THP
interaction at 700 MHz.
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Figure 9.41: Downfield doublet components of the IPAP-[15N, 1H]-HSQC spectrum of the (Tm)MMP-
1·THP interaction at 700 MHz.
Figure 9.42: Upfield doublet components of the IPAP-[15N, 1H]-HSQC spectrumof the (Tm)MMP-1·THP
interaction at 700 MHz.
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